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Heat s hock pr oteins o f 70kDa ( Hsp70s) a nd their J  dom ain-containing H sp40 c ofactors a re 
conserved chaperone pairs that facilitate diverse cellular processes. One essential Hsp70 in the 
endoplasmic r eticulum ( ER) lum en, BiP (Kar2p i n yeast), participates i n polypeptide 
translocation into the ER, protein f olding, a nd ER-associated de gradation ( ERAD). Like ot her 
Hsp70s, BiP cont ains an  N -terminal A TPase do main, f ollowed b y a s ubstrate bi nding dom ain 
and a C-terminal lid domain. To better define how substrate affinity and Hsp40 interaction affect 
BiP f unction, I constructed and characterized a mutation, R 217A, i n t he put ative J  dom ain-
interacting surface of yeast BiP. The mutation compromises ATPase stimulation by Sec63p, an 
Hsp40 required for t ranslocation, but  stimulation by J em1p, an Hsp40 required for E RAD, is 
robust. In accordance with these data, yeast expressing R217A BiP exhibit translocation defects, 
but no E RAD defects, and a genetic interaction study using this mutant yielded data consistent 
with defects in translocation. In contrast, mutations in the substrate binding domain that e ither 
disrupt an ionic contact with the lid or remove this domain are deficient for peptide-stimulated 
ATPase activity. Expression of these mutants in yeast results in varying translocation and ERAD 
defects. Taken together, t hese d ata i ndicate t hat B iP can distinguish between its E R-resident 
cochaperones, and that optimal substrate binding is a key determinant of BiP function. 
 Next, I te sted the h ypothesis tha t the  f unctional s pecificity of  Hsp70s i s r egulated by 
cognate Hsp40s. If this is t rue, one might expect divergent Hsp70-Hsp40 pairs to be unable to 
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 v 
function in vivo. H owever, I discovered that a mammalian ER-lumenal Hsp40, E Rdj3, w hen 
directed to the yeast cytosol, was able to rescue the temperature-sensitive growth phenotype of  
yeast c ontaining mutant a lleles in two cytosolic H sp40s, HLJ1 and YDJ1. M oreover, E Rdj3 
activated the ATPase activity of Ssa1p, the yeast cytosolic Hsp70 that partners with Hlj1p and 
Ydj1p. Intriguingly, ERdj3 mutants that were compromised for substrate binding were unable to 
rescue t he hlj1ydj1 growth defect, even t hough t hey stimulated Ssa1p ATPase act ivity. These 
data suggest that the substrate binding properties of certain Hsp40s—not simply the formation of 
unique Hsp70-Hsp40 pairs—is critical to specify in vivo function. 
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1.0  INTRODUCTION 
The environment w ithin a c ell is  c hemically complex and c rowded, with macromolecular 
structures occupying 20-40% of the total volume16, 17. It is in such an environment that proteins 
have t o fold i nto their functional three-dimensional conformations. While small s ingle domain 
proteins ( <100 a mino a cids) f old de novo on a  s ub-second time s cale, larger mul tidomain 
proteins require protracted folding periods8. This is due to the observation that the folding energy 
landscape o f a longer p olypeptide chain contains s everal off-pathway n on-native int ermediate 
states in addition to the lowest energy state corresponding to the native conformation8 (Figure 1). 
Therefore, a larger protein might ‘sample’ several states before it reaches its native conformation 
or a lternately, might te rminally r eside in an intermediate non -native s tate ( ‘misfolded’ s tate). 
One c onsequence of  t his phe nomenon i s t he formation of  t oxic pr otein a ggregates w ithin t he 
cell18. Not surprisingly, several human di seases can be  correlated t o p rotein misfolding and/or 
aggregation, i ncluding cystic f ibrosis, antitrypsin deficiency and pr otein a ggregation di seases 
such as Huntington’s, Parkinson’s, Alzheimer’s and prion-associated diseases.   
Apart f rom i naccuracies dur ing de novo protein f olding, m isfolding c an a rise due  t o 
stochastic va riations in the c hemical environment of  the  c ell, spontaneous e rrors i n cellular 
processes such as transcription and translation, genetic mutations, environmental stresses such as 
elevated temperature and osmotic stress, toxic compounds, and defects in oligomeric assembly. 
 2 
Figure 1: A schematic depiction of the folding energy landscape of a polypeptide 
chain. 
 The unf olded s tate of  a  pr otein i s the hi ghest e nergy s tate a nd i s c omprised of  s everal 
conformations which are shown on t he surface of  the ‘ funnel’. As a  protein folds into i ts na tive 
conformation via intramolecular contacts, it passes through intermediate states as well as partially 
folded s tates; e ach o f t hese f orm e nergy t raps a nd a  pr otein m ight r equire t he a ssistance of  
molecular chaperones t o r evert t o t he correct folding pa th. A lternately, a  protein might begin t o 
acquire i ntermolecular c ontacts t o f orm hom o-oligomers, he terogeneous a ggregates, or  a myloid 
fibrils; the exact mechanism by which this occurs is  s till unclear. It is  important to note that the 
structures of most intermediate states are unknown. 
 The figure was adapted from Jahn and Radford, 20058. 
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To prevent misfolding-induced toxicity, cells have developed several quality control mechanisms 
to monitor protein folding, and in the case of terminal misfolding, to rapidly turn over the toxic 
species19, 20. One such preventive measure is the stress induction of a class of proteins called heat 
shock proteins (Hsps). 
1.1 HEAT SHOCK PROTEINS 
Hsps constitute a unique family of molecular chaperones that is found in all living organisms and 
in every subcellular or ganelle. They w ere i nitially classified according to molecular m ass i nto 
Hsps of  70kD a, i.e., Hsp70s, H sps of  40 kD a, i.e., Hsp40s, a nd s o f orth. S ubsequently, as 
additional H sps w ere i dentified, t hey w ere s orted i nto a  p articular s ubfamily p redominantly 
based on their s tructural a nd functional s imilarity, not  n ecessarily mol ecular ma ss. A s econd 
distinction w as m ade b etween t he i nducible Hsps a nd t he constitutively expressed H scs; 
however, be cause t he H sps a nd H scs a re ne arly i ndistinguishable at  t he l evels of  am ino acid 
sequence and biochemical properties, the term Hsp in this dissertation will encompass all family 
members. 
Hsp70s, Hsp40s and Hsp90s are some of the most abundant proteins in the cell (refer to 
Table 1 for a l ist of  s elect m embers) and a long w ith pl aying a  r ole i n protein f olding, t hey 
participate i n ke y s ignal t ransduction pa thways21, 2 2, a ssembly o f mul ti-protein c omplexes23-25, 
resolution of protein aggregates26, protein translocation across membranes24, 27, 28, endocytosis29, 
protection a gainst a poptosis30, 31, a nd i mportantly, t he r ecognition a nd t argeting of  m isfolded 
proteins for degradation5, 32, 33. In the specific case of the Hsp70s and Hsp40s, where Hsp40s can 
act as cochaperones for Hsp70s, 3 Hsp70s and 6 Hsp40s have been characterized in bacterial  
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Table 1: Hsp90s, Hsp70s, Hsp70-like proteins and select Hsp70 co-factors found in 
the ER and cytosol   
 
Component  Location  Yeast  Mammals  
Hsp90 
 
ER 
 
Cytosol 
- 
 
Hsp82 
GRP94 
 
Hsp90α, Hsp90β 
Hsp70 ER 
 
Cytosol  
BiP/Kar2p 
 
Ssa1-4p, Ssb1-2p  
BiP/GRP78 
 
Hsc70, Hsp70-1, Hsp70-2, 
Hsp70-3  
Hsp70-homologous 
nucleotide exchange factors  
ER 
 
Cytosol  
Lhs1p 
 
Sse1p  
GRP170 
 
HSP110 
Other Nucleotide Exchange 
Factors  
ER 
 
Cytosol  
Sls1p/Sil1p 
 
Fes1p, Snl1p 
SIL1, BAP 
 
BAG1–2, HSPBP1 
Hsp40  ER 
 
 
 
 
Cytosol  
Sec63p, Scj1p and Jem1p 
 
 
 
Apj1p, Djp1p, Jjj1p, Jjj2p, Jjj3p, 
Sis1p, Swa2p, Xdj1p, Ydj1p, 
Zuo1p. Cwc23p, Hlj1p, Caj1p 
ERj1, ERj2/SEC63, ERdj3, 
ERdj4, ERdj5, ERj6/p58
IPK
  
 
 
HDJ1–2, HSJ1, DNJ3, Dj4, 
Djb4/HLJ1, MPP11, HSPF1, 
CSP, Auxilin 
Other interacting proteins 
 
Lectin-like chaperones 
 
 
 
Protein Disulfide Isomerase  
 
 
ER 
 
ER  
 
ER 
 
 
Cne1p/calnexin  
 
Yos9p 
 
Eps1p and Pdi1p  
 
 
Calnexin, Calreticulin  
 
OS-9, XTBP3-B 
 
PDI, ERp57, ERp72, ERdj5  
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cells, 14 Hsp70s and 22 Hsp40s in the budding yeast Saccharomyces cerevisiae, and 20 Hsp70s 
and > 50 H sp40s i n hum ans. T herefore, H sp70s a nd H sp40s a ppear t o be  r equired f or m ore 
complex processes in higher eukaryotes and consequently, the intricacy of their interactions also 
increases. 
A de fined or ganelle t o s tudy t he i nteractions be tween H sp70s a nd Hsp40s i s t he 
endoplasmic r eticulum ( ER). T he E R of  yeast a nd m ammals c ontains one  H sp70, t he 
immunoglobulin heavy chain binding protein, BiP34, 35. BiP is also referred to as Kar2p in yeast 
due t o i ts i dentification i n a  genetic s creen f or m utants de fective f or nuclear f usion dur ing 
mating, i.e., karyogamy36-38, and glucose regulated protein of 78 kDa, GRP78, in humans, due to 
its induction by low serum glucose levels39, 4 0. Additionally, the yeast ER contains three well-
characterized Hsp40s, S ec63p, J em1p and Scj1p ( refer t o s ection 1.2.2) , and possibly a f ourth 
poorly-characterized Hsp40, ERj541, while the mammlian ER harbors six Hsp40s: MTJ1/ERj142, 
SEC63/ERj243, 4 4, HEDJ/ERj3/ERdj345-47, E Rdj448, 4 9, E Rdj550, 5 1 and p58 IPK/ERj652-54. For t he 
remainder of this chapter, I will discuss the multitude of functions performed by BiP in the ER, 
with an emphasis on its interactions with resident Hsp40 cochaperones. 
1.2 BIP IS AN ER LUMENAL HSP70 
A ba cterial H sp70, D naK, a nd i ts c ognate Hsp40, D naJ, w ere a mongst t he f irst H sp70s a nd 
Hsp40s discovered, due to their roles in bacteriophage lambda DNA replication55-57. Subsequent 
experiments s howed t hat D naK m odulates t he he at s hock r esponse i n Escherichia coli58. As 
eukaryotic homologs began to be identified in the late 1970s and early 1980s, Munro and Pelham 
determined that E R-lumenal B iP34 and G RP7839, 40  were, in f act, t he s ame pr otein, a nd t hat 
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BiP/GRP78 be longed t o t he H sp70 s ubfamily of  m olecular c haperones; t his w as t he f irst 
identification of  a  eukaryotic ER chaperone35. It was i n 1989 t hat the laboratories of  Rose and 
Sambrook independently established the identity of BiP in yeast and showed that the essential 
gene r equired f or ka ryogamy, KAR236, e ncoded t he yeast B iP hom olog36-38. S ince t hen, 
remarkable progress has been made toward understanding BiP functions and I describe a number 
of these below. Moreover, the discovery of non-Hsp40 cofactors that interact with BiP, and the 
correlation of  B iP d ysfunction t o i mportant h uman di seases, ha ve ope ned up s everal ne w 
avenues of investigation with regard to this critical regulator of ER homeostasis. 
1.2.1 Insights from Hsp70 structural studies 
Hsp70s typically contain a ~44 kDa highly conserved N-terminal ATPase domain, followed by a 
less c onserved ~ 18 kD a s ubstrate bi nding do main, a nd a  ~ 10 k Da variable C -terminal lid 
domain24, 31, 59-62. In the ATP-bound state, the ‘open’ conformation adopted by the Hsp70s results 
in low affinity and high release rates for substrates. The energy derived f rom subsequent ATP 
hydrolysis is utilized to drive a conformational change in the Hsp70s such that in the resulting 
ADP-bound ‘ closed’ c onformation, t he H sp70s exhibit hi gh a ffinity and l ow r elease r ates f or 
substrates. Thus, through multiple cycles of ATP hydrolysis-driven substrate binding and release, 
Hps70s participate in protein folding by providing a protected environment for their substrates 
and preventing aggregation.  
However, Hsp70s are poor ATPases, with specific activities in the range of 15-20 nmol 
ATP hydrolyzed/mg/min63, 64  (as compared to strong ATPases such as m yosin that exhibits an 
activity of  200 -600 nm ol A TP h ydrolyzed/mg/min65). Therefore, two classes of  cof actors 
activate the Hsp70 ATP hydrolysis cycle (Figure 2): J domain-containing Hsp40s and  
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Figure 2: Hsp70 ATP hydrolysis cycle 
 The ATPase domain of the Hsp70 is depicted in orange, the substrate binding domain in 
red and the l id domain in pink. Binding of ATP in the nucleotide-binding pocket of the ATPase 
domain results in an Hsp70 conformation that exhibits low substrate affinity due to an ‘open’ lid 
domain. The interaction with a J  domain-containing Hsp40, a polypeptide substrate, or a Hsp40-
substrate c omplex, c an s timulate t he A TPase a ctivity o f t he H sp70 t o generate a hi gh s ubstrate 
affinity A DP-bound c onformation. In t his s tate, t he l id dom ain i s ‘ closed’ a nd e ncloses t he 
substrate in the hydrophobic pocket of  the substrate binding domain. The subsequent binding of  
NEFs to the ATPase domain engenders the exchange of ADP for ATP, and in the resultant ATP-
bound c onformation, t he s ubstrate i s r eleased. T herefore, t hrough m ultiple c ycles of  A TP 
hydrolysis, the Hsp70 can assist in substrate folding. 
 The figure was adapted from Vembar and Brodsky, 20085. 
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Nucleotide E xchange F actors ( NEFs). H sp40s interact w ith t he A TPase dom ain of  H ps70s 
through the highly conserved J domain (usually found at the N-terminus of Hsp40s) and promote 
ATP h ydrolysis66; s ome H sp40s a lso ha ve t he ability t o bi nd t o H sp70 s ubstrates vi a a  C -
terminal substrate binding domain and deliver them to Hsp70s67, 68. In contrast, the NEFs release 
ADP, which allows for ATP binding, and act synergistically with the Hsp40s to stimulate Hsp70 
ATP h ydrolysis24. Finally, substrate int eraction can stimulate Hsp70 ATPase activity69, 7 0. Not 
surprisingly, the ATP h ydrolysis r ates of  Hsp70s a re m aximally s timulated in the c ollective 
presence of the Hsp40s, NEFs and peptide substrates.  
The first Hsp70-derived crystal structure was for the isolated ATPase domain of bovine 
Hsc70, crystallized in the presence of ATP1 (Figure 3A). The ATPase domain is predominantly 
α-helical and can be sub-divided into two lobes, I and II, with a deep cleft in between them; each 
lobe is further composed of sub-domains a and b. Due to the presence of the bound nucleotide in 
the structure, the key residues that participate in nucleotide binding were mapped to the base of 
the cl eft be tween s ubdomains Ia and IIa. S ubsequent m utagenesis s tudies i n va rious H sp70s 
established t he essentiality of  t hese residues for f unction24, 7 1-75. S urprisingly, t he t ertiary 
structure of  the nucleotide-binding pocket resembled the ATP and substrate binding regions of  
hexokinase1, e ven t hough t he s tructure a dopted by t he r emainder o f t he A TPase dom ain w as 
closer t o that of  actin1. However, the s imilarities to hexokinase s uggested that the  ATPase 
domain of  Hsp70s might undergo a  substantial conformational change upon ATP hydrolysis76. 
For example, this conformational change might occur in the presence of a substrate or an Hsp40, 
which c ould t hen be  t ransmitted t o t he s ubstrate bi nding dom ain t o e nable s ubstrate bi nding. 
Importantly, this finding supported previous limited proteolysis studies that indicated that Hsp70 
function may be allosterically regulated77. 
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Figure 3: Crystal structures of isolated Hsp70 domains. 
 (A) The crystal structure of the ATPase domain of Bos taurus Hsc70 (Protein Data Bank 
ID: 3HSC) was solved at 2.2 Å  resolution in the presence of  ATP (not shown)1. The ATPase 
domain i s pr edominantly α-helical a nd consists of  t wo l obes, I and II, t hat c an be  further 
divided i nto s ubdomains a  a nd b. (B) The crystal s tructure of  t he substrate bi nding and l id 
domains of  Escherichia coli DnaK (Protein Data B ank ID: 1 DKZ) was solved a t 2.0 Å  
resolution i n t he pr esence of  t he pe ptide N RLLLTG9. The s ubstrate bi nding dom ain i s 
comprised of a β-sandwich structure followed by two α-helices. The lid domain terminates as 
an α-helical bundle. The peptide binds in an extended conformation to a  hydrophobic cleft in 
the β-sandwich of the substrate binding domain. 
The structures were generated using RasMol11. 
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 Next, the cr ystal s tructure of  t he C -terminal por tion of  ba cterial D naK (including t he 
substrate binding domain and a part of the lid domain), was solved in the presence of the peptide 
NRLLLTG9 (Figure 3B). The structure showed that the substrate binding domain was composed 
of a β sandwich f ollowed b y an α-helical bund le, w hile t he l id dom ain w as c omposed of  α-
helices. A hydrophobic pocket formed by the β sandwich directly bound to the peptide (which 
was present in an extended conformation) through numerous van der Waals interactions, while 
the α-helical po rtion di d not  c ontact t he pe ptide; i nstead, t his por tion l atched ont o t he 
β sandwich to capture the peptide. Moreover, the linker region between the ATPase and substrate 
binding dom ains r emained e xposed t o s olvent a nd t herefore, w as not  o rdered i n t he c rystal. 
Based on a second crystal structure in which the α-helical portion appeared to be more mobile, 
the authors concluded that this mobility might be essential for the substrate to thread in and out 
of the β sandwich. Given these structural features, it is not surprising that the β sandwich portion 
of the Hsp70 substrate b inding domain has a  higher degree of  sequence conservation amongst 
family members as compared to the α-helical portion. 
In spite of the early structural resolution of individual Hsp70 domains, efforts to resolve 
the structure of a full-length Hsp70 have remained largely unsuccessful, probably because of the 
inherent f lexibility o f t he va rious Hsp70 dom ains24. Instead, s everal s tudies have used nuc lear 
magnetic r esonance ( NMR) and/ or di rected mutagenesis t o designate s imilarities be tween the 
nucleotide-bound a nd n ucleotide-free s tates of  full-length H sp70s, a s well a s t o i dentify t he 
residues required for inter-domain communication78-81. Based on t hese efforts, the inter-domain 
linker appears to be a key regulator of Hsp70 allostery. In the ATP-bound state, the linker binds 
in a  h ydrophobic c left t hat i s pr esent be tween s ub-domains Ia a nd IIa o f t he A TPase dom ain. 
This induces a conformational change in each Hsp70 domain such that the molecule as a whole 
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is com pact and has w eakened s ubstrate bi nding. T he A TP-bound state i s t herefore a s tate i n 
which the Hsp70 molecule i s l ess accessible t o pr oteolytic cleavage. In t he A DP-bound a nd 
nucleotide-free states, the linker is disordered and results in a conformation in which the ATPase 
and substrate binding domains are disjointed and can act independently of each other. In addition 
to the int er-domain l inker, a  uni versally c onserved P  r esidue ( P143 i n DnaK) i n t he A TPase 
domain r egulates Hsp70 a llostery81. T he P  i s not  onl y essential t o s tabilize t he ope n 
conformation of the peptide binding pocket, but it also relays the change in the nucleotide-bound 
state of  t he A TPase dom ain t o t he s ubstrate bi nding dom ain t hrough a n i nvariant R  ( R151 i n 
DnaK) 81. Lastly, m utagenesis s tudies ha ve a lso i dentified t he r esidues t hat a re r equired f or 
interactions between the lid and substrate binding domains and their contribution to inter-domain 
communication82, 83.  
More recently, the crystallization of  60 kD a t runcation mutants of  bovine Hsc70 in the 
nucleotide-free state7 (Figure 4A) and rat Hsc70 in the ADP-bound state12 (Figure 4B) have lent 
support to models that depict the mechanism for inter-domain communication. The structure of 
the bovi ne H sc70 t runcation s upports t he obs ervation t hat t he l inker r egion i s required f or 
communication, a nd e xtensive m utagenesis s tudies of  t his r egion i dentified select r esidues 
required for Hsp70 function. On the other hand, the structure of the rat Hsc70 truncation supports 
the model in which the ATPase and substrate binding domains are disjointed in the ADP-bound 
state, and also provides evidence for the supposition that substrate binding can induce a similar 
change. Finally, the cr ystal s tructure of  full-length ATP-bound Sse1p14, a  yeast Hsp110 which 
bears a high degree of sequence similarity to Hsp70s in the ATPase domain and acts as a NEF in 
the Hsp70 ATPase cycle84, 85, has provided tremendous insight into the mechanism of allosteric 
regulation of Hsp70s (Figure 1-4C). For example, the binding of ATP in the ATPase domain of 
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Figure 4: Crystal structures of select truncated Hsp70 isolates and Hsp70-like proteins. 
 (A) The crystal structure of a 60 kD a truncation mutant of Bos taurus Hsc70 (Protein Data 
Bank ID: 1YUW) was solved a t 2.6  Å resolution and l acked nucleotide7. The ATPase domain i s 
represented i n bl ue and green w hile t he s ubstrate bi nding dom ain and a  s mall por tion of  t he l id 
domain i s r epresented i n r ed, yellow and or ange. In t his s tructure, t he substrate bi nding a nd l id 
domains establish contacts with the interdomain linker as well as lobe I of the ATPase domain. (B) 
The crystal structure of a 60 kDa truncation mutant of Rattus norvegicus Hsc70 (Protein Data Bank 
ID: 2V 7Z) was s olved at 3.5 Å resolution i n t he pr esence o f A DP a nd i norganic phos phate ( not 
shown)12. T he A TPase dom ain ( represented i n blue a nd gr een) i s di sjointed f rom t he s ubstrate 
binding and lid domains (represented in orange, yellow and red) via an exposed linker region. (C) 
The crystal structure of full-length Saccharomyces cerevisiae Sse1p (Protein Data Bank ID: 2QXL), 
a m ember o f t he r elated H sp110 f amily, was s olved a t 2.4 Å resolution i n t he p resence of  ATP 
(depicted in white)14. In this structure, the ATPase domain is represented in blue and dark green, the 
substrate binding domain in yellow and l ight green, and the l id domain in red and orange. Sse1p 
was present as a  dimer in the c rystal s tructure with the substrate binding and l id domains of  one 
monomer contacting the ATPase domain of the second monomer, thus stabilizing the structure. (D) 
The crystal structure of the ATPase domain of Bos taurus Hsc70 crosslinked to the J domain of Bos 
taurus auxilin (Protein Data Bank ID: 2QWR) was solved at 2.2 Å resolution in the presence of the 
ATP analog, AMPPNP (not shown)15. In this structure, the R171 residue of Hsc70 was altered to a 
C w hile t he D 876 r esidue of  a uxilin w as a ltered t o a  C  t o e nable d isulfide br idge-mediated 
crosslinking. The J domain of auxilin forms three predominant α-helices and is depicted in blue. 
 The structures were generated using RasMol11. 
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Sse1p a ppears t o b e c ommunicated t o t he h ydrophobic pe ptide bi nding c left o f t he substrate 
binding domain through hydrogen bonds that are formed not only between the catalytic residues 
and A TP, but  a lso b etween t he i nterdomain l inker a nd t he A TPase and s ubstrate bi nding 
domains. Indeed, mutating the linker residues involved in hydrogen bond formation disrupted the 
function of  S se1p a nd the yeast c ytosolic H sp70, S sa1p. However, because not  all of  t he 
analogous mutations in DnaK and Ssc1p, a  yeast mitochondrial Hsp70, disrupted function, the 
universality of this communication mechanism is unclear.  
In a ddition t o s uggesting a  m echanism f or t he a llosteric c oupling of  t he nuc leotide 
binding a nd s ubstrate bi nding dom ains, a nother facet of  H sp70 c rystallography h as a ddressed 
how H sp70s i nteract with t heir c ofactors. S tructures of  uni que N EFs in complex w ith their 
cognate Hsp70 ATPase domains have been solved, and these studies have identified the Hsp70 
residues that are involved in contacting the NEF86-90. Similarly, a crystal structure of the ATPase 
domain of bovine Hsc70 in complex with the J domain of auxilin, a cytosolic Hsp40 homolog, 
was recently solved in the presence of the ATP analog, AMPPNP15 (Figure 4D). In this structure, 
the J  domain of auxilin directed the Hsc70 interdomain l inker onto a hydrophobic patch of the 
ATPase dom ain, hi nting a t a  pos sible m echanism b y w hich H sp40s r egulate H sp70 a llostery. 
However, to obtain a stable structure, the authors crosslinked the Hsc70 ATPase domain and the 
auxilin J domain via disulfide bridges by mutating a highly conserved R residue in the ATPase 
domain of  bovine Hsc70, and an invariant D in the J  domain of  auxilin, to cysteines to enable 
crosslinking. Interestingly, t he H sc70 R  m aps t o a  region i n t he A TPase dom ain t hat i s 
implicated in directly contacting the J domain of Hsp40s91, 92.  
Absent from these studies is the resolution of a BiP structure. While BiP exhibits a high 
degree of  sequence conservation with several Hsp70s (for example, yeast BiP and Escherichia 
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coli DnaK s hare 50 % o verall s equence i dentity; yeast B iP a nd Bos taurus Hsc70, a  cytosolic 
protein, s hare 61%  ove rall s equence i dentity), t he E R i s m ore ox idizing t han t he c ytosol; t his 
might result in certain structural alterations that are unique to BiP. Furthermore, BiP participates 
in Ca2+ storage in the ER by directly binding to Ca2+ (refer to section 1.2.8).  
Overall, a crystal s tructure of  full-length Hsp70 in the presence of  di fferent nucleotides 
will be  c ritical to better de fine th e nuc leotide-dependent allosteric ch ange ex hibited by t hese 
chaperones. 
1.2.2 Yeast BiP’s Hsp40 cochaperones 
Yeast BiP i nteracts with t hree Hsp40 hom ologs to pe rform i ts v arious f unctions. T he uni que 
localization of these proteins within the ER and differences in domain organization might target 
BiP for specialized functions. 
Sec63p, an essential protein, was initially discovered in a genetic screen targeted toward 
identifying yeast mutants defective for the ER t ranslocation ( refer to section 1.2.4)  of  a  signal 
peptide-cytosolic e nzyme h ybrid pr otein93. Subsequent e xperiments de monstrated t hat sec63 
mutant yeast w ere de fective f or t he t ranslocation of  a  va riety o f s oluble pr oteins93, 94 and t he 
translocation defect could be recapitulated in vitro93. The identification of an internal J domain in 
Sec63p indicated that it was a member of the Hsp40 sub-family of chaperones94; however, the J 
domain is the only region shared with the founding member of this protein class, DnaJ. Topology 
analysis ne xt de termined that S ec63p contains t hree t ransmembrane dom ains a nd that its  J 
domain resided within the ER, ideally positioned to interact with BiP95. Since its identification, 
the vital r ole pl ayed by Sec63p during co- and pos t-translational tr anslocation across the  E R 
membrane (refer to section 1.2.4) has been addressed using in vivo and in vitro analyses, which 
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have revealed that Sec63p functions in translocation by: (i) residing in a complex with the Sec61 
translocation channel ( refer to section 1.2.4)  in the ER membrane95-100, ( ii) by interacting with 
two pr oteins on t he c ytosolic f ace of  t he E R m embrane, S ec71p a nd Sec72p98, 101-106, w hich 
either a ssist the  s ignal recognition particle in targeting r ibosome-nascent pol ypeptide chain 
complexes to the translocation channel or directly participate in signal peptide recognition103, 105, 
and (iii) b y int eracting with BiP in the E R lum en and directing it t o nascent t ranslocating 
polypeptide chains98, 105-114. Additionally, the interaction between mammalian SEC63 and BiP is 
required to localize B iP a t the  E R me mbrane s o that it c an function as a  pl ug/gate f or the  
translocation channel that opens into the ER115, 116. 
Scj1p (Saccharomyces cerevisiae DnaJ) was characterized in a genetic screen which was 
designed t o i dentify genes t hat w hen overexpressed resulted in the mis sorting o f a nuc lear-
targeted protein117. Scj1p shares 37% overall sequence identity with DnaJ and in addition to an 
N-terminal J domain, also contains a G/F-rich region and a cysteine-rich region similar to DnaJ. 
Subsequent s tudies de termined that Scj1p was ER-localized and interacted with BiP in the ER 
lumen118; indeed, Scj1p’s J domain contained the information required to specify BiP interaction 
because it could replace the J domain of Sec63p in vivo118. Further analyses revealed that Scj1p 
acted a s a B iP c ofactor dur ing p rotein f olding i n t he E R, e specially unde r c onditions of  
hypoglycosylation i nduced e ither b y m utating components of  t he ol igosaccharyl t ransferase 
(OST) c omplex (re fer to section 1.2.5) or  b y tr eating c ells w ith a s mall molecule inhi bitor of  
glycosylation, i.e., tunicamycin119. F inally, i t w as de monstrated t hat S cj1p a nd J em1p ( see 
below) p articipate in ER-associated degradation ( ERAD; r efer t o s ection 1.2.6) , e ither b y 
assisting BiP in the recognition of misfolded substrates, or by targeting BiP-substrate complexes 
to the retrotranslocation channel120. Given that Scj1p has a substrate binding domain that bears 
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homology to DnaJ, it is possible that Scj1p directly binds to substrates and delivers them to BiP, 
as has be en observed for t he mammalian homolog, ERdj3 ( refer t o s ection 1.2.2.1) . A  critical 
role f or S cj1p i n t he maintenance o f E R protein hom eostasis i s f urther s upported b y t he 
observation that scj1∆ yeast exhibit a high induction of the unfolded protein response121 (UPR; 
refer to section 1.2.7). 
When t he S. cerevisiae genome w as s equenced in 1996, s everal ope n reading f rames 
encoding J  domain-containing Hsp40 homologs were identified. One such open reading frame, 
YJL073w, was pr edicted t o encode a J  dom ain-containing pr otein w ith a put ative m embrane 
spanning domain and was named Jem1p (DnaJ-like protein of the ER membrane)122, 123. Targeted 
experiments determined that Jem1p is localized to the ER, and plays a role during karyogamy122 
(refer to section 1.2.8). Since J domain mutants of Jem1p were karyogamy-defective, the authors 
concluded that J em1p’s r ole i n ka ryogamy d epended on B iP i nteraction122. S ubsequently, an 
overlapping role for Jem1p and Scj1p in ERAD was also described120, and  yeast deleted for scj1 
and jem1 exhibit a  s ynthetic te mperature-sensitive gr owth phe notype122. U nlike m ost H sp40s, 
Jem1p has an atypical d omain arrangement wherein the J dom ain is l ocated at t he C -terminus 
and a putative substrate binding domain is N-terminal to the J domain. Moreover, since Jem1p 
might be membrane-associated122, 123, it could target BiP-substrate complexes during ERAD by 
interacting with components of the retrotranslocation channel (refer to section 1.2.6). 
Recently, a fourth ER-resident Hsp40 homolog, ERj5p, encoded b y the YFR041c open 
reading f rame41, was i dentified i n yeast. T he function of  t his pr otein is unc lear a lthough i t 
appears to be required to preserve the protein folding capacity of the ER, possibly by regulating 
BiP41.  
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1.2.2.1 The human Hsp40, ERdj3 
Compared to yeast, more Hsp40 cochaperones interact with BiP in the mammalian ER and six 
such factors have been identified to date (refer to section 1.1); one  of  these proteins is ERdj3. 
ERdj3 was i nitially de scribed as a S cj1p homolog i n dog  pa ncreatic microsomes45 and was 
subsequently isolated from human cells in a phenotypic cloning approach to identify genes that 
played a  role i n S higa t oxin t rafficking46. Like Scj1p a nd D naJ, E Rdj3 ha s a n N -terminal J  
domain f ollowed b y G/F-rich and  C -rich regions a nd a  s ubstrate bi nding dom ain; t he C -rich 
region m ight be  i nvolved i n t he f ormation of  i ntramolecular di sulfide br idges124. T he ke y 
residues in ERdj3’s substrate binding domain that are required for substrate binding have been 
identified125 based on h omology m odeling t o t he s ubstrate bi nding dom ain of  Y dj1p2, a yeast 
cytosolic H sp40126, 1 27. These include r esidues c onstituting dom ain II o f t he s ubstrate bi nding 
domain ( spanning a mino a cids 160 -200), a  r esidue i nvolved i n di merization, F 326, a nd f our 
residues in domain I, I134, V153, L208 and F223 that directly contact the substrate. It was also 
demonstrated that ERdj3 is expressed in all human tissues and stimulates BiP’s ATPase activity, 
thus acting as a BiP cochaperone in the mammalian ER46.  
 ERdj3 a lso c o-purified a s pa rt of  a  m ultiprotein c omplex c ontaining B iP, E R-resident 
molecular chaperones and incompletely folded immunoglobulin (Ig) heavy chains128. Follow-up 
biochemical experiments revealed that ERdj3 could di rectly bind to Ig heavy chains and other 
soluble substrates such as a non-secreted Ig κ light chain and a temperature-sensitive mutant of 
VSV-G129. Since the ERdj3-substrate association was lost upon the binding of BiP to substrate, a 
model w as pr oposed i n w hich E Rdj3 bi nding he lps t o m aintain s ubstrates in a  s oluble, 
aggregation-free state until BiP binds to them129. More recently, this mechanism has been further 
elaborated130: E Rdj3 recruits B iP to ERdj3-substrate c omplexes vi a J  dom ain-mediated 
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interactions and stimulates BiP’s ATPase activity so that BiP has high substrate affinity. In the 
process, ERdj3 e licits i ts ow n di ssociation from t he chaperone-substrate c omplex. G iven t hat 
another E R H sp40, p58 IPK, adopts a  s imilar me chanism to target B iP to its s ubstrates131, t he 
authors on t he p apers s peculate th at H sp40 substrate de livery to  H sp70s a nd stimulation of 
Hsp70 ATP hydrolysis are universally required to release substrates from Hsp40s. 
1.2.3 Nucleotide Exchange Factors for yeast BiP and other BiP-interacting proteins 
The yeast E R harbors t wo N EFs, S ls1p/Sil1p and Lhs1p; imp ortantly, mammalian 
homologs/orthologs of both of these proteins exist (SIL1 and GRP170, respectively).  
 Yeast SLS1 (synthetic lethal mutations with the 7S
Lhs1p (Lumenal Hsp Seventy; YKL073w) was categorized as an ER-lumenal Hsp70-like 
protein when the yeast genome was sequenced in 1996136, 137. Although non-essential, synthetic 
 RNA mutation) was initially isolated 
in a g enetic s creen in the yeast Yarrowia lipolytica targeted toward identifying genes tha t 
demonstrated synthetic l ethality w ith mutations in the s ignal r ecognition particle132 (refer t o 
section 1.2.4). Further analyses revealed that Sls1p localizes to the ER lumen and participates in 
protein translocation across t he E R m embrane a s a B iP co factor132, 1 33. When these da ta were 
recapitulated in S. cerevisiae and because Sls1p synergistically activated BiP’s ATPase activity 
in the presence o f the J  domain of  Sec63p134, the authors concluded that S ls1p acted as a BiP 
NEF dur ing pr otein translocation; thi s w as the  f irst ide ntification of a  B iP N EF. The S tirling 
group then determined that the overexpression of S. cerevisiae SLS1/SIL1 suppressed the growth 
defect observed in ire1∆lhs1∆ yeast135. Ire1p is the signal transducer kinase/endoribonuclease for 
the unf olded pr otein r esponse ( refer t o s ection 1.2.7)  a nd Lhs1p i s a  s econd B iP N EF ( see 
below)135. 
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growth defects were obs erved in yeast l acking lhs1 and c ontaining kar2 mutant a lleles136, 1 37. 
These data suggested that BiP and Lhs1p might exhibit partially overlapping functions; indeed 
the lhs1∆ strain accumulated pr ecursors o f s everal s ecretory proteins, s uggesting t hat Lhs1p 
played a  role i n pr otein t ranslocation136. L hs1p w as a lso de monstrated t o pa rticipate i n t he 
refolding of  denatured substrates in the ER lumen138; it is  still unclear whether this function is 
BiP de pendent or  not . Moreover, Lhs1p c an a ct a s a  B iP N EF139, similar to its ma mmalian 
ortholog, G RP170, which acts a s a  B iP N EF i n the ma mmalian E R140. Taken t ogether, t he 
features of Lhs1p, i.e., the sequence similarity of its ATPase domain to Hsp70s and the ability of 
Lhs1p to act as  a B iP N EF, are r eminiscent of  ot her m embers of  t he H sp110 f amily of  
chaperones84, 85, 141. Strikingly, the simultaneous deletion of sls1 and lhs1 is lethal, indicating that 
these NEFs confer an essential function in yeast, possibly during translocation135.  
BiP functions within the context of the crowded ER and hence, in addition to the Hsp40s 
and NEFs t hat ar e de dicated to BiP r egulation, BiP g enetically and physically i nteracts w ith 
several other proteins to ensure ER homeostasis. For example, a member of the protein disulfide 
isomerase (PDI) family of molecular chaperones, Eps1p, binds to BiP in vitro with a dissociation 
constant of 5.83 * 10 -6 M142. Therefore, Eps1p and BiP might function in a coordinated manner 
in vivo in order to fold proteins that require the formation of disulfide bonds. Further evidence 
for a combinatorial role of BiP and PDIs comes from studies on a soluble misfolded substrate143. 
It was s hown t hat a  yeast P DI hom olog, P di1p, f unctionally interacts w ith B iP dur ing t he 
targeting of  the misfolded substrate to the retrotranslocation machinery during ERAD (refer to 
section 1.2.6). In addition, Rot1p, an essential ER membrane protein, is thought to act as a BiP 
cofactor during the folding of proteins involved in the maintenance of cell wall integrity and in 
the resolution of  authophagic vesicles144, 1 45. Moreover, Yos9p, an ER lectin, forms a  ph ysical 
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ER-lumenal ‘surveillance complex’ with BiP and a membrane component, Hrd3p3. This complex 
targets t erminally m isfolded pr oteins t o t he r etrotranslocation a nd/or ubi quitination m achinery 
during E RAD ( refer t o s ection 1.2.6) . Intriguingly, e ach m ember of t his c omplex c an 
individually recognize misfolded pr oteins, a nd w hether t his s erves t o di stinguish be tween 
different non -native con formers within the s ame s ubstrate, or t o ensure t he r apid cl earance o f 
toxic species, remains to be resolved.  
1.2.4 BiP is required for co- and post-translational protein translocation across the ER 
membrane 
In yeast, secretory proteins can be translocated into the ER as they are being translated, i.e., co-
translationally, or after they have been synthesized, i.e., post-translationally27; a role for BiP has 
been de scribed i n bot h of  t hese pr ocesses ( Figure 5). T he h eterotrimeric S ec61 t ranslocation 
channel (also known as the “translocon”) is the conduit through which soluble and membrane-
bound pr oteins e nter t he E R. T he t ranslocon i s c omposed of  S ec61p (Sec61α in mammals), 
Sbh1p (Sec61β in mammals), and Sss1p (Sec61γ in mammals). Sec61p is essential, possesses ten 
transmembrane s egments a nd f orms t he a queous t ranslocation por e96, 1 46. The t ail-anchored 
membrane protein Sss1p (Sec sixty-one suppressor) acts as an essential regulatory and Sec61p-
stabilizing subunit147, 148. The role of the non-essential subunit, Sbh1p149, during translocation is 
still unc lear, though recent e vidence s uggests tha t its  tr ansmembrane dom ain is required 
primarily f or c otranslational t ranslocation ( refer t o A ppendix A ) a nd may r egulate N -linked 
glysocylation (refer to section 1.2.5). 
During c o-translational t ranslocation (Figure 5A), t he s ignal pe ptide or  t ransmembrane 
domain of a growing polypeptide chain is recognized by the signal recognition particle (SRP), a 
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Figure 5: Protein translocation across the endoplasmic reticulum membrane. 
 (A) During c o-translational pr otein translocation, the s ignal r ecognition particle ( SRP) 
binds to t he s ignal pe ptide a s i t e merges from the r ibosomal pol ypeptide t unnel. N ext, t he 
binding of  S RP to its r eceptor at the  E R membrane ta rgets the  ribosome-nascent pol ypeptide 
chain c omplex t o t he S ec61 t ranslocation c hannel ( Sec61 t ranslocon). A t t he s ame time, BiP 
gates the ER-lumenal side of the translocon by interacting with its J domain-containing Hsp40 
cochaperone, Sec63p. The release of  SRP from the s ignal peptide, the interaction between the 
ribosome a nd S ec61p, resumption of  t ranslation, a nd s ubsequent BiP bi nding r esults i n 
polypeptide t ranslocation. T ransmembrane s egments c an di rectly enter t he E R m embrane 
through a gate i n t he t ranslocon ( not s hown). (B) During pos t-translational t ranslocation, t he 
polypeptide i s c ompletely synthesized i n t he c ytosol, a nd t he bi nding o f H sp70s a nd H sp40s 
help t o m aintain t he na scent pr otein i n a n a ggregation-free s tate. T he pol ypeptide i s ne xt 
targeted to the translocon by these cytosolic chaperones, and upon release, progresses into the 
translocation channel. The subsequent cleavage of the s ignal peptide and BiP binding ensures 
that t he pol ypeptide c hain t ravels i nto t he ER vi a a  B rownian r atchet m echanism. T he 
interaction between BiP and Sec63p is essential to localize BiP to the translocating polypeptide. 
A critical role is also played by the membrane-bound translocon-associated protein, Sec62p (not 
shown in the figure). 
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ribonucleoprotein complex. This interaction results in a pause in translation. SRP then targets the 
ribosome-nascent pol ypeptide c hain c omplex t o t he E R m embrane by  i nteracting w ith i ts 
membrane-bound receptor. O nce t he pol ypeptide c hain h as be en t ransferred f rom S RP t o t he 
Sec61 c hannel, t ranslation r esumes a nd t he t ight bi nding be tween t he r ibosome a nd S ec61p 
ensures t hat t he pol ypeptide c hain t ranslocates i nto t he E R. B y i nteracting w ith S ec63p, BiP 
localizes to the translocation channel and initially forms a gate to prevent the release of ions from 
the ER115, 116. When translocation is initiated, BiP binds to the polypeptide chain and promotes 
ER entry in an ATP-dependent manner. The genetic interactions observed between sec61, sec63 
and kar2 temperature-sensitive mutant a lleles, as well as the  ph ysical int eractions between the 
corresponding wild-type proteins lend strong support for this model93, 108-110, 114, 150. Furthermore, 
in vitro translocation a ssays pe rformed us ing r econstituted E R-derived m icrosomes l acking 
BiP115 and synthetic proteoliposomes reconstituted with BiP mutants that are unable to interact 
with Sec63p or hydrolyze ATP116, supports a role for BiP in co-translational translocation. 
In yeast, several soluble proteins contain signal peptides that are poorly recognized by the 
SRP and t herefore, t hey utilize a pos t-translational m ode of  t ranslocation i nto t he E R ( Figure 
5B). P rior t o t ranslocation, t hese pr oteins ha ve t o be  m aintained in a pa rtially-unfolded 
aggregation-free state. Therefore, they associate with cytosolic Hsp70s and Hsp40 which are also 
responsible f or de livering t he s ubstrates t o t he t ranslocation c hannel. O nce s ubstrate ha ndover 
has t aken place, the cytosolic chaperones di ssociate f rom t he c omplex, a nd t ranslocation i s 
initiated, possibly through a Brownian ratcheting mechanism. This may be activated by Sec63p 
interaction with BiP and by BiP ATP hydrolysis, which ultimately ‘pulls’ the polypeptide into 
the E R99, 1 05, 1 07, 1 11-113, 1 51. E specially i mportant f or pos t-translational tr anslocation is the  
interaction of Sec63p with Sec62p, an essential membrane-bound protein93, 96, 97, 152, 153, and two 
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other non -essential, membrane-associated pr oteins, S ec71p a nd S ec72p98, 101-106. It is  
hypothesized that one or all of these proteins might contribute directly towards the recognition of 
a s ubset of  signal pe ptides103, 10 5. I n f act, B iP, S ec63p, S ec71p a nd S ec72p f orm t he S ec63 
complex w hich ha s be en s hown t o pa rticipate in pos t-translational tr anslocation98. O f not e, 
secreted proteins i n mammals al most a lways ut ilize the co-translational tr anslocation pathway, 
and it is not surprising that mammalian homologs of Sec71p and Sec72p have not been identified 
to date. However, a mammalian Sec62p homolog exists44, 154. 
In addition t o t he s ignal pe ptidase c omplex a nd ol igosaccharyl t ransferase c omplex, 
which are closely associated with the translocon (refer to section 1.2.5), unique membrane-bound 
components ha ve be en i dentified a s r egulators of  t ranslocation in mammalian cells. One 
glycoprotein, t he t ranslocon-associated m embrane p rotein (TRAM) i s es sential f or t he 
translocation of  a  m ajority of  pr oteins155, 1 56. T hough t he e xact role pl ayed b y T RAM i s s till 
unclear, given its transitory presence i n t he a queous t ranslocon por e a nd i ts i nteraction w ith 
translocating membrane proteins, it is possible that TRAM acts as a membrane chaperone156, 157. 
A second translocon-associated protein complex, TRAP, is also present in close proximity to the 
mammalian translocon, though its function has not been described156, 158. Additional membrane-
associated components may also regulate the yeast Sec61 translocon. Recently, a  nine-member 
complex cal led the E R m embrane com plex ( EMC) ha s be en implicated in the bi ogenesis and  
insertion of yeast membrane proteins into the ER121. 
1.2.5 BiP participates in nascent protein folding in the ER 
As a p rotein traverses int o the E R, there a re t wo primary modi fications tha t ma y oc cur c o-
translocationally: (i) cleavage of the signal peptide in soluble proteins which is catalyzed by the  
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Figure 6: N-linked glycosylation and the degradation of glycosylated proteins in the 
mammalian ER. 
 Proteins that enter the  ER are of ten modified b y the addition of  a  GlcNAc2-Man9-Glc3 
glycan t o t he s ide-chain ni trogen of N residues i n t he c onsensus N-X-S/T motif. F irst, the 
translocon-associated oligosaccharyl t ransferase ( OST) complex co -translationally tr ansfers 
GlcNAc2-Man9-Glc3 glycans f rom dol ichol t o s ubstrate p roteins. N ext, glucosidase-I and 
glucosidase-II s equentially remove t wo t erminal g lucoses, generating m onoglucosylated 
substrates t hat ar e recognized b y c alnexin a nd c alreticulin t hrough t heir carbohydrate-binding 
globular dom ains ( calreticulin is a  s oluble protein a nd i s not  s hown). T he i nteraction with 
calnexin and calreticulin facilitates folding. ERp57, a  PDI homolog that is associated with the 
arm domain of calnexin and calreticulin, catalyzes disulphide bond formation. Following release 
from the  c alnexin–calreticulin cycle, the f inal g lucose is  tr immed by glucosidase-II. If  
glycoproteins have adopted their native conformations, they can be demannosylated (denoted by 
the use of parentheses around the mannoses) by ER mannosidases I and II (ER man-I and man-
II) and exit the ER through coatomer protein complex-II vesicles. However, the folding of some 
glycoproteins r equires m ultiple rounds of  association with calnexin–calreticulin. Such proteins 
are reglucosylated by U DP-glucose:glycoprotein glucosyltransferase (UGGT), which recognize 
non-native s tates and transfers a glucose f rom UDP-glucose t o the N -linked GlcNAc2-Man9 
glycan. R e-monoglucosylation promotes r e-entry int o the f olding c ycle. Terminally mis folded 
glycoproteins might also be targeted for ERAD by calnexin and calreticulin or by other ERAD-
requiring c omponents s uch a s E DEM ( ER de gradation enhancing α-mannosidase-like le ctin), 
and in some cases, BiP. GlcNAc, N-acetylglucosamine; Man, mannose; Glc, glucose. 
The figure was adapted from Vembar and Brodsky, 20085. 
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membrane-associated s ignal p eptidase complex c onsisting of  S ec11p, S pc1p, S cp2p a nd 
Spc3p159-163, a nd ( ii) N -linked g lycosylation164, 1 65 which is cat alyzed by t he ol igosaccharyl 
transferase complex (OST) consisting of  Ost1p, Ost2p, Ost3p, Ost5p, Swp1p and Wbp1p. The 
N-linked oligosaccharide, GlcNAc2-Man9-Glc3, of which GlcNAc is N-acetylglucosamine, Man 
is ma nnose and Glc i s glucose, is a dded ont o an N  i n a c onsensus N -X-S/T mot if ( with X 
representing any amino acid) (Figure 6). The subsequent removal of terminal glucose residues by 
glucosidases, and facilitated folding by the carbohydrate-binding lectin-like chaperones calnexin 
and calreticulin, results i n a  glycoprotein t hat contains a G lcNAc2-Man9 moiety. Proteins with 
this sugar a re competent f or E R e xit a nd can transit to their final de stinations. In yeast, a 
calreticulin hom olog i s absent, a nd m embrane-bound c alnexin i s non -essential, indicating tha t 
other pr oteins pa rticipate i n t he f olding of  glycosylated pr oteins, i ncluding BiP. In f act, BiP 
function i s e ssential for t he f olding of  t he m odel g lycosylated s ubstrate, va cuolar 
carboxypeptidase Y  ( CPY)166. F urthermore, s ince f olding of  s everal pr oteins i nitiates c o-
translocationally167, 168, a role for BiP becomes critical not only to promote correct folding, but 
also to prevent the formation of non-native conformers, which could occur when the N- and C-
termini of certain substrates are unable to interact until the conclusion of translocation.  
The m ethod us ed b y B iP t o pr omote f olding i s w ell-established in mammalian cells, 
especially with r egards t o t he folding and subsequent a ssembly of immunoglobulin heavy and 
light chains169, 170. Given that BiP was initially identified as part of immunoglobulin heavy chain 
complexes34, BiP’s requirement in this process is not surprising. BiP can recognize hydrophobic 
patches in its substrates171, 172 either as part of unfolded polypeptide chains or on the surfaces of 
unassembled s ubunits. Through c ycles of  s ubstrate bi nding a nd r elease m ediated b y A TP 
hydrolysis a nd i nteractions w ith i ts H sp40 c ofactors119 and NEFs138, BiP pr events pr otein 
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aggregation and retains substrates in the folding pathway. Interestingly, ATPase mutants of BiP 
can still bind to their substrates and maintain them in an aggregation-free state; however, they are 
unable to complete the folding cycle, and the substrates therefore cannot be folded to a secretion-
competent state74.  
1.2.6 BiP-mediated recognition and targeting of misfolded proteins for ER-associated 
degradation 
The ER is a unique protein folding environment and approximately one-third of  all proteins in 
eukaryotes are targeted to this compartment173, 174. In addition to molecular chaperones, the ER 
contains unique enzymes that maintain an oxidizing environment relative to the cytoplasm (i.e., 
PDIs) and catalyze co - and pos t-translational modifications (i.e., enzymes i n the N -linked 
glycosylation pathway). Therefore, to ensure that the ER assembly l ine manufactures products 
that m eet t he needs of  t he cel l, secreted proteins are subject t o ER qua lity control (ERQC)175. 
The primary m ediators of  E RQC ar e m olecular cha perones that not  onl y s ample a nd he lp 
polypeptides to fold but also evaluate the conformations of their substrates. If a polypeptide has 
attained its native conformation, it might be targeted to its final destination. If folding is delayed 
or a n illegitimate c onformation arises, the s ubstrate is e ither s ubjected to additional f olding 
cycles or  is s elected for ERAD176. I f, how ever, t he c oncentration of  these potentially tox ic 
protein species increases, compensatory pathways are induced, including lysosomal degradation 
of bulk c ytosolic pr oteins or  e ven e ntire or ganelles, i.e., autophagy177. The individual s teps 
during ERAD (F igure 1 -7) i nclude substrate r ecognition, targeting, retrotranslocation, 
ubiquitination and proteasomal degradation5. 
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Figure 7: A step-by-step illustration of endoplasmic reticulum-associated 
degradation.  
(A) Protein recognition. M isfolded pr oteins c ontaining c ytoplasmic, i ntramembrane or  
ER-lumenal l esions ar e r ecognized b y cytoplasmic a nd l umenal cha perones and associated 
factors, such as Hsp70s, calnexin and calreticulin, and PDIs. (B) Protein targeting. ERAD 
substrates a re t argeted t o t he r etrotranslocation m achinery ( the retrotranslocon) a nd/or t o 
ubiquitin ligases. (C) Retrotranslocation initiation. S ubstrate r etrotranslocation i nto t he 
cytoplasm mi ght be  ini tiated in part b y the cell-division c ycle-48 ( Cdc48p) c omplex; ot her 
components, s uch a s m olecular c haperones or  t he pr oteasome, m ight a lso be  r equired f or t his 
step. The energy derived from ATP hydrolysis by Cdc48p, which is a AAA+ ATPase, is coupled 
to retrotranslocation. (D) Ubiquitination and further retrotranslocation. A s pr oteins e xit t he 
retrotranslocon t hey are pol yubiquitinated b y ubiquitin l igases. T his pr omotes f urther 
retrotranslocation a nd i s a ided b y c ytoplasmic ubi quitin-binding pr otein c omplexes. (E) 
Proteasomal targeting and degradation. Once a polyubiquitinated substrate is displaced into the 
cytoplasm, it is recognized by receptors in the 19S cap of the 26S proteasome. De-ubiquitinating 
enzymes (not shown) remove the polyubiquitin tag, and peptide N-glycanase (not shown) might 
also be  required for e fficient degradation. The substrate i s t hen threaded into the 20S  catalytic 
core o f t he pr oteasome w here i t i s br oken do wn i nto pe ptide fragments. U biquitin t hat i s 
generated by this process can be recycled for subsequent rounds of modification. 
The figure was adapted from Vembar and Brodsky, 20085. 
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 BiP participates in the recognition of substrates with misfolded lesions in the ER lumen 
by binding to h ydrophobic patches171, 17 2. In the native conformation, h ydrophobic patches are 
usually buried within the interior of soluble proteins in order to maintain the lowest energy state8. 
However, since the  mis folded state is  not  the  most energetically f avorable s tate, these pa tches 
can become exposed, which can lead to aggregation. Indeed, various groups have demonstrated 
that BiP, either independently or with i ts Hsp40 co-factors, i s required for the recognition of  a 
variety of  m isfolded s ubstrates in mammalian and yeast s ystems, including un glycosylated 
invertase a nd m isfolded pr olactin178, una ssembled i mmunoglobulin l ight c hains179, m isfolded 
human surfactant protein C180, and mutant forms of yeast CPY (CPY*) and pre-pro-alpha factor 
(∆gpαF), the yeast mating pheromone120, 1 81. However, the role o f the NEFs that interact with 
BiP during ERAD in yeast is ill-defined.  
In mammalian cells, another w ell-described aspect dur ing E RAD r ecognition i s t he 
crosstalk between BiP and the lectin-like proteins, calnexin and calreticulin. For example, some 
substrates i nteract sequentially with BiP a nd calnexin/ calreticulin in the cell182, whereas 
calnexin and BiP s ynergistically s uppress the aggregation of  a  non -glycosylated substrate in 
vitro183. Furthermore, BiP can compensate for the absence of the calnexin–calreticulin cycle by 
binding to glycosylated substrates with which it does not normally interact184. In some cases, the 
two chaperone s ystems even have unique e ffects on the fate of  a substrate185-188. Additionally, 
BiP cooperates with the PDIs during ERAD5. As previously stated, BiP and Pdi1p recognize a 
misfolded substrate in yeast and target it f or retrotranslocation143. Another novel component of 
ERAD in mammalian cells is the recently characterized Hsp40 homolog, ERdj5, which not only 
contains a J domain for BiP interaction, but also contains four canonical thioredoxin-like active-
site Cys-X-X-Cys motifs, suggesting that it can function as a PDI189. Indeed, in a BiP-dependent 
 35 
manner, E Rdj5 r egulates t he de gradation of  nu ll Hong K ong (NHK), a di sease-causing α1-
antitrypsin variant, by accelerating t he f ormation of de gradation competent NHK m onomers 
from disulfide-linked dimers. Therefore, the complexity of BiP interactions necessary to catalyze 
ERAD in mammals is increased relative to yeast. 
 Soluble E RAD s ubstrates mus t f irst be  s elected (i.e., targeted) for r etrotranslocation to 
the c ytosol because t he enz ymes required for ubi quitination (Figure 1 -8) reside in this 
compartment. H owever, s ubstrate recognition and targeting c an be come i ndistinguishable 
because E RAD s ubstrates m ight not  be  pa ssed between distinct r ecognition and targeting 
complexes. Recent observations s uggest t hat f actors r equired f or r ecognition reside w ithin 
multiprotein complexes that are also essential for targeting. For example, as noted above (refer to 
section 1.2.4) yeast BiP is tethered to the ER membrane by virtue of its interaction with Sec63p, 
which i n t urn r esides i n a m ultiprotein e nsemble t hat i ncludes S ec61p, a c andidate for t he 
retrotranslocation channel190-192. Therefore, a complex c ontaining B iP, S cj1p, Jem1p a nd 
misfolded s ubstrates c ould di rectly t arget s ubstrates f or r etrotranslocation t hrough t he S ec61 
channel. Alternately, as discussed above (section 1.2.3), BiP forms a complex with Yos9p and 
membrane-bound Hrd3p, a  pr otein t hat i nteracts w ith t he ubi quitin l igase, H rd1p, a s econd 
candidate for the retrotranslocation channel193, and this complex might suffice for the targeting 
of glycosylated and un glycosylated s ubstrates. In mammals, a recent s tudy impl icated a 
transmembrane ER-resident protein, Herp, as a receptor for non-glycosylated BiP substrates194. 
As Herp coprecipitates with Derlin-1195, a thi rd candidate for the r etrotranslocation channel196, 
197, and with ubiquitinated proteins and the 26S proteasome195, this targeting factor might bridge 
the ER-recognition machinery to the cytoplasmic ubiquitin–proteasome system. A Herp  
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Figure 8: The ubiquitin-proteasome system. 
 Ubiquitin ( Ub), a  76 amino-acid peptide, i s co valently attached t hrough a n i sopeptide 
bond to ε-amino groups of K in substrates. Ub itself contains several K residues, but the covalent 
linkage through K48 seems to be a hallmark for proteasome-mediated degradation. Degradation 
also requires at least a tetra-Ub chain6. 
Ub conjugation f irst r equires an E1 Ub-activating enzyme. The C -terminal G  of  Ub is  
adenylated b y t he E 1 a nd t hen di splaced f ollowing t he nuc leophilic a ttack of  a  c onserved C  
residue in the E1, resulting in a thioester linkage between the E1 and Ub. The next step involves 
the transfer of Ub to an E2 Ub-conjugating enzyme through the formation of another thioester 
linkage. T he cov alent at tachment of  U b t o substrates i s catalysed by E3 U b ligases, s uch as  
RING, U-box a nd H ECT dom ain-containing proteins. T he R ING and U -box dom ain E 3s 
facilitate the transfer of Ub from the E2 to selected substrates (step 1). The HECT domain E3s 
are covalently c oupled to U b b y a t hioester b ond i n t he H ECT dom ain. T he s ubsequent 
interaction with substrates is  required f or U b modification ( step 2) . O nce pol yubiquitinated, a  
substrate can be targeted to the 26S proteasome and degraded13. 
The figure was adapted from Vembar and Brodsky, 20085. 
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homolog, Usa1p, exists in yeast and has been shown to interact with the yeast Derlin homolog, 
Der1p, and also with Hrd1p198. 
Given the various roles of BiP during ERAD, it will become important to characterize the 
structural features in BiP that aid in the recognition of misfolded substrates. Notably, it will be 
necessary t o di scover t he m echanism b y w hich B iP di stinguishes be tween unf olded a nd 
misfolded proteins. This specificity of  function might l argely d epend on  the Hsp40-containing 
complexes in which BiP resides. 
1.2.7 BiP is required for the induction of the unfolded protein response 
Under conditions of  E R s tress, m isfolded protein accumulation in the E R can lead to the  
induction of the UPR, which reduces ER-protein load by several elaborate mechanisms199-202: the 
volume of  t he E R e xpands b y up regulated l ipid s ynthesis, the c oncentration of  m olecular 
chaperones and enzymes required for post-translational modifications rises, the transcription of 
components of the ERAD machinery increases in order to enhance misfolded protein clearance, 
protein translation a nd ER t ranslocation de crease, and p rotein t ransport t hrough t he secretory 
pathway probably i ncreases, t hereby emptying t his c ompartment of pot entially tox ic 
polypeptides. U PR i nduction m ight also result i n the cl eavage of  E R-associated mRNAs t hat 
encode secreted proteins203.  
The existence of a U PR pathway in yeast was first revealed by the identification of a 22  
bp cis-acting element in the promoter region of BiP which was transcriptionally responsive to the 
accumulation of unfolded proteins in the ER204, 205 (i.e., the unfolded protein response element or 
UPRE). T he s ubsequent di scovery o f t he E R m embrane-bound inositol-requiring protein-1 
(Ire1p), a transmembrane S er/Thr kinase a nd s ite-specific e ndoribonuclease, as an essential 
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component of the response pathway206, 207, and the observation that activated Ire1p could cleave 
an unspliced intron in t he mRNA o f t he t ranscriptional activator Hac1p208, 2 09 (homologous t o 
ATG6/CREB), implicated Ire1p directly in signal transduction. The next step was to establish the 
mechanism of Ire1p activation. Based on t he observation that BiP and Ire1p physically interact 
under normal growth conditions, and that this interaction is lost under conditions of ER stress210, 
it was hypothesized that the titration of BiP away from Ire1p, due to an accumulation of unfolded 
proteins, c ould t rigger Ire1p ol igomerization, a nd he nce U PR i nduction211-213. T his h ypothesis 
was s upported b y the  analysis of  BiP mut ants tha t di ssociated from Ire1p a t r estrictive 
temperatures leading to an induction of the UPR214 as well as ire1 alleles that were defective for 
BiP interaction and therefore exhibited a sustained UPR215. However, it is also becoming clear 
that Ire1p itself can directly bind to unfolded proteins. The first evidence for this came from the 
crystal s tructure of  t he Ire1p E R l umenal dom ain, w hich w as f ound t o r esemble t he bi nding 
pocket of  the  ma jor hi stocompatibility complex I (MHCI) pr otein for its  pe ptide a ntigens216. 
Follow-up e xperiments de monstrated t hat t he l umenal dom ain of Ire1p could i ndeed bi nd t o 
unfolded polypeptides217, 218.  
Based on all of  these data, a working model for the induction of the UPR is as follows 
(Figure 9): Under unstressed conditions, BiP binds to Ire1p in the ER lumen and maintains the 
enzyme in an inactive s tate. When B iP is titrated away from I re1p to bi nd t o m isfolded 
substrates, Ire1p is act ivated (Figure 9, s tep 1) . Ire1p also dimerizes an d binds to misfolded 
proteins ow ing t o t he formation of  a  pe ptide-binding poc ket i n t he E R-lumenal domain, t hus 
resulting in further activation (Figure 9, s tep 2) . Ire1p activation i nvolves t he 
transphosphorylation of  i ts cytoplasmic dom ain, w hich t riggers e ndoribonuclease activity a nd 
splices an intron in the mRNA that encodes Hac1p, the dedicated UPR transcriptional activator.  
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Figure 9: Induction of the unfolded protein response (UPR) in yeast. 
 Under unstressed conditions, BiP binds to Ire1p and maintains it in an inactive state, i.e., 
Ire1p cannot function as an endoribonuclease. Consequently, an intron in the mRNA of HAC1 
remains unprocessed and forms a hairpin structure that inhibits Hac1p translation (not shown). 
When the ER is stressed due to an accumulation of misfolded proteins, two phenomena occur: 
1) BiP titrates away from Ire1p to bind to its misfolded substrates either to prevent them from 
aggregating or  t o t arget them f or E RAD, and 2)  Ire1p di merizes o r pol ymerizes a nd di rectly 
binds to misfolded proteins due to the presence of an ER-lumenal peptide binding pocket. This 
results i n Ire1p t rans-autophosphorylation a nd s ubsequent a ctivation of  i ts e ndoribonuclease 
activity. Active Ire1p c leaves th e inhibitory intron in the mRNA o f HAC1, permitting H ac1p 
translation. Hac1p t ranslocates into the nucleus to upregulate UPR-responsive genes (listed in 
the figure). 
 The figure was adapted from Vembar and Brodsky, 20085. 
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The pr ocessed mRNA i s r e-ligated by a  tR NA lig ase, Trl1p, a nd translated219. Hac1p then 
translocates int o the nu cleus, bi nds t o U PREs and pos sibly ot her s equences i n the pr omoter 
region of target genes, including those regulated by Gcn4p220, and upregulates their expression.  
Making the s ignaling mechanism mor e intricate, i n t he pa st year, t wo r eports ha ve 
demonstrated t hat t he c ytosolic dom ain of  Ire1p f orms m ultimers ( not di mers a s ha d be en 
previously hypothesized), and upon activation, Ire1p multimers localize to discrete foci in the ER 
membrane221, 222. This phenomenon appears to be essential to recruit the unspliced form of the  
mRNA of  H ac1p f or s ubsequent c leavage. F inally, t he m ammalian E R harbors t wo a dditional 
signal t ransducers, PERK a nd A TF6, and t he i ntricacy of  t heir i nteractions w ith B iP c hanges 
specific aspects of the responses elicited by the mammalian UPR223-225. 
1.2.8 Other BiP functions 
In a ddition t o t he f unctions de scribed a bove, B iP a lso pa rticipates i n the m aintenance of  E R 
calcium stores (in yeast and mammals), as well as in nuclear fusion during mating in yeast; each 
of t hese f unctions i s br iefly discussed i n t his s ection. T he pos sibility t hat ot her BiP-regulated 
processes remain to be discovered cannot be ruled out. 
The r ole of  B iP i n calcium s torage i s be st established in mammalian cells. The 
concentration of calcium in the mammalian ER is nearly a thousand-fold higher as compared to 
the c ytosol, and ER c alcium s torage is  vi tal to maintain ER hom eostasis a s w ell a s f or r apid 
physiological s ignaling226. B esides t he e mployment of  s ignaling receptors a nd E R c alcium 
pumps, t he pr imary m echanism t o m aintain a  high E R calcium c oncentration i s t hrough t he 
binding of calcium to low-affinity c alcium bi nding p roteins s uch as c alnexin, calreticulin and 
GRP94, the ER-lumenal Hsp90, and high-affinity calcium binding proteins such as reticulocalbin 
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and calstorin227. Also amongst thi s ensemble of  c alcium bi nding proteins is  B iP228. D ue t o i ts 
abundance in the ER, and the presence of acidic amino acid clusters in BiP’s sequence that are 
common to other calcium binding proteins, it was determined that BiP contributes to nearly 25% 
of t he E R cal cium s tores170, 2 29. F urthermore, B iP’s c alcium bi nding a ctivity a ppeared t o be  
independent of its chaperoning activity because a BiP mutant lacking the substrate binding and 
lid domains s uccessfully maintained ER calcium le vels229. Interestingly, drugs (for ex ample, 
thapsigargin230) that inactivate the family of sarco-ER-Ca2+ ATPases, i.e., SERCA, which pumps 
calcium into the ER230, also activate the UPR231. This suggests that proteins that fold in the ER, 
in a BiP and calnexin/calreticulin dependent manner, require high levels of calcium to attain their 
native conformations. Finally, the anti-apoptotic function exhibited by BiP in transformed cells 
could be correlated to the maintenance of calcium stores in the ER by BiP39, 232, 233. 
During t he s exual c ycle of  S. cerevisiae, nuc lear f usion or  k aryogamy i s e ssential t o 
produce diploid progeny234. The first gene characterized to participate in karyogamy, KAR1, was 
also required dur ing mitosis and conjugation, possibly for the function and formation of  intra- 
and extra-nuclear microtubules235, 236. A random mutagenesis screen was subsequently performed 
to isolate additional mutants that were defective for karyogamy, and two other genes, KAR2 and 
KAR3, were i dentified36. The characterization of KAR2 as t he yeast BiP hom olog37, a nd t he 
implication of  t he S ec63 c omplex c ontaining Sec63p, B iP, S ec71p a nd S ec72p i n nu clear 
fusion237, s upported a  r ole f or B iP dur ing k aryogamy. Furthermore, t he ge netic i nteractions 
exhibited b y kar2 alleles w ith kar8/jem1238, a nd t he nuc lear f usion de fects obs erved i n jem1∆ 
yeast122, s trongly s uggest tha t the  f ormation of a  f unctional B iP-Jem1p pair is  e ssential f or 
nuclear fusion. Since the yeast ER is contiguous with the nuclear envelope, i t is not  surprising 
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that ER proteins play a role during karyogamy. However, the mechanistic details of this process 
remain ill-defined.  
1.2.9 BiP and human disease 
Given the multiple processes in which BiP partakes, as well as the diverse proteins with which it 
interacts, BiP function must be tightly regulated. Indeed, BiP dysfunction, either due to BiP up- 
or down-regulation or due to mutations in its interacting partners, correlates with several disease 
states239, 240 (Table 2). 
For example, s ome t oxic s trains of  E. coli produce t oxins s uch a s t he S higa t oxin a nd 
subtilase AB (or AB5 toxin) which enter the cell through endocytosis and subsequently traffic to 
the ER by retrograde transport via the secretory pathway. In the ER, the A subunit of the toxin, 
which possesses serine protease activity, proteolytically cleaves BiP and inactivates it241, 242; the 
resulting loss of  BiP function i s l ethal t o t he i nfected c ells. Moreover, BiP pl ays a role i n t he 
entry o f Coxsackie B and Dengue Fever vi ruses by serving as  a cel l surface receptor for these 
viruses243, 2 44. Several s tudies ha ve s hown t hat BiP t rafficks t o the c ell s urface of  m ammalian 
cells a nd pa rticipates i n s ignaling c ascades a nd a ntigen pr esentation, pos sibly b y bi nding t o 
unfolded polypeptide substrates239.  
In addition, autosomal dominant pol ycystic l iver di sease i s an i nherited di sorder which 
has be en l inked t o m utations i n t he SEC63 gene245; pa tients pr esent w ith t he pr ogressive 
development of multiple biliary epithelial liver cysts. Though the mechanism that results in the 
disease s tate i s unc lear, i t i s pr oposed t hat the l oss of  S EC63 f unction r esults i n t he 
mislocalization of  s ecretory proteins r equired for t he r egulation of  l iver cell growth a nd 
proliferation. This leads to an expansion of the liver epithelium, in turn forming cysts. Also, the  
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Table 2: Select human diseases related to BiP malfunction. 
 
Protein 
 
 
Related Disease 
 
Causative phenomenon 
 
 
Reference 
 
SEC63 
 
Polycystic liver disease 
 
Hereditary nonpolyposis colorectal cancer 
(HNPCC)-associated malignancies (i.e., 
small bowel cancer) 
 
 
Gastric cancer 
 
 
Genetic mutations 
 
Frameshift mutations due to 
DNA mismatch repair 
deficiencies 
 
 
Biallelic mutations due to 
microsatellite instability 
 
 
Davila et al., 2004245 
 
Schulmann et al., 
2005246 
 
 
 
Mori et al., 2002247 
 
SIL1 
 
Marinesco-Sjçgren syndrome 
 
 
Genetic mutations 
 
Annesi et al., 2007248 
 
SEC62 
 
 
Prostate and colorectal cancers 
 
Gene amplification 
 
Jung et al., 2006249 
 
HERP 
 
Sporadic inclusion-body myositis 
 
 
Alzheimer’s disease 
 
 
Upregulation 
 
 
Upregulation 
 
Nogalska et al., 
2006250 
 
Sai et al., 2002251 
 
BP 
 
Shiga toxinogenic Escherichia coli 
infection 
 
 
Dengue Virus and Coxsackie B viral 
infections 
 
 
 
Several kinds of cancers 
 
 
 
 
 
Diabetes 
 
BiP sequestration and 
proteolysis  
 
 
BiP acts as receptor for the 
virus during viral entry 
 
 
 
BiP upregulation due to an 
induction of the unfolded 
protein response; Increased 
expression of BiP on the cell 
surface of cancer cells 
 
Defects in UPR signaling 
 
Falguieres and 
Johannes, 2006242; 
Paton et al., 2006241 
 
Jindadamrongwech et 
al., 2004244;  
Triantafilou et al., 
2002243 
 
For reviews: 
Lee, 2007252; Wang et 
al., 2009253 
 
 
 
For a review: 
Scheuner and 
Kaufman, 2008254  
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autosomal r ecessively i nherited ne urodegenerative di sease, Marinesco-Sjçgren s yndrome, is 
caused by mutations in the SIL1 gene that result either in its truncation or inactivation248; SIL1 is 
the homolog of yeast Sls1p, one of BiP’s NEFs (Table 1) 255. The disease state probably results 
from a reduction in functional BiP pools in the ER due to SIL1 malfunction. 
Beyond these infectious and inherited diseases, mutations in SEC63 have been linked to 
several cancers that exhibit defects in DNA mismatch repair, and overproduction of SEC62 has 
been linked to prostate cancers (Table 2). BiP expression levels can also be directly correlated to 
different can cers252, 2 53; in particular, BiP participates in tumor p roliferation, metastasis and in 
some cas es, resistance to therapies. Since can cer c ells ar e unde r hi gh levels of  ox idative, 
nutritional and other environmental stresses, it is  not surprising that upregulated BiP levels are 
essential for cancer cell survival. Indeed, BiP can be found on the cell surface of cancer cells252, 
253, a nd t his popul ation may be us ed as a t arget f or t he de velopment of  canc er t herapies. In 
addition, recent studies have linked defective UPR signaling to the failure of pancreatic beta cells 
to s ecrete i nsulin i n di abetic i ndividuals254. This e ffect ma y b e BiP-dependent b ecause t he 
overexpression of B iP i n pancreatic be ta cel ls i n an in vitro system is  s ufficient to increase 
insulin secretion256. Finally, given t he c onnections be tween t he U PR a nd ne urodegenerative 
diseases including Alzheimer’s, Huntington’s and Parkinson’s diseases257, 258, and BiP’s role in 
the i nduction of  t he U PR ( refer t o s ection 1.2.7 .), ameliorating the U PR b y modul ating BiP 
function might provide a novel therapeutic strategy for curing these diseases.  
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1.3 A PREVIEW OF CHAPTERS 2 AND 3 
I chose to focus this chapter on yeast BiP and its functions within the ER, with an emphasis on 
the t hree w ell-characterized H sp40s w ith w hich it i nteracts. H owever, t he di versity of  H sp70s 
and H sp40s i ncreases i n hi gher eukaryotes a nd in s ome ot her s ubcellular c ompartments. For 
example, t he yeast c ytosol c ontains s ix H sp70s a nd 13 H sp40s259. T hus, t here i s a n i ntricate 
network of Hsp70-Hsp40 interactions. In the particular case of the yeast cytosol, members of the 
Ssa H sp70 s ub-family (Ssa1p, S sa2p, S sa3p a nd S sa4p) a re not  essential w hen i ndividually 
deleted; however, the deletion of ssa1, ssa2 and ssa4 results in yeast inviability unless Ssa3p is 
overexpressed f rom t he SSA2 promoter260. T his i ndicates t hat c ytosolic H sp70s c an perform 
overlapping f unctions a nd t hat t he l evel of  pr otein e xpression de termines t heir e ssentiality. In 
contrast, a subset of the cytosolic Hsp40s has been classified as ‘generalized cochaperones’ since 
these proteins can substitute for each other to enable cell survival, while others are considered to 
be ‘specialized’, since they are indispensable for yeast growth261. This is probably not surprising 
because t he s pecialized H sp40s m ay c ontain uni que dom ains tha t a re vi tal f or the ir 
functionality259, 261. Based on these observations, an understanding of a less complex system, i.e., 
BiP function within the ER, might shed light on the general mechanisms through which Hsp70s 
and H sp40s i nteract i n order t o pe rform di verse f unctions. A lternately, b y und erstanding t he 
requirements for a  di vergent Hsp40 t o f unction in a  non -native environment, it ma y b ecome 
possible to identify features that distinguish individual Hsp40s from one another.  
In C hapter 2, i n or der to be tter di ssect B iP f unction a nd i ts i nteraction w ith H sp40 
partners and substrates, I generated three yeast BiP mutants and characterized them in vitro and 
in vivo. I identified a mutant, R217A BiP, which was defective for protein translocation into the 
ER, ow ing t o a  r eduction i n f unctional activation b y S ec63p. T his result s uggested t hat BiP 
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possesses i nherent pr operties t hat enable i t to di fferentiate be tween i ts va rious H sp40 
cochaperones. I then utilized a screen to identify genes that exhibited genetic interactions with 
R217A B iP a nd di scovered a  pr eviously unc haracterized E R m embrane pr otein, Ilm1p, a s a  
potential regulator of translocation.  
In Chapter 3, i n order to understand the minimal requirements for Hsp40 function in the 
yeast c ytosol, I expressed w ild-type a nd m utant ve rsions of  E Rdj3, a  m ammalian E R-lumenal 
Hsp40, and tested the ability of these diverse ERdj3 forms to substitute functionally for two yeast 
cytosolic Hsp40s, Hlj1 and Ydj1. I found that the J domain-mediated interactions of ERdj3 with 
the yeast H sp70s, as w ell as  ef ficient H sp70-independent s ubstrate bi nding, w ere e ssential f or 
ERdj3 t o f unction i n t he yeast c ytosol. T his r esult s uggested t hat H sp40s a re not  j ust H sp70 
cochaperones but can perform cellular functions that require specialized properties. 
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2.0  THE TRANSLOCATION-SPECIFIC BIP MUTANT, R217A, GENETICALLY 
INTERACTS WITH ILM1, A NOVEL PLAYER IN CO-TRANSLOCATIONAL 
PROTEIN TRANSLOCATION ACROSS THE ER MEMBRANE 
The endoplasmic reticulum (ER) is the major site of protein synthesis in the eukaryotic cell, with 
nearly one-third of all cellular proteins being targeted to their final destinations in the secretory 
pathway vi a t he E R173, 174. O wing to the hi gh p rotein l oad e ncountered by t he E R, t here a re 
several quality control mechanisms in place to ensure that only correctly folded proteins reside 
within or e xit f rom the  E R5, 175, 2 62-264. T he pr imary l ine o f de fense i s f ormed by m olecular 
chaperones such as Hsp70s, calnexin/calreticulin and protein disulfide isomerases, which assist 
in protein folding as well as in protein quality control33, 175, 264, 265.  
One such molecular chaperone, the ER lumenal Hsp70, BiP/Grp78/Kar2p34, 35 , 37, 266, 267, 
is referred to as the ‘master regulator’ of the ER169, 170 and constitutes a large proportion of the 
soluble pr otein i n t he E R173. B iP pa rticipates in multiple c ellular pr ocesses, including 
polypeptide translocation across the ER membrane98, 100, 105, 107-111, 113, 114, 150, 268-270, maintenance 
of the permeability barrier of the ER during translocation115, 116, protein folding74, 166, 267, 270-277, 
recognition a nd t argeting of  m isfolded pr oteins f or r etrotranslocation dur ing E R-associated 
degradation (ERAD)3, 120, 181, 190, 278, 279, induction of the unfolded protein response (UPR)210, 213-
215, 217, 218, 223, 280-284, calcium homeostasis228, 229, and karyogamy in yeast36, 3 7, 237, 285. Therefore, 
most pr oteins t hat t raverse t he s ecretory p athway are bound t o e ncounter BiP a t s ome poi nt 
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during t heir m aturation. B iP’s e ssentiality i s f urther unde rscored b y t he va riety of  hum an 
diseases that have been correlated to BiP dysfunction239, 240. 
Like a ll Hsp70s24, B iP i s comprised of  a  hi ghly conserved N -terminal ATPase domain 
(divided into subdomains Ia, Ib, IIa and IIb) followed by a substrate binding domain and a C-
terminal lid domain. BiP uses the energy derived from ATP hydrolysis to bind to hydrophobic 
sequences within its substrates171, 172, 271, 286. In the ATP-bound conformation, BiP exhibits low 
affinity and high release rates for substrates, while in the ADP-bound conformation, it binds to 
substrates with high affinity, thus providing an environment for the substrate to attain its native 
three-dimensional f old and pr eventing a ggregation. S ince B iP i s a  p oor A TPase ( turnover 
number of  0.18 sec-1), it interacts with two classes of  cofactors to enhance its  ATP h ydrolytic 
cycle: J domain-containing Hsp40s that stimulate ATPase activity due to an interaction between 
the resident J domain and the ATPase domain of BiP, and Nucleotide Exchange Factors (NEFs) 
that e xchange A DP f or A TP. The int eraction with peptide s ubstrates is  a lso s ufficient to  
stimulate BiP’s ATPase activity70, 171. 
In yeast, the int eraction with the me mbrane-bound H sp40 hom olog, S ec63p, is 
indispensable for BiP’s role in co- and post-translational protein translocation95, 9 7, 9 8, 105, 1 07-112, 
114, whereas the interaction with the membrane-associated Hsp40, Jem1p, and the soluble Hsp40, 
Scj1p, i s c ritical f or B iP’s f unction dur ing t he ERAD of  s oluble s ubstrates, t hough t he exact 
contributions of  t hese H sp40s dur ing E RAD a re unc lear120. M oreover, a  c ompetent B iP-Scj1p 
interaction catalyzes protein folding in the ER119 while a functional BiP-Jem1p pair is required 
for karyogamy122, 238. In turn, the NEFs, Sls1p/Sil1p and Lhs1p, assist BiP and increase protein 
translocation efficiency133-136. 
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Another important role for BiP is during the induction of the UPR210, 213-215, 217, 218, 223, 280-
284. U nder nor mal uns tressed c ellular c onditions, B iP bi nds t o t he U PR-dedicated signal 
transducer kinase, Ire1p, and maintains i t in an inactive state214, 215. However, when there is an 
increased load of unfolded proteins in the ER, for example, in the presence of a reducing agent, 
BiP is titrated away from Ire1p and binds to unfolded substrates, in turn activating Ire1p210, 217, 
218. T he e nd r esult of  Ire1p s ignaling i s t he up regulation of  genes i nvolved i n pr otein f olding 
(including BiP), l ipid synthesis and transport of secreted proteins to later compartments. These 
events mitigate the unfolded protein load of the ER199. Therefore, Ire1p-mediated UPR induction 
is of ten us ed a s an i ndicator o f E R hom eostasis224, 2 25. Recently, t he BiP r esidues t hat either 
directly int eract w ith Ire1p or a re loc ated pr oximal to a r egion that int eracts w ith Ire1p were 
mapped onto subdomain Ib of BiP’s ATPase domain287.  
While the  s ignificance of B iP’s A TPase a ctivity for mos t o f its  f unctions is  w ell-
established73, 74, 151, the amino acid residues that contribute to BiP’s interactions with its Hsp40 
cofactors are less defined. The Brodsky lab recently demonstrated that the mutation of residues 
in BiP’s substrate binding domain that reduce substrate affinity specifically affects ERAD181. To 
understand t his f urther, I report on the  c haracterization of B iP mut ants tha t e xhibit de fects in 
Hsp40 i nteraction a nd/or s ubstrate bi nding. S pecifically, I i dentified a point m utation in BiP, 
R217A, w hich r esulted in de fective S ec63p i nteraction in vitro and a  translocation-specific 
defect in vivo. W hen t he genetic i nteractions be tween R 217A B iP a nd a  s ubset of  t he yeast 
knockout collection were examined in a UPR-based screen, I then discovered a novel player in 
protein t ranslocation, Ilm1p, w hich ha s t hus f ar be en poor ly characterized. T aken t ogether, I 
conclude that the ut ilization of  function-specific alleles of  essential genes in a targeted genetic 
screen can provide new insights into essential cellular processes. 
 52 
2.1 MATERIALS AND METHODS 
2.1.1 Yeast strains and plasmids 
All s trains a nd plasmids used i n t his s tudy are l isted i n T ables 4 a nd 5,  r espectively. U nless 
otherwise i ndicated, s tandard c onditions w ere us ed f or pl asmid m anipulation a nd yeast 
growth288. 
For t he h eterologous expression of  m utant BiP pr oteins i n Escherichia coli, t he KAR2 
coding sequence contained in pMR2623151 was mutagenized using the Quikchange site-directed 
mutagenesis ki t ( Stratagene) w ith the f ollowing primer pa irs ( underlined letters r epresent the  
altered sequence): (i) R217A:- 5’ primer:  
GCTGGTTTGAACGTTTGGCA
GCGGTTGTTCATTAACAAT
ATTGTTAATGAACCAACCGC, and 3’ primer:  
TGC
GGCCAAGGTGAATCTAGAAAC
CAAAACGTTCAAACCAGC; (ii) K584X:- 5’ primer:  
TAA
GTGAGCGTAGTTTTCTAA
TTAGAAAACTACGCTCAC, and 3’ primer:  
TTA
CGAGGTGAAAGAGCCATG
GTTTCTAGATTCAACCTTGGCC; (iii) S493F:- 5’ primer:  
TTT
CCTAATAGATTGTTGTCCTT
AAGGACAACAATCTATTAGG, and 3’ primer:  
AAA
For the expression of wild-type BiP protein from the galactose-inducible PGAL1 promoter 
in yeast, t he c oding s equence f or w ild-type BiP w as amplified f rom p MR713 ( CEN4, LEU2, 
PKAR2-KAR2) w ith the f ollowing pr imer p air ( italicized letters indi cate t he BamH1 recognition 
site on the 5’ primer and the XhoI recognition site on the 3’ primer):- 5’ primer:  
CATGGCTCTTTCACCTCG. T he r esultant pl asmids 
were transformed into E. coli RR1 cells for large-scale purification. 
GTAGGATCCCCAGAGTAGTCTCAA, and 3’ primer:  
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TACCTCGAGCTACAATTCGTCGTGTTC. T he r esulting P CR pr oduct was i nserted i nto t he 
pYES2 ve ctor ( 2µ URA3; Invitrogen) t o ge nerate pG AL1-KAR2. The pr imer pa irs de scribed 
above were then used to introduce the R217A, K584X and S493F mutations into pGAL1-KAR2. 
Next, the diploid yeast strain MMY2181 (MATa/α, his3-∆200/his3-∆200, leu2-∆1/leu2-∆1, ura3-
52/ura3-52, trp1-∆63/trp1-∆63, KAR2/kar2::HIS3) was tr ansformed with wild-type or  m utant 
pGAL1-KAR2 vectors a nd s porulated a nd t etrads w ere di ssected on yeast e xtract-peptone-
galactose m edium. H aploid s pores with t he f ollowing genotype were s elected: MATα, his3-
∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, pGAL1-KAR2 (wild-type or mutant) resulting in 
the GAL-KAR2, GAL-R217A, GAL-K584X and GAL-S493F yeast strains. 
For t he e xpression of  wild-type BiP f rom t he PTEF1 and PCYC1 promoters i n yeast, t he 
DNA sequence encoding BiP was removed from the pGAL1-KAR2 vector using the restriction 
enzymes BamH1 and Xho1. N ext, t he pl asmids p414T EF1 ( CEN4/ARS, TRP1, PTEF1) and 
p414CYC1 ( CEN4/ARS, TRP1, PCYC1)289 were i ndependently di gested w ith t he r estriction 
enzymes BamHI and Sal1, and the BiP coding sequence was inserted. The ligation mixture was 
transformed i nto t he yeast s train MMY8-2 ( MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, 
kar2::HIS3, pMR397 ( 2µ, URA3, KAR2))181 and transformants w ere selected on s ynthetic 
complete medium lacking uracil and tryptophan and containing 2% glucose. Positive clones were 
then pl ated ont o s elective s ynthetic c omplete medium l acking t ryptophan a nd c ontaining 2%  
glucose a nd 1 m g/ml 5 -fluoroorotic a cid ( 5-FOA). C lones t hat s urvived i n the pr esence o f 5 -
FOA ha d t he genotype: MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, pTEF1-
KAR2 (CEN4/ARS, TRP1, PTEF1-KAR2) or  MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, 
kar2::HIS3, pCYC1-KAR2 (CEN4/ARS, TRP1, PCYC1-KAR2) a nd w ere c alled TEF1-KAR2 and 
CYC1-KAR2 respectively. T he TEF1-R217A, TEF1-K584X and TEF1-S493F strains w ere 
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similarly created. In order to generate an isogenic control strain in which KAR2 was expressed 
from i ts e ndogenous pr omoter, pM R713 ( CEN4, LEU2, PKAR2-KAR2) w as i ntroduced i nto 
MMY8-2 and transformants w ere s elected on synthetic complete m edium l acking u racil and 
leucine a nd containing 2% g lucose. In a  m anner s imilar t o t hat de scribed a bove, t he pl asmid 
pMR397 was cured us ing 5 -FOA generating the strain MMY713 (MATα, his3-∆200, leu2-∆1, 
ura3-52, trp1-∆63, kar2::HIS3, pMR713). 
To create the TEF1-KAR2 jem1∆ and TEF1-R217A jem1∆ strains, the NATMX6 cassette 
was amplified from pFA6a-NATMX6290 with primers bearing homology to flanking regions of 
the JEM1 open reading frame (the underlined sequence indicates homology to regions upstream 
and downstream of JEM1):- 5’ primer:  
TGTATTACTAAGGCCGATCTTAACGTCTACGAAACGAAGTCGGATCCCCGGGTTAAT
TAA and 3’ primer:  
TGTTGTGGTATCCTAGTTAATGGGCATAGAATGTATTTCAGAATTCGAGCTCGTTTA
AAC. T he r esulting P CR pr oduct w as t ransformed i nto TEF1-KAR2 or TEF1-R217A, a nd 
transformants w ere s elected on yeast ex tract-peptone-dextrose m edium s upplemented w ith t he 
antibiotic nourseothricin at a  f inal concentration of  100 µg/ml ( CloNAT; Werner BioAgents, 
Germany). Positive cl ones w ere conf irmed by P CR. The TEF1-KAR2 scj1∆ and TEF1-R217A 
scj1∆ strains w ere cr eated in an analogous m anner but  t he P CR pr imers t hat w ere us ed 
complemented t he f lanking r egions of  t he SCJ1 open r eading frame (the unde rlined s equence 
indicates homology to regions upstream and downstream of SCJ1):- 5’ primer:  
CCAGAAGAGCGTGCATTGGCTGGCGAAAAGATCGAGGACACGGATCCCCGGGTTAA
TTAA and 3’ primer:  
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CTATCTATATATGCATGTGTGCGTACGTAGGATTATCTGT
To generate FLAG-tagged Ilm1p, the ILM1 coding sequence including the open reading 
frame and ~350 basepairs of 3’-UTR was amplified from genomic DNA extracted from BY4742 
wild-type yeast utilizing the primer pair (italicized letters represent the PvuII recognition site on 
the 5’ primer and BamHI recognition site on the 3’ primer):- 5’ primer:  
GAATTCGAGCTCGTTTAA
AC. 
GAATGGTAGTGTAACAGCTGACAACATAAT, and 3’ primer:  
CGAATGTGCGGATCCATTCGTGATGA. T he r esulting P CR pr oduct w as i nserted i nto 
pFA6a-NATMX6 immediately ups tream of  the  NATMX6 coding sequence t o pr oduce t he 
plasmid pILM1-UTR-NAT. Next, a 3XFLAG epitope was introduced at the 3’ end of the ILM1 
open reading frame in pILM1-UTR-NAT using a modified site-directed mutagenesis protocol291 
with the following primer pair:- 5’ primer:  
GATGGGAAAGATGAGAAAGGTGACTACAAGGACGATGACGATAAGAGGCCCGACT
ACAAGGACGATGACGATAAGAGGCCCGACTACAAGGACGATGACGATAAGAATGA
TGATAGCGATGCAAAA, and 3’ primer:  
TTTTGCATCGCTATCATCATTCTTATCGTCATCGTCCTTGTAGTCGGGCCTCTTATCGT
CATCGTCCTTGTAGTCGGGCCTCTTATCGTCATCGTCCTTGTAGTCACCTTTCTCATCT
TTCCCATC, to cr eate pILM1-3XFLAG. F or hom ologous r ecombination, t he r esulting ILM1-
3XFLAG-UTR-NAT sequence w as a mplified us ing t he pr imer pa ir (the unde rlined s equence 
indicates homology to regions upstream and downstream of ILM1):- 5’ primer:  
GTATCGCATTCAGCAAAAGTAAAGAATAAATTCTAAGAAAATGGCTCAAGCCTTGA
ACTC, and 3’ primer:  
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GTCTATATCTACATACATACACAGGTATCTACTATAAGA
2.1.2 Protein purification 
GAATTCGAGCTCGTTTAA
AC, and t ransformed into BY4741 wild-type yeast ( MATa, his3-∆1, leu2-∆0, ura3-∆0, met15-
∆0). P ositive c lones ( ILM1-FLAG-NAT) w ere s elected on yeast ex tract-peptone-dextrose 
medium supplemented with nourseothricin and analyzed for FLAG-tagged Ilm1p expression by 
immunoblotting with anti-FLAG antibodies (Santa Cruz Biochemicals). 
Hexahistidine-tagged wild-type and mutant BiP proteins expressed from pMR2623 were purified 
from E. coli RR1 c ells us ing a  p reviously optimized pr otocol151. GST-tagged J  dom ains of  
Sec63p (Sec63‘J’)111 and Jem1p (Jem1‘J’)181 were purified from E. coli BL21(DE3) and E. coli  
TG1 cells, respectively, according to previously established protocols.  
For he terologous e xpression of  S cj1p i n E. coli, a pl asmid c onstruct ( pET-SCJ1) w as 
generated b y i ntroducing t he D NA f ragment t hat c orresponds t o m ature S cj1p l acking t he E R 
retention signal ( amino acid residues 23 -373) i nto pE T21a ( Novagen) b etween t he NdeI and 
Not1 restriction enzyme sites (a kind gift from S. Nishikawa, Nagoya University, Japan). Upon 
transformation of pET-SCJ1 into E. coli BL21(DE3) cells and addition of isopropyl-β-D-1-thio-
galactopyranoside (IPTG), a C-terminally hexahistidine-tagged Scj1p was expressed. For large-
scale purification, logarithmic phase cells (OD600 = 0.8 to 1.0) in a volume of 1 L were induced 
with 1 mM IPTG for 4 h  at 37ºC. The cells were harvested, washed with sterile double distilled 
water and resuspended in 20 ml of denaturing lysis buffer (10 mM Tris, pH 8.0, 300 mM NaCl, 8 
M urea and 10 mM imidazole) supplemented with the protease inhibitors pepstatin, leupeptin and 
phenylmethylsulphonyl-fluoride (PMSF) at a con centration of 1 mM each. Next, the cells were 
lysed on ice by sonication (4 time, 30 s), and subjected to two rounds of centrifugation to remove 
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unbroken c ells a nd c ell debris: t he f irst r ound w as f or 10 m in a t 13000 r pm a t 4 ºC, a nd t he 
second round was for 20 min at 16000 r pm at 4ºC. The cleared lysate was loaded onto a 2 m l 
Ni2+-NTA agarose column (Qiagen) prequilibrated in lysis buffer and proteins were allowed to 
bind. All subsequent steps were performed at 4ºC. The column was then washed with 20 m l of 
10 mM Tris, pH 8.0, 300 m M NaCl and 10 m M imidazole, and 10 m l of 10 m M Tris, pH 8.0, 
300 mM NaCl and 20 mM imidazole. Proteins were eluted with a linear imidazole gradient from 
25 mM to 500 mM in 10 mM Tris, pH 8.0 and 300 mM NaCl which was set up using a gradient 
maker, and 1 ml fractions were collected. Once the peak fractions were detected by SDS-PAGE 
analysis, the protein was dialyzed into 50 mM Tris, pH 7.4, 50 mM NaCl, 2 mM MgCl2, and 0.8 
mM DTT. The protein concentration of the dialysate was determined using the Bradford reagent 
(BioRad) and protein aliquots were stored at -80ºC. The purity of the enriched protein samples 
was determined by silver staining. 
2.1.3 ATP hydrolysis and limited proteolysis assays 
Steady state-like ATPase assays were performed as described127, 151. The amount of BiP present 
in e ach r eaction a nd the r atios of  t he J  dom ain-containing cofactors or  pe ptide p5 292 
(CLLLSAPRR) to BiP a re indi cated in the f igure le gends. T he J  dom ain-containing c ofactors 
and peptide were pre-incubated with BiP on i ce for 10 m in in the absence of radiolabeled ATP 
before starting the assay at 30ºC. 
 Limited proteolysis a ssays w ere pe rformed with Proteinase K  ( Sigma) b y s lightly 
modifying the conditions described by McClellan et al., 1998151. Briefly, each reaction mixture 
contained 5 µg of wild-type or mutant BiP and 5 mM ATP or ADP as indicated, made up t o a 
volume of 64 µl in reaction buffer (20 mM HEPES, pH 7.2, 25 mM KCl, 2 mM MgCl2, 0.1 mM 
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EDTA and 0.5 mM DTT). After incubating the reaction mixture at 20ºC for 1 h to allow for BiP-
nucleotide binding, proteolysis was initiated by the addition of 2 µl of a 1 mg/ml Proteinase K 
solution i n r eaction bu ffer. The di gestion r eaction w as carried out  a t 3 0ºC f or 10 m in and 
quenched with 25  µl of  a  s olution of  10 m M P MSF a nd 90%  t ri-chloro acetic aci d (TCA). 
Finally, proteins were precipitated, resolved by SDS-PAGE and analyzed by Coomassie Brilliant 
Blue staining. 
2.1.4 Serial dilutions 
The GAL-KAR2, GAL-R217A, GAL-K584X and GAL-S493F strains were grown to logarithmic 
phase (OD600 = 0.6 t o 0.8) in selective synthetic complete medium containing 2% galactose for 
16-24 h. T en-fold s erial di lutions of e quivalent O Ds of  ea ch strain were s potted ont o s olid 
medium and cultured at the indicated temperatures for 2 d. Where indicated, the growth medium 
was supplemented with 8 mM dithiothreitol (DTT) or 0.2% glucose. 
The TEF1-KAR2, CYC1-KAR2, TEF1-R217A, TEF1-K584X, TEF1-S493F, TEF1-KAR2 
jem1∆ and TEF1-KAR2 scj1∆, TEF1-R217A jem1∆ and TEF1-R217A scj1∆ strains were grown 
to logarithmic phase in selective s ynthetic complete medium containing 2% glucose for ~16 h 
and analyzed i n a m anner s imilar t o t hat d escribed above. (The GAL-S493F and TEF1-S493F 
strains are slow-growing and required longer incubation periods to reach the logarithmic phase 
of growth.) 
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2.1.5 Preparation of yeast cell extracts and immunoblotting 
To detect expression of the wild-type and mutant BiP proteins in vivo, protein extracts of cells in 
the logarithmic phase of growth were prepared using a previously established TCA precipitation 
protocol293.  
For immunoblotting, the following antibodies were used: anti-BiP98, anti-Sec61294, anti-
Sec63‘J’ a gainst t he J  dom ain of  S ec63p (a kind g ift f rom R . S chekman, U niversity of  
California, Berkeley), anti-Sec71102, a nti-Sec7298, a nti-FLAG ( Sigma and Santa C ruz 
Biochemicals), anti-Ssh1 (a kind gift from T. Rapoport, Harvard Medical School), anti-G6PDH 
(Sigma) and  ant i-HA (Roche). P rimary, bound  a ntibodies were de corated with t he appropriate 
horse r adish pe roxidase-conjugated secondary antibody a nd signals w ere de tected using t he 
SuperSignal® West Pico Chemiluminescent Substrate  (Thermo Scientific). 
2.1.6 Pulse-labeling of cells and immunoprecipitation 
To measure the  s tability of BiP in wild-type a nd m utant TEF1-KAR2 strains, c ells were 
radioactively l abeled and chased as pr eviously described295. B riefly, 20  O Ds of  log arithmic 
phase c ells w ere h arvested, washed and  r esuspended in synthetic com plete m edium l acking 
methionine to 10 ODs/ml. After recovery at 30°C for 30 min, the cells were labeled with 25 µl of 
Express 35S la beling mi x ( Perkin-Elmer) for  1 0 min. Next, cycloheximide w as adde d at a 
concentration of 200 µg/ml to stop protein translation, and samples were collected at 0, 20, 40 , 
60 and 90 min. At each time point, 4 ODs of cells were harvested, quenched with 0.1 M sodium 
azide, and cell ex tracts w ere pr epared using g lass be ad lysis i n the pr esence of  pr otease 
inhibitors. The radioactivity of each sample was measured using a scintillation counter, and for 
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each sample, a total volume corresponding to 5 million radioactive counts per minute (cpm) was 
treated with pol yclonal anti-BiP a ntisera. Immunoprecipitated pr oteins w ere r esolved b y S DS-
PAGE a nd t he r adiolabeled pr oteins w ere de tected b y autoradiography. Relative a mounts of  
radioactivity, which c orresponded t o pr otein l evels, were qua ntified us ing Image G auge 
(FujiFilm). 
To analyze pre-pro-alpha factor (ppαF) translocation in vivo, the TEF1-KAR2 and TEF1-
R217A strains w ere tr ansformed with the pl asmid pSM36-∆gppαF-HA296, which expresses an  
HA-tagged v ersion of  mutant pr e-pro-alpha f actor l acking t he c ore consensus g lycosylation 
sequences. Transformants w ere grown to logarithmic pha se, labeled and cha sed as de scribed 
above, e xcept t hat s amples w ere collected at 0 a nd 10 m in. Immunoprecipitation of  a  s ample 
volume corresponding to 10 m illion cpm was performed with an anti-HA monoclonal antibody 
(Roche) and analyzed as above. 
To evaluate the effects of the KAR2 mutations on CPY* degradation, a plasmid encoding 
an HA-tagged version of CPY*, pDN431201, was transformed into wild-type and mutant TEF1-
KAR2 strains. T ransformants w ere grown t o l ogarithmic pha se, labeled, chased and 
immunoprecipitates were analyzed as above. 
To examine C PY f olding efficiency, wild-type a nd m utant TEF1-KAR2 strains w ere 
assayed us ing a  s lightly m odified pul se-labeling pr otocol145. E ight O Ds of  c ells g rown to 
logarithmic pha se w ere ha rvested and r esuspended i n 800 µl of  s ynthetic mini mal me dium 
supplemented with all amino acids except cysteine and methionine. After recovery at 30°C for 
15 min, cells were labeled with 10 µl of Express 35S labeling mix (Perkin-Elmer) for 10 min. A 
solution of unlabeled cysteine and methionine was added to start the chase and time points were 
taken at 0 a nd 30 m in. Cell extracts were prepared using glass bead lysis and a sample volume 
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corresponding t o 10 m illion c pm w as t reated w ith a nti-CPY a ntibodies ( Molecular P robes) t o 
immunoprecipitate CPY. The immunoprecipitates were analyzed as described above. In the case 
of kar2-113, a kar2 mutant strain t hat s erved a s a  pos itive c ontrol166, t he f olding de fect was 
induced by a temperature shift from 30°C to 37°C for 30 min, after which the cells were labeled 
and chased at 37°C. 
To determine t he e ffects of  de leting ILM1 on the t ranslocation efficiency of  s elect 
proteins in vivo, wild-type and ilm1∆ cells were labeled for 10 min as described above and either 
chased for 0 and 20  m in or i mmediately harvested. Proteins from cel l ex tracts w ere 
immunoprecipitated with anti-BiP (5 million cpm), anti-DPAP-B ( 10 m illion c pm; a  ki nd g ift 
from R. Gilmore, University of Massachusetts Medical School), anti-Pho8p (10 million counts; 
Invitrogen) or anti-ppαF (10 million cpm; a kind gift of R. Schekman, University of California, 
Berkeley) antisera as indicated. 
2.1.7 β-galactosidase assays to measure the induction of the UPR 
Wild-type and m utant TEF1-KAR2 strains w ere t ransformed w ith t he U PR r eporter pl asmid, 
pJC104208, w hich c ontains t he β-galactosidase ge ne dow nstream o f four unf olded pr otein 
response elements (UPREs). The readout for UPR induction is β-galactosidase expression which 
was assayed using a standard protocol297. The conditions that were tested for the various strains 
include: cells grown to logarithmic phase at 30°C, cells shifted to 37°C for 1 h, and cells treated 
with 8 mM DTT for 1 h at 30°C.  
 62 
2.1.8 In vitro translocation and ERAD assays 
To m easure t he t ranslocation a nd E RAD e fficiencies c orresponding t o wild-type and m utant 
forms of  pp αF, ER-derived vesicles, i.e., microsomes107, were prepared from the TEF1-KAR2, 
TEF1-R217A, TEF1-K584X and TEF1-S493F strains. In br ief, 2000 -3000 O Ds of  l ogarithmic 
phase cells were harvested, washed and subjected to lyticase treatment in order to digest the cell 
wall. After digestion, spheroplasts lacking the cell wall were collected using 0.8 M sucrose, 1.5% 
Ficoll 400, 20  mM HEPES-NaOH, pH 7.4. Next, the spheroplasts were homogenized in 0.1 M 
sorbitol, 50 mM KOAc , 2 mM EDTA, 20 m M HEPES-NaOH, pH  7.4, s upplemented w ith 
protease inhibitors, and microsomes were collected using 1.0 M sucrose, 50 mM KOAc, 20 mM 
HEPES-NaOH, pH 7.4, 1 mM DTT. Finally, the microsomes were washed and resuspended in 
HEPES-NaOH, pH 6.8 , 150 m M K OAc, 5 m M MgOAc, 250 m M s orbitol at a pr otein 
concentration of 10-12 mg/ml. Single use aliquots were stored at -80°C. 
 Next, r adiolabeled pp αF a nd ∆gppαF w ere s ynthesized using the  pl asmid templates 
pDJ100298 and pG em2α36-3Q176, r espectively, with P romega’s T nT® Coupled Reticulocyte 
Lysate S ystem. Each plasmid template w as m ixed on ice w ith Express 35S la beling mix,  
ribonuclease i nhibitor, and s upplied S P6 R NA pol ymerase, a mino acid m ixture ( lacking 
methionine), a nd r abbit r eticulocyte l ysate, a ccording t o m anufacturer’s i nstructions. T he 
reaction m ixture w as i ncubated a t 30°C  f or 90 min a nd t he r esultant r adiolabeled t ranslation 
product was aliquoted and stored at -80ºC. Translation efficiency was analyzed by SDS-PAGE 
and autoradiography. 
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For in vitro translocation assays, m icrosomes de rived f rom w ild-type or  m utant TEF1-
KAR2 strains were mixed with radiolabeled ppαF and an ATP regenerating system, and the assay 
was performed as previously described107.  
For in vitro ERAD a ssays176, t ranslocation of  ∆gppαF w as ini tially carried out  b y 
incubating r adiolabeled ∆gppαF w ith microsomes pr epared f rom wild-type or  mut ant TEF1-
KAR2 strains and an ATP regenerating system. Next, to measure ERAD efficiency, microsomes 
containing t ranslocated ∆gpαF w ere ha rvested, washed and e ither m ixed w ith 0.5 m g/ml of  
cytosol derived from RSY607 yeast, and an ATP regenerating system, or directly resuspended in 
reaction buffer (20 mM HEPES, pH 6.8, 150 mM KOAc, 250 mM sorbitol, and 5 mM MgOAc). 
The r eaction m ixture w as i ncubated a t 30°C  f or 20 m in, a fter w hich pr oteins w ere TCA-
precipitated, resolved by SDS-PAGE and analyzed by autoradiography. The data were quantified 
using Image Gauge (FujiFilm). 
2.1.9 Purification of the Sec63 complex 
The Sec63 complex containing Sec63p, BiP, Sec71p and Sec72p was purified from microsomes 
derived f rom TEF1-KAR2 and TEF1-R217A yeast unde r non -denaturing c onditions us ing a  
three-step chromatography pr otocol w hich h as be en d escribed p reviously98. T he onl y 
modification involved replacing the Superose 6 r esin that was recommended for size exclusion 
chromatography w ith a 32 ml S ephacryl S -300 column ( Amersham Biosciences) t hat w as r un 
under gravity. After pur ification, t he components of  t he complex were de tected b y Coomassie 
Brilliant Blue staining and immunoblotting. 
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2.1.10 UPR-based genetic analysis 
To generate s trains amenable for genetic analysis in the UPR-based screen, the KAR2 locus of 
BY4741 wild-type yeast was tagged with the NATMX6 casssette as described in Appendix B to 
create t he KAR2::NAT strain. Using a s imilar s trategy, the kar2-R217A::NAT strain was 
generated. Next, the KAR2::NAT and kar2-R217A::NAT strains w ere ind ividually ma ted with 
350 yeast strains (listed in Table 6 in Appendix B); each of these 350 strains carried a deletion in 
a s pecific non -essential g ene ( yfg::KANMX) a nd m aintained a  G FP-based U PR r eporter 
plasmid121. N ext, s ynthetic g enetic a rray (SGA) a nalysis w as pe rformed i n t he l aboratory o f 
Jonathan W eissman a t t he U niversity of  C alifornia, S an F rancisco, t o generate ha ploid s trains 
with t he f ollowing ge notypes: KAR2::NAT, yfg::KANMX, pUPRE-GFP or kar2-R217A::NAT, 
yfg::KANMX, pUPRE-GFP. T o m easure t he l evels of  U PR i nduction in t he r esultant ha ploid 
strains, flow cytometry was performed and the results analyzed according to Jonikas et al., 2009. 
Based on c omputational a nalyses, a cor relation coefficient w as generated which indicates t he 
similarity of ge netic int eractions exhibited by KAR2::NAT or kar2-R217A::NAT and 
yfg::KANMX. Deletion strains tha t di splayed the hi ghest c orrelation coefficient va lues w ere 
considered most similar to KAR2::NAT or kar2-R217A::NAT and could be grouped functionally 
with e ither s train. A  s econd va lue w as a lso generated w hich c orresponds t o t he l ikelihood of  
genetic i nteractions be tween KAR2::NAT or kar2-R217A::NAT and yfg::KANMX. A gain, t he 
more positive this value, the higher the probabiltity that KAR2::NAT or kar2-R217A::NAT and 
yfg::KANMX genetically interact. 
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2.1.11 Native immunoprecipitations of FLAG-tagged Ilm1p 
To identify proteins th at int eract with Ilm1p, a FLAG-tagged v ersion of  Ilm1p w as generated 
(refer to section 2.1.1). Next, native immunoprecipitations were performed as described3, except 
that the ER membrane preparation protocol was modified299. In brief, 2 L of BY4741 and ILM1-
FLAG yeast grown to an OD600 of 2-3 were harvested, washed with sterile double distilled water 
and stored at -20°C. The next day, the cell pellets were thawed on ice and resuspended in 20 ml 
of lysis buffer (20 mM HEPES, pH 7.4, 50 mM KOAc, 2 mM EDTA, 0.1 M sorbitol and 1 mM 
DTT) supplemented with protease inhibitors. Glass beads were added up to the meniscus and the 
cells were disrupted by agitation on a Vortex mixer (ten times for 30 s with 1 min incubation on 
ice between each round). The resulting lysate was layered onto 20 mM HEPES, pH 7.4, 50 mM 
KOAc, 1.0 M sucrose, and 1 mM DTT, and centrifuged for 10 min at 6000 rpm at 4°C in an HB-
6 rotor (Sorvall). The supernatant was collected and further centrifuged at 16000 rpm for 30 min 
at 4°C in an SS-34 rotor (Sorvall) to isolate the ER-enriched membrane fraction. The membranes 
were washed once in IP buffer (50mM HEPES, pH 6.8, 150mM KOAc, 2 mM MgOAc, and 1 
mM Ca Cl2) s upplemented w ith pr otease i nhibitors, a nd i mmunoprecipitation w as pe rformed 
using anti-FLAG agarose beads (Sigma) as described3. Proteins in the precipitate were resolved 
by SDS-PAGE and analyzed by immunoblotting. 
2.1.12 Cycloheximide-chase ERAD assays 
To measure the ERAD efficiency of ilm1∆ yeast, the following plasmids were transformed into 
the B Y4742-based ilm1∆ strain: C PY*-3HA300 (CEN/ARS, URA3, prc1-1:3HA), p425-Ste6p*-
HA (2µ, LEU2, PPGK1-ste6-166:HA) ( refer t o s ection 3.1.6) , p SM1152293 (2µ, URA3, PPGK1-
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CFTR:HA) and pS LW1-B29301 (2µ, URA3, PGAL1-APOB29:HA). Transformants w ere s elected, 
grown to logarithmic pha se and cycloheximide chase ana lysis was c arried out at  t he i ndicated 
temperature according to an established protocol299. The resulting cell extracts were resolved by 
SDS-PAGE a nd i mmunoblotted w ith a n a nti-HA a ntibody to detect th e H A-tagged E RAD 
substrates. The amount of HA-tagged substrate present in each sample was quantified using the 
Image S tation s oftware ( Kodak) a nd w as nor malized t o the l evel of  g lucose-6-phosphate 
dehydrogenase (G6PDH), which served as a loading control. 
2.1.13 Data analysis 
The e xperimental a verage of  t hree o r m ore i ndependent r eplicates a nd t he c orresponding 
experimental er ror w ere calculated in Microsoft E xcel 2003 using t he ave rage ( AVG) and  
standard e rror ( STEYX) f unctions, respectively. All of  t he graphs w ere pl otted us ing 
Kaleidograph (version 3.0.4; Synergy software).  
2.2 RESULTS 
2.2.1 Generation of the yeast BiP mutants, R217A, K584X and S493F 
As stated above, a previous genetic screen in the lab identified BiP mutants that were defective 
for s ubstrate bi nding, bu t not  f or i nteraction w ith t he J  dom ains of  H sp40s181. Intriguingly, in 
vivo expression of  t hese mutants r esulted specifically i n ERAD de fects, Therefore, i n order t o 
better understand the r equirements f or J  dom ain i nteraction a nd s ubstrate bi nding i n BiP 
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function, three yeast BiP mutants, R217A, K584X and S493F, were generated (Figure 10A). The 
invariant R217 residue lies in subdomain IA of BiP’s ATPase domain and maps to the positively 
charged l ower cl eft t hat i s thought t o di rectly contact t he J  domain91, 9 2. S everal s tudies ha ve 
demonstrated t hat m utating t his r esidue i n H sp70s r esults i n r educed i nteraction w ith H sp40 
cochaperones91, 116, 302. The K584X mutation generates a truncated protein that lacks part of the 
lid dom ain. In vitro studies s howed t hat K 584X B iP (amino a cids 43 -583) bi nds t o t he s ame 
range of peptide substrates as wild-type BiP but exhibits a higher off-rate for the peptides303. The 
S493F mut ant w as is olated in a g enetic s creen directed to identify B iP mut ants de fective f or 
ERAD181, but was not reported (Kabani, M. and Brodsky, J.L., unpublished data). This mutation 
is predicted to disrupt a  salt br idge between BiP’s susbtrate binding and l id domains, and may 
affect peptide binding. 
 Hexahistidine-tagged wild-type and mutant proteins were purified from E. coli and their 
endogenous ability t o h ydrolyze ATP w as e xamined. I obs erved t hat R217A B iP h ydrolyzed 
ATP to similar levels as the wild-type protein whereas the K584X and S493F mutants exhibited 
reduced activity (Figure 10B). The specific activity of wild-type BiP was 1.48 + 0.06 nmol ATP 
hydrolyzed/ mg/ min while that of R217A, K584X and S493F was 1.47 + 0.09, 0.78 + 0.12 and 
0.53 + 0.09, respectively. This suggested that mutations in the substrate binding and lid domains 
affected the a ctivity of  BiP t o a greater extent t han a m utation in an ATPase dom ain surface 
residue.  To determine whether t he e ffects on ATPase a ctivity w ere d ue t o altered protein 
conformation, t he pr otease s usceptibility pa tterns of  t he w ild-type and  mutant pr oteins w ere 
compared. I found that the protease digestion pattern of the R217A mutant was similar to wild-
type B iP; how ever, t he K 584X m utant e xhibited a n i ncreased s usceptibility t o p rotease 
irrespective of the bound nucleotide (Figure 10C). This suggested that K584X BiP might have  
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 Figure 10: Three yeast BiP mutants: R217A, S493F and K584X.  
 (A) The r esidue R 217 w as m apped ont o t he c rystal s tructure of  t he A TPase dom ain of  
bovine Hsc701 after al igning the sequences of BiP and Hsc70. This residue is conserved between 
BiP and Hsc70. The residues S493 and K584 were mapped onto the crystal structure of the peptide 
binding and lid domains of the bacterial Hsp70, DnaK9, after aligning the BiP and DnaK sequences. 
While K584 is conserved in DnaK, serine at 493 is an alanine in DnaK. Also included is a linear 
representation of  t he mutations on B iP’s s econdary s tructure. (B) The e ndogenous A TPase 
activities of 3 µg of wild-type (   )  and mutant BiP isolates (R217A (O), K584X (   )  and S493F (   
)) were measured a t 30°C . ATPase act ivity i s ex pressed as nm oles of  A TP h ydrolyzed per 
milligram of protein. Data represent the means of a minimum of three independent experiments + 
standard errors. (C) Protease susceptibility assays were performed at 30°C on wild-type and mutant 
BiP i solates i n t he pr esence of  5 m M A TP or  ADP, a s i ndicated. Data ar e r epresentative of  a  
minimum of three independent experiments. 
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reduced s tability in vitro. In c ontrast, t he p rotease s usceptibility pa ttern of  S 493F B iP w as 
different from  w ild-type B iP i n bot h t he ATP- and ADP-bound s tates ( Figure 10C), impl ying 
that S493F BiP adopts a non-native conformation. This could, in turn, account for i ts observed 
defect in ATP hydrolysis. 
2.2.2 R217A BiP exhibits defective interaction with Sec63p and Scj1p 
Next, I analyzed the ability of the wild-type and mutant BiP proteins to functionally interact with 
the J domains of BiP’s cognate JDPs, Sec63p, Jem1p and Scj1p. To this end, the J domains of 
Sec63p ( Sec63‘J’) a nd Jem1p ( Jem1‘J’), a nd f ull-length Scj1p (Scj1) w ere ex pressed and 
purified from E. coli and tested in ATPase assays. As expected, wild-type BiP’s ATP hydrolsysis 
activity was robustly stimulated by all three JDPs (Figure 11). In contrast, R217A BiP exhibited 
a specific defect for interaction with Sec63‘J’ (Figures 11A and 11D) and Scj1 (Figures 11C and 
11F), but its  A TPase a ctivity w as efficiently s timulated by J em1‘J’ ( Figures 11B a nd 11E).  
Taken together, these results suggest that a unique point mutation in the ATPase domain of BiP 
is s ufficient to  c onfer di fferential r ecognition towards the  J  dom ains of  cognate J DP 
cochaperones. Furthermore, t he A TPase a ctivity of K 584X a nd S 493F B iP w as pr oficiently 
stimulated by Sec63‘J’ and Jem1‘J’, with the observed fold-stimulation being greater than wild-
type levels (Figures 11A and 11B); however, these mutants were defective for Scj1 stimulation 
(Figure 11C). One possible explanation for this observation is that the interactions of K584X and 
S493F with the J domains of Sec63p and Jem1p, but not with full-length Scj1p, might shift the 
stabilities/conformations of these mutants toward a state which resembles the wild-type protein. 
Hence, they are now competent to hydrolyze ATP at rates similar to wild-type BiP. 
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 Figure 11: R217A is compromised for stimulation of ATPase activity by the J 
domain of Sec63p and full-length Scj1p, but not by the J domain of Jem1p.  
 ATPase as says w ere pe rformed either i n t he absence (white ba rs) or  presence ( black 
bars) o f (A) the J  domain of  Sec63p (Sec63‘J’), (B) the J  domain of  J em1p (Jem1‘J’), or (C) 
full-length Scj1p (Scj1). Wild-type or mutant BiP proteins (3 µg) and the JDP constructs were 
present in equimolar amounts in the reactions. By increasing the molar amounts of (D) Sec63‘J’, 
(E) Jem1p‘J’, or  (F) Scj1 present in t he reaction, t he stimulation of  R 217A BiP’s A TPase 
activity ( O) b y t hese J DPs was specifically compared to WT (    ). The A TPase a ctivity is  
expressed as nmoles of ATP hydrolyzed per mg of protein per min. Data represent the means of 
a minimum of three independent experiments + standard errors. 
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  Next, I examined the ability o f the pe ptide p5 292 (CLLLSAPRR) t o activate t he A TP 
hydrolysis rates of wild-type and mutant BiP isolates. By analyzing a range of p5 concentrations, 
I observed that wild-type and R217A BiP interacted productively with p5 (Figure 12). However, 
the two peptide binding domain mutants, K584X and S493F, exhibited significantly reduced p5-
stimulated ATPase act ivities (Figure 12). These data suggest that the presence o f a lid domain 
and the ability of the lid domain to clamp onto the substrate binding domain are both critical for 
BiP to functionally interact with peptide substrates.  
Overall, my in vitro analyses indicate that K584X and S493F BiP are primarily defective 
for substrate binding, whereas R217A BiP exhibits a specific defect in the interaction with two of 
BiP’s JDP cochaperones, Sec63p and Scj1p.  
2.2.3 High level expression of BiP mutants results in yeast strains displaying varied 
sensitivity to elevated temperature and ER stress 
Next, I  genetically e ngineered yeast t o e xpress the R 217A, K 584X or  S493F B iP m utants in 
order t o e xamine t he c onsequences of  t hese m utations on B iP f unction. Initially, t he genes 
encoding t he w ild-type and m utant B iP pr oteins w ere expressed f rom t he ga lactose-inducible 
PGAL1 promoter to generate the s trains: GAL-KAR2, GAL-R217A, GAL-K584X and GAL-S493F 
(Figure 13A). Because the ability of a protein to support cellular growth is an important measure 
of its  f unction, I te sted the a bility of  the se w ild-type a nd m utant kar2 strains to grow in the 
presence of environmental stresses. GAL-KAR2, GAL-R217A, GAL-K584X and GAL-S493F cells 
were serially diluted onto selective medium and exposed to a range of temperatures. I found that 
the expression of  wild-type BiP from PGAL1 did not affect yeast growth at a ll the  temperatures 
tested (Figure 13B), as expected. However, expression of R217A, K584X and S493F BiP from  
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 Figure 12: K584X and S493F are defective for peptide stimulation of ATPase 
activity.  
 ATPase assays were performed in the presence of increasing molar ratios of peptide p5 
(CLLLSAPRR). 1 µg of wild-type (   ), R217A (O), K584X (   ) or S493F (   ) BiP isolates was 
present in each reaction. The ATPase activity is expressed as nmoles of ATP hydrolyzed per mg 
of protein per min. Data represent the means of a minimum of three independent experiments + 
standard errors. 
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PGAL1 resulted in a growth defect at 37°C (Figure 13B). In fact, the S493F mutant was unable to 
support g rowth e ven a t 30°C ( Figure 13B), indicating tha t the  pr esence of  thi s mu tation was 
unfavorable for cellular homeostasis under normal growth conditions. Furthermore, the growth 
defect o f t he GAL-R217A and GAL-K584X mutant s trains w as ex acerbated in the pr esence o f 
DTT, a  reducing a gent t hat i nduces E R s tress ( Figure 13C), e ven t hough t he w ild-type GAL-
KAR2 grew robustly in the presence of DTT. This suggested that the GAL-R217A and the GAL-
K584X mutant strains were unable to mount an adequate UPR to counteract the damaging effects 
of DTT. 
To de termine w hether t he obs erved de fects c ould be  a ttributed t o di fferential l evels of  
protein expression from PGAL1 (and also due to variations in plasmid copy number), I prepared 
cell extracts from wild-type and mutant strains and compared BiP levels by immunoblotting with 
a pol yclonal a nti-BiP a ntiserum. A s s hown i n F igure 13D, R 217A B iP i s e xpressed t wo-fold 
higher than wild-type BiP while the S493F mutant is expressed three-fold higher. In contrast, the 
K584X BiP m utant i s e xpressed t hree-fold l ower t han w ild-type, a fter h aving a ccounted for a  
two-fold reduction in antibody recognition for t his t runcation mutant. This was de termined b y 
analyzing equal amounts of purified wild-type and K584X BiP proteins by immunoblotting with 
the anti-BiP antiserum (data not shown).  
 Taken together, these d ata indi cate tha t the  g rowth defects r esulting f rom mut ant B iP 
expression could be explained in two ways: (i) the level of mutant protein expression determines 
the viability o f the  yeast s train; for example, high levels of  S493F BiP may be d etrimental to 
yeast s urvival, or  ( ii) the B iP m utants ar e f unctionally de fective and are una ble t o completely 
substitute for wild-type B iP in vivo; for example, R217A BiP which shows specific de fects in 
vitro. To test the first possibility, the wild-type and mutant strains were serially diluted onto  
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 Figure 13: Expression of BiP mutants from the galactose-inducible PGAL1 promoter 
results in yeast strains exhibiting varied sensitivities to elevated temperature and ER stress.  
 (A) An outline of the methodology used to construct yeast strains expressing wild-type and 
mutant B iP pr oteins f rom the  PGAL1 promoter. (B) Ten-fold s erial di lutions of  t he PGAL1–based 
kar2 wild-type and mutant strains (denoted here as KAR2, R217A, K584X and S493F) were plated 
onto selective m edium containing 2%  galactose a s t he onl y c arbohydrate s ource. Plates w ere 
incubated at 26, 30, 35 and 37°C, for 2 d. (C) Ten-fold serial dilutions of the wild-type and mutant 
strains were plated onto selective medium lacking (-DTT) or containing 8mM DTT (+DTT) and 
containing 2% galactose as the only carbohydrate source. Plates were incubated at 35°C for 2 d. 
(D) Cell e xtracts were prepared f rom w ild-type or  m utant s trains grown a t 30 °C in medium 
containing 2% galactose as the only carbohydrate source and immunoblotted with polyclonal anti-
BiP antisera. The level of Sec61p in cell extracts served as a loading control. (E) Ten-fold serial 
dilutions of  the  wild-type and mutant s trains were pl ated onto selective medium containing 2 % 
galactose ( SC -ura + 2%gal) or  a  m ixture of  2%  ga lactose a nd 0.2%  glucose ( SC –ura +2% gal 
+0.2%glu). Plates were incubated at 26 or 30°C for 2 d. 
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medium c ontaining 2%  ga lactose w hich w as supplemented w ith 0.2 % glucose t o r educe 
expression from the PGAL1 promoter304. To my surprise, reducing the levels of each of the three 
mutant proteins by glucose-mediated PGAL1 repression resulted in inviability even though, again, 
the wild-type GAL-KAR2 strain grew in the presence of glucose (Figure 13E). This observation 
lent strong support to the second possibility that the BiP mutants are functionally defective and 
that hi gh l evels o f p rotein e xpression a re required t o compensate f or a ny functional d efects. 
Given the potential drawbacks of using a galactose-inducible promoter on a multicopy plasmid 
for protein expression, I decided to use an alternative BiP expression system. 
2.2.4 Lower level expression of the K584X and S493F BiP mutants results in yeast strains 
exhibiting sensitivity to elevated temperature and ER stress 
For lower and, ideally, comparable levels of  expression, the genes encoding the wild-type and  
mutant BiP proteins were engineered under the control of the constitutive PTEF1 promoter, which 
drives moderate levels of protein expression on a CEN4/ARS plasmid, p414TEF289. The resulting 
strains were denoted TEF1-KAR2, TEF1-R217A, TEF1-K584X and TEF1-S493F (Figure 14A). 
Similarly, I attempted to engineer the se genes unde r the  control of  the  c onstitutive PCYC1 
promoter which drives even lower levels of protein expression289. However, I was unsuccessful 
in obtaining strains in which the mutant proteins were expressed from PCYC1, even though I was 
able to generate the wild-type CYC1-KAR2 strain. This further supported the observation that a 
reduction in the levels of the mutant proteins results in inviability (Figure 13E). 
I first compared the expression levels of BiP in TEF1-KAR2, TEF1-R217A, TEF1-K584X 
and TEF1-S493F yeast and observed that t he l evel of  wild-type B iP expressed from t he PTEF1 
promoter was identical to that from BiP’s endogenous promoter (Figure 14B; compare WT and 
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TEF1-KAR2). Thus, the TEF1-KAR2 strain can be treated as a wild-type strain for the purposes 
of this study. Next, I found that the mutant proteins were expressed at levels similar to wild-type 
BiP in the PTEF1-based kar2 strains ( Figure 14B), a lthough t he K 584X m utant w as e xpressed 
two-fold lower, even after accounting for the r educed recognition b y the anti-BiP antiserum. I 
therefore tested whether K584X BiP was unstable in vivo. To measure stability, I radioactively 
labeled the w ild-type a nd m utant PTEF1-based kar2 strains a nd assayed t he l evel of  BiP b y 
performing a  c hase a nalysis a nd immunoprecipitating B iP f rom c ell e xtracts a t va rious tim e-
points. As anticipated, K584X was turned over more rapidly than the wild-type protein (Figure 
14C), confirming that this mutant has a reduced stability in vivo. This observation suggests that 
BiP’s lid domain confers stability. The stabilities of R217A and S493F were similar to wild-type 
(Figure 14C), consistent with the behavior of these proteins in limited proteolysis assays (Figure 
10C).  
I next tested the ability of the wild-type and mutant PTEF1-based kar2 strains to grow at 
elevated temperatures o r in t he pr esence of  D TT. I f ound t hat t he TEF1-KAR2 strain grew 
robustly at all temperatures tested as well as in the presence of DTT (Figures 14D and 14E). The 
CYC1-KAR2 strain, on t he other h and, grew s lowly at 26°C  and 37°C , and in t he pr esence of  
DTT ( Figures 14D a nd 14E). Since h alf as muc h BiP is  pr esent in  the  CYC1-KAR2 strain as 
compared to the TEF1-KAR2 strain (data not shown), these data indicated that a reduction in the 
levels of wild-type protein is sufficient to create a cellular stress, which is exacerbated by non-
optimal growth conditions. I then compared the mutant kar2 strains and found that the growth of 
TEF1-R217A yeast was most s imilar to the wild-type s train (Figures 14D and 14E). However, 
the TEF1-K584X and TEF1-S493F strains showed modest and strong temperature-sensitive and 
DTT-sensitive growth defects, respectively (Figures 14D and 14E).  
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Figure 14: Expression of K584X and S493F BiP from the constitutive PTEF1 promoter 
results in yeast strains exhibiting sensitivity to elevated temperature and ER stress.  
(A) An outline of the methodology used to construct yeast strains expressing wild-type and 
mutant BiP proteins from the constitutive PTEF1 and PCYC1 promoters. (B) Cell ex tracts prepared 
from the PTEF1-based kar2 wild-type or  m utant strains g rown a t 30 °C were resolved by S DS-
PAGE a nd i mmunoblotted w ith polyclonal a nti-BiP ant isera. The l evel of S ec61p served as a 
loading c ontrol. (C) Pulse-chase followed b y immunoprecipitation a ssays w ere pe rformed on 
TEF1-KAR2 (    ),  TEF1-R217A ( O ), TEF1-K584X (   ) and TEF1-S493F (   )  strains grown at 
30°C using anti-BiP antisera. Data represent the means of three or more independent experiments 
+ standard e rrors. (D) Ten-fold serial di lutions of  the  w ild-type a nd m utant s trains were pl ated 
onto selective m edium. Plates w ere i ncubated at 26, 30 a nd 37 °C for 2  d. (E) Ten-fold serial 
dilutions of the wild-type and mutant strains were plated onto selective medium without (-DTT) or 
with 8mM DTT (+DTT). Plates were i ncubated at 30 °C for 2 d . (F) Induction of  t he unfolded 
protein r esponse ( UPR) i n w ild-type a nd m utant PTEF1–based strains was an alyzed us ing β-
galactosidase reporter assays. Cells were incubated either at 30°C (-), shifted to 37°C for one hour 
(37), or treated with 8mM DTT for one hour at 30°C (DTT). Where indicated, WT corresponds to 
the MMY713 strain (refer to section 2.1.1). 
Note that the exacerbated growth defect of  the TEF1-K584X strain relative to the TEF1-
S493F strain probably arises from different stabilities of the corresponding BiP mutant proteins.  
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 Since the Brodsky lab previously showed that the expression of BiP mutants deficient for 
substrate binding resulted in a DTT-sensitive growth phenotype due to a constitutive induction of 
the U PR181, I  a sked whether yeast e xpressing K584X a nd S 493F B iP, m utants t hat e xhibit 
reduced peptide interaction (Figure 12), also display high, constitutive UPR levels. Therefore, a 
UPR reporter plasmid was t ransformed into the PTEF1-based kar2 wild-type and mutant s trains 
and UPR induction levels were measured using a β-galactosidase assay.  As expected, the TEF1-
K584X and TEF1-S493F strains showed a  greater than 10-fold higher induction of  the UPR at 
30°C when compared to the TEF1-KAR2 strain (Figure 14F; compare columns labeled ‘-’ of the 
wild-type and mutant strains). Moreover, stressors such as elevated temperature and DTT did not 
exaggerate t he l evel of  UPR i nduction in TEF1-K584X and TEF1-S493F yeast ( Figure 14F; 
compare columns labeled ‘-’ to those labeled ‘37’ and ‘DTT’). These data suggest that the UPR 
is ma ximally induc ed i n t hese m utant s trains. C onsequently, t he growth de fects e xhibited b y 
TEF1-K584X and TEF1-S493F yeast may be explained by their inability to mount a greater UPR 
at elevated temperatures and in the presence of DTT. 
Taken together, these observations suggest that mutations in the substrate binding domain 
predominantly affect BiP’s ability to bind to substrates, and the expression of  such mutants in 
yeast may result in large-scale protein unfolding in the ER, thus inducing the UPR. However, a 
mutation that affects J  domain interaction and does not alter substrate binding has no e ffect on 
growth under stress conditions. 
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2.2.5 The TEF1-R217A strain exhibits a defect in protein translocation across the ER 
membrane, but is proficient for ERAD and ER protein folding 
Protein translocation across the  E R me mbrane i s the  f irst commitment s tep in the s ecretory 
pathway. Given that BiP plays a role during co- and post-translational protein translocation (refer 
to s ection 1.2.4) , I m easured t he t ranslocation efficiencies of  t he TEF1-KAR2, TEF1-R217A, 
TEF1-K584X and TEF1-S493F strains. I therefore prepared ER-derived microsomes from these 
strains and performed in vitro translocation assays for a w ell-characterized substrate, the yeast 
mating pheromone precursor, pre-pro-alpha factor (ppαF)298, 305-308. Upon translocation into the 
ER, t he ‘ pre’ s ignal s equence o f pp αF i s cl eaved309 by t he c atalytic subunit of  t he s ignal 
peptidase com plex, Sec11p159, a nd t he r esulting protein i s t riply N-glycosylated t o the 3 gpαF 
form305. These t ransformations can be as sessed by al tered electrophoretic m obilities on a 
denaturing polyacrylamide gel.  
When microsomes derived from TEF1-KAR2 wild-type yeast were incubated with ppαF, 
a translocation efficiency of ~50% was obtained (Figure 15A). This efficiency is comparable to 
the l evel i n m icrosomes pr epared f rom t he M MY713 w ild-type s train ( data not  s hown). 
However, m icrosomes c ontaining R 217A B iP w ere ha lf as efficient ( Figure 15A). T his result 
could be partly explained by my observation that R217A BiP is defective for interaction with the 
J domain of Sec63p, the Hsp40 cochaperone dedicated to translocation (Figures 11A and 11D). 
Moreover, microsomes containing the substrate binding mutants, K584X and S493F BiP, were 
defective f or t ranslocation (Figure 15A), a lthough t he m utant pr oteins i nteracted c ompetently 
with S ec63p ( Figure 11A). In f act, m icrosomes c ontaining S 493F ha d ne gligible levels of  
translocation, similar to a previously characterized kar2 mutant with a lesion in the ATPase  
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 Figure 15: Yeast expressing R217A BiP exhibit translocation, but not ERAD or ER 
folding defects.  
(A) In vitro ppαF t ranslocation assays were pe rformed us ing microsomes derived f rom 
wild-type and mutant PTEF1–based strains. Two controls included reactions lacking microsomes 
(-) a nd m icrosomes d erived f rom a  kar2 mutant s train, kar2-159. A fter t ranslocation, e ach 
reaction was divided and treated in one of three ways: A-buffer, B-trypsin, C-trypsin and Triton 
X-100. T he pe rcent translocation efficiency is i ndicated below e ach panel. Data a re 
representative o f a  m inimum of  f our i ndependent e xperiments. (B) Accumulation of  pp αF or  
signal sequence-containing pr e-BiP w as ana lyzed at the  indi cated time-points dur ing a  pul se-
chase immunoprecipitation experiment to determine the translocation efficiencies of  the TEF1-
KAR2 and TEF1-R217A strains. sec11-7 was us ed a s a  pos itive control. (C) In vitro ERAD 
assays assessing t he de gradation of  ∆gpαF w ere pe rformed using mic rosomes f rom w ild-type 
and m utant PTEF1–based strains. Reactions w ere ca rried out i n the ab sence (white ba rs) or  
presence ( black bars) of  an ATP regeneration system and 0.5 mg/ml o f yeast cytosol. Data 
represent t he m eans of  a m inimum of  t hree i ndependent e xperiments + standard errors. (D) 
Pulse-chase followed by immunoprecipitation assays were used to analyze the degradation of a 
soluble ERAD substrate, CPY*, in the TEF1-KAR2 (   ),  TEF1-R217A ( O ), TEF1-K584X (   )  
and TEF1-S493F (   )  s trains. Data represent t he m eans o f a m inimum of t hree i ndependent 
experiments + standard e rrors. (E) CPY f olding was e xamined in the  wild-type a nd m utant 
PTEF1–based strains by pul se-labeling t he c ells and pe rforming a c hase f or 30 m in. kar2-113 
served as a pos itive co ntrol. Data ar e r epresentative of  t hree i ndependent ex periments. The 
various CPY forms are described in the text.  
All of the experiments were performed at 30°C. 
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domain, kar2-159p268. These da ta suggest t hat b oth Sec63p J  domain interaction and substrate 
affinity are important determinants of BiP’s ability to support translocation. 
 To verify the obs erved t ranslocation de fects in vivo, I examined the translocation 
efficiency o f the TEF1-KAR2 and TEF1-R217A strains. These s trains are of  the MATα mating 
type and I ini tially imm unoprecipitated ppαF from r adiolabeled cell ex tracts us ing ant i-ppαF 
antiserum. However, I was unable to observe an accumulation of ppαF in the TEF-R217A strain 
(data not  s hown) either due  t o l ow l evels o f e xpression of t his p rotein or ine fficient 
immunoprecipitation. Therefore, I transformed t hese strains w ith a  pl asmid e ncoding a n H A-
tagged version of a ppαF mutant (∆gppαF) and performed immunoprecipitations with anti-HA 
antiserum. ∆gppαF cannot be  N -glycosylated as i t translocates ac ross t he E R membrane; 
however, the s ignal s equence c an be cl eaved to generate ∆gpαF, which becomes an ERAD 
substrate176, 310. Based on this analysis, I observed that ∆gppαF accumulated in the TEF1-R217A 
strain (Figure 15B). This species was also present in the control strain, sec11-7159, which carries 
a mut ant a llele in the SEC11 gene ( Figure 15B). Furthermore, I observed t hat t he s ignal 
sequence-containing form of  BiP, i.e., pre-BiP, a lso accumulated in the TEF1-R217A strain 
(Figure 15B). Taken together, these data demonstrate that the expression of R217A BiP in yeast 
results in translocation defects.  
Next, I evaluated the ability of microsomes containing either the wild-type or mutant BiP 
proteins to degrade ∆gpαF via ERAD and observed that microsomes prepared from the TEF1-
R217A strain de graded ∆gpαF to a s imilar e xtent a s mic rosomes de rived from the  w ild-type 
strain (Figure 15C). T his r esult w as ini tially s urprising be cause R 217A BiP w as d efective f or 
interaction with Scj1p, one of two JDP cochaperones required for ERAD (Figures 11C and 11F), 
but not  J em1p ( Figures 11B a nd 11E). H owever, g iven t he f act t hat S cj1p a nd J em1p e xhibit 
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overlapping functions d uring the ERAD of  ∆gpαF120, i t follows that the i nteraction of  R217A 
BiP with Jem1p is sufficient to support ERAD. In contrast, microsomes derived from the TEF1-
K584X and TEF1-S493F strains demonstrated defects in mutant pαF degradation (Figure 15C). 
Again, s ince K 584X a nd S 493F B iP e fficiently i nteracted w ith J em1p (Figure 11B), but  not  
Scj1p (Figure 11C), this defect can be directly attributed to their substrate binding incompetence 
(Figure 12).  
To confirm t hese da ta, I measured t he ability of the  w ild-type a nd m utant PTEF1-based 
strains t o de grade t he m odel E RAD substrate, C PY*, w hich i s a  m utant f orm of  t he va cuolar 
protease, carboxypeptidase Y  ( CPY). As a bove, t he TEF1-K584X and TEF1-S493F strains 
exhibited de fects i n t he E RAD of  CPY* (Figure 15D) w hereas t he TEF1-KAR2 and TEF1-
R217A strains efficiently degraded C PY*. T aken t ogether, t hese r esults s uggest t hat s ubstrate 
binding is an important determinant of BiP’s ability to support ERAD. 
I then examined the ability of the BiP mutants to support ER protein folding by following 
the in vivo maturation of CPY311-313. Upon translocation into the ER, the signal sequence of pre-
pro-CPY is cleaved to generate pro-CPY, which is N-glycosylated to the ‘p1CPY’ ER precursor 
form. S ubsequent t rafficking t o t he G olgi r esults i n a dditional s ugar m odifications, ge nerating 
the ‘ p2CPY’ G olgi pr ecursor f orm. F inally, t he “ pro” s equence i s cleaved i n t he v acuole, 
resulting in the ma ture a nd active mC PY f orm. mCPY ha s a  mo lecular ma ss s imilar to the 
immature pre-pro-CPY form while p2CPY and p1CPY have higher molecular masses and hence 
migrate at a slower rate on a denaturing polyacrylamide gel. Defects in CPY folding in the ER 
result in an accumulation of the p1CPY ER precursor form. 
CPY was immunoprecipitated from TEF1-KAR2, TEF1-R217A, TEF1-K584X and TEF1-
S493F yeast that were pulse-labeled for 10 min at 30°C and then chased for 30 min (Figure 15E). 
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The t emperature-sensitive kar2 mutant s train, kar2-113, s erved a s a  p ositive c ontrol166. As 
expected, in the wild-type TEF1-KAR2 strain, bands corresponding to the p1CPY, p2CPY and 
mCPY forms were observed after 10 min of pulse-labeling (Figure 15E; lane marked ‘0’), and at 
the end of the 30 m in chase, the p1CPY and p2CPY forms matured to the mCPY form (Figure 
15E); since signal peptide cleavage occurs co-translocationally, the pre-pro-CPY form cannot be 
detected in a wild-type strain. In the kar2-113 mutant strain, on the other hand, the pre-pro-CPY 
and p1CPY forms persisted at 30 m in, confirming that this strain has a translocation as well as 
folding de fect ( Figure 6 E). S urprisingly, t he C PY f olding pr ofile i n t he TEF1-R217A, TEF1-
K584X and TEF1-S493F strains a t 30 min resembled that of  the  wild-type s train (Figure 15E) 
suggesting that these strains were not deficient for CPY folding. This was unexpected because I 
had obs erved t hat t he R217A, K 584X a nd S 493F B iP m utants w ere defective for in vitro 
interaction w ith S cj1p (Figure 2C ). S cj1p c ooperates w ith B iP t o f old E R pr oteins unde r 
conditions of  s tress i nduced b y h ypoglycosylation119, and exhibits g enetic int eractions w ith 
several kar2 alleles118, 119. However, it is possible that the expression of these kar2 mutants has 
no e ffect on N -linked glycosylation a nd h ence t hese m utants a re not  de pendent on S cj1p 
cooperation for folding CPY. Also, in the absence of Scj1p, it has been observed that Jem1p can 
take over a s a f olding c ofactor f or B iP119, a nd none  of  t hese m utants are de fective f or J em1p 
interaction (Figure 11B). Furthermore, even though the K584X and S493F BiP mutants exhibit 
substrate binding defects, they induce the UPR to very high levels (Figure 14F), which might be 
sufficient to compensate for folding problems in the ER.  
Overall, I have identified a  BiP mutant, R217A, which exhibits a  t ranslocation-specific 
defect w hen e xpressed i n yeast. H owever, ow ing t o i ts c ompetent i nteraction w ith Jem1p, t he 
R217A m utant doe s not  e xhibit E RAD de fects. I ha ve a lso i dentified t wo s ubstrate bi nding 
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mutants, K 584X a nd S 493F, w hich s how de fects i n bot h t ranslocation a nd E RAD, s uggesting 
that substrate binding is important for multiple BiP functions. 
2.2.6 Sec63 complex formation is reduced for R217A BiP 
The t ranslocation complex in yeast i s composed of  t he core proteins Sec61p (Sec61α), Sbh1p 
(Sec61β), a nd S ss1p ( Sec61γ)93, 9 6, 146, which are as sociated with Sec62p152, 1 53 and t he S ec63 
complex98. T he S ec63 complex c ontains S ec63p, B iP, S ec71p a nd S ec72p. E ach o f t hese 
complexes can be purified under non-denaturing conditions from yeast microsomes96, 98, 100 and it 
has been de monstrated t hat B iP a nd S ec63p c opurify i n e qual a mounts a s pa rt of  t he S ec63 
complex98. The interaction between BiP and Sec63p is thought to be critical to localize BiP at the 
ER membrane, where it can catalyze protein translocation.  
Since I observed a defect in the interaction of R217A BiP with the J domain of Sec63p in 
vitro (Figures 11A and 11D), I wanted to determine the stoichiometry of the Sec63 complex in 
the TEF1-R217A strain. T o t his e nd, m icrosomes w ere pr epared f rom TEF1-KAR2 or TEF1-
R217A yeast, s olubilized i n a  non -ionizing de tergent, a nd s ubjected t o i on-exchange, size 
exclusion a nd m ixed mode i on-exchange chromatography t o isolate t he S ec63 c omplex. 
Individual components of t he c omplex w ere i dentified us ing C oomassie bl ue s taining o r 
immunoblotting after S DS-PAGE. A s pr eviously r eported98, I found t hat w ild-type BiP and  
Sec63p were present in equal amounts in the Sec63 complex purified from the TEF1-KAR2 wild-
type s train (Figure 16). However, there was a  40-50% reduction in the amount of  R217A BiP 
that c opurified w ith S ec63p w hen t he complex w as ana lyzed from t he TEF1-R217A strain 
(Figure 16). This observation, along with the results from Figures 11A and 11D, provides an  
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Figure 16: The translocation defect in TEF1-R217A yeast is due to reduced complex 
formation between Sec63p and R217A.  
The S ec63p c omplex c ontaining S ec63p, BiP, Sec71p a nd S ec72p, w as pur ified from 
microsomes derived from the TEF1-KAR2 and TEF1-R217A strains, resolved by SDS-PAGE and 
subjected to Coomassie Brilliant Blue staining or immunoblotting. The ratio of BiP to Sec63p is 
indicated below each panel. 
 93 
explanation for the translocation defect exhibited by TEF1-R217A yeast (Figures 15A and 15B).  
2.2.7 Scj1p and Jem1p function redundantly in TEF1-R217A yeast 
The observation that: ( i) R217A BiP was defective for in vitro Scj1p interaction (Figures 11C 
and 11F) but not Jem1p interaction (Figures 11B and 11E), and (ii) TEF1-R217A yeast degraded 
soluble E RAD s ubstrates ef ficiently (Figures 15C a nd 15D), s uggested that a competent 
interaction between Jem1p and R217A BiP was sufficient to support ERAD in the TEF1-R217A 
strain. Therefore, I hypothesized that if this interaction between Jem1p and R217A BiP were to 
be disrupted, it would result in an ERAD defect. To test this hypothesis, I created  
TEF1-R217A yeast strains lacking a functional copy of either JEM1 or SCJ1, thus generating the 
TEF1-R217A jem1∆ and TEF1-R217A scj1∆ strains. As cont rols, I al so g enerated the TEF1-
KAR2 jem1∆ and TEF1-KAR2 scj1∆ strains.  
The resulting strains were initially tested for their ability to grow at elevated temperature 
or in t he pr esence of  D TT. I found t hat t he d eletion of  jem1 or scj1 in either TEF1-KAR2 or 
TEF1-R217A yeast di d not  a ffect growth a t elevated temperatures ( Figure 17A), a lthough t he 
TEF1-R217A scj1∆ strain showed reduced growth at 37°C. Moreover, deletion of scj1, but  not  
jem1, in the TEF1-KAR2 and TEF1-R217A strains resulted in DTT sensitivity (Figure 17B). This 
was not  s urprising be cause pr evious s tudies de monstrated t hat scj1∆ yeast c annot gr ow 
efficiently i n the pr esence of  E R s tress-inducing a gents s uch a s t unicamycin a nd β-
mercaptoethanol, whereas jem1∆ yeast can grow in the presence of these compounds119.  
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Figure 17: Jem1p and Scj1p function redundantly to support ERAD in the 
TEF1-R217A strain.  
(A) Ten-fold serial di lutions of  the i ndicated strains were pl ated onto selective 
medium and i ncubated at 30, 35 o r 37 °C for 2 d. (B) Ten-fold s erial di lutions of  t he 
indicated strains were plated onto selective medium without (-) or with 8mM DTT (DTT). 
Plates were incubated at 30°C for  2 d. (C) Pulse-chase immunoprecipitation experiments 
were us ed t o a nalyze t he de gradation of  C PY* in TEF1-KAR2 (   ), TEF1-R217A (O), 
TEF1-KAR2 jem1∆ (     ), TEF1-KAR2 scj1∆ (    ), TEF1-R217A jem1∆  (    ) and TEF1-
R217A scj1∆ (   ) s trains at 30°C . Data r epresent t he m eans of  a m inimum of  t hree 
independent experiments + standard errors. 
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 Next, I measured the ERAD efficiencies of  the TEF1-KAR2 jem1∆, TEF1-KAR2 scj1∆, 
TEF1-R217A jem1∆ and TEF1-R217A scj1∆ strains by examining the degradation rate of CPY*. 
I f ound t hat t he i ndividual de letions of  jem1 or scj1 in the TEF1-KAR2 strain di d not  a ffect 
CPY* degradation efficiency ( Figure 17C), c onsistent w ith t heir ove rlapping r oles du ring 
ERAD120. Moreover, the deletion of scj1 in TEF1-R217A yeast did not result in an ERAD defect, 
in keeping with my hypothesis (Figure 17C). However, contrary to my expectation, the deletion 
of jem1 in TEF1-R217A yeast ha d no e ffect on C PY* de gradation ( Figure 17C). A  pos sible 
explanation for this result is that even though R217A BiP and Scj1p are unable to interact with 
each other, as was observed in vitro (Figures 11C and 11F), in the absence of  J em1p, the two 
proteins m ight cooperate t o a n e xtent t hat i s s ufficient t o s upport E RAD. In f act, t he UPR i s 
induced upon deletion of Jem1p (data not shown) and this might be sufficient to compensate for 
ERAD de fects i n TEF1-R217A jem1∆ cells. A lternately, R 217A BiP a nd S cj1p m ight 
independently, but simultaneously, bind to CPY* and other misfolded proteins during ERAD and 
maintain them in a s oluble, retrotranslocation-competent s tate. Indeed, Scj1p ha s a  s ubstrate 
binding dom ain t hat i s similar t o t hat of  ba cterial D naJ, t he f ounding member of  t he H sp40 
family314, and to Ydj1, a  yeast cytosolic Hsp40 that requires i ts substrate binding properties to 
function efficiently in the c ell315. In a ddition, the c ontribution of  E Rj5, a ne wly characterized 
yeast ER Hsp40 (refer to section 1.2.2), during ERAD might explain this discrepancy. Finally, I 
cannot discount the possibility that the results that were obtained in vivo might not fully mirror 
the in vitro defects observed for the interaction between R217A BiP and Scj1p. 
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2.2.8 Identification of genetic interactions specific for the R217A BiP allele 
In order to better understand the range of cellular functions altered by R217A BiP expression, I 
decided to take an unbiased genetic approach. This genetic approach might also identify novel 
players i n t ranslocation and/or ot her BiP-regulated pr ocesses. T o t his e nd, 350 gene de letions 
were s elected which resulted i n a  c onstitutive i nduction of  t he U PR ( Table 6 i n A ppendix B ; 
Jonikas et al., 2009). T hese gene de letions not  onl y i ncluded t hose e xpected t o a lter t he E R 
folding environment s uch a s E R a nd c ytosolic c haperones, c omponents of  t he N -linked 
glycosylation machinery, and ERAD, but  also included genes encoding factors required for O-
mannosylation, GPI anchor synthesis, vesicular t rafficking, vacuole function, l ipid biosynthesis 
and, intriguingly, cytoskeletal organization and chromatin remodeling. I asked whether deleting 
these genes i n combination w ith kar2-R217A::NAT (Appendix B) produced unusually high or  
low l evels of  UPR, as a ssessed through the us e of  a f luorescent UPR reporter ( see Table 7 in 
Appendix B ). T his a pproach w as c hosen due  to a  hi gher s ensivtivity t han a  g rowth-based 
genomic analysis (J.S.Weissman, personal communication).  
 Next, a kar2-R217A::NAT genetic i nteraction profile w as generated ( Figure 18B) a s 
recently detailed121. The efficacy of this approach was verified by the fact that hac1∆ and ire1∆ 
were epistatic t o all other e xamined i nteractions. A n i nitial c omparison of  t he w ild-type 
KAR2::NAT and kar2-R217A::NAT genetic i nteraction pr ofiles ( Figure 18; da tapoints on t he 
horizontal bl ue l ine) s howed t hat t he kar2-R217A::NAT allele ma sked the U PR induc tion 
otherwise ob served i n a  s ubset of  de letion s trains, including las21∆, opi3∆, ilm1∆, vps53∆, 
yur1∆, spc1∆, sys1∆, rav1∆, vtc4∆ and mtc1∆ (refer to Table 6 i n Appendix B for a description 
of these genes). These data suggest that the kar2-R217A::NAT allele is epistatic to these gene 
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Figure 18: Genetic interaction profile of kar2-R217A::NAT with 350 gene deletions 
that induce the UPR.  
The l evels o f U PR i nduction i n t he 350 gene deletion s trains w as m easured us ing a 
fluorescent reporter either in the absence (values represented on the x-axis) or presence (values 
represented on t he y-axis) of  (A) wild-type KAR2::NAT, or  (B) the kar2-R217A::NAT mutant, 
with each datapoint on the graph corresponding to a unique gene deletion. The horizontal blue 
line r epresents t he ba sal l evel of  U PR i nduction obs erved i n t he KAR2::NAT or kar2-
R217A::NAT strains. The diagonal blue line represents the expected values of UPR induction in 
each of the individual deletion strains if the presence of KAR2::NAT or kar2-R217A::NAT does 
not induce an additional ER stress. The red line represents the ‘best f it’ curve to the predicted 
values in the double mutant strains when each gene deletion is combined with either KAR2::NAT 
or kar2-R217A::NAT.  
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deletions. Additionally, when the kar2-R217A::NAT genetic interaction profile was compared to 
interaction profiles previously collected for the 350 gene deletions (Jonikas et al., 2009), a very 
high correlation was noted to the set of genetic interactions exhibited by the sec71∆ and sec72∆ 
strains, consistent w ith a tr anslocation-specific defect i n t his m utant. M oreover, t he kar2-
R217A::NAT allele lacked a cha racteristic s ignature s hared by ge nes r equired for ERAD, 
including a ggravating i nteractions w ith cne1Δ, rer1Δ and yur1Δ. Therefore, us ing a  nove l 
method of genetic analysis, I was able to recapitulate the t ranslocation-specific defect that was 
observed for the R217A allele of BiP (Figure 15). 
2.2.9 Ilm1p is a novel player during protein translocation across the ER membrane 
Owing to the s imilarity of t he kar2:R217A, sec71∆ and sec72∆ genetic i nteraction profiles, I 
postulated that ge ne deletions t hat s howed significant genetic i nteractions w ith each of  t hese 
strains m ight a lso be  defective f or t ranslocation. Based on the s trength of t heir genetic 
interactions a nd ba sed o n the f act t hat t hese m utants w ere r elatively u ncharacterized, I t hen 
selected three strains, ilm1∆, erd1∆ and sur4∆, for further analyses (Table 3). Ilm1p (Increased 
loss of  mitochondrial D NA) i s a n unc haracterized pr otein t hat i s pr edicted t o pos sess t hree 
transmembrane dom ains a nd l ocalize t o t he E R. E rd1p ( ER retention defect) i s a poor ly-
characterized ER t ransmembrane protein; deletion of  erd1 results in increased secretion of ER 
lumenal pr oteins, t hough t he m echanism i s unk nown316, 3 17. S ur4p (Suppressor of  rvs161 and 
rvs167 mutations) is an ER-resident protein that is involved in the synthesis of very long chain 
fatty acids318, 319.  
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Table 3: Quantification of the genetic interactions between individual deletion 
strains (columns) and the indicated query strain (rows).  
 
* A p ositive g enetic interaction v alue means th at t he d ouble mutant strain had a  lo wer le vel o f U PR 
induction than what was predicted. 
** A positive genetic interaction value which is statistically significant is highlighted in red. 
*** Note that the value for the absence of a genetic interaction is ~0121.  
**** N/A indicates either that the double mutant strain was inviable or that a value was not obtained due to 
experimental error. 
 
 
Mutant ilm1∆ erd1∆ sur4∆ ccw12∆ vtc4∆ 
kar2:R217A 1.2534 1.3922 0.9569 0.6068 0.4451 
sec71∆ -0.1357 1.4758 0.3603 #N/A 0.0184 
sec72∆ 0.778 0.3587 0.4122 0.4514 #N/A 
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 To determine w hether t he ilm1∆, erd1∆, sur4∆ strains ha d t ranslocation-related 
phenotypes, I examined the in vivo translocation efficiencies of  pp αF and BiP in these s trains 
(Figure 19A). I found that pre-BiP accumulated only in the ilm1∆ strain, suggesting that Ilm1p 
might pl ay a  r ole i n t ranslocation. H owever, be cause pp αF di d not  a ccumulate i n ilm1∆ yeast 
(Figure 19A), I de cided t o l ook a t t he t ranslocation e fficiency of  t wo ot her w ell-characterized 
substrates, d ipeptidyl a minopeptidase-B ( DPAP-B) a nd t he repressible va cuolar al kaline 
phosphatase, Pho8p. Upon translocation into the ER, pre-DPAP-B is N-glycosylated at multiple 
sites resulting in an increase in the molecular mass from ~95 kDa to 130 kDa320. Pre-Pho8p is N-
glycosylated at a single site after its translocation resulting in an increase in molecular mass from 
~68 kDa to 72  kDa321. When I analyzed the t ranslocation of  DPAP-B and Pho8p in wild-type 
and ilm1∆ yeast cells, I did not see an accumulation of pre-DPAP-B or pre-Pho8p as compared 
to t he c ontrol s train, sec65-1322, w hich c ontains a  m utant a llele i n t he Sec65p s ubunit of  t he 
signal recognition particle (SRP; Figure 19A). Therefore, of the four substrates that I examined, 
the deletion of ilm1 uniquely affected the translocation of pre-BiP. 
 The i nduction of  t he U PR r esults i n B iP upr egulation a nd a ttenuation of  t ranslocation 
across the ER membrane199. It is therefore possible that the pre-BiP-specific translocation defect 
observed in ilm1∆ yeast i s an artefact of  the hi gh l evels of  U PR i nduction obs erved i n t his 
strain121. To rule out this possibility, I examined BiP translocation in another deletion strain that 
induces t he U PR t o ve ry high l evels, scj1∆121. I  f ound t hat pr e-BiP di d not a ccumulate i n t he 
scj1∆ strain, e ven t hough t he ilm1∆ strain, again, a ccumulated pr e-BiP ( Figure 19A, bot tom 
row). Taken together, these observations suggest that Ilm1p either plays a specific role in BiP 
translocation, or  t hat i t might be  r equired f or t he t ranslocation of  a  un ique s ubset of  p roteins, 
which includes BiP. 
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Figure 19: Ilm1p is required for the efficient translocation of BiP and interacts with 
components of the translocation machinery.  
(A) The t ranslocation e fficiency of  pp αF, BiP, DPAP-B a nd P ho8p w as a ssessed i n the 
indicated wild-type and mutant s trains b y performing a  pulse-chase immunoprecipitation assay a t 
the s pecified temperatures. The sec63-1 strain which carries a t ranslocation-defective al lele of  
SEC63, and t he sec65-1 strain which carries a t emperature-sensitive a llele of  SEC65, served as 
positive c ontrols. (B) The ability of  mic rosomes derived from the  indi cated strains to translocate 
ppαF and ∆gppαF was evaluated at 20°C. After translocation, each sample was divided and treated 
in one  of  three w ays: A -buffer, B-trypsin, C -trypsin and Triton X-100. The pe rcent t ranslocation 
efficiency is indicated below each panel. Data are representative of three independent experiments. 
(C) Native immunopr ecipitations us ing a nti-FLAG-agarose be ads a gainst Ilm1p-FLAG we re 
performed as described3. The BY4741 wild-type strain containing an untagged copy of ILM1 served 
as a  ne gative c ontrol. Input: 5%  of  t he m aterial t hat w as i mmunoprecipitated; I P: 
Immunoprecipitation; IB: Immunoblotting. T he components of  t he S ec61 c omplex a re de picted 
pictorially. 
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 Next, I examined microsomes derived from the ilm1∆ strain for the translocation of ppαF 
and m utant ∆gppαF. In agreement w ith m y in vivo results, microsomes la cking Ilm1 were a s 
efficient as wild-type microsomes for ppαF and ∆gppαF translocation (Figure 19B). 
Finally, I t ested w hether Ilm1p i nteracted with c omponents of  t he t ranslocation 
machinery. For this purpose, I generated a chromosomal version of  FLAG-tagged ILM1 in the 
BY4741 s train ba ckground. P re-BiP di d not  a ccumulate i n t his s train ( data not  s hown), 
indicating tha t F LAG-tagged Ilm1p i s f unctional. N ext, I i mmunoprecipitated Ilm1p-FLAG-
associated protein complexes from yeast cells in the presence of Triton X-100, resolved proteins 
in the precipitate by SDS-PAGE, and performed immunoblot analysis with antisera against the 
the FLAG epitope, Sec61p, Sec62p, Sec63p, Sec72p and BiP. As shown in Figure 19C, Sec61p, 
Sec62p a nd S ec63p c o-immunoprecipitated w ith Ilm1p, s uggesting t hat these pr oteins form a  
complex with Ilm1p. Furthermore, the absence of Sec72p and BiP from this complex emphasizes 
the s pecificity of  th e Ilm1p-Sec61-Sec62-Sec63 i nteraction. A s a c ontrol, I a lso e xamined 
whether S sh1p, a S ec61p hom olog323, resided i n t he i mmunoprecipitated c omplex, but  t his 
species w as absent ( Figure 19C). T his r esult indi cates tha t Ilm1p cooperates w ith the S ec61 
complex, but probably not the Ssh1 complex, to enable the translocation of distinct factors. 
2.2.10 Deletion of ilm1 does not result in ERAD defects 
To test if Ilm1p plays a specific role in translocation, but not in ERAD, I measured the ability of 
the ilm1∆ strain to degrade different classes of ERAD substrates: (i) substrates with ER lumenal 
lesions, such as CPY*; (ii) integral membrane substrates with cytosolic lesions, such as Ste6p*, a 
mutant f orm of  the  yeast a-factor t ransporter324, and CFTR ( cystic f ibrosis tr ansmembrane 
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conductance r egulator325); a nd (iii) c o-translocational s ubstrates s uch a s A poB29 ( a t runcated 
version of  hum an a polipoprotein B 301). I  obs erved t hat S te6p*, C FTR a nd A poB29 w ere 
degraded efficiently in ilm1∆ yeast (Figure 20B, 20C and 20D, respectively) although there was 
a s light r eduction i n t he de gradation of  C PY* ( Figure 20A). However, since t he ge netic 
interaction profile of  ilm1∆ yeast l acks an  E RAD-specific s ignature121, I do  not  c onsider t his 
effect to be significant. Furthermore, when I measured the degradation of mutant ∆gpαF using 
microsomes de rived f rom t he ilm1∆ strain, I  f ound that ∆gpαF w as d egraded comparably t o 
microsomes de rived f rom the  w ild-type BY4742 s train (Figure 11E). T aken together, I  c an 
conclude that ilm1∆ yeast do not exhibit ERAD defects. 
2.3 DISCUSSION 
BiP is a highly conserved, essential protein in eukaryotes; for example, the yeast and mammalian 
BiP hom ologs s hare greater t han 65%  s equence i dentities. Several hum an di seases i ncluding  
Alzheimer’s disease, Marinesco-Sjögren syndrome, autosomal dominant polycystic liver disease, 
Wolcott-Rallison syndrome, and a variety of cancers may result from either the overexpression 
of BiP or the malfunction of BiP and/or its cofactors239, 240. Hence, insights into the function of 
this protein, in particular its interactions with various cofactors, are critical toward understanding 
the etiology of these various diseases. Owing to the amenability of Saccharomyces cerevisiae to 
genetic ma nipulations a nd the a vailability of s pecific bi ochemical a ssays to evaluate B iP 
function, this model organism is  an excellent s tarting point to characterize the  determinants of  
BiP-cofactor interaction. 
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 Figure 20: Deletion of ilm1 has no effect on ERAD.  
The ERAD efficiencies of wild-type (BY4742) (    )  and ilm1∆ (    ) yeast were compared 
using a c ycloheximide cha se as say f or t he s ubstrates (A) CPY* ( assayed a t 30°C ), (B) Ste6p* 
(assayed at 37°C ), (C) CFTR ( assayed a t 40° C), a nd (D) ApoB29 ( assayed a t 30°C ). D ata 
represent t he m eans of  a m inimum of  t hree i ndependent e xperiments + standard e rrors. (E) In 
vitro ERAD a ssays us ing mic rosomes de rived from w ild-type a nd ilm1∆ yeast w as pe rformed 
either in the absence (-) or presence (+) of  an ATP regenerating system and 0.5 mg/ml of  yeast 
cytosol at 30°C. Microsomes derived from the sec63-1 and TEF1-K584X strains served as positive 
controls. The percent ∆gpαF remaining after 20 min was calculated by normalizing the amount of 
∆gpαF p resent i n t he ‘ +’ l ane t o t he a mount present i n t he c orresponding ‘ -’ l ane. Data ar e 
representative of three independent experiments + standard errors. 
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2.3.1 Identification of a translocation-specific BiP mutant, R217A 
I have demonstrated that a specific mutation in the putative J domain interacting surface of yeast 
BiP/Kar2p, R217A, results in a pr otein that di fferentially int eracts w ith its cognate H sp40 
cochaperones. S pecifically, R 217A B iP c ompetently i nteracts w ith J em1p but i s de fective f or 
maximal ATPase stimulation by Sec63p and Scj1p. This might seem surprising given that the J 
domains of  S ec63p a nd S cj1p s hare a  l ower s equence i dentity ( i.e., 34%) t han t he s equence 
identity shared by the J domains of Sec63p and Jem1p (i.e., 40%), and by the J domains of Scj1p 
and Jem1p ( i.e., 40%; Figure 21). However, the observation that the J  domains of  Sec63p and 
Scj1p are i nterchangeable in vivo118 indicates t hat t he c ontext of  t he J dom ain a nd pe rhaps 
individual amino acids within this domain are as important as the overall sequence and percent 
conservation. Notably, the in vitro studies utilized the J domain alone from Sec63p (~70 amino 
acids), the J domain with its flanking sequences from Jem1p (~110 amino acids), but full-length 
Scj1p (~350 amino acids). Therefore, one  cannot rule out  t he possibility t hat r esidues i n t he J  
domain other than the HPD motif might also be required for optimal BiP-Hsp40 interaction, as 
has be en obs erved for o ther H sp70-Hsp40 p airs66, 326. Formally, it is  a lso possible tha t the  J  
domains of  B iP’s c ognate H sp40s ha ve di verged s o t hat t hey c an t arget B iP t o f unction 
specifically in the ER. 
I also found that the expression of R217A BiP in yeast reduced translocation efficiency 
across the ER membrane, and this could be explained by a reduced complex formation between 
Sec63p a nd BiP. S ince S ec63p i nteraction he lps t o l ocalize B iP a t t he E R f or bi nding t o 
translocating pol ypeptide c hains t his r esult is not  s urprising. T aken t ogether w ith m y 
observations t hat t he E RAD a nd f olding e fficiencies of  yeast e xpressing R 217A B iP r emain 
unaltered, I conclude that a unique mutation in BiP’s ATPase domain is sufficient to affect a  
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Figure 21: An alignment of the J domains of Sec63p, Jem1p and Scj1p.  
The amino acid sequences corresponding to t he J domains of  Sec63p (amino acids 125-
203), J em1p ( amino a cids 541 -623) a nd S cj1p ( amino a cids 23 -94) were a ligned us ing t he 
program Multalin4. The highest conservation is observed at the canonical HPD motif. Amino acid 
notations in the row labeled “consensus” include:!- isoleucine or valine; $- leucine or methionine; 
%- phenylalanine or tyrosine; #- asparagine, aspartate, glutamine or glutamate. 
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specific BiP function, i.e., translocation. Also, because yeast cells expressing R217A BiP do not 
induce the UPR, and can be sensitized to induce the UPR by treatment with DTT, I surmise that 
this mutant is not defective for Ire1p interaction. Indeed, the R217 residue is distal to the putative 
Ire1p-interacting surface of BiP287. 
Prior s tudies ha ve a ddressed t he e ffects of  m utating t he a nalogous ar ginine r esidue i n 
DnaK91, the bacterial Hsp70, and Chinese hamster BiP/Grp78116, 302. In fact, the R167A mutant 
of DnaK was identified in a screen directed toward identifying suppressors of a mutation in the 
bacterial Hsp40, DnaJ, which negatively affected DnaK interaction; this was the first report of an 
Hsp70 m utant t hat w as de fective for J  dom ain i nteraction91. R ecent s tudies i n w hich t he 
analogous R 197 of  C hinese ha mster BiP w as altered t o di verse a mino a cids w ith uni que 
chemical p roperties further e mphasized t he c ontributions of  R 197 t owards i nteraction w ith 
ERdj3, the ER-lumenal Hsp40116, 302, and possibly toward inter-domain communication between 
the ATPase and substrate binding domains302. However, none of these studies addressed whether 
the mutant Hsp70s demonstrated Hsp40 binding specificity. Further implications of the R217A 
mutation on BiP function are discussed in Chapter 4. 
Finally, t he closely-related f amily o f H sp110s and G rp170, i ncluding BiP’s c ofactor 
Lhs1p, contain an alanine in place of this invariant Hsp70 arginine, and it is not surprising that 
the ATPase activity of Lhs1p cannot be stimulated by the ER-resident Hsp40s139. 
2.3.2 Substrate binding mutants of BiP affect ER homeostasis and multiple BiP functions 
Two mutations in BiP’s substrate binding domain, K584X that lacks the lid domain and S493F 
that de stroys a  s alt br idge b etween t he s ubstrate bi nding a nd l id dom ains, w ere de fective f or 
functional substrate interaction as determined in a peptide-stimulated ATPase assay. K584X BiP 
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also exhibited reduced stability in vitro and in vivo, w hile S 493F BiP a dopted a n alternate 
conformation from wild-type BiP. Since these mutants maintained their ability to interact with 
two of  B iP’s H sp40s, S ec63p a nd J em1p, I s peculate t hat m utations i n t he s ubstrate bi nding 
domain only affect BiP’s ability to bind to substrates. To further confirm the inability of K584X 
and S493F BiP proteins to bind to substrates, I intend to perform peptide binding assays using a 
fluorescently-labeled peptide substrate according to a previously established protocol181. 
Interestingly, the expression of these mutants in yeast resulted in both translocation and 
ERAD de fects. T his w as i n c ontrast t o t he E RAD-defective s ubstrate bi nding m utants, P 515L 
and T473F, which the Brodsky laboratory identified in a previous genetic screen181. However, in 
the current study, the mutant BiP proteins were expressed from the constitutive PTEF1 promoter, 
whereas i n t he pr evious s tudy, t he m utants w ere e xpressed f rom B iP’s endogenous pr omoter 
which contains heat shock204 and UPR elements204, 2 05; therefore, the expression of  P515L and 
T473F was sensitive to ER stress. Since the expression of substrate binding BiP mutants results 
in UPR induction (Ref. 174 and Figure 5), it is formally possible that the mutant proteins in the 
previous s tudy w ere e xpressed a t s ufficiently h igh l evels f rom t he e ndogenous pr omoter t o 
suppress translocation defects. This could also account for the inability to identify translocation-
specific m utants i n t he s ame genetic s creen. The c ontribution of  s ubstrate bi nding t o BiP 
function is further elaborated upon in Chapter 4. 
2.3.3 Characterization of the genetic interactions of R217A BiP 
To unde rstand t he r ange of f unctions a ltered b y R217A B iP in vivo, I ut ilized a n unbi ased 
genetic approach in which I analyzed the effect of R217A BiP expression on the UPR induction 
in 350 i ndividual g ene deletions t hat pe rturb t he E R f olding environment. S ince R 217A B iP 
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expression does not in itself induce the UPR (Figure 14E), I hypothesized that this BiP mutant 
might e xacerbate or  alleviate the  U PR w hen combined with another d eletion with which it 
genetically i nteracts. A ccordingly, I f ound t hat kar2-R217A::NAT masked the U PR induction 
normally observed in a subset of gene deletions, indicating that R217A BiP was epistatic to these 
gene de letions; one  s uch de letion w as spc1∆. Spc1p i s a  c omponent of t he s ignal p eptidase 
complex160, 1 61. This was not  s urprising be cause s ignal s equence cl eavage oc curs a fter 
polypeptide t ranslocation ha s be en i nitiated27, a nd B iP i s r equired f or t he l atter pr ocess, 
especially during co-translational protein translocation. I also determined that in the presence of 
R217A B iP, t he U PR i nduction i n t he sls1∆ strain ( also know n as sil1∆) w as s lightly 
exacerbated. T his i s a gain consistent w ith B iP a nd S ls1p pl aying a c oordinated role i n 
translocation, a lthough whether S ls1p s imply acts a s a  BiP NEF, or  pl ays another role, i s s till 
unclear133-135. Interestingly, I was unable to analyze data for the lhs1∆ strain, suggesting either 
that the kar2-R217A::NAT lhs1∆ double mutant is inviable, in agreement with a role for Lhs1p in 
translocation135, 1 36, 1 38, or  t hat t he kar2-R217A::NAT and t he lhs1∆ strains mig ht ha ve 
mating/sporulation incompatibility. Since t he ge nes e ncoding K ar2p a nd Lhs1p a re l ocated on  
different c hromosomes, the pos sibility of  pol ar effects c an be  r uled out . Finally, I found t hat 
UPR levels were alleviated in the hlj1∆ strain in the presence of R217A BiP, suggesting that the 
corresponding pr oteins function i n t he s ame o r pa rallel pa thways. T his r esult i s intriguing 
because the only known function for Hlj1p that has been identified thus far is  in ERAD324, 327. 
However, my data suggest that Hlj1p may also play a role in translocation (or even translation). 
Furthermore, by comparing the genetic interaction profile of R217A BiP to the 350 gene 
deletions, w e f ound t hat, s trikingly, R 217A BiP’s pr ofile c losely resembled t he genetic 
interactions exhibited by two other translocation components, Sec71p and Sec72p. Not only did 
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this confirm that the expression of  R217A BiP in vivo specifically affects translocation, it also 
encouraged us to identify the gene deletions that exhibited the highest levels of interactions with 
the three translocation-related alleles, and test their translocation efficiency; one s uch candidate 
was ilm1∆. 
2.3.4 Ilm1p, a previously uncharacterized protein, plays a role in the translocation of BiP 
Ilm1p was f irst characterized in a genetic s creen targeted toward the identification of yeast 
mutants t hat w ere s ensitive t o f ilamentous g rowth i nduced b y s lowed-DNA s ynthesis; i t w as 
suggested t hat Ilm1p pl ays a  r ole i n t he m aintenance of  m itochondrial D NA328. But, g iven i ts 
localization to the  E R membrane329, a nd the o bserved genetic i nteractions w ith R 217A BiP, 
sec66∆ and sec72∆ (Table 3), I speculated that Ilm1p may play a role in translocation. Consistent 
with my expectations, I found that ilm1∆ yeast exhibit a specific defect for pre-BiP translocation. 
Furthermore, Ilm1p, an i ntegral m embrane pr otein, interacts w ith other int egral me mbrane 
components of the translocation machinery, i.e., Sec61p, Sec62p and Sec63p, indicating that it is 
present a t t he r ight l ocation i n t he E R m embrane. H owever, I w as una ble t o obs erve a  
translocation defect for three other substrates, ppαF, DPAP-B and Pho8p. Previous studies have 
demonstrated that while ppαF uses an SRP-independent post-translational translocation pathway 
to g et i nto t he E R, D PAP-B a nd P ho8p us e a  S RP-dependent c o-translational tr anslocation 
mechanism330. Interestingly, BiP uses both modes of translocation, and only one other substrate, 
Och1p, a mannosyltranferase of the cis-Golgi apparatus, was shown to behave similar to BiP330. 
Therefore, it is  possible that ilm1∆ yeast may also be defective for Och1p translocation. If this 
were the case, Ilm1p might be the linchpin that mediates the recognition of substrates that require 
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the pos t-translational an d co-translational m odes of  t ranslocation. H owever, t his h ypothesis 
remains to be tested. 
An interesting feature of BiP’s signal sequence is its unusual length, i.e., 42 amino acids, 
compared to the average signal sequence length of ~20-30 amino acids331. In fact, only five other 
yeast proteins have predicted signal sequences of comparable or greater length, as compiled from 
the S ignal P eptide da tabase ( http://proline.bic.nus.edu.sg/spdb/). Therefore, an alternate 
explanation for Ilm1p’s unique effects on pre-BiP translocation may be that Ilm1p either directly 
binds t o or  f acilitates t he r ecognition of  a  s ubset of  s ignal s equences in a  l ength-dependent 
manner. A second explanation could be that signal sequences of a certain chemical nature might 
require Ilm1p for their recognition. Previous studies have demonstrated that signal sequences are 
typically comprised of an N-terminal basic domain, followed by a core hydrophobic region and a 
C-terminal s lightly pol ar dom ain. O ther t han t hese f eatures, s ignal s equences l ack s ignificant 
homology332, and whether t here are addi tional determinants t hat cl assify signal s equences i s 
currently unknown. It is also possible that Ilm1p might be dedicated to the translocation of BiP, 
one of the most abundant proteins in the ER, and our observation that kar2:R217A was epistatic 
to ilm1∆ supports this hypothesis (Figure 18B). This could also provide an explanation for the 
observed UPR induction upon ilm1 deletion. Each of these hypotheses remains to be tested. 
2.3.5 Perspective 
Recently, a  l arge num ber of  nove l, high-throughput g enetic s creening t echnologies ha ve be en 
developed f or yeast333-345. H owever, t he a pplication of  t hese t echnologies t o unde rstand yeast 
biology i s i n i ts i nfancy and can easily be  extended to ke y metabolic p athways. As a specific 
example, I demonstrate that t he c areful i nvestigation of  uni que m utant alleles of an essential 
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multi-functional ge ne when c ombined w ith a t argeted genetic screen can lead to t he 
identification of novel p layers in  an otherwise w ell-studied cellular process. Moreover, dur ing 
the course of such a study, functions can also be assigned to poorly characterized open reading 
frames. Based on my success, i t i s not  h ard t o c onjecture t he widespread a pplication of  t his 
technique.  
Taking this study one step further, I can also examine the genetic interactions of the same 
mutant alleles with the entire yeast deletion series (~4800 genes), possibly identifying a number 
of new interactions. 
Additional future directions are discussed in Chapter 4. 
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3.0  COMPLEMENTATION OF HSP40-DEPENDENT YEAST PHENOTYPES 
DIFFER IN THEIR REQUIREMENTS FOR THE J DOMAIN AND SUBSTRATE 
BINDING ACTIVITIES OF A MAMMALIAN HOMOLOG 
Hsp70s c onstitute a  hi ghly conserved f amily o f m olecular c haperones t hat a re f ound i n a ll 
organisms a nd i n all c ellular or ganelles. D ue t o t heir a bility to bi nd t o unf olded r egions on  
nascent pol ypeptides or  una ssembled s ubunits of  he teromeric c omplexes i n a  nuc leotide-
dependent manner, these chaperones pl ay c ritical roles in diverse cellular processes35, 3 46. Two 
distinct s ets of  c ofactors tig htly moni tor H sp70 action by regulating A TPase a ctivity24, 3 47: J 
domain containing proteins ( JDPs) of  t he Hsp40/DnaJ family and nu cleotide exchange factors 
(NEFs). T he hi ghly conserved ~ 70 a mino a cid J  dom ain of  JDPs c ontacts H sp70’s nuc leotide 
binding domain and enhances ATPase activity by inducing a conformational change92, 348. This 
leads t o enhanced bi nding o f H sp70s to s ubstrates. M oreover, s ome J DPs di rectly bi nd t o 
unfolded regions on s ubstrate pr oteins t hrough t heir s ubstrate bi nding d omain a nd d eliver t he 
unfolded pr otein t o t he A TP-bound form of  t heir H sp70 pa rtner67, 6 8, while ot hers c ontain 
atypical dom ains tha t s pecify e xclusive f unctions189, 3 49. T he N EFs, on t he ot her ha nd, r elease 
bound ADP, which triggers ATP rebinding and subsequent substrate release from the Hsp70. 
 The J DPs can be  c lassified i nto t hree groups66, 3 50: ( i) T ype I J DPs a re mos t s imilar to  
DnaJ and contain a J domain followed by a glycine/phenylalanine-rich region and a cysteine-rich 
region with four repeats of a  CxxCxGxG-type z inc f inger; ( ii) Type II JDPs lack the cysteine-
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rich r egion a nd are un able t o c oordinate Zn2+; (iii) T ype III J DPs onl y ha ve t he J  dom ain in 
common with DnaJ. Notably, the number of JDPs exceeds the number of Hsp70s and NEFs in 
most or ganisms/ or ganelles. In f act, a  s ingle H sp70 c an i nteract w ith di fferent J DPs t o f orm 
unique H sp70-JDP pa irs tha t pa rticipate in specific c ellular f unctions261, 3 50. D espite t he hi gh 
conservation o f t he J  do main, J DPs a re not  ne cessarily i nterchangeable b etween organelles or  
organisms66, 351, further suggesting that there is specificity in the interaction between Hsp70s and 
JDPs. Specificity might be  essential for substrate recognition and delivery, for the  targeting of  
Hsp70 to distinct c ellular loc ations, and/or f or c atalyzing pr otein folding in distinct c hemical 
environments within organelles. 
 To begin to address this hypothesis, a recent study tested the ability of 13 different JDPs 
to interact with resident Hsp70s in the yeast cytoplasm261. In many cases, the ability of a JDP to 
stimulate the ATPase activity of a particular Hsp70 was sufficient to constitute a functional pair. 
However, distinct features of JDPs, such as the ability to interact with substrates, might also be 
required for specific functions67, 151, 3 15, 35 2. To better r esolve this apparent di screpancy, I have 
compared the a bilities of tw o type I J DPs, a ma mmalian, ER-lumenal pr otein ( ERdj3), a nd a  
yeast cytosolic protein (Ydj1) to functionally substitute for each other (refer to Figures 22 and 23 
for the domain organization and sequence comparison of ERdj3 and Ydj1). The data obtained in 
this study, combined with those of a previous study261, suggest that both the binding of JDPs to 
substrates and their association with Hsp70s are essential to support cell viability and chaperone-
dependent functions.  
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Figure 22: A schematic representation of select JDPs.  
DnaJ, the founding member of this family of chaperones, is a bacterial Type I JDP. Ydj1, 
ERdj3 a nd S cj1 a re T ype I J DPs f ound i n t he yeast c ytosol, m ammalian E R a nd yeast E R, 
respectively. H lj1 i s a  T ype II J DP found in the yeast c ytosol whereas J em1 is a T ype III J DP 
found in the yeast ER with an atypical domain organization. The domains are indicated by: J - J 
domain; G /F - glycine/phenylalanine rich region; I a, I I, Ib, I II - various s ubdomains of  t he 
substrate bi nding domain ba sed on Y dj1’s c rystal s tructure2; C ys-rich - cysteine r ich r egion 
containing the Zn2+-finger motifs; ss - signal sequence; TM - transmembrane domain, and are not 
drawn to scale. 
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Figure 23: Sequence comparison of DnaJ, Ydj1, Scj1, ERdj3, Hlj1 and the J domain of 
Jem1.  
The protein sequences of DnaJ (AAC73126), Ydj1 (CAA95937), Scj1 (CAA41529), ERdj3 
(NP_057390), H lj1 ( NP_013884) a nd t he J  domain of  J em1 ( amino a cids 531 -645; N P_012462) 
were a ligned us ing the s oftware Multalin4. The numbers i n pa rantheses indicate NCBI accession 
numbers. The various domains are represented by: J - J domain; G/F- glycine/ phenylalanine r ich 
domain; Ia and Ib- domain I; I I- domain II; III- domain III. Amino acid notations in the row that 
indicates t he c onsensus sequence i nclude:!- isoleucine o r v aline; $ - leucine or  me thionine; % - 
phenylalanine or t yrosine; # - asparagine, aspartate, glutamine or  glutamate. Where i ndicated 
throughout the main text, % sequence identity was calculated using the program Kalign10. 
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3.1 MATERIALS AND METHODS 
3.1.1 Preparation of Ydj1 and ERdj3 constructs 
The plasmids utilized in this study are listed in Table 5. Unless otherwise indicated, the plasmids 
were constructed by Yi Jin, a graduate student in the laboratory of Linda Hendershot at St. Jude 
Children’s Hospital, Memphis.  
 To target Ydj1 to the mammalian ER, a signal sequence (ss) was engineered onto the N-
terminus of Ydj1 using pAV4353 as a template and the following PCR primers (lower case letters 
represent the inserted ss and the italics indicate a BamHI site):- 5’ primer: 
CGGGATCCatggctccgcagaacctgagcaccttttgcctgttgctgctatacctcatcggggcggtgattgccGTTAAAGAA
ACTAAGTTTTACGATATTCTAGGTGTTCC and 3’ primer:  
CGGGATCCTCATTGAGATGCACATTGAACACCTTC. The PCR product was digested with 
BamHI and inserted into 3HA-DSL, a mammalian expression vector which was modified from 
the or iginal pS G5 ve ctor ( Neupogen) b y t he a ddition of  s everal uni que r estriction e nzyme 
recognition sequences to the multiple cloning site (mcs) and a triple-HA sequence at the 3’ end 
of t he m cs. After de termining the  di rectionality of i nsertion, t he t ranslation ‘ STOP’ c odon i n 
ssYdj1-3HA-DSL w as de stroyed us ing t he Q uikchange s ite-directed mutagenesis ki t 
(Stratagene) with the following primers:- 5’ primer:  
GAAGGTGTTCAATGTGCATCTCAAGGATCCCCGGAATTCCTCGAG and 3’ primer:  
CTCGAGGAATTCCGGGGATCCTTGAGATGCACATTGAACACCTTC. Next, a r ibosomal-
binding K ozak s equence ( underlined, s ee be low) w as i nserted i mmediately ups tream o f t he 
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translation s tart s ite of  ssYdj1 us ing t he Q uikchange s ite-directed mutagenesis ki t w ith the 
following primers:- 5’ primer:  
GTTTAAACGGATCCACCCGGGACAGAGGAACC
GTTCTGCGGAGCCAT
ATGGCTCCGCAGAAC and 3’primer: 
GGTTCCTCTGTCCCGGGT
GGTGGCGAAGGTGTTCAA
GGATCCGTTTAAAC. Finally, a second 
construct was made in which the farnesylation acceptor site in ssYdj1 was mutated (denoted by 
the underlined sequence) with the primer pair:- 5’ primer:  
AGT
CGGGGATCCTTGAGATGCACTT
GCATCTCAAGGATCCCCG and 3’ primer:  
TGA
To express ERdj3 in yeast, two constructs were produced under the control of the PGPD 
promoter i n t he m ulti-copy pG PD426 ve ctor289: ( i) F ull-length hum an ERdj3 containing its  
endogenous E R-targeting s ignal s equence w as amplified by P CR f rom t he ERdj3-3HA-DSL 
vector125 with the f ollowing pr imer pa ir ( the i talicized letters r epresent t he EcoRI and BamHI 
sites i ntroduced f or c loning pur poses):- 5’ p rimer: CGGAATTCGGACCCGGGAC and 3’  
primer: CGGGATCCATATCCTTGCAGTCCATTGTATACCTTCTG. The  r esulting PCR 
product w as di gested w ith EcoRI and BamHI and i nserted i nto pG PD426; ( ii) F or c ytosolic 
expression, CaaX-ERdj3 was generated using the following primer pair with ERdj3-3HA-DSL 
serving as t he t emplate (the unde rlined letters o n the 5’  pr imer r epresent the  beginning o f the  
coding sequence for the mature ERdj3 protein without its signal sequence, while the underlined 
sequence on the 3 ’ pr imer represents the farnesylation sequence; the i talicized letters represent 
the restriction sites used for cloning):- 5’ primer:  
ACACCTTCGCCACC, to generate ssYdj1C406S. 
CGGGATCCGGAACCATGGGACGAGATTTCTATAAGATCTTGGGG
CCCAAGCTTTCA
 and 3’ primer:  
TTGAGATGCACATTGCAGTCCATTGTATACCTTCTGC. The r esulting 
PCR pr oduct l acked the N -terminal signal s equence, and contained a ‘ CASQ’ f arnesylation 
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sequence in lieu of the final two C-terminal amino acids (GY) in ERdj3. Next, the PCR product 
was di gested w ith BamHI and HindIII and i nserted i nto pG PD426. A ll C aaX-ERdj3 m utants 
were generated by Q uikchange s ite-directed mutagenesis us ing pr imer pa irs pr eviously 
described, except for the H53Q and D55N mutants125. I generated these mutants with the primer 
pairs: (i) H53Q:- 5’ primer: CTAGCCCTGCAGCTTCAGCCCGACCGGAACCCTGATGATC, 
and 3’ pr imer: GATCATCAGGGTTCCGGTCGGGCTGAAGCTGCAGGGCTAG; ( ii) D55N:- 
5’ pr imer: C TAGCCCTGCAGCTTCATCCCAAGCGGAACCCTGATGATC, and 3’ pr imer: 
GATCATCAGGGTTCCGGTTGGGATGAAGCTGCAGGGCTAG. 
3.1.2 Expression and detection of Ydj1 in mammalian cells 
Cells w ere t ransfected with the i ndicated vectors us ing t he FuGENE 6 transfection reagent 
(Roche). A  v ector t hat encodes C hinese h amster B iP ha s pr eviously been de scribed74. F or 
immunofluorescence255, transfected c ells gr own on c overslips w ere f ixed a nd s tained with a n 
anti-HA a ntibody t o de tect s sYdj1 f ollowed b y F ITC-labeled secondary antibody. G rp94, a n 
abundant E R l umenal p rotein, s erved a s a n E R m arker a nd w as de tected w ith a n a nti-Grp94 
antiserum255 followed by a TRITC-conjugated secondary antibody.  
To detect interactions between JDPs and either BiP or substrate, 48 h pos t-transfection, 
cells w ere l abeled with 35S T ranslabel ( Amersham B iosciences) f or 3 h, and cell l ysates w ere 
prepared125.  To stabilize protein complexes, cells were t reated with 150 μg/ml 3,3’-dithio-bis-
propionic acid N-hydroxysuccinimide ester (DSP) for 1 h on i ce and lysed in a non-ionic lysing 
buffer ( 50 m M T ris-HCl, pH  7.5, 150 m M NaCl, 0.5%  D OC a nd 0.5% N P-40) after fi rst 
quenching the crosslinker with 100 μl of 1M glycine.  Solubilized proteins were incubated with 
the indicated antisera and precipitated with Protein A-Sepharose beads. The immunoprecipitated 
 125 
complexes were subjected to denaturing gel el ectrophoresis and after en hancing with Amplify 
(Amersham Bioscience), the signals were detected by chemiluminescence. 
3.1.3 Protein expression, purification and ATPase assays 
Hexahistidine-tagged recombinant w ild-type a nd m utant hum an E Rdj3125 and hamster B iP354 
proteins were expressed in E. coli M15 cells and purified under non-denaturing conditions using 
Ni2+-NTA agarose ( Qiagen QIAexpress S ystem) as  de scribed. The f ollowing pr oteins w ere 
purified us ing p reviously established pr otocols: S sa1p151, Y dj1127, GST-tagged J  dom ain of  
Hlj1327, hexahistidine-tagged Kar2151, and the GST-tagged J domain of Sec63111.  
Steady-state ATPase assays us ing the indicated molar ratios o f the J DP to Hsp70 were 
performed as described127, 151. 
3.1.4  Rescue of the slow growth phenotype of mutant yeast strains 
The following Saccharomyces cerevisiae yeast s trains were used for complementation studies: 
SCJ1JEM1 (MATα lys2-801 leu2-3,112 his3-∆200 trp1-∆901 ura3-52 suc2-∆9) a nd scj1∆ 
jem1∆ (MATα ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1-100 scj1∆::TRP1 
jem1∆::LEU2)122; YDJ1 (MATα ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1-100) and 
ydj1∆ (MATα ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1-100 ydj1-2::HIS3)355; 
HLJ1YDJ1 (MATα ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1-100) a nd hlj1∆ydj1-151 
(MATα ade2-1 leu2-3,112 his3-11,15 trp1-1 ura3-1 can1-100 hlj1∆::TRP1 ydj1-2::HIS3 
LEU2::ydj1-151)327. The yeast strains were grown to logarithmic phase at 26°C in yeast extract–
peptone–dextrose medium containing 2% glucose and t ransformed with the indicated plasmids 
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using lithi um a cetate356. T he r esulting t ransformants w ere s elected a nd g rown t o l ogarithmic 
phase a t 26°C  i n s elective s ynthetic c omplete m edium c ontaining 2%  glucose. T en-fold serial 
dilutions w ere s potted o nto s olid m edium a nd c ultured a t t he i ndicated temperatures f or 2 d.  
Where indicated, NaCl was included in the medium at a final concentration of 0.4M, sorbitol at a 
final concentration of 1M and DTT at a final concentration of 8 mM. 
3.1.5 Detection of ERdj3 in yeast 
Wild-type cells transformed with an empty vector or plasmids expressing either ERdj3 or CaaX-
ERdj3 w ere g rown t o l ogarithmic pha se ( OD600 of 0.8 -1.0) in selective s ynthetic c omplete 
medium containing 2% glucose. A total of ~200 OD600 equivalents of cells were harvested, and 
ER-derived microsomal m embranes w ere pr epared as  p reviously de scribed299. F or pr otein 
detection, ~20 µg of membranes were resolved by SDS-PAGE and immunoblots were analyzed 
using a polyclonal anti-ERdj3 antiserum129.   
 For indirect immunofluorescence microscopy, wild-type and mutant yeast expressing the 
various ERdj3 constructs were analyzed according to an established protocol357. 
3.1.6 Assays for ER-Associated Degradation (ERAD) 
The g ene enc oding H A-tagged S te6p* was s ub-cloned f rom pS M1911 (2µ URA3 PPGK ste6-
166::HA)324 into p RS425 ( 2µ LEU2)358 to g enerate t he p425 -Ste6p*-HA pl asmid. In br ief, 
pSM1911 was digested with the restriction enzymes HindIII and Sac I to generate products of 
size 5.5 kb ( corresponding t o PPGK ste6-166::HA) and 6.2  kb ( corresponding t o t he v ector 
backbone); t he pr oducts w ere r esolved b y agarose gel electrophoresis. N ext, t he PPGK ste6-
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166::HA fragment w as extracted from t he agarose ge l us ing Qiagen’s G el E xtract kit, a nd 
inserted into pRS425, a lso t reated with HindIII and SacI. After many unsuccessful at tempts at  
transforming E. coli with the ligation mixture, I transformed the ligation mixture into HLJ1YDJ1 
yeast a nd s elected t ransformants on s ynthetic c omplete m edium l acking l eucine. T o i dentify 
positive clones, cell ex tracts were prepared f rom select t ransformants, resolved by SDS-PAGE 
and immunoblotted with anti-HA antibodies to detect Ste6p*-HA expression. After identifying 
positive clones, genomic DNA was prepared from these s trains, t ransformed into E. coli XL1-
Gold ul tracompetent c ells a nd s elected on Luria-Bertini-agar m edium s upplemented w ith 
ampicillin (50 µg/ml). The resulting E. coli strains harbored the p425-Ste6p*-HA plasmid. 
To enable selection of p425-Ste6p*-HA in the hlj1∆ydj1-151 strain, the LEU2 gene was 
replaced with the NATMX6 cassette, which confers r esistance t o the ant ibiotic nour seothricin, 
using PCR-mediated gene di sruption359. Briefly, the NATMX6 cassette was amplified from the  
pFA6a-NATMX6 plasmid (Table 5) with the primer pair:- 5’ primer: 
GCTATTTCTGATGTTCGTTCCAATGTCAAGTTCGATTTCGCGGATCCCCGGGTTAATT
AA, and 3’ primer:  
GGCAAGTTCAATGACAATTTCAACATCATTGCAGCAGACAGAATTCGAGCTCGTTTA
AAC. The resulting PCR product was t ransformed into hlj1∆ydj1-151 yeast and t ransformants 
were selected on yeast extract-peptone-dextrose-agar medium supplemented with nourseothricin. 
Positive clones were confirmed by PCR, thus generating the hlj1∆ydj1-151 leu2::NAT strain. 
Cycloheximide cha se assays t o measure the d egradation efficiency of  S te6p* w ere 
performed as described299 at 37°C. 
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3.2 RESULTS 
3.2.1 Ydj1 expressed in the mammalian ER functions as an Hsp70 cofactor 
To better understand the restrictions guiding the formation of functional Hsp70-JDP pairs, I first 
asked whether Ydj1, a cytosolic yeast JDP, could interact with BiP/GRP78, the mammalian ER-
lumenal Hsp70. Ydj1 is a type I JDP and bears an overall sequence identity of 37% to ERdj3, a 
cognate BiP JDP (Figures 22 and 23). For this set of  experiments, COS cells were t ransfected 
with plasmids expressing BiP a long with either a C-terminally HA-tagged form of  ERdj3 as a  
positive control, or with two different Ydj1 constructs engineered with an N-terminal ER signal-
sequence for targeting to the ER and a C-terminal HA tag for detection.  In one construct, Ydj1’s 
farnesylation s ite w as r emoved ( ssYdj1C406S) a nd i n t he ot her, i t w as retained ( ssYdj1). In 
yeast, f arnesylation e nables Y dj1 t o a ssociate with t he c ytosolic s urface of  the ER a nd i s 
essential for Ydj1’s function at elevated temperatures353.  
 Post-transfection, t he E R l ocalization of  t he t wo Y dj1 i soforms w as c onfirmed us ing 
indirect immunofluorescence (Fig 24A). The transfected cells were metabolically labeled, treated 
with a cr oss-linking agent t o s tabilize m ultiprotein c omplexes a nd l ysed. P roteins w ere 
immunoprecipitated with antisera against BiP, or  a  monoclonal antibody against HA, to detect 
Ydj1.  I found t hat t he t wo Y dj1 i soforms e fficiently a ssociated w ith B iP, at l evels s imilar t o 
those obs erved for E Rdj3 ( Figure 24B). Importantly, interaction between B iP a nd Y dj1 was 
detected regardless of whether the immunoprecipitation was performed with anti-BiP or anti-HA 
antibodies. Given t hat B iP i s m ore a bundant t han t he J DPs i n t he E R and that t he ant i-BiP 
antiserum is inefficient for immunoprecipitation, it was not surprising that I detected a stronger 
BiP signal when the JDPs were immunoprecipitated with the anti-HA antibody. 
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Figure 24: Ydj1 interacts with both BiP and κLC in the mammalian ER.  
(A) COS cel ls t ransfected with HA-tagged s sYdj1 or  s sYdj1-C306S w ere grown on  
coverslips, fixed and stained with an anti-HA antibody to detect the Ydj1 isoforms. Grp94 served 
as an ER marker. (B) COS cells were co-transfected with cDNAs encoding BiP and the indicated 
HA-tagged ERdj3 or Ydj1 constructs.  M etabolically labeled, DSP cross-linked cell lysates were 
immunoprecipitated with anti-HA or anti-BiP antibodies, or Protein A Sepharose alone.  Isolated 
proteins were separated by denaturing gel electrophoresis.  (C) COS cells were co-transfected with 
cDNAs encoding κLC and either ERdj3 or ssYdj1. Cell lysates were immunoprecipitated wth anti-
κ or anti-HA ant ibodies, or  P rotein A S epharose al one. Samples w ere an alyzed as d escribed in 
(B). (D) The ATPase activity of BiP was measured in the absence (-) or presence of either ERdj3 
or Ydj1. Reactions contained 1 μg of BiP and an eight-fold m olar e xcess of  E Rdj3 or  Y dj1. 
ATPase activity is expressed as nmoles of ATP hydrolyzed per milligram of protein per minute. 
Data represent the means of a minimum of three independent experiments + standard errors. 
The ex periments i n part A -C w ere p erformed b y Y i J in i n t he l aboratory of  Linda 
Hendershot at St. Jude Chidren’s Hospital, Memphis. 
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 Next, when COS cel ls w ere co-transfected with plasmids e xpressing Y dj1 a nd 
immunoglobulin κ light chain ( κLC), w hich i s normally a BiP a nd E Rdj3 s ubstrate129, Y dj1 
interacted w ith κLC t o the s ame extent as  E Rdj3 (Figure 24C). Taken t ogether, these d ata 
suggested that Ydj1 attains its native conformation in the mammalian ER, and is active. Finally, I 
observed that Ydj1 robustly stimulated BiP’s ATP hydrolysis activity to an even greater degree 
than ERdj3 (Figure 24D).  Thus, Ydj1 when targeted to the mammalian ER can function as a BiP 
cofactor. This r esult w as i ntriguing, be cause t he Brodsky l ab had pr eviously s hown t hat Y dj1 
does not bind to or functionally interact with the yeast ER-lumenal Hsp70, BiP/Kar2, in vitro151.  
3.2.2 Overexpression of cytosolically localized ERdj3 rescues the temperature-sensitive 
growth defect of hlj1Δydj1-151 yeast 
In yeast, Scj1 and Jem1 are two ER-localized JDPs118, 122 that interact with Kar2, the yeast BiP 
homolog, a nd are required f or m ultiple ER f unctions, i ncluding pr otein f olding119 and E R-
associated degradation (ERAD)120.  S cj1 is a  s oluble type I J DP ( Figure 22) w hose s tructural 
organization is s imilar to ERdj3, although i ts overall sequence is only 30% identical to that of  
ERdj3 (Figure 23). Jem1 is a  membrane-associated type III JDP (Figure 22), and owing to i ts 
non-canonical domain arrangement, the sequence comparison of Jem1 and ERdj3 was limited to 
that of the J domains, which revealed that they share 35% sequence identity (Figure 23). Loss of 
both S cj1 a nd J em1 ( scj1Δjem1Δ) r educes t he de gradation e fficiency of s oluble E RAD 
substrates120 and induces the unfolded protein response (UPR)119, 122. In addition, the scj1Δjem1Δ 
strain exhibits a slow growth phenotype at elevated temperatures122.   
 Since E Rdj3 i s E R-localized a nd c ontains i ntramolecular di sulfide bon ds124, I initially 
tested whether this JDP can substitute for Scj1 and Jem1 in the yeast ER.  Two ERdj3 constructs 
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were created for strong, constitutive expression from the PGPD promoter289. One contains an ER-
targeting signal sequence (wild-type ERdj3), whereas the other lacks this sequence but possesses 
a CASQ farnesylation sequence at the C-terminus that attaches the protein to the cytosolic side 
of t he E R m embrane ( CaaX-ERdj3); t he f arnesylation s equence i s t he s ame a s t hat f ound i n 
Ydj1353. When t he c onstructs w ere i ntroduced i nto w ild-type SCJ1JEM1 yeast, t hey di d not  
affect growth, indicating tha t the overexpression of t hese he terologous pr oteins i s not  t oxic 
(Figure 25A). As expected, when c ytosolically-targeted CaaX-ERdj3 was overexpressed in the 
scj1Δjem1Δ strain, it did not restore growth at elevated temperatures, however, neither did ERdj3 
(Figure 25A). To determine w hether t he l ack of an effect on scj1∆jem1∆growth w as due  t o 
ineffective K ar2-ERdj3 i nteraction, I measured ERdj3’s a bility to stimulate K ar2’s A TPase 
activity. A s s hown i n F igure 25B, ERdj3 onl y weakly s timulated t he A TP h ydrolysis r ate of  
Kar2, as compared t o Sec63, a co gnate K ar2 JDP t hat i s es sential f or na scent pol ypeptide 
translocation across the ER membrane98, 109, 111. Moreover, the lack of an effect was not  due to 
ERdj3 be ing uns table i n yeast cells, as I w as able to detect its  expression b y western blotting 
(Figure 25C). T aken t ogether, t hese obs ervations s uggest t hat E Rdj3 i s una ble t o functionally 
interact with Kar2 and hence cannot substitute for Scj1 and Jem1 in vivo.  
 Based on my observation that a yeast cytosolic JDP could function in the mammalian ER 
(Figure 24), I next asked i f ERdj3 was able to function in the yeast cytosol. The yeast cytosol 
contains 13 J DPs of which the best characterized is Ydj1. YDJ1 deletion results in slow growth 
at 30°C and inviability at elevated temperatures126. However, the slow growth of the ydj1∆ strain 
can be rescued by the overexpression of at least five other cytosolic JDPs261. Interestingly,  
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Figure 25: ER expressed ERdj3 is unable to rescue the growth phenotype of the 
scj1∆jem1∆ strain.   
(A) Ten-fold s erial di lutions w ere pe rformed f or w ild-type ( SCJ1JEM1) and m utant 
(scj1∆jem1∆) yeast strains containing an empty vector (-), a vector for the expression of an ER-
targeted form (ERdj3), or a ve ctor encoding a c ytosolically localized form (CaaX) of full-length 
ERdj3. C ells w ere pl ated ont o s elective m edium a nd i ncubated for 2 d a t t he i ndicated 
temperatures. (B) The ATPase a ctivity o f K ar2 was m easured alone ( -) or  i n t he pr esence o f 
equimolar amounts of the J domain of Sec63 or an eight-fold molar excess of ERdj3 as described 
in t he l egend t o Figure 24 D. Data r epresent t he m eans of  a m inimum of  t hree i ndependent 
experiments + standard errors. (C) Microsomal membranes were prepared from wild-type yeast 
strains that were transformed with an empty vector (-) or vectors encoding either ERdj3 or CaaX-
ERdj3. E Rdj3 w as de tected us ing a nti-ERdj3 antisera a nd primarily m igrates a t its  pr edicted 
molecular m ass of  42 kDa. Sec61, as de tected us ing a nti-Sec61 antiserum, served a s a l oading 
control. 
 135 
expression of the J domain alone of these five JDPs is sufficient to substitute for Ydj1 at 30°C, 
suggesting that the J domain-mediated activation of Hsp70 ATPase activity is critical to support 
the growth of ydj1∆ yeast261.  
 To determine whether ERdj3 could substitute for Ydj1, I first asked whether ERdj3 could 
stimulate the ATPase activity of Ssa1, an essential cytosolic Hsp70 that interacts with Ydj1 to 
execute ke y c ellular f unctions324, 32 7, 351, 3 60-364. I  discovered t hat ERdj3 proficiently stimulated 
Ssa1’s ATP hydrolysis rate, to a s imilar extent as Ydj1 and Hlj1, another J  domain containing 
Ssa1 cofactor (Figure 26A; see below). Next, I performed serial dilution analyses on w ild-type 
YDJ1 and m utant ydj1∆ yeast s trains t ransformed w ith pl asmids e xpressing e ither E Rdj3 or  
CaaX-ERdj3. E Rdj3 di d not  r escue t he s low g rowth phe notype of  ydj1∆ yeast, which was 
anticipated due  to i ts expression in t he ER lumen rather t han on t he c ytosolic f ace of  the ER. 
However, c ontrary t o m y expectations, ne ither di d c ytosolically t argeted C aaX-ERdj3 (Figure 
26B). These data suggest that in spite of its ability to be expressed in yeast (Figure 25C), and to 
stimulate the ATPase activity of Ssa1 in vitro (Figure 26A), cytosolic expression of ERdj3 is not 
sufficient to overcome the s trong impairment of  cellular homeostasis that results from deleting 
the YDJ1 locus. 
 I therefore d ecided to utilize an alternate yeast s train, hlj1∆ydj1-151, w hich c ontains a  
temperature-sensitive al lele of  YDJ1 and l acks another E R-associated JDP w ith a c ytosolic J  
domain, Hlj1327. Hlj1 is a type II JDP and bears 27% overall sequence identity to ERdj3 (Figures 
22 and 23). T he hlj1∆ydj1-151 yeast s train exhibits a  tig ht te mperature-sensitive g rowth 
phenotype but not the slow growth displayed by ydj1∆ yeast; this strain also exhibits defects in 
the E RAD of  s elect i ntegral m embrane pr oteins, s uch as a m utant f orm of  t he yeast a-factor 
transporter, Ste6p (i.e., Ste6p*)324 and the cystic fibrosis transmembrane conductance regulator  
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Figure 26: Cytosolic expression of ERdj3 rescues the temperature-sensitive growth 
phenotype of the hlj1∆ydj1-151 strain.  
(A) The ATPase activity of  Ssa1 was measured either alone (-) or  in the presence of Ydj1, 
Hlj1 or ERdj3 as described in the legend to Figure 24D. The molar ratio of Ssa1 to the JDPs was 1:2. 
Data represent the means of a minimum of three independent experiments + standard errors. (B & C) 
Either an empty v ector ( -), or  a  ve ctor c ontaining a n E R-targeted form ( ERdj3) or  a  ve ctor 
engineered t o pr oduce a n E R-tethered, cytosolically loc alized form ( CaaX) of  E Rdj3 w as 
transformed i nto (B) wild-type ( YDJ1) a nd mutant ( ydj1∆) yeast strains, or (C) wild-type 
(HLJ1YDJ1) and m utant (hlj1∆ydj1-151) yeast strains. The r esulting tr ansformants w ere s erially 
diluted onto selective medium and incubated as described in the legend to Figure 25A.  
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(CFTR)327. To this end, plasmids engineered for the expression of ERdj3 and CaaX-ERdj3 were 
transformed into HLJ1YDJ1 and hlj1∆ydj1-151 yeast s trains and i ndirect i mmunofluorescence 
microscopy was performed to confirm that the proteins were expressed (Figure 27). Next, serial 
dilution analyses w ere p erformed t o a nalyze t he g rowth of  t he t ransformed s trains a t va rious 
temperatures. In contrast to the results using ydj1∆ yeast, I observed that cytosolic CaaX-ERdj3, 
but not  E R-targeted E Rdj3, r estored t he growth of  hlj1∆ydj1-151 cells at t emperatures up to 
37°C (Figure 26C). In fact, the ER lumenally expressed ERdj3 actually exacerbated the growth 
defect o f t he hlj1∆ydj1-151 strain (Figure 26C), pr obably due  t o i ts dr astic effect on ER 
morphology (Figure 27). These results indicate that CaaX-ERdj3 functions as a cochaperone for 
Ssa1 in vivo and c an c ompensate f or Hlj1 a nd Y dj1, but  on ly i n the presence of  a pa rtially 
functional copy of Ydj1.  
3.2.3 The substrate binding domain of ERdj3 is required to rescue the slow growth 
phenotype of hlj1Δydj1-151 yeast 
Previous studies showed that substrate binding is essential for Ydj1 to optimally function in vivo 
and in vitro315, 352, 365, and Ydj1 and ERdj3 have similar substrate binding domains (Figure 23). 
The Hendershot lab recently demonstrated that the binding of ERdj3 to substrates requires three 
features: (i) the presence of domain II (Figure 22), (ii) the pocket formed by hydrophobic amino 
acids i n dom ain I, a nd ( iii) di merization, w hich occurs t hrough i nteractions i n t he C -terminal 
region and requires the presence of phenylalanine 326125.  
 Having e stablished a  n ew s ystem t o a ssay t he f unction of  E Rdj3, I next w ished t o 
determine whether substrate interaction is required for CaaX-ERdj3 to rescue the growth of  
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Figure 27: Detection of the various wild-type and mutant ERdj3 proteins in yeast by 
indirect immunofluorescence.  
Wild-type HLJ1YDJ1 and mutant hlj1Δydj1-151 yeast strains containing an empty vector (-
), or  expression vectors for an ER-targeted form of  ERdj3 (ERdj3), an ER-tethered cytosolically 
localized f orm of  f ull-length E Rdj3 ( CaaX) or  CaaX m utants ( CaaX-D55N, CaaX-ΔII-GSGG, 
CaaX-F326D, CaaX-L204A and CaaX-IVLFa) were s tained with antibodies a gainst E R-lumenal 
Kar2 (TRITC-labeled secondary antibody) and ERdj3 (FITC-labeled secondary antibody). DAPI 
was used to visualize the nuclear DNA.  
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hlj1∆ydj1-151 yeast. I therefore expressed seven CaaX-ERdj3 substrate binding mutants in this 
strain.  These included mutants in which domain II, spanning amino acids 160-200, was deleted 
(∆II) or was replaced by a “GSGG” linker (∆II-GSGG), two mutants in which dimerization was 
inhibited (F326A and F326D), s ingle amino acid substitution mutants in domain I ( I134A and 
L208A), a nd a  m utant i n w hich f our h ydrophobic r esidues in dom ain I  that af fect s ubstrate 
binding, i ncluding I134A a nd L208A, were a ltered ( IVLFa). In a ddition, I expressed two 
versions of CaaX-ERdj3 that are defective for Hsp70 interaction, H53Q and D55N129, 130. These 
mutations lie in the invariant HPD motif of the J domain366.  
 Expression of  t he m utant C aaX-ERdj3 proteins in wild-type HLJ1YDJ1 yeast did not  
affect cell growth (Figure 28A), indicating that these proteins do not  exert a dominant negative 
effect.  M oreover, none of  t he s ubstrate bi nding m utants r escued t he temperature-sensitive 
phenotype of  t he hlj1Δydj1-151 strain, e ven t hough C aaX-ERdj3 w as again able t o i mprove 
growth up t o 37°C  ( Figure 28B). T he f ailure o f t he s ubstrate bi nding mutants t o r escue t he 
growth phenotype was not due to their inability to stimulate the ATPase activity of Ssa1, since a 
member of each mutant class stimulated Ssa1 ATP hydrolysis to levels comparable to wild-type 
ERdj3 (Figure 28C and data not shown); however, the IVLFa mutant stimulated Ssa1’s ATPase 
activity only about half as efficiently as wild-type ERdj3. I also noted that the mutant proteins 
were expressed at similar levels as CaaX-ERdj3 as determined by indirect immunofluorescence 
microscopy (Figure 27B and data not shown).  
 In contrast to the ina bility o f the  s ubstrate bi nding mut ants to restore v iability, the J  
domain mutants rescued the growth of the hlj1Δydj1-151 strain as efficiently as wild-type CaaX-
ERdj3 ( Figure 28B). A s a nticipated, these mut ant pr oteins w ere un able to stimulate S sa1’s 
ATPase activity in vitro (Figure 28C).  Taken together, these data argue that the substrate  
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Figure 28: ERdj3 substrate binding mutants fail to enhance the growth of hlj1∆ydj1-
151 yeast.  
Cytosolic forms (CaaX) of wild type or mutant ERdj3 were expressed in HLJ1YDJ1 wild 
type (A) or hlj1∆ydj1-151 mutant (B) yeast strains. Cells were plated and incubated as described in 
the legend to Figure 25A.  (C) The ATPase act ivity of  Ssa1 was measured in the absence (-) or  
presence of the indicated wild-type and mutant ERdj3 proteins as described in the legend to Figure 
25D. The m olar r atio of S sa1 to the i ndicated JDPs w as 1: 2. Data r epresent t he m eans of  a 
minimum of three independent experiments + standard errors. 
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binding pr operties o f CaaX-ERdj3 a re required t o c omplement t he gr owth de fect of  t he 
hlj1Δydj1-151 strain, and that t his does not  s imply d epend on  (or even require) t he functional 
interaction of JDPs with a cognate Hsp70. 
 
3.2.4 Cytosolically expressed ERdj3 compensates for cell wall defects in the hlj1Δydj1-151 
strain 
Yeast cells are fortified by a cell wall that is comprised of two layers: an inner layer composed of 
β-1,3-glucans, β−1,6-glucans and small amounts of chitin, and a protective outer layer composed 
of glycosylphosphatidylinositol ( GPI) a nd P ir g lycoproteins. C ell w all i ntegrity, w hich i s 
essential dur ing growth, c ell di vision a nd s tress, i s m aintained b y t he coordinated a ction of  
several s ignaling pa thways367. Recently, the Brodsky l ab demonstrated t hat Y dj1 a lso pl ays a 
role in the maintenance of cell wall integrity355. For example, the growth of ydj1∆ mutant yeast 
was rescued by osmostabilizing agents such as sodium chloride (NaCl) and sorbitol. However, 
the role of Ydj1 in cell wall integrity appeared to be independent of Ssa1 function because yeast 
cells car rying a t emperature-sensitive mut ant a llele i n SSA1, ssa1-45, did not  e xhibit t hese 
phenotypes. Based on t hese da ta, I next as ked if hlj1∆ydj1-151 yeast d emonstrated cell w all 
defects, and if so, whether CaaX-ERdj3 expression could rescue these phenotypes. 
 First, HLJ1YDJ1 and hlj1∆ydj1-151 cells were t ransformed w ith a  ve ctor c ontrol a nd 
serially diluted on growth medium supplemented with NaCl or sorbitol. I found that the growth 
of hlj1∆ydj1-151 was partially restored at 37°C under these conditions (Figure 29, row labeled ‘-
’), suggesting that the mutant s train has a cell wall phenotype. Next, hlj1∆ydj1-151 yeast were 
transformed with plasmids expressing e ither wild-type o r mutant ve rsions of  CaaX-ERdj3 and 
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Figure 29: CaaX-ERdj3 complements the cell wall phenotype of the hlj1∆ydj1-151 
strain.  
Either an empty ve ctor ( -), a ve ctor c ontaining an E R-targeted form ( ERdj3), or  a  ve ctor 
engineered t o pr oduce a  c ytosolically l ocalized f orm ( CaaX) of  E Rdj3 was t ransformed i nto w ild-
type (HLJ1YDJ1) and mutant (hlj1∆ydj1-151) yeast st rains. In addition, cytosolic forms (CaaX) o f 
mutant E Rdj3 w ere e xpressed i n hlj1∆ydj1-151 yeast. Cells w ere s erially di luted onto selective 
medium c ontaining or l acking 8 m M D TT, 0.4M N aCl or  1  M  s orbitol, a nd w ere i ncubated as 
described in the legend to Figure 25A. 
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were t ested for growth on NaCl- or sorbitol-supplemented m edium. I observed t hat t he 
expression of  w ild-type and J dom ain m utants o f C aaX-ERdj3, but  not  the s ubstrate bi nding 
mutants, significantly rescued the c ell w all de fects of  hlj1∆ydj1-151 yeast ( Figure 29). T hese 
data further support the hypothesis that Ydj1’s role in the maintenance of cell wall integrity is  
not reliant upon its interaction with Ssa1355. 
 Finally, I tested whether di -thio-threitol ( DTT), a r educing agent t hat c auses acut e E R 
stress, affected the growth of hlj1∆ydj1-151 yeast expressing wild-type and mutant CaaX-ERdj3 
proteins. I found t hat, at nor mal growth t emperatures, i.e., 30°C, t he hlj1∆ydj1-151 strain 
transformed with an empty vector did not exhibit sensitivity to DTT (data not shown) suggesting 
that hlj1∆ydj1-151 yeast are able to mount an adequate UPR to combat ER stress. In contrast, at 
elevated temperatures and at a DTT concentration of 8 mM, the hlj1∆ydj1-151 strain is inviable 
(Figure 29, row labeled ‘-’), and the expression of wild-type or mutant CaaX-ERdj3 proteins was 
unable t o r escue t his growth defect (Figure 29). One i mplication of  t hese obs ervations i s t hat 
CaaX-ERdj3 adopts i ts correct three-dimensional s tructure b y forming int ramolecular disulfide 
bridges124 in the yeast cytosol, an environment that is less oxidizing than the mammalian ER, and 
it t akes t he a ddition of  a  r educing a gent t o i nduce unf olding a nd abrogate E Rdj3 f unction. 
Alternately, i t i s pos sible t hat t he c ombination of D TT a nd e levated t emperature i s a hi ghly 
unsuitable growth condition for hlj1∆ydj1-151 yeast, and even the overexpression of  c ytosolic 
ERdj3 is unable to compensate for this. 
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3.2.5 CaaX-ERdj3 expression restores ERAD in hlj1∆ydj1-151 yeast 
In t he pr evious s ection, I found t hat E Rdj3 r escues a  J DP-dependent c ellular pr ocess t hat i s 
independent of  S sa1. N ext, I wished t o e xamine t he e ffects of  E Rdj3 on a n Hsp70-dependent 
process, namely ERAD. ERAD is a quality control process during which misfolded ER-localized 
proteins are retrotranslocated to the cytosol and targeted to the 26S proteasome for degradation5.  
The Brodsky lab previously showed that Hlj1 and Ydj1 act as Ssa1 cofactors during the ERAD 
recognition and targeting of integral membrane proteins such as Ste6p* and CFTR, and that the 
hlj1∆ydj1-151 strain is defective for the ERAD of these substrates324, 327. To determine whether 
CaaX-ERdj3 c ould s ubstitute f or H lj1 a nd Y dj1 dur ing E RAD, I co-expressed wild-type or  
mutant C aaX-ERdj3 pr oteins w ith S te6p* i n t he hlj1∆ydj1-151 strain a nd pe rformed a  
cycloheximide c hase analysis t o m easure t he d egradation efficiency o f S te6p*. A lthough t he 
hlj1∆ydj1-151 strain de graded S te6p* poor ly, I found t hat C aaX-ERdj3 ove rexpression 
significantly accelerated the degradation of Ste6p* (Figure 30A). In contrast, none of the ERdj3 
mutants were as efficient as wild-type CaaX-ERdj3 in compensating for the ERAD defect in the 
hlj1∆ydj1-151 strain (Figure 30B). However, the strongest defect was observed when the ability 
of t he D 55N J  dom ain m utant f orm of  C aaX-ERdj3 w as t ested, w hich is una ble t o s timulate 
Ssa1’s ATPase activity (Figure 28C). These data indicate that CaaX-ERdj3’s ability to improve 
ERAD is pr imarily d ependent on its int eraction with the c ytosolic H sp70, but tha t di rect 
interaction with substrates is also important. 
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Figure 30: CaaX-ERdj3 substitutes for Hlj1 and Ydj1 during ERAD.  
Cycloheximide chase assays were pe rformed to measure t he de gradation of   S te6p* in (A) 
wild-type ( HLJ1YDJ1) yeast tr ansformed with an empty vector (     ) and hlj1∆ydj1-151 yeast 
transformed with either an empty vector (    ) , a vector containing an ER-lumenal form of ERdj3 (    
), or  a  v ector e ngineered t o pr oduce a cytosolically localized form of  ERdj3 (     ) ,  or  (B) in 
hlj1∆ydj1-151 yeast transformed with vectors engineered to produce cytosolically localized forms of 
wild-type (   ) and the following mutant ERdj3 proteins: D55N  (    ) , ∆II-GSGG (    ), F326D (    ), 
and IVLFa (    ). D ata r epresent t he m eans of  a  m inimum of  t hree i ndependent experiments + 
standard errors. 
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3.3 DISCUSSION 
Ydj1 and ERdj3 are Type I JDPs and share a similar domain organization (Figure 22). However, 
the che mical e nvironments w ithin t heir r esident or ganelles a re s ignificantly di fferent. Y dj1 
resides in the yeast cytosol, an environment that is relatively less oxidizing than ERdj3’s native 
milieu, t he m ammalian E R. C onsequently, E Rdj3’s c ysteines a re i nvolved i n i ntramolecular 
disulfide br idges124, w hile t he c ysteine-rich r egion of  Ydj1 c oordinates Zn2+, similar to other 
Type I DnaJ homologs368. Given these differences and the low overall sequence identity shared 
by Ydj1 and ERdj3 (i.e., 37%), one might expect that these JDPs would be unable to substitute 
for one another in vivo. Surprisingly, I observed that Ydj1 could function in the mammalian ER 
and ERdj3 could function in the yeast cytosol, indicating that these JDPs attain their native or 
near-native conformations in diverse environments. In contrast, ERdj3 was unable to compensate 
for t wo ER-localized yeast J DPs, Scj1 and Jem1, most like ly due  to its f ailure to efficiently 
stimulate the  A TPase a ctivity of  t he yeast B iP hom olog, K ar2 ( Figure 25B). T ogether, t hese 
results de monstrate tha t Y dj1 a nd E Rdj3 a ssociate pr oductively with H sp70s i n uni que 
subcellular c ompartments a nd c an e xhibit a  r elaxed H sp70 s pecificity. In a ddition, g iven the 
previous observation that Ydj1 cannot interact productively with Kar2151, these data also indicate 
that Kar2 is more fastidious than Ssa1 or BiP with regards to JDP association. 
I also di scovered t hat a lthough c ytosolically expressed E Rdj3 could c omplement t he 
temperature-sensitive gr owth of  t he hlj1∆ydj1-151 strain, it c ould no t r escue t he s low g rowth 
phenotype of  ydj1∆ yeast. T his w as s omewhat s urprising given t hat the ove rexpression of  
isolated J domains is sufficient to compensate for the loss of Ydj1261. This phenomenon probably 
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arises due  to the a ctivation of the  A TPase a ctivity o f c ytosolic H sp70s b y t he e xamined J  
domains, and I show that ERdj3 robustly s timulates the ATPase activity of a  cytosolic Hsp70, 
Ssa1 (Figure 26A). H owever, s ince t he l evel of J  dom ain e xpression a lso i nfluences t he 
efficiency of  ydj1∆ growth rescue261, it is  possible t hat C aaX-ERdj3 w as not  e xpressed t o 
sufficiently high levels in vivo either to interact with Ssa1 or localize correctly, and hence was 
unable t o c ompensate f or t he l oss of  Y dj1. A lternately, t he i nteraction of  E Rdj3 w ith a nother 
cytosolic Hsp70 such as Ssb1369 may be required to complement ydj1∆ growth, and ERdj3 might 
be unable to stimulate the activity of this Hsp70. It is also formally possible that ERdj3 is more 
suited to complement the functions of Hlj1 than those of Ydj1; because Hlj1-specific functions 
and phenotypes have not been reported, there is no ready way to test this possibility.  
I determined that ERdj3 mutants that fail to associate with Ssa1 are competent to rescue 
the temperature-sensitive and cell wall phenotypes associated with hlj1∆ydj1-151 mutant yeast. 
This suggests that these phenotypes result from defects in processes that are independent of Ssa1 
interaction. B ased on  t he obs ervation t hat s ubstrate bi nding m utants o f ERdj3 w ere un able t o 
rescue hlj1∆ydj1-151 phenotypes (Figure 28 and 29), and that hlj1∆ yeast do not  exhibit s low 
growth and cell wall phenotypes (data not  shown) but  ydj1∆ do126, 3 55, I surmise that cell wall 
function and robust growth at elevated temperature are l inked to the ability of Ydj1 to bind to 
specific substrates. Formally, the cell wall phenotypes may also arise from the ability of Ydj1 to 
partner with Hsp82, the cytosolic Hsp90 which p lays a  role in high osmotic s tress response in 
yeast355, 3 70, 371 and functions in conjunction with Ydj1 in the folding and maturation of certain 
client proteins368, 372, 373. The cell wall phenotype may additionally arise from altered association 
with Sse1, the cytosolic Hsp110370, which has previously been shown to genetically interact with 
YDJ1141. 
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The substrate binding dependent effects of  ERdj3 expression on hlj1∆ydj1-151 growth, 
but not on ydj1∆ growth, are reminiscent of prior studies suggesting that although Ydj1 and Sis1, 
an essential yeast cytosolic JDP374, perform unique essential cellular activities, they also exhibit 
substrate binding promiscuity: (i) Ydj1 overexpression is unable to support the viability of sis1∆ 
yeast, although Sis1 overexpression rescues the growth defect of the ydj1∆ strain261, 374; and, (ii) 
the substrate binding domains of either Ydj1 or Sis1, but not both, are required for optimal yeast 
growth a nd s urvival315. Taken t ogether w ith my results, I infer tha t w hile c ertain substrate 
proteins c an i nteract w ith m ultiple J DPs f or de livery t o c ognate H sp70s for f olding/assembly, 
others may require specific JDPs for cellular targeting or protein folding. 
To my knowledge, this study is the first demonstration that a full-length mammalian JDP 
can f unction i n a  non -native or ganelle i n a di vergent or ganism. S everal ot her r eports ha ve 
analyzed t he e ffects of  ove rexpressing the J  dom ains of  c ognate or  non-cognate J DPs i n 
related/divergent model systems261, 375, 376, but rarely has the specific impact of the JDP substrate 
binding domain been investigated. My data, together with those of others, reveal novel insights 
into the biology of DnaJ family proteins.  For example, since isolated J domains can complement 
a subset of JDP-related defects261, it appears that for many cellular processes, the JDP-stimulated 
high affinity binding of partner Hsp70s to substrates is sufficient. In other cases (i.e., ERAD), the 
JDP must interact both with the substrate and the Hsp70, presumably to aid in the recruitment of 
the Hsp70 to its substrate.  Finally, for other functions (i.e., cell wall integrity), the JDPs do not 
have to interact with an Hsp70, but merely need to recognize their substrates.  In keeping with 
these diverse models/pathways, ERdj3 was able to function both in ERAD and in maintaining 
cell w all i ntegrity, a rguing t hat t his JDP i s a ble to pe rform bot h H sp70 dependent a nd H sp70 
independent functions through its substrate binding activity.  Very recently, a novel class of Type 
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IV J DPs ha s be en i dentified, c onstituting pr oteins t hat l ack t he c anonical H PD m otif t hat i s 
essential f or i nteracting with H sp70s but pos sess put ative s ubstrate bi nding domains377. T hus, 
this g roup of  J DPs m ay ha ve e volved t o s imply bind t o s ubstrates, p resumably i n a n H sp70 
independent fashion.   
Finally, this study opens-up a new avenue to determine the functions of mammalian JDPs 
in ERAD. In particular, the Brodsky lab is now positioned to examine the ability of any JDP to 
substitute for cytosolic homologs during this quality control process. 
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4.0  CONCLUSIONS AND PERSPECTIVES 
The di versity o f H sp70s a nd H sp40s i ncreases i n hi gher eukaryotes a nd va ries be tween s ub-
cellular compartments. Therefore, the pathways and networks coordinated by these chaperones 
are intricate and essential for cell survival. In order to better understand the rules that govern the 
formation of functional Hsp70-Hsp40 pairs, I utilized a two-pronged approach. First, I examined 
the properties of the ER-lumenal Hsp70, BiP, that contribute toward the recognition of its Hsp40 
cochaperones, Sec63p, Scj1p and Jem1p, in the yeast ER. Second, I evaluated the capacity of a 
mammalian ER-lumenal H sp40, E Rdj3, t o f unction i n yeast a nd a ddressed t he i mportance of  
ERdj3’s substrate binding activity. The results from these studies have not only provided insights 
into the mechanisms utilized by Hsp70s and Hsp40s to achieve optimal function, but have also 
resulted in the formulation of novel hypotheses, which I discuss below. 
BiP differentially interacts with its Hsp40 cochaperones 
In the yeast ER, BiP i nteracts w ith: ( i) S ec63p to catalyze protein translocation across t he ER 
membrane, (ii) Scj1p to chaperone protein folding, (iii) Jem1p to facilitate karyogamy, and (iv) 
both Scj1p and Jem1p to recognize misfolded proteins and target them for ERAD. However, the 
specific pr operties of  B iP t hat e nable i t t o di stinguish be tween i ts H sp40 c ochaperones a re 
unknown. D uring t he c ourse of  m y s tudies, I di scovered t hat m utating a  c onserved R  i n s ub-
domain Ia of BiP’s ATPase domain to an A resulted in a protein that was defective for Sec63p 
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and Scj1p interaction, but maintained i ts ability to interact with Jem1p (refer to section 2.2.2). 
This result suggests that surface residues in sub-domain Ia of BiP’s ATPase domain, including 
R217, a re vi tal for t argeting BiP to specific cochaperones, possibly b y f orming unique sets of  
hydrogen bonds , e lectrostatic i nteractions a nd/or va n de r W aals interactions. To test thi s 
hypothesis, c onserved r esidues t hat a re l ocated a djacent t o R 217 c ould be  m utated a nd t he 
resulting proteins examined for their ability to interact with the J domains of Sec63p, Scj1p and 
Jem1p. However, since charged surface residues in subdomain Ia of Hsp70s may form hydrogen 
bonds w ith r esidues i n t he i nter-domain l inker7, 1 5, i t i s pos sible that al tering t hese cons erved 
amino acids in BiP’s ATPase domain might result in a loss of the allosteric regulation mediated 
by all Hsp40 cochaperones. Conversely, i t is possible that the J  domains of Sec63p, Scj1p and 
Jem1p have evolved to contact different residues in BiP’s ATPase domain. These variations may 
explain the low sequence similarities shared by these and other J domains (refer to section 2.3.1). 
To a ddress t his h ypothesis, non -conserved r esidues i n t he J  dom ains o f S ec63p, S cj1p a nd 
Jem1p, w hich a re a djacent t o t he conserved, i nvariant H PD m otif could be  m utated a nd t he 
resulting proteins analyzed for BiP interaction. Finally, each of these Hsp40 cochaperones might 
reside within unique multiprotein complexes and therefore enhance BiP’s ability to participate in 
specific functions. One such complex has been identified for membrane-bound Sec63p, which is 
is positioned to interact with components of the Sec61 translocation machinery (refer to section 
1.2.4), and target BiP to nascent, translocating polypeptide chains. 
 I also found that the expression of R217A BiP in yeast resulted in translocation-specific 
defects ( refer t o s ection 2.2.5) . W hile t his r esult c ould be  c orrelated t o a  r educed i nteraction 
between R217A BiP and Sec63p (refer to sections 2.2.2 a nd 2.2.6) , i t is formally possible that 
R217A BiP is defective for interacting with other proteins. For example, R217A BiP might be 
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unable t o e fficiently associate w ith BiP’s N EFs, S ls1p a nd Lhs1p, w hich a ssist i n pr otein 
translocation ( refer t o s ection 1.2.3) . T his h ypothesis c ould be  e valuated b y pe rforming l arge-
scale pul ldowns t o i dentify BiP-associated pr oteins f rom w ild-type a nd m utant kar2 strains. 
Alternately, a genetic screen can be performed to discover similarities/dissimilarities in genetic 
interactions be tween wild-type and m utant kar2 alleles. In fact, I em ployed this appr oach to 
identify a gene that appears to play a unique role in translocation (see below and refer to section 
2.2.8 and Appendix B). 
 Taken t ogether w ith pr evious s tudies t hat a nalyzed m utants of  D naK91 and Chinese 
hamster B iP302 that w ere de fective f or c ognate Hsp40 i nteraction, t he be havior of  t he R 217A 
mutant of  yeast B iP ha s i mproved our  know ledge o f t he s tructural de terminants r equired f or 
Hsp40 r ecognition. H owever, t he aforementioned s tudies di d not  address w hether t his uni que 
mutation di fferentially affected t he r ecognition of e very pot ential H sp40. T hese s tudies a lso 
failed to address whether the conserved mutation affected multiple functions performed by the 
Hsp70.  
Substrate binding is a key determinant of yeast BiP function 
A pr evious s tudy s howed t hat t he ove rexpression of  t he s ubstrate bi nding a nd l id dom ains of  
bacterial DnaK in E. coli abrogates cell viability378, possibly because this isolated fragment can 
bind to substrates but is unable to fold them379. The random mutagenesis of this substrate binding 
and l id dom ain fusion led t o t he i dentification of  r esidues i mportant for s ubstrate bi nding, 
including G400D, L459P, G443D, G443S, S398F, G539D, P419L, P419S, E444K, M408I, 
G405S, G406D, E402K, A488T, a nd D526N378. Intriguingly, w hile n one of  t hese residues 
directly cont act the peptide, many of  them cluster to a  specific region in the substrate binding 
domain consisting o f loop L1,2, loop L4,5, and the β1 s trand. Moreover, these a re conserved in 
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several H sp70s. T he a uthors s urmised t hat t hese r esidues a re i nvolved i n t he s tabilization of 
DnaK-substrate interaction and are therefore important for the in vivo function of DnaK. Since 
the mutations were isolated by mutagenizing a DnaK fragment that lacked the ATPase domain, 
they most likely do not contribute to Hsp70 allostery.  
 I also constructed and identified two mutations in BiP, K584X and S493F in the substrate 
binding domain that affected BiP’s ability to functionally interact with substrates (refer to section 
2.2.2). N either of  t hese mutations m aps t o t he h ydrophobic c left that bi nds t o s ubstrates, but  
instead the K584X mutation results in a loss of the lid domain while the S493F mutation alters a 
putative link between the substrate binding and lid domains. My results with K584X and S493F 
BiP indicate that modifications distal to the h ydrophobic peptide binding cleft also a lter BiP’s 
substrate recognition properties. Moreover, because the in vivo expression of K584X and S493F 
BiP resulted in translocation and ERAD defects, as well as an induction of the UPR, I suggest 
that B iP’s a bility to bind to substrates is  pr imarily controlled by in teractions be tween the 
substrate bi nding a nd l id dom ains. T o f urther a ddress t his h ypothesis, m utations i n B iP 
analogous to those identified in the study described above could be constructed and examined. 
Hsp70 interaction and substrate binding determine ERdj3’s ability to function in yeast 
In the mammalian ER, an environment that is relatively more oxidizing than the cytosol, ERdj3 
functions a s a  BiP c ofactor dur ing t he f olding of s everal pr oteins, i ncluding i mmunoglobulin 
subunits ( refer t o s ection 1.2.2.1) . It ha s b een o bserved t hat E Rdj3 m utants t hat a re una ble t o 
interact with BiP robustly bind to substrates129, and conversely, ERdj3 mutants that are defective 
for substrate binding maintain their ability to cooperate with BiP125 and stimulate BiP’s ATPase 
activity (personal c ommunication, J in, Y . a nd H endershot, L.M.). However, be cause t he 
mammalian ER harbors five other Hsp40 homologs that act as BiP cofactors, the interpretation 
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of results obtained from ERdj3 overexpression studies becomes complicated. Therefore, I used a 
yeast expression system to understand the cellular requirements for ERdj3 function.  
 When wild-type ERdj3 was expressed in the yeast ER, I observed that i t was unable to 
substitute for Scj1p and Jem1p, possibly because of its poor functional interaction with yeast BiP 
(refer to section 3.2.2). This result was initially surprising because ERdj3 normally resides in the 
ER. N onetheless, yeast BiP i s f astidious w ith r egards t o i ts H sp40 i nteractions151. Hence, I 
postulate that ERdj3 does not possess the correct recognition elements to form a functional pair 
with yeast BiP, even though it may bind to yeast BiP substrates. For example, during a process 
such as ERAD, ERdj3 might be defective for targeting BiP to misfolded substrates, even though 
it ma y be c ompetent to interact w ith these s ubstrates. Alternately, it is  pos sible tha t E Rdj3 
overexpression in the yeast ER is toxic, which was observed as reduced growth and aberrant ER 
morphology (refer to section 3.2.2 and Figure 27). Taken together, these data indicate that not all 
Hsp70s a nd H sp40s c an f unction i n a c oordinated m anner, a nd t hat t hese c haperones pos sess 
inherent a bilities t o di stinguish be tween t heir p artners. To f urther und erstand t he s tructural 
properties of  H sp40s t hat a re r ecognized b y yeast B iP, poi nt m utants i n E Rdj3 c ould be  
generated by r andom m utagenesis, with the g oal of  ide ntifying mut ations tha t e nhance B iP 
binding a nd A TPase activation. I pr edict tha t ERdj3 mutants w ith these pr operties w ill be  
competent to restore the growth of scj1∆jem1∆ yeast at 37°C. 
 In contrast, when wild-type ERdj3 was targeted to the yeast cytosol, it complemented the 
growth defects of  the hlj1∆ydj1-151 strain, which contains mutations in two cytosolic Hsp40s, 
Hlj1p and Ydj1p (refer to section 3.2.2). One explanation for this observation may be the ability 
of ERdj3 to stimulate the ATPase activity of the cytosolic Hsp70, Ssa1p (refer to section 3.2.2). 
However, since ERdj3 was unable to rescue the growth defects of ydj1∆ yeast (refer to section 
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3.2.2) unl ike other overexpressed J  domains261, other endogenous properties of  ERdj3 must be  
required for function. Accordingly, I found that substrate binding mutants of ERdj3 were unable 
to substitute for Hlj1p and Ydj1p (refer to section 3.2.3), possibly because they fail to fold/traffic 
specific s ubstrates t hat nor mally de pend upon Hlj1p a nd Y dj1p. Moreover, be cause E Rdj3 
mutants tha t w ere de fective f or H sp70 interaction maintained their a bility to complement 
hlj1∆ydj1-151 temperature-sensitive growth, I speculate th at s ubstrate bi nding is  a critical 
determinant of  ERdj3 function. Therefore, a  careful s tructure/function analysis of the substrate 
binding pr operties of  un ique H sp40s, a s w ell a s t he i dentification of  t he s ubstrate e nsemble 
targeted by each Hsp40, is necessary to fully understand Hsp40 function. 
A genetic screen leads to the identification of novel players in ER protein translocation  
To further examine the in vivo ramifications of R217A BiP expression, I utilized a targeted UPR-
based genetic screen. In brief, yeast strains expressing R217A BiP were crossed against a set of 
350 deletion strains (refer to section 2.2.8 and Appendix B). The strains were chosen because the 
UPR is constitutively induced, which is indicative of a reduction in ER homeostasis121. From this 
analysis, I determined that the genetic interaction profile of kar2-R217A resembled the profiles 
of two other mutants, sec71∆ and sec72∆, which also exhibit defects in translocation. Moreover, 
kar2-R217A genetically interacted with a subset of the gene deletion strains; one such strain was 
ilm1∆. My s ubsequent analyses of  t his s train de fined a  r ole f or I lm1p, a  pr eviously 
uncharacterized integral membrane protein, during the translocation of pre-BiP. I also identified 
an a ssociation of  Ilm1p w ith c omponents of  t he t ranslocation m achinery, not ably S ec61p, 
Sec62p a nd S ec63p ( refer t o s ection 2.2.9) . However, g iven t hat ilm1∆ yeast efficiently 
translocated three other substrates (ppαF, DPAP-B and Pho8p) it will be vital to: (i) characterize 
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the t ranslocation e fficiencies of  ot her s ubstrates, i ncluding C PY, O ch1p a nd G as1p ( a β-1,3-
glucanosyltransferase involved in cell w all a ssembly), i n ilm1∆ yeast, (ii) de termine w hether 
Ilm1p plays a specific role in the recognition of pre-BiP, which will be completed by attaching 
the s ignal s equence f rom pr e-BiP t o ot her pr oteins a nd a ssessing Ilm1p-dependence, and ( iii) 
evaluate w hether ilm1 mutants e xhibit g enetic int eractions w ith components of  the  s ignal 
recognition a nd E R t ranslocation m achinery. I h ave be gun experiments t oward e ach of  t hese 
goals.  
 My data suggest that the function of  the yeast translocon may be regulated by Ilm1p, a  
phenomenon that is reminiscent of the regulation of the mammalian translocation apparatus by 
integral membrane proteins such as TRAM and TRAP (refer to section 1.2.4). Although Ilm1p 
homologs are only found in other fungi, Ilm1p physically interacts with an uncharacterized but 
essential integral membrane protein encoded by YNL181w. YNL181w is highly conserved in all 
eukaryotes. Since Ynl181p is predicted to possess oxidoreductase activity, I conjecture that this 
protein acts as  a m embrane chaperone f or t ranslocating polypeptide c hains; I lm1p may e ither 
assist Y nl181p dur ing t ranslocation, or  p erform an i ndependent f unction pr ior t o t ranslocation 
initiation, s uch a s s ignal s equence recognition f or a  s ubset of  p roteins. Because YNL181w is 
essential, and mutant al leles of  t his gene ar e no t ava ilable, I am pr esently ch aracterizing t he 
translocation efficiency of a strain harboring a hypomorphic allele of YNL181w. 
What next? 
In the genetic screen described in this study, I utilized an approach wherein I chose specific kar2 
alleles and examined their genetic interactions with a subset of  the yeast genome. To elaborate 
on KAR2’s g enetic int eractions, it w ill be come impor tant to screen the e ntire yeast genome, 
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including e ssential a nd non -essential ge nes. Strains car rying h ypomorphic a lleles of  e ssential 
genes344, 380 (~940 in number) and deletions of non-essential genes381, 382 (~4800 in number) are 
available, and the effects of mutant BiP expression on the growth of these strains could now be 
analyzed. I hypothesize that this study will not only lead to an enhanced understanding of BiP-
regulated pr ocesses but  w ill a lso he lp e stablish t he f unction of  unc haracterized ge nes. T his 
screen might also identify new BiP-catalyzed processes in cells.  
 The U PR-based s creen can a lso b e ut ilized t o a ssign pr operties t o nov el kar2 alleles, 
especially those that do not affect cellular growth. For example, I found that the expression of the 
translocation-defective BiP m utant, R 217A, f rom t he PTEF1 promoter di d not  result i n 
temperature-sensitive o r D TT-sensitive growth phenotypes ( refer t o s ections 2.2.4 a nd 2.2.5 ). 
However, the genetic interaction profile of kar2-R217A in the UPR-based screen resembled the 
profiles of  ot her gene deletions t hat e xhibit t ranslocation de fects ( refer t o s ection 2.2.8) . 
Therefore, analyzing t he genetic i nteraction profiles of  nove l kar2 alleles in this s creen might 
lead to the identification of BiP mutants that exhibit specific functional defects. As a  p roof o f 
principle, such an analysis was applied to characterize the genetic interactions of the kar2-P515L 
allele, which exhibits ERAD-specific defects in vitro181 (Appendix B). 
Extrapolating my observations to human BiP function 
Not onl y do t he yeast a nd hum an ve rsions of  B iP s hare 70%  ove rall s equence i dentity, t he 
cofactors t hat i nteract w ith these pr oteins ar e also conserved (Table 1 ). F or ex ample, human 
homologs or orthologs of Sec63p, Scj1p, Jem1p, Sls1p and Lhs1p exist, and importantly, some 
of these proteins have been l inked to human diseases (refer to section 1.2.9). I propose that an 
understanding of  t he interactions of  yeast B iP w ith its cof actors ca n be ex trapolated to 
comprehend the BiP interaction n etwork in humans. In addition, i f t he amino acid r esidues i n 
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BiP’s s tructure tha t d etermine c ofactor r ecognition and discrimination were ide ntified, small 
molecule i nhibitors c ould be  d esigned t o m odulate uni que B iP-cofactor i nteractions. These 
inhibitors could then be used as novel therapeutic agents to alleviate disease states that arise from 
the m isregulation of  B iP or  i ts c ofactors. M oreover, t he essential c ontribution of  s ubstrate 
binding to BiP function underscores the possibility that peptide mimics can be used as a first line 
of therapy to t reat cancers that a rise due  to BiP overexpression. Based on t he observation that 
ERdj3’s substrate binding property is critical to its function in the yeast cytosol (refer to section 
3.2.3), I predict that substrate binding also determines ERdj3’s ability to function in the human 
ER.  B ecause ERdj3 acts upstream to BiP in the folding of several substrates, disrupting ERdj3 
function by targeting its substrate binding domain might provide an alternate mechanism to more 
specifically alter BiP function in human cells.  
 Several ope n que stions on our  unde rstanding of  B iP bi ology i n hum ans r emain 
unanswered. For example, the mechanism by which mammalian BiP trafficks to the cell surface 
to participate in signal transduction pathways is unknown239. Though yeast BiP is not normally 
expressed at the cell surface, under high levels of UPR induction205, and in mutant strains that are 
defective for Golgi to ER retrograde transport316, 317, 383, BiP is secreted. Therefore, yeast can be 
used as a  model system to understand the BiP t rafficking mechanism. This becomes important 
because several cancer cells exhibit elevated surface BiP levels252, 253. In addition, it is unknown 
whether BiP’s anti-apoptotic properties39, 232, 233 can be correlated to its role in UPR induction or 
calcium storage.  
 Overall, my studies have hopefully helped to better define the functions of this complex 
protein. 
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Table 4: Strains used in this study 
Strain name Genotype Source/ Reference 
MMY2  MATa/α, his3-∆200/his3-∆200, leu2-∆1/leu2-∆1, ura3-
52/ura3-52, trp1-∆63/trp1-∆63, KAR2/kar2::HIS3  
Kabani et al., 2003  
GAL-KAR2  MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pGAL1-KAR2  
This study  
GAL-R217A MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pGAL1-R217A  
This study 
GAL-K584X MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pGAL1-K584X  
This study 
GAL-S493F MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pGAL1-S493F  
This study 
MMY8-2  MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pMR397  
Kabani et al., 2003  
TEF1-KAR2  MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pTEF1-KAR2  
This study 
TEF1-R217A MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pTEF1-R217A  
This study 
TEF1-K584X MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pTEF1-K584X  
This study 
TEF1-S493F MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pTEF1-S493F  
This study 
CYC1-KAR2 MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pCYC1-KAR2  
This study 
MMY713  MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
pMR713  
This study 
TEF1-KAR2 jem1∆  MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
jem1∆::NAT, pTEF1-KAR2  
This study 
TEF1-KAR2 scj1∆  MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
scj1∆::NAT, pTEF1-KAR2  
This study 
TEF1-R217A 
jem1∆  
MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, kar2::HIS3, 
jem1∆::NAT, pTEF1-R217A  
This study 
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Strain name Genotype Source/ Reference 
TEF1-R217A scj1∆  MATα, his3-∆200, leu2-∆1, ura3-52, trp1-∆63, 
kar2::HIS3, scj1∆::NAT, pTEF1-R217A  
This study 
RSY607  MATα, leu2-3, 112, ura3-52, PEP4::URA3  R. Schekman  
sec11-7  MATa, sec11-7, ura3-52, leu2-3, his4-619  Bohni et al., 1988  
kar2-159 MATα, ura3-52, ade2-101, leu2-3,112,  
kar2-159  
M. Rose  
kar2-113 MATα, ura3-52, ade2-101, leu2-3,112,  
kar2-113  
M. Rose  
BY4742  MATα, his3-∆1, leu2-∆0, ura3-∆0, lys2-∆0  Lab stock  
ilm1∆  MATα, his3-∆1, leu2-∆0, ura3-∆0, lys2-∆0, 
ilm1∆::KANMX  
Yeast Knockout 
Collection  
erd1∆  MATα, his3-∆1, leu2-∆0, ura3-∆0, lys2-∆0, 
erd1∆::KANMX  
Yeast Knockout 
Collection 
sur4∆  MATα, his3-∆1, leu2-∆0, ura3-∆0, lys2-∆0, 
sur4∆::KANMX  
Yeast Knockout 
Collection 
sec63-1  MATα sec63-1 leu2-3, 112 ura3-52  R. Schekman  
sec65-1  MATa, sec65-1, ade2, his3, leu2, trp1, ura3  Wilkinson et al., 1997  
scj1∆  MATα, his3-∆1, leu2-∆0, ura3-∆0, lys2-∆0, 
scj1∆::KANMX  
Yeast Knockout 
Collection 
BY4741 MATa, his3-∆1, leu2-∆0, ura3-∆0, met15-∆0  J. S. Weissman  
ILM1-FLAG  MATa, his3-∆1, leu2-∆0, ura3-∆0, met15-∆0, 
ILM1-3XFLAG::NAT  
This study 
SCJ1 JEM1  MATα, lys2-801, leu2-3,112, his3-∆200, trp1-
∆901, ura3-52, suc2-∆9,  
Nishikawa and Endo, 
1997  
scj1∆ jem1∆  MATα ade2-1 leu2-3,112 his3-11,15 trp1-1 
ura3-1 can1-100 scj1∆::TRP1 jem1∆::LEU2  
Nishikawa and Endo, 
1997 
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Strain name Genotype Source/ Reference 
YDJ1 and HLJ1 YDJ1 
(W303)  MATα, ade2-1, leu2-3,112, his3-11,15, trp1-1, ura3-1, can1-100  
Lab stock  
ydj1∆  MATα, ade2-1, leu2-3,112, his3-11,15, trp1-1, ura3-1, 
can1-100, ydj1-2::HIS3  
Wright et al., 2007 
hlj1∆ ydj1-151  MATα, ade2-1, leu2-3,112, his3-11,15, trp1-1, ura3-1, 
can1-100, hlj1∆::TRP1, ydj1-2::HIS3, LEU2::ydj1-151  
Youker et al., 2004 
hlj1∆ ydj1-151 leu2::NAT MATα, ade2-1, leu2-3,112, his3-11,15, trp1-1, ura3-1, 
can1-100, hlj1∆::TRP1, ydj1-2::HIS3, leu2::NAT::ydj1-
151  
This study  
BY4743  MATa/α, his3-∆0/his3-∆0, leu2-∆0/leu2-∆0, ura3-
∆0/ura3-∆0, TRP1/TRP1, LYS2/lys2-∆0, MET15/met15-
∆0 
J. S. Weissman  
KAR2::NAT  MATa, his3-∆1, leu2-∆0, ura3-∆0, met15-∆0, 
KAR2::NAT  
This study  
kar2-R217A::NAT  MATa, his3-∆1, leu2-∆0, ura3-∆0, met15-∆0, kar2-
R217A::NAT  
This study  
kar2-P515L:NAT MATa, his3-∆1, leu2-∆0, ura3-∆0, met15-∆0, kar2-
P515L::NAT  
This study 
kar2-DamP::NAT  MATa, his3-∆1, leu2-∆0, ura3-∆0, met15-∆0, kar2-
DamP::NAT  
This study 
kar2-P515L-DamP::NAT MATa, his3-∆1, leu2-∆0, ura3-∆0, met15-∆0, kar2-
P515L-DamP::NAT  
This study 
vtc4∆  MATα, his3-∆1, leu2-∆0, ura3-∆0, lys2-∆0, 
vtc4∆::KANMX  
Yeast Knockout 
Collection 
ylr104w∆  MATα, his3-∆1, leu2-∆0, ura3-∆0, lys2-∆0, 
ylr104w∆::KANMX  
Yeast Knockout 
Collection  
SLS1 (RSY801) MATa, ade2-101, leu2-3,113, ura3-52  R. Schekman  
sls1∆ MATa, ade2-101, leu2-3,113, ura3-52, sls1::URA3  Kabani et al., 2000  
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Table 5: Plasmids used in this study 
Plasmid name Details Source/Reference 
pMR2623(wt)  IPTG-inducible His
6
-BiP expression  M. Rose  
pMR2623(R217A) IPTG-inducible His
6
-R217A BiP 
expression 
This study  
pMR2623(K584X) IPTG-inducible His
6
-K584X BiP 
expression 
This study 
pMR2623(S493F) IPTG-inducible His
6
-S493F BiP 
expression 
This study 
pMR713  CEN4/ARS, LEU2, PKAR2-KAR2  M. Rose  
pYES2  2µ, URA3  Invitrogen  
pGAL1-KAR2  2µ, URA3, PGAL1-KAR2  This study 
pGAL1-R217A  2µ, URA3, PGAL1-kar2-R217A  This study 
pGAL1-K584X  2µ, URA3, PGAL1-kar2-K584X  This study 
pGAL1-S493F  2µ, URA3, PGAL1-kar2-S493F  This study 
p414TEF1  CEN4/ARS, TRP1, PTEF1  Mumberg et al., 1995  
p414CYC1  CEN4/ARS, TRP1, PCYC1  Mumberg et al., 1995 
pTEF1-KAR2  CEN4/ARS, TRP1, PTEF1-KAR2  This study 
pCYC1-R217A  CEN4/ARS, TRP1, PTEF1-kar2-R217A  This study  
pTEF1-K584X CEN4/ARS, TRP1, PTEF1-kar2-K584X  This study 
pTEF1-S493F CEN4/ARS, TRP1, PTEF1-kar2-S493F  This study 
pFA6a-NATMX6 E. Coli oriC, NATMX6, AMPR  J. S. Weissman  
pILM1-UTR-NAT E. Coli oriC, ILM1::NATMX6, AMPR  This study 
pILM1-3XFLAG E. Coli oriC, ILM1-
3XFLAG::NATMX6, AMP
R
  
This study 
pET-SCJ1 IPTG-inducible Scj1-His
6
 expression  S. I. Nishikawa  
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Plasmid name Details Source/Reference 
pSM36-∆gppαF-HA  Yeast expression vector for HA-tagged 
mutant pre-pro-alpha factor (asparagines of 
the three consensus glycosylation sites 
mutated to glutamine), URA3  
D. Ng  
pDN431 CEN4/ARS, URA3, PPRC1-prc1-1:HA  Ng et al., 2000  
pJC104 2µ, URA3, P4XUPRE-lacZ  Cox and Walter, 1996  
pDJ100 pSP65 vector containing pre-pro-alpha 
factor under the SP6 promoter; AMP
R
  
Hansen et al., 1986 
pGem2α36-3Q  Vector containing mutant pre-pro-alpha 
factor under the SP6 promoter, AMP
R
  
Mccracken and Brodsky, 
1996  
pCPY*-3HA  CEN4/ARS, URA3, PPRC1-prc1-1:3HA  Bhamidipati et al., 2005  
pSM1911  2µ, URA3, PPGK1-ste6-166:HA  Huyer et al., 2004  
p425-Ste6p*HA  2µ, LEU2, PPGK1-ste6-166:HA  This study 
pSM1152 2µ, URA3, PPGK1-CFTR:HA  Zhang et al., 2002 
pSLW1-B29  2µ, URA3, PGAL1-APOB29:HA  Hrizo et al., 2007  
pAV4  CEN4/ARS, URA3, PYDJ1–YDJ1  Caplan et al., 1992 
pssYdj1-3HA-DSL  A modified pSG5 vector (Stratagene) for 
mammalian expression of signal sequence 
-containing Ydj1 with a 3HA tag at the C-
terminus  
This study  
pssYdj1-C406S-3HA-DSL  pssYdj1-3HA-DSL with the C406S 
mutation in Ydj1 (disrupts the 
farnesylation of Ydj1)  
This study 
pGPD426  2µ, URA3, PGPD  Mumberg et al., 1995 
pGPD426-ERdj3  2µ, URA3, PGPD-ERdj3  This study 
pGPD426-CaaX  2µ, URA3, PGPD-(∆ss)ERdj3-CASQ  This study 
pGPD426-CaaX-∆ΙI pGPD426CaaX with a deletion of domain 
II in ERdj3  
This study 
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Plasmid name Details Source/Reference 
pGPD426-CaaX-∆II-
GSGG 
pGPD426CaaX with the GSGG linker 
replacing domain II in ERdj3  
This study 
pGPD426-CaaX-F326A pGPD426CaaX with the F326A mutation 
in ERdj3  
This study 
pGPD426-CaaX-F326D pGPD426CaaX with the F326D mutation 
in ERdj3  
This study 
pGPD426-CaaX-I134A  pGPD426CaaX with the I134A mutation in 
ERdj3  
This study 
pGPD426-CaaX-L208A  pGPD426CaaX with the L208A mutation 
in ERdj3  
This study 
pGPD426-CaaX-IVLFa pGPD426CaaX with the I134A, VL208A, 
mutations in ERdj3  
This study 
pGPD426-CaaX-H53Q pGPD426CaaX with the H53Q mutation in 
ERdj3  
This study 
pGPD426-CaaX-D55N pGPD426CaaX with the D55N mutation in 
ERdj3  
This study 
pKAR2-UTR-NAT E. Coli oriC, KAR2-UTR::NATMX6, AMPR  This study 
pkar2-DamP-NAT E. Coli oriC, kar2-DamP::NATMX6, 
AMP
R
  
This study 
pkar2-R217A-UTR-NAT E. Coli oriC, kar2-R217A::NATMX6, 
AMP
R
  
This study 
pkar2-R217A-DamP-
NAT 
E. Coli oriC, kar2-R217A-
DamP::NATMX6, AMP
R
  
This study 
pkar2-P515L-UTR-NAT E. Coli oriC, kar2-P515L::NATMX6, 
AMP
R
  
This study 
pkar2-P515L-DamP-
NAT 
E. Coli oriC, kar2-P515L-
DamP::NATMX6, AMP
R
  
This study 
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APPENDIX A 
THE TRANSMEMBRANE DOMAIN OF EITHER SBH1p OR SBH2p IS SUFFICIENT 
TO COMPENSATE FOR N-GLYCAN TRIMMING DEFECTS OBSERVED IN 
sbh1∆ sbh2∆ YEAST 
This work was performed in collaboration with the laboratories of Jussi Jantti at the University of Helsinki, Finland 
and Karin Römisch at Cambridge University, U.K. and is published: 
Feng, D., Zhao, X., Soromani, C., Toikkanen, J., Römisch, K., Vembar, S.S., Brodsky, J.L.
 
, Keränen, S., 
Jäntti, J. The transmembrane domain is sufficient for Sbh1p function, its association with the Sec61 complex, and 
interaction with Rtn1p. J Biol Chem 282, 30618-28 (2007). 
The f unction of S bh1p100, 1 49, the β-subunit of  t he yeast Sec61 t ranslocation c omplex, and i ts 
homologue, S bh2p149, 3 23 which f orms pa rt of  a  second yeast t ranslocation c omplex, the S sh1 
complex, is not c learly understood. S bh1p i s a n 82 a mino a cid protein with a s ingle 
transmembrane domain. Several groups have demonstrated that: (i) Yeast lacking sbh1 and sbh2 
are temperature-sensitive and accumulate secretory precursors, especially those that require co-
translational translocation to get into the ER149, 323; (ii) Sbh1p interacts with subunits of the signal 
peptidase com plex384 and oligosaccharyl t ransferase com plex385; ( iii) S bh1p may a ct as  a 
guanine-nucleotide exchange factor for the GTPase subunit of  the SRP receptor386; ( iv) Sbh1p 
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mediates t he i nteraction between Sec61p and the ex ocyst com plex387, 388, a lthough t he 
significance of this interaction is still unknown. The exocyst complex includes of Sec3p, Sec5p, 
Sec6p, Sec8p, Sec10p, Sec15p, Exo70p, and Exo84p, and along with select small Rab GTPases 
such a s S ec4p, it pa rticipates in the te thering o f s ecretory v esicles t o the pl asma m embrane 
during exocytosis389. Therefore, it is possible that Sbh1p acts as a guanine-nucletotide exchange 
factor for these essential GTPase.  
To e laborate t he r ole of  S bh1p a nd Sbh2p dur ing t ranslocation, our  c ollaborators f irst 
examined the translocation efficiency of sbh1∆sbh2∆ yeast. They recapitulated the observations 
that Sbh1p and Sbh2p are required for co-translational protein translocation into the ER, but not 
for post-translational protein translocation. Second, they showed that the deletion of Sbh1p and 
Sbh2p affected the N-glycan trimming of proteins that are glycosylated upon entry into the ER 
(refer to section 1.2.5 and Figure 6); this effect was independent of whether the substrate was co- 
or pos t-translationally t ranslocated across t he E R m embrane. Third, t o establish the mini mal 
domain requirements for Sbh1p and Sbh2p function, they expressed different fragments of either 
protein i n sbh1∆sbh2∆ yeast and examined the r escue of  t emperature-sensitive g rowth. 
Intriguingly, t he ov erexpressed t ransmembrane dom ain of  e ither pr otein w as s ufficient t o 
complement the growth defect of sbh1∆sbh2∆ yeast, and this effect could be directly correlated 
to a rescue of co-translational protein translocation in sbh1∆sbh2∆ cells.  
To determine w hether the de fect i n N-glycan t rimming c ould be  a lso r escued b y 
overexpression of the Sbh1p or Sbh2p transmembrane domain (i.e., Sbh1p-TM or Sbh2p-TM), I 
examined the e fficiency of  pr e-pro-alpha factor t ranslocation i nto m icrosomes de rived f rom 
sbh1∆sbh2∆ yeast tr ansformed either w ith an empty ve ctor, or  expression ve ctors for S bh1p, 
Sbh2p, S bh1p-TM or  S bh2p-TM. A s s hown i n F igure 31, t he o verexpression of  t he 
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transmembrane domain of either Sbh1p or Sbh2p was sufficient to support N-glycan trimming in 
sbh1∆sbh2∆ yeast, further emphasizing the sufficiency of  the t ransmembrane domain of  e ither 
Sbh1p or Sbh2p for Sbh function. In agreement with these results, a recent report examined the 
species s pecificity of  S bh1p hom ologs f rom Schizosaccharomyces pombe, S. cerevisiae and 
humans390, and observed that the transmembrane domains of these homologs were sufficient to 
substitute for one another during translocation and other Sbh1-regulated processes. 
 Finally, our collaborators established a novel correlation between Sbh1p and the exocyst 
complex. They showed that Sbh1p exists as two subpopulations within the cell, one that interacts 
with Sec61p and the other that interacts with Rtn1p. Rtn1p is an ER membrane protein belonging 
to t he hi ghly conserved r eticulon A -like f amily that r egulates c ortical E R mor phology by 
interacting  with Sec6p, a component of the exocyst complex391. 
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Figure 31: Complementation of the N-glycan trimming defect of sbh1∆sbh2∆ yeast 
by either Sbh1p or Sbh2p.  
Microsomes derived from the sbh1∆sbh2∆ strain transformed with either an empty vector (-) or 
vectors ha rboring t he indicated SBH constructs w ere te sted in duplicate f or the ir ability to  
translocate p re-pro-alpha factor (ppαF), thus generating the glycosylated pro-alpha factor form 
(3gpαF). A ssays w ere pe rformed a t 20°C  f or 20 m in. D ata a re r epresentative of  t hree 
independent experiments. TM=transmembrane domain. 
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APPENDIX B 
ANALYSIS OF THE GENETIC INTERACTIONS OF TWO BIP MUTANTS, R217A 
AND P515L, WITH A SUBSET OF YEAST GENES THAT REGULATE ER FOLDING 
HOMEOSTASIS 
This work was performed in collaboration with Martin Jonikas, a graduate student in the laboratory of Jonathan 
Weissman at the University of California, San Francisco. 
 
In recent years, it ha s become evi dent f rom s everal S. cerevisiae genomic a nd pr oteomic 
analyses173, 3 33-345, 39 2-394 that mos t pr oteins in  the  cell e ither f unction i n t he c ontext of  
multiprotein complexes or affect mul tiple cellular pathways. Proteomic s tudies such as protein 
localization173 and pr otein-protein interaction analyses392, 3 93 have examined the f eatures of  
essential a nd non -essential ge nes, and ha ve be en s uccessful i n assigning putative f unctions t o 
select unc haracterized o pen r eading frames. However, m ost genomic s tudies ha ve ut ilized t he 
haploid Yeast Knockout (YKO) collection381, 38 2, a  set of  s trains in which each o f ~4800 non-
essential genes has been individually deleted with an antibiotic-resistance cassette, consequently 
neglecting t he es sential genes. The l imited genomic ana lyses t hat h ave been performed with 
essential g enes ha ve ut ilized h ypomorphic ‘ decreased a bundance b y m RNA pe rturbation’ or 
‘DamP’ alleles w herein the 3’  unt ranslated r egion ( 3’UTR) of  t hese genes ha s be en di srupted 
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with an antibiotic-resistance cassette344, 380. But, given that the efficacy of DamPing is dependent 
on mRNA stability and copy number as well as transcription and translation rates344, the results 
obtained for each essential gene varies. Moreover, in some cases, DamPing is lethal344, 380, while 
in others it ma y affect specific f unctions of  a  mul tifunctional g ene333. O ne s olution t o t his 
problem could be  t he ut ilization of  mutant a lleles of  an essential gene w hich a re known to be  
defective for specific functions. Accordingly, in this section, I describe the application of a novel 
UPR-based genetic screen to dissect the genetic interaction profiles exhibited by unique alleles 
of the essential gene, KAR2. To highlight any differences, I also utilized ‘DamP’ed versions of 
the wild-type and mutant KAR2 alleles. 
As de scribed i n C hapter 2, R 217A B iP ( encoded b y kar2-R217A) e xhibits a  s pecific 
defect f or t ranslocation into the E R w hich can be  a ttributed to its r educed interaction with 
Sec63p, t he H sp40 c ochaperone d edicated t o t ranslocation; t his i s t he f irst i dentification of  a  
translocation-specific B iP m utant. C onversely, t he Brodsky l ab h ad pr eviously characterized a 
point mutant, P515L, in BiP’s substrate binding domain that was deficient for substrate binding, 
and the expression of this protein resulted in an ERAD-specific defect in vivo181.  
Given the functional distinction exhibited by R217A and P515L BiP, I hypothesized that 
these mutant BiP proteins might function in the context of unique protein complexes, or exhibit 
unique sets of genetic interactions with other cellular components that are required to maintain 
ER hom eostasis. T o t est t his h ypothesis, I chose t o e xamine t he genetic i nteractions be tween 
R217A BiP and P515L BiP with 350 other non-essential genes. The deletions of these 350 genes 
lead to a constitutive induction of the UPR121, and can be measured in a defined assay121. This set 
of 350 g enes includes ER and cytosolic chaperones, components of  the N-linked glycosylation 
machinery and ERAD, and genes required for O-mannosylation, GPI anchor synthesis, vesicular 
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trafficking, v acuole function, l ipid biosynthesis, cytoskeletal or ganization a nd c hromatin 
remodeling. This study is ongoing and I summarize the results that I have obtained thus far. 
 
B.1. CONSTRUCTION OF KAR2 STRAINS FOR UPR-BASED GENETIC ANALYSIS 
 
To generate wild-type and m utant kar2 strains amenable to manipulation in the U PR-based 
genetic screen, the first step involved the construction of vectors in which the wild-type KAR2 
gene, l acking or  containing the nucleotide sequence corresponding to the 3’UTR, was inserted 
upstream of the NATMX6 antibiotic resistance cassette. To do this, the KAR2 gene lacking the 3’ 
UTR (henceforth referred to as kar2-DamP) was amplified from yeast genomic DNA with the 
primer pair (the underlined sequence in the 5’ primer represents the PvuII recognition site and in 
the 3’ primer represents the BamHI recognition site):- 5’primer: 
GTCCCCAAGAGCAGCTG
CAACCTTGAA
CAAGGGAAA, and 3’ primer:  
GGATCCAGCAGCAAAA, whereas t he KAR2 gene containing t he 3 ’UTR 
(henceforth referred to as KAR2-UTR) w as amplified with the pr imer pa ir ( the unde rlined 
sequence in the 5’ primer represents the PvuII recognition site and in the 3’ primer represents the 
BamHI recognition site):- 5’ pr imer: GTCCCCAAGAGCAGCTGCAAGGGAAA, a nd 3’  
primer: CAATAGTGATGGGATCC
AAAGATTAACGTGTTACTGTTTTACTTTTTTAAAGTCCCCAAGAGTAGTCTCAAGGG
AAAAAGCGTATC, and 3’ primer:  
GATGAGATGA. T he resultant P CR pr oducts w ere 
digested with the indicated restriction enzymes and inserted into the plasmid pFA6a-NATMX6 
to generate pkar2-DamP-NAT and pKAR2-UTR-NAT, respectively. Next, the kar2-DamP-NAT 
or KAR2-UTR-NAT cassette was amplified with the primer pair:- 5’ primer: 
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CCATTTCAGTATTAGGTTCTCGAGCCTTTCAACTCTCTCTGTTATAATGTGAATTCGA
GCTCGTTTAAAC. T he r esulting P CR pr oduct w as t ransformed i nto t he B Y4743 s train 
(MATa/α, his3-∆0/his3-∆0, leu2-∆0/leu2-∆0, ura3-∆0/ura3-∆0, TRP1/TRP1, LYS2/lys2-∆0, 
MET15/met15-∆0, KAR2/KAR2) and transformants w ere s elected on yeast ex tract-peptone-
dextrose medium supplemented with nourseothricin. To identify strains in which one copy of the 
chromosomal KAR2 gene w as r eplaced w ith either t he kar2-DamP-NAT  or KAR2-UTR-NAT 
cassettes, PCR amplification was performed with the primer pair:- 5’ primer: 
GGCTATGTAATTCTAAAGATTAACGT, and 3’ primer: 
GTATGAAGCTCGAAGTTTGAATTAGCT, or 5’ primer:  
GGCTATGTAATTCTAAAGATTAACGT, and 3’ primer: 
GTTATCTTAGGGTCATACTCATCAATT, r espectively. The P CR pr oduct w as obs erved t wo 
bands after agarose gel el ectrophoresis corresponding to 2.1 kb ( endogenous KAR2) and either 
3.3 kb ( kar2-DamP-NAT) or  3.9  kb ( KAR2-UTR-NAT). Next, t he de sired di ploid s trains w ere 
subjected to sporulation and tetrad analysis, and haploid strains of the genotype MATa, his3-∆1, 
leu2-∆0, ura3-∆0, met15-∆0, kar2-DamP-NAT or MATa, his3-∆1, leu2-∆0, ura3-∆0, met15-∆0, 
KAR2-UTR-NAT were selected for further analysis. These NAT-marked strains were called kar2-
DamP::NAT and KAR2::NAT, respectively, and are isogenic to BY4741. 
 To construct the mutant kar2 strains, a point mutation corresponding to R217A BiP was 
introduced into the pkar2-DamP-NAT and pKAR2-UTR-NAT vectors using the primer pair:- 5’ 
primer: GCTGGTTTGAACGTTTGGCAATTGTTAATGAACCAACCGC, and 3’ primer:  
GCGGTTGTTCATTAACAATTGCCAAAACGTTCAAACCAGC. T he kar2-R217A::NAT 
strain was generated in  a  s imilar ma nner to that de scribed for th e wild-type KAR2 gene. 
However, several at tempts t o generate t he kar2-R217A-DamP::NAT strain were uns uccessful 
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suggesting t hat r educing t he l evels of  R 217A B iP i s l ethal, as obs erved in C hapter 2  ( Figure 
13E). Next, a point mutation corresponding to P515L BiP was introduced into the pkar2-DamP-
NAT and pKAR2-UTR-NAT vectors using the primer pair: 5’ primer: 
CCAGCACCAAGAGGTGTACTTCAAATTGAAGTCACATTTG, and 3’ primer: 
CAAATGTGACTTCAATTTGAAGTACACCTCTTGGTGCTGG, a nd t he kar2-P515L::NAT 
and kar2-P515L-DamP::NAT strains were generated in a manner similar to that described for the 
wild-type KAR2 gene. Once the strains were generated, the chromosomal integration of the wild-
type or mutant kar2 genes was confirmed by PCR (Figure 32) and DNA sequence analysis. 
B.2 CHARACTERIZATION OF TRANSLOCATION AND ERAD IN THE kar2 
STRAINS GENERATED FOR UPR-BASED GENETIC ANALYSIS 
Prior to utilizing the KAR2::NAT, kar2-DamP::NAT, kar2-R217A::NAT, kar2-P515L::NAT and 
kar2-P515L-DamP::NAT strains in the U PR-based genetic s creen, I w anted to examine t heir 
growth pattern as well as their translocation and ERAD efficiencies. First, I tested was the ability 
of the strains to grow at elevated temperatures and in the presence of the reducing agent, DTT. 
To this end, the strains were serially diluted onto yeast extract-peptone-dextrose medium and the 
plates were incubated at a range of temperatures (Figure 33A). I found that the KAR2::NAT and 
kar2-DamP::NAT strains e xpressing w ild-type BiP g rew r obustly a t a ll te mperatures te sted 
whereas t he kar2-P515L::NAT and kar2-P515L-DamP::NAT  mutant s trains w ere s ensitive to 
elevated temperatures. This was not  surprising because previous s tudies had shown that the in 
vivo expression of P515L BiP resulted in a temperature-sensitive growth phenotype. Moreover, 
in ke eping w ith pr evious obs ervations, t he kar2-P515L::NAT and kar2-
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Figure 32: PCR amplification of wild-type and mutant kar2 alleles from genomic DNA. 
 Genomic DNA was prepared from the indicated wild-type and mutant NAT-marked strains and 
the cor responding kar2 alleles w ere a mplified us ing t he pr imers de scribed i n s ection B.1. The 
expected sizes of the bands are: KAR2=2.1 kb, KAR2-NAT corresponding to the DamPed allele=3.3 
kb, and KAR2-UTR-NAT=3.9 kb. 
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P515L-DamP::NAT  mutant strains were also sensitive to DTT181 (Figure 33A). In contrast, the 
behavior of the kar2-R217A::NAT strain, which was slow-growing at all temperatures and in the 
presence of  D TT ( Figure 33A), w as hi ghly une xpected. T his w as be cause I ha d pr eviously 
observed t hat t he TEF1-R217A strain was not  s ensitive to temperature or  D TT, similar to the 
wild-type TEF1-KAR2 strain (Figure 14 in Chapter 2). But, given that R217A BiP is expressed 
from its endogenous promoter at the KAR2 choromosomal locus in the kar2-R217A::NAT strain 
and f rom t he pl asmid-borne PTEF1 promoter i n the TEF1-R217A strain, its tr anscriptional 
regulation in these strains is most likely different. This could, in turn, account for the differential 
growth patterns. Therefore, it became imperative to test the functional defects exhibited by kar2-
R217A::NAT.  
 Next, I examined t he e xpression l evels of  w ild-type a nd m utant BiP p roteins i n t he 
KAR2::NAT, kar2-DamP::NAT, kar2-R217A::NAT, kar2-P515L::NAT and kar2-P515L-
DamP::NAT strains. I prepared cell extracts from these strains, resolved them using SDS-PAGE 
and subjected them to immunoblotting with anti-BiP antisera. As shown in Figure 33B, there was 
a ~30% and ~50% reduction in the levels of BiP expression in the kar2-DamP::NAT and kar2-
P515L-DamP::NAT strains a s c ompared t o t he KAR2::NAT and kar2-P515L::NAT strains, 
respectively. Since t he DamPing t echnique causes a  reduction i n m RNA s tability and 
consequently a decrease in protein expression344, this result was anticipated. On the other hand, 
the kar2-R217A::NAT strain  showed increased levels of  B iP ex pression ( Figure 33B). 
However, this could be accounted for by the observation that pre-BiP accumulates in this strain 
(indicated by ‘6% ’ w here a lower p ercentage o f ac rylamide w as us ed for S DS-PAGE), a nd 
derives from the ~8 kDa difference in molecular mass between pre-BiP and BiP, which cannot 
be resolved on a 10% gel.  
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Figure 33: Characterization of the growth patterns and BiP expression levels in the wild-
type and mutant kar2 strains generated for the UPR-based genetic screen. 
 (A) Ten-fold serial dilutions of the wild-type and mutant NAT-marked strains were plated onto 
yeast extract-peptone-dextrose (YPD) medium either lacking or containing 8 m M DTT. Plates were 
incubated at 26, 30 , 34 a nd 38°C for 2 d. (B) Cell extracts prepared from the indicated wild-type or 
mutant strains grown at 30°C were resolved by SDS-PAGE and immunoblotted with polyclonal anti-
BiP antisera. The level of G6PDH in cell extracts served as a l oading control. Unless indicated, the 
cell extracts were resolved on 10%  polyacrylamide gels under non-native and reducing conditions. 
(C) Top pa nel: Q uantification of  B iP l evels in t he i ndicated s trains us ing t he K odak ImageStation 
software. Bottom panel: Normalization of BiP levels in the indicated strains to the levels of G6PDH. 
The numbers 0.69 and 0.53 indicate the fold change in BiP levels observed in the kar2-DamP::NAT 
and kar2-P515L-DamP::NAT strains, r espectively, a s c ompared t o t he c orresponding un DamPed 
strains. Data represent the means of four determinations + standard deviation. 
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 Given that the expression of  P515L BiP leads to a  constitutive induction of  the UPR181 
and consequently, a  DTT-sensitive growth phenotype, BiP levels in the kar2-P515L::NAT and 
kar2-P515L-DamP::NAT strains w ere us ed as a di rect m easure of  U PR i nduction. T his i s 
because BiP expressed from its endogenous promoter is upregulated upon UPR induction204, 205. 
Therefore, I quantified the amount of BiP in these strains and compared the levels either directly 
or a fter nor malizing B iP le vels to those of g lucose-6-phosphate d ehydrogenase (G6PDH), a  
loading control that is not a UPR target199 (Figure 33C). As expected, there was a 2-fold increase 
in the levels of BiP in the kar2-P515L::NAT and kar2-P515L-DamP::NAT strains as compared 
to KAR2::NAT and kar2-DamP::NAT, respectively, indicating tha t the  UPR i s i nduced upon 
P515L B iP e xpression. I a lso c onfirmed t his r esult us ing β-galactosidase r eporter as says t o 
measure UPR induction (data not shown).  
Next, I measured the ERAD efficiencies of the five strains by following the degradation 
of CPY* using pulse-chase followed by immunoprecipitation assays (as described in Chapter 2). 
As s hown i n F igure 34A, CPY* was ef ficiently d egraded in the KAR2::NAT and kar2-
DamP::NAT strains at 30°C. In contrast, there was a stabilization of CPY* in the kar2-P515L-
DamP::NAT strain at  3 0°C (Figure 34A) indicating that this strain exhibited an ERAD defect. 
Unexpectedly, the kar2-P515L::NAT strain degraded CPY* to levels similar to the KAR2::NAT 
strain at 30°C. However, when the assay was performed at 37°C (Figure 34B), the mutant strain 
exhibited an ERAD de fect.  T herefore, it app ears t hat t he kar2-P515L::NAT strain has a 
temperature-dependent E RAD de fect. Finally, I e xamined t he C PY* degradation efficiency o f 
the kar2-R217A::NAT strain. I obs erved t hat t his s train ha d a  s trong defect fo r C PY* 
translocation (data not  shown), and hence, I was unable t o accurately qu antify the amounts of  
CPY* present at various time points. An alternate in vitro approach needs to be taken to measure 
 182 
 
Figure 34: Characterization of the ERAD efficiencies of the wild-type and mutant 
strains generated for the UPR-based genetic screen. 
 To analyze t he d egradation efficiency o f an HA-tagged form of  C PY*, p ulse-chase 
followed b y immunoprecipitation assays using a nti-HA a ntibodies were pe rformed on  (A) 
KAR2::NAT (   ) , kar2-DamP::NAT (    ) , kar2-P515L::NAT (    )  and kar2-P515L-DamP::NAT (    
) strains grown at 30°C, and (B) KAR2::NAT (   ) and kar2-P515L::NAT (    ) grown at 37°C. 
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the ERAD efficiency of this strain, but it is beyond the scope of this study.  
Lastly, I analyzed the t ranslocation efficiency of the KAR2::NAT, kar2-DamP::NAT, 
kar2-R217A::NAT, kar2-P515L::NAT and kar2-P515L-DamP::NAT strains. T o t his e nd, I  
examined t he t ranslocation of  E R-lumenal S ls1p, B iP’s nuc leotide ex change f actor (refer t o 
section 1.2.3). I found that as Sls1p translocates into the ER, it is modified by the addition of N-
linked g lycans, and this i s obs erved as an increase i n molecular m ass ( Figure 35A). The 
sensitivity of  t he glycosylated species t o endoglycosidase H , an enzyme t hat cl eaves N-linked 
oligosaccharides (Figure 35A, compare the Endo-H treated and untreated lanes), and the absence 
of t he glycosylated b and i n t he sec63-1 strain which carries a  tr anslocation-deficient mut ant 
allele of  SEC63, c onfirms t hat the N-linked glycosylation of  S ls1p oc curs upon t ranslocation. 
Next, I prepared cell extracts from the five strains, resolved the proteins using SDS-PAGE and 
performed immunoblotting with anti-Sls1p antisera. As shown in Figure 35B, the unglycosylated 
form of Sls1p accumulated in the kar2-R217A::NAT strain, similar to the control strain, sec63-1. 
Therefore, the expression of  R 217A B iP from t he KAR2 endogenous p romoter resulted in a 
translocation defect, as ant icipated. The remaining s trains e fficiently translocated S ls1p, a s 
evidenced by the formation of the glycosylated species in these strains (Figure 35B), suggesting 
that they are not deficient for translocation. 
Taken together, these data i ndicate t hat t he kar2-P515L::NAT and kar2-P515L-
DamP::NAT strains exhibit ERAD-specific defects, and this results in a constitutive induction of 
the UPR. In contrast, the kar2-R217A::NAT strain exhibits a  t ranslocation defect, although the 
absence of an ERAD defect cannot be ruled out without performing additional assays. However, 
the s evere growth phenotype o f t his s train can most like ly be a ttributed to its tr anslocation 
deficiency. 
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A.1 
Figure 35: Characterization of the translocation efficiencies of the wild-type and 
mutant kar2 strains generated for the UPR-based genetic screen. 
 (A) Cell e xtracts pr epared from w ild-type ( SLS1) or  t ranslocation-deficient ( sec63-1) 
strains w ere s ubjected t o e ndoglycosidase H  ( Endo H ) t reatment a s i ndicated. T he r esulting 
samples were resolved using SDS-PAGE and immunoblotted with anti-Sls1p antisera (a kind gift 
of M. Kabani and C. Gaillardin, INRA, France). The anti-Sls1p antiserum has not been affinity-
purified a nd t herefore c ross-reacts w ith a hi gher m olecular m ass ba nd t hat c orresponds t o BiP. 
G6PDH s erved a s a l oading c ontrol. (B) Cell e xtracts pr epared from t he i ndicated strains w ere 
resolved us ing S DS-PAGE a nd i mmunoblotted w ith a nti-BiP or  a nti-Sls1p a ntisera. G 6PDH 
served as a loading control. 
 185 
B.3 ANALYSIS OF GENETIC INTERACTIONS OF THE VARIOUS WILD-TYPE 
AND MUTANT kar2 STRAINS  
After examining the phenotypes of the KAR2::NAT, kar2-DamP::NAT, kar2-R217A::NAT, kar2-
P515L::NAT and kar2-P515L-DamP::NAT strains, t he ne xt s tep w as t o c ross each strain 
individually against t he ~ 350 i ndividual g ene deletions ( listed i n T able 2) , t hat c ontain a  
fluorescent UPR reporter plasmid. Because these deletion strains exhibit a constitutive induction 
of the UPR, it is assumed that the absence of each of these ~350 genes perturbs the ER folding 
environment121. As de scribed i n C hapter 2 , SGA ana lysis w as pe rformed to generate double 
mutant haploid strains with the following genotypes: KAR2::NAT, yfg::KANMX, pUPRE-GFP or 
kar2-R217A::NAT, yfg::KANMX, pUPRE-GFP, and s o on . To measure t he l evels of  U PR 
induction i n t he r esultant ha ploid s trains, f low c ytometry w as pe rformed a nd t he r esults were 
quantified according to Jonikas et al121. The GFP-fluorescence data obtained for each of the kar2 
strains a re t abulated i n Tables 3 t hrough 6. T he da ta obt ained f or t he KAR2::NAT and kar2-
R217A::NAT strains a re r epresented i n graphical f orm i n F igure 18 in Chapter 2 w hile t hose 
obtained for the kar2-DamP::NAT, kar2-P515L::NAT and kar2-P515L-DamP::NAT strains are 
represented in graphical form in Figure 36. 
When perusing these graphs t here ar e c ertain key features t hat ne ed to be not ed121. As 
indicated in the figure legends of Figures 18 and 36, the horizontal blue line represents the basal 
level of  U PR i nduction obs erved i n t he kar2 strains in the abs ence of an y gene d eletion. 
Therefore, if a gene de letion does not  a ggravate or  alleviate t he ba sal ER s tress of  t he kar2 
strains, then its datapoint on the graph will lie on the horizontal blue line. This suggests that the 
presence of  w ild-type o r m utant BiP ha s an  ep istatic or  ‘ fully m asking’ ef fect on the gene 
deletion. Next, the diagonal blue line in the graphs represents the expected values of UPR 
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Figure 36: Genetic interaction profiles of the indicated mutant kar2 strains.  
 The l evel of  U PR i nduction i n t he 350 gene de letion s trains w as measured us ing a  
fluorescent r eporter ei ther i n the abs ence ( values r epresented on the x -axis) or  pr esence ( values 
represented on t he y-axis) of  (A) kar2-P515L::NAT, (B) kar2-P515L-DamP::NAT, or  (C) kar2-
DamP::NAT, w ith e ach da tapoint on t he g raph c orresponding t o a  uni que g ene de letion. T he 
horizontal blue line represents the basal level of UPR induction observed in the kar2 mutant strain. 
The di agonal blue line represents t he expected v alues of  UPR induction in each of  t he i ndividual 
deletions i f t he pr esence of  t he kar2 allele doe s not i nduce a n a dditional E R s tress. T he r ed l ine 
represents the ‘best f it’ curve to the predicted values in the double mutant strains when each gene 
deletion is combined with kar2-P515L, kar2-P515L-DamP or kar2-DamP.  
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 induction in each of the individual deletion strains if the presence of wild-type or mutant kar2 
does not  i nduce an a dditional E R s tress or a lternately, result i n a  r eduction of  E R s tress. 
Therefore, if a datapoint lies on the diagonal blue line, this suggests that the corresponding gene 
deletion exhibits an epistatic effect on wild-type or mutant BiP. Finally, the red line represents 
the ‘best fit’ curve to the predicted values in the double mutant strains when each gene deletion 
is combined with wild-type or mutant KAR2; the predicted values are computationally generated 
as described in Jonikas et al121. If the experimental values lie on the red line, it is suggestive of a 
lack of genetic interaction between the gene deletion and wild-type or mutant kar2. Conversely, 
if the experimental va lues l ie ei ther above  or  be low this l ine, it is indicative of  aggravating or  
alleviating genetic i nteractions, respectively. There ar e s everal w ays i n which such datapoints 
can be interpreted. Aggravating interactions can occur when a given gene deletion and wild-type 
or mut ant B iP affect t he f unction o f pa rallel pa thways o r pr otein c omplexes. A lleviating 
interactions c an oc cur when a  given gene d eletion a nd w ild-type or  mutant B iP a ffect th e 
function of  t he s ame p athway o r pr otein c omplex. T herefore, ba sed on t he obs erved U PR 
induction values, it is possible to generate hypotheses as to whether the gene corresponding to an 
individual de letion c omplements B iP f unction. T his be comes e specially us eful i n t he c ase o f 
understanding potential functions of uncharacterized open reading frames. 
Another key feature of the graphs which is indicative of the behavior of the wild-type and 
mutant kar2 strains in  thi s U PR-based ge netic a ssay i s t he l ocation of  t he da tapoints 
corresponding t o hac1∆ and ire1∆121. To recapitulate, Ire1p is t he E R t ransmembrane s ignal 
transducer kinase of the UPR, and its downstream target, Hac1p, is the dedicated transcriptional 
regulator of the UPR (refer to section 1.2.7). Therefore, in the absence of either hac1 or ire1, the 
UPR c annot be  i nduced, a nd da tapoints c orresponding t o hac1∆ and ire1∆ should lie on t he 
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diagonal blue line, very close to the (0,0) value on the graph. Accordingly, in Figure 18, parts A 
and B, and in Figure 36A, the positions of the hac1∆ and ire1∆ datapoints are as expected. This 
indicates tha t the  genetic int eraction pr ofiles obt ained f or t he KAR2::NAT, kar2-R217A::NAT, 
kar2-P515L::NAT strains are robust and can be trusted. However, as observed in Figure 36, parts 
B and C, the positions of the hac1∆ and ire1∆ datapoints are either on the red line or are skewed 
from the diagonal blue line. This indicates that the behavior of the kar2-P515L-DamP::NAT and 
kar2-DamP::NAT strains in the UPR-based genetic assay cannot be trusted. The reason for this 
effect is not  clear. Overall, I can conclude that this assay has lent us valuable information with 
regard to the genetic interactions of kar2-R217A and kar2-P515L, and I begin to address some of 
these in the subsequent sections.  
B.4 PRELIMINARY CHARACTERIZATION OF SELECT GENETIC 
INTERACTIONS EXHIBITED BY R217A BIP 
Since the kar2-R217A::NAT strain was the focus of this study, computational analysis was used 
to generate a correlation coefficient that quantified the similarity of genetic interactions exhibited 
by KAR2::NAT or kar2-R217A::NAT and yfg::KANMX. Deletion strains th at e xhibited the 
highest values o f t he c orrelation coefficient were considered most s imilar to KAR2::NAT or 
kar2-R217A::NAT with regard to their genetic int eractions with the 349  other d eletion strains. 
Based on this, it was determined that the genetic interaction profiles of sec71∆ and sec72∆ yeast 
(Sec71p and Sec72p are components of the Sec63 complex; refer to section 1.2.4) were highly 
correlated to that of  kar2-R217A::NAT. T herefore, t his nove l ge netic screen i ndependently 
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confirmed t hat t he e xpression of R 217A B iP from i ts e ndogenous pr omoter r esulted i n a  
translocation-specific phenotype, as predicted (Chapter 2).  
 A s econd value was generated which corresponded to the like lihood of genetic 
interactions be tween KAR2::NAT or kar2-R217A::NAT and yfg::KANMX. A gain, the m ore 
positive t his va lue, t he hi gher t he pr obability tha t KAR2::NAT or kar2-R217A::NAT and 
yfg::KANMX genetically interact. To identify the most suitable candidates for further analysis, I 
asked w hether a  given gene de letion s howed a  pos itive g enetic int eraction value w ith kar2-
R217A::NAT, sec71∆ and sec72∆. This w ould i ncrease t he pos sibility t hat t he c orresponding 
gene participates in translocation. The results from this analysis, as summarized in Table 7, led to 
the identification of ilm1∆, sur4∆ and erd1∆ as putative candidates for analysis in translocation 
assays. In Chapter 2, I showed that ilm1∆ yeast exhibit a specific defect for BiP translocation and 
also e stablished a n i nteraction be tween Ilm1p a nd c omponents of  t he t ranslocation m achinery 
(Figures 18 and 19). Here, I report on the initial characterization of sur4∆ and erd1∆ yeast. 
The fi rst p roperty of t he sur4∆ and erd1∆ strains tha t I examined was the  in vivo 
translocation efficiencies for pre-pro-alpha factor (ppαF) and BiP. I found that ppαF and pre-BiP 
did not accumulate in these strains (Figure 37A) as compared to the sec63-1 control, suggesting 
that Sur4p and Erd1p do not play a role in translocation. In contrast, when I performed in vitro 
assays f or ppαF t ranslocation, I f ound t hat m icrosomes de rived f rom sur4∆ and erd1∆ yeast 
were de ficient f or pp αF t ranslocation a s c ompared t o m icrosomes de rived f rom t he B Y4742 
wild-type strain (Figure 37B). This was initially surprising, but given that Sur4p is a fatty acid 
elongase318, 319, it is possible that the integrity of the ER is affected in sur4∆ yeast. Therefore, the 
microsomal me mbranes derived from the se cells mig ht be  f ragile/defective, in turn affecting 
translocation efficiency. On the other hand, although Erd1p is an uncharacterized protein, the  
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Figure 37: Characterization of the translocation and ERAD efficiencies of sur4∆ and 
erd1∆ yeast. 
 (A) The translocation efficiency of ppαF and BiP was assessed in the indicated wild-type 
and mutant s trains by performing a pulse-chase followed by immunoprecipitation assay at 30°C. 
The sec63-1 strain w hich carries a  tr anslocation-defective al lele of  SEC63 served as  a pos itive 
control. (B) The ability of microsomes derived from the indicated strains to translocate ppαF was 
measured at 20°C. Each sample was divided and treated in one of three ways: A-buffer alone, B-
trypsin, C-trypsin and t riton X-100. The percent translocation efficiency i s indicated below each 
panel. Data are representative of a minimum of two independent experiments. (C) In vitro ERAD 
assays using microsomes derived from the indicated strains were performed either in the absence (-
) or  pr esence ( +) of  an A TP r egenerating s ystem a nd 0.5 m g/ml of  yeast c ytosol at 30°C . 
Microsomes derived from the TEF1-K584X strain served as a positive control. The percent ERAD 
efficiency is indicated below each panel. Data are representative of a minimum of two independent 
experiments. (D) The C PY* ERAD ef ficiencies of  w ild-type ( BY4742) (    ) , sur4∆ (    ) , a nd 
erd1∆ yeast (     )  were compared using c ycloheximide chase assays at  30°C. Data represent the 
means of a minimum of three independent experiments + standard errors. 
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erd1∆ strain exhibits a BiP secretion phenotype316, 317. Therefore, the microsomes derived from 
erd1∆ yeast might have reduced amounts of BiP which could indirectly affect translocation. 
Next, I t ested the E RAD ef ficiencies of  t he sur4∆ and erd1∆ strains. I ana lyzed the 
degradation of mutant pαF in vitro and found that there was a marked stabilization (~100%) of 
mutant p αF i n m icrosomes pr epared from t he sur4∆ strain (Figure 37C), a nd a s light 
stabilization (~72%) in the microsomes prepared from erd1∆ yeast. Again, these ERAD defects 
may be attributed to the reduced integrity of sur4∆ microsomes, and the reduced amounts of BiP 
present in erd1∆ microsomes. Finally, I tested the ability of these strains to degrade CPY* using 
cycloheximide chase assays in vivo (Figure 37D). Intriguingly, while the sur4∆ strain (top panel 
of F igure 37D) di d no t e xhibit a  s ignificant de fect for C PY* de gradation, t here was an 
acceleration of  CPY* degradation in the erd1∆ strain (bottom panel of  Figure 37D). However, 
since the erd1∆ strain secretes BiP316, 317, it is possible that the accelerated degradation observed 
in Figure 37D is an indirect effect of CPY* secretion. Alternately, a  factor other than BiP that 
contributes to CPY* f olding/stabilization might be  s ecreted in erd1∆ yeast, and it w ill be  
interesting to determine the identity of this pro-stabilization factor. 
Another uncharacterized gene that I analyzed was YLR104w. Although ylr104w∆ did not 
exhibit a  pos itive g enetic int eraction with R217A B iP, it s howed positive genetic int eractions 
with sec71∆ and sec72∆ yeast (Table 7 of  Appendix B). Ylr104p is predicted to be an integral 
membrane protein of the ER, and the study by Jonikas et al. grouped Ylr104p with proteins that 
participate in ERAD121. F irst, I ex amined the t ranslocation efficiency of ylr104w∆ yeast and  
found t hat pp αF a nd pr e-BiP di d not a ccumulate in this s train (Figure 38A), indicating tha t 
Ylr104p does not contribute to translocation. Next, I examined the ability of ylr104w∆ yeast to 
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Figure 38: Characterization of the translocation and ERAD efficiencies of 
ylr104w∆ yeast. 
 (A) The translocation efficiency of ppαF and BiP was assessed in the indicated wild-
type and mutant strains by performing a pulse-chase followed by immunoprecipitation assay at 
30°C. The sec63-1 strain which carries a t ranslocation-defective al lele o f SEC63 served as a 
positive control. The ERAD efficiencies of wild-type (BY4742) (    )  and ylr104w∆ (    )  yeast 
were compared using a c ycloheximide cha se a ssay for (B) CPY* ( assayed a t 30°C ), (C) 
Ste6p* (assayed at 37°C), (D) CFTR (assayed at 40°C), and (E) ApoB29 (assayed at 30°C). 
Data represent the means of a  minimum of three independent experiments + standard errors. 
The data for Ste6p* ERAD in the ylr104w∆ strain are preliminary and will be repeated. 
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degrade different classes of E RAD s ubstrates in vivo: ( i) s ubstrates with ER lum enal le sions, 
such as C PY* (Figure 38B); ( ii) int egral me mbrane s ubstrates w ith cytosolic le sions, such as 
Ste6p* (Figure 38C) and CFTR (Figure 38D); and (iii) co-translocationally degraded substrates 
such as ApoB29 (Figure 38E). While CPY*, CFTR and ApoB29 were efficiently turned-over in 
ylr104w∆ yeast, I observed that there was a marked stabilization of Ste6p* as compared to the 
wild-type strain. Therefore, it is possible that Ylr104p contributes to the ERAD of select integral 
membrane s ubstrates. Two other int egral m embrane s ubstrates th at r emain t o be  t ested a re 
Sec61-2p, a  mutant form of  the t ranslocon subunit Sec61p395, and HMG-CoA reductase, a key 
enzyme in the sterol biosynthesis pathway that is regulated by ERAD396. 
Overall, the genetic interactions exhibited by R217A BiP have led to the formulation of 
several new hypotheses which remain to be tested. 
B.5 A BRIEF ANALYSIS OF THE GENETIC INTERACTIONS EXHIBITED BY 
P515L BIP 
It is evident from the position of the horizontal blue line in the genetic interaction profile of kar-
P515L::NAT (Figure B5-A) that there is a very high basal induction of the UPR upon P515L BiP 
expression, as expected181. Furthermore, the proximity of the red line to the horizontal blue line, 
and t he clustering o f s everal d atapoints ont o t he r ed l ine, i ndicate t hat a ma jority of  the  gene 
deletions do not exhibit genetic int eractions w ith kar2-P515L::NAT. H owever, a  s ubset of  t he 
datapoints localizes to  the diagonal blue line, suggesting that the corresponding gene deletions 
are epistatic to P515L BiP. Strikingly, all the members of the GET complex (get1∆, get2∆ and 
get3∆), which is required for tail-anchored protein insertion397, and several members of  the N-
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linked glycosylation pathway that are involved in the assembly of the oligosaccharide moiety398 
(alg3∆, alg5∆, alg6∆, alg8∆, alg9∆, alg12∆ and ost3∆), belong to this c ategory. While thi s 
effect coul d be an experimental ar tefact, the pr esence o f s everal m embers of  a com plex or  
pathway suggests that this is a true genetic interaction.  
 What is the significance of the epistasis exhibited by members of the GET complex for 
P515L BiP? It has been observed that deletion of the members of the GET complex leads to BiP 
secretion333. Accordingly, it is feasible that a reduction in the amounts of P515L BiP in the ER of 
kar2-P515L::NAT get∆ strains r esults in an ER e nvironment tha t r esembles the  s ingle get∆ 
strains. This is observed as an epistatic genetic interaction in the UPR-based screen. Alternately, 
the genetic interaction might be an indirect effect of GET complex function. The GET complex 
is r equired f or t he membrane insertion of ta il-anchored (TA) proteins, i.e., proteins t hat a re 
inserted into lipid bilayers vi a a  s ingle C -terminal tr ansmembrane do main397. T A pr oteins 
participate in multiple processes in cluding p rotein translocation into the E R ( i.e., Sbh1p), 
secretory vesicle fusion (i.e., SNAREs), membrane protein degradation, and apoptotic signaling 
(i.e., Bcl2 in mammalian cells). One such SNARE, Sec22p, plays a key role in the retention of 
several ER-lumenal proteins, including BiP, in the yeast ER383, 399, 400. Therefore, it is formally 
possible that deletion of members of the GET complex in the kar2-P515L::NAT strain results in 
Sec22p mislocalization, in turn affecting P515L BiP retention in the ER. This possibility is also 
supported b y t he e pistatic int eractions e xhibited by sec22∆ towards kar2-P515L::NAT (figure 
36A). Another i ntriguing s cenario i s t hat BiP pl ays an a s yet uni dentified r ole i n T A pr otein 
insertion, which may be addressed in the future. 
Likewise, what are the consequences of the genetic interactions between P515L BiP and 
members of  t he N -linked g lysocylation pa thway? A pr evious s tudy de monstrated t hat m utant 
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alleles of  an essential m ember of  t he ol igosaccharyl t ransferase com plex, WBP1, e xhibit 
synthetic interactions with the kar2-1 allele of BiP (kar2-1 encodes P515L BiP), establishing the 
first c onnection be tween t he N -linked g lycosylation pa thway and P 515L BiP401. Since t he 
addition of  N -linked glycans i s r equired for t he s table f olding of s everal s ecretory 
glycoproteins402, t his s tudy s uggested t hat c ombining a n N -glycosylation de fect w ith a mut ant 
kar2 allele that is defective for folding generates high levels of ER folding stress. This, in turn, 
affects c ell growth. The e pistatic e ffects e xhibited by the  alg3∆, alg5∆, alg6∆, alg8∆, alg9∆, 
alg12∆ and ost3∆ strains for  kar2-P515:::NAT in the s creen described here c an also be 
interpreted i n l ight o f the f olding de fects t hat m ay arise due  t o P 515L BiP e xpression. 
Conversely, i t i s also well-known that the glycosylation s tatus of  mutant proteins, in particular 
the number and positioning of the N-linked glycans, is an important recognition element for the 
ERAD machinery5. Therefore, in the absence of the correct glycans, i t is possible that proteins 
are i nefficiently recognized and/or t argeted for degradation. In s uch a  s ituation, B iP f unction 
during ERAD may become unnecessary. However, all of these hypotheses are rudimentary and 
need to be addressed in the future. 
 Given t he E RAD-specific de fect ex hibited by P515L B iP181, the g enetic int eraction 
profile of kar-P515L::NAT was expected to resemble other ERAD-related genes such as hrd1∆ 
and yos9∆. S urprisingly, t his s creen r esulted i n t he i dentification of s everal nov el a nd 
unprecedented P515L BiP interactions. Moreover, since the kar-P515L::NAT genetic interaction 
profile does not  show a  significant correlation to the profile o f any other gene deletion in this 
UPR-based screen, it will be interesting to further test this mutant in a growth/colony size-based 
assay in which the kar-P515L::NAT strain will be crossed against the entire YKO collection. 
   
 199 
Table 6: A list of the genes that were analyzed in the UPR-based screen 
Gene name ORF Cellular localization Function (either established or predicted) 
ADD66/PAC2 YKL206C cytoplasm Proteasome assembly; also plays a role in ERAD 
AGX1 YFL030W mitochondrion Alanine : glyoxylate aminotransferase, catalyzes the synthesis of glycine from glyoxylate, 
AHC2 YCR082W cytoplasm, nucleus 
Protein of unknown function, putative transcriptional 
regulator; proposed to be a Ada Histone acetyltransferase 
complex component 
ALF1 YNL148C ambiguous 
Alpha-tubulin folding protein, similar to mammalian 
cofactor B; apart from folding alpha-tubulin,may play an 
additional role in microtubule maintenance 
ALG12 YNR030W ER Alpha-1,6-mannosyltransferase involved in the N-linked glycosylation pathway 
ALG3 YBL082C cytoplasm, vacuole 
Dolichol-P-Man dependent alpha(1-3) 
mannosyltransferase involved in the  N-linked 
glycosylation pathway 
ALG5 YPL227C ER 
UDP-glucose:dolichyl-phosphate glucosyltransferase 
involved in asparagine-linked glycosylation in the 
endoplasmic reticulum 
ALG6 YOR002W ER 
Glucosyltransferase, involved in transfer of 
oligosaccharides from dolichyl pyrophosphate to 
asparagine residues of proteins during N-linked protein 
glycosylation 
ALG8 YOR067C ER membrane Glucosyltransferase similar to Alg6p 
ALG9 YNL219C ER 
Mannosyltransferase, involved in N-linked glycosylation; 
catalyzes the transfer of mannose from Dol-P-Man to lipid-
linked oligosaccharides 
APE3 YBR286W ER membrane Vacuolar aminopeptidase Y, processed to mature form by Prb1p 
ARC18 YLR370C actin? Subunit of the ARP2/3 complex, which is required for the motility and integrity of cortical actin patches 
ARL1 YBR164C punctate composite, early Golgi 
Soluble GTPase with a role in regulation of membrane 
traffic; regulates potassium influx; G protein of the Ras 
superfamily, similar to ADP-ribosylation factor 
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ARO1 YDR127W cytoplasm 
Pentafunctional arom protein, catalyzes steps 2 through 6 
in the biosynthesis of chorismate, which is a precursor to 
aromatic amino acids 
ARP6 YLR085C cytoplasm, nucleus Nuclear actin-related protein involved in chromatin remodeling 
ARV1 YLR242C ER/Golgi Protein required for normal intracellular sterol distribution and for sphingolipid metabolism; similar to Nup120p 
ASM4 YDL088C nuclear periphery Nuclear pore complex subunit, part of a subcomplex also containing Nup53p, Nup170p, and Pse1p 
ATG8 YBL078C cytoplasm 
Protein involved in autophagy; E2-like enzyme that plays a 
role in formation of Atg8p-phosphatidylethanolamine 
conjugates 
BNR1 YIL159W bud neck 
Formin, nucleates the formation of linear actin filaments 
during budding and mitotic spindle orientation; functionally 
redundant with BNI1 
BOP2 YLR267W 0 Protein of unknown function, overproduction suppresses a pam1 slv3 double null mutation 
BRE5 YNR051C cytoplasm 
Ubiquitin protease cofactor; forms deubiquitination 
complex with Ubp3p that coregulates anterograde and 
retrograde transport between the ER and Golgi 
compartments 
BST1 YFL025C ER GPI inositol deacylase of the ER that negatively regulates COPII vesicle formation 
BTS1 YPL069C mitochondrion Geranylgeranyl diphosphate synthase; increases the intracellular pool of geranylgeranyl diphosphate, 
BUG1 YDL099W punctate composite, early Golgi Protein of unknown function 
CAC2 YML102W Nucleus 
Component of the chromatin assembly complex (with 
Rlf2p and Msi1p) that assembles newly synthesized 
histones onto recently replicated DNA 
CAJ1 YER048C Nucleus, cytoplasm Nuclear type II Hsp40 
CAP1 YKL007W Cortical actin 
Beta subunit of the capping protein (CP) heterodimer 
(Cap1p and Cap2p) which binds to the barbed ends of 
actin filaments preventing further polymerization 
CCW12 YLR110C ER/Cell wall Cell wall protein, mutants are defective in mating and agglutination 
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CKA2 YOR061W cytoplasm, nucleus Alpha' catalytic subunit of casein kinase 2, a Ser/Thr protein kinase with roles in cell growth and proliferation 
CNE1 YAL058W ER Calnexin; integral membrane ER chaperone involved in folding and quality control of glycoproteins; 
COG5 YNL051W Golgi, early Golgi 
Component of the conserved oligomeric Golgi complex 
(Cog1p through Cog8p), a cytosolic tethering complex that 
functions in protein trafficking 
COG6 YNL041C Golgi Component of the conserved oligomeric Golgi complex (Cog1p through Cog8p) 
COG8 YML071C punctate composite Component of the conserved oligomeric Golgi complex (Cog1p through Cog8p) 
CPA1 YOR303W cytoplasm 
Small subunit of carbamoyl phosphate synthetase, which 
catalyzes a step in the synthesis of citrulline, an arginine 
precursor 
CPR6 YLR216C cytoplasm 
Peptidyl-prolyl cis-trans isomerase (cyclophilin), catalyzes 
the cis-trans isomerization of peptide bonds N-terminal to 
proline residues 
CRD1 YDL142C mitochondrion 
Cardiolipin synthase; produces cardiolipin, an important 
constituent of mitochondrial membranes that is required 
for normal mitochondrial membrane potential and function 
CSF1 YLR087C 0 Protein required for fermentation at low temperature 
CSN12 YJR084W cytoplasm, nucleus 
Subunit of the Cop9 signalosome, which is required for 
deneddylation, or removal of the ubiquitin-like protein 
Rub1p from Cdc53p (cullin) 
CUE1 YMR264W ER, cytoplasm 
Endoplasmic reticulum membrane protein that recruits the 
E2 ubiquitin-conjugating enzyme Ubc7p to the ER where it 
functions in protein degradation 
CWH41 YGL027C ER membrane 
Processing alpha glucosidase I; ER type II integral 
membrane N-glycoprotein involved in assembly of cell wall 
beta 1,6 glucan and asparagine-linked protein 
glycosylation 
CWH43 YCR017C ER Putative sensor/transporter protein involved in cell wall biogenesis 
CYS3 YAL012W cytoplasm 
Cystathionine gamma-lyase, catalyzes one of the two 
reactions involved in the transsulfuration pathway that 
yields cysteine from homocysteine 
DAL81 YIR023W nucleus Positive regulator of genes in multiple nitrogen degradation pathways 
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DAS1 YJL149W 0 
Putative SCF ubiquitin ligase F-box protein of unknown 
function; interacts physically with both Cdc53p and Skp1 
and genetically with CDC34 
DER1 YBR201W ER membrane Involved in ER-associated protein degradation, during retrotranslocation 
DFG10 YIL049W 0 Protein of unknown function, involved in filamentous growth 
DGK1/HSD1 YOR311C ER 
Overproduction induces enlargement of ER-like 
membrane structures and suppresses a temperature-
sensitive sly1 mutation 
DIE2 YGR227W 0 Dolichyl-phosphoglucose-dependent glucosyltransferase of the ER; involved in N-linked glycosylation 
DOM34 YNL001W cytoplasm Probable RNA-binding protein, functions in protein translation to promote G1 progression and differentiation 
DRS2 YAL026C early Golgi, late Golgi Integral membrane Ca(2+)-ATPase involved in aminophospholipid translocation 
DUS3 YLR401C cytoplasm, nucleus 
Dihydrouridine synthase, member of a widespread family 
of conserved proteins including Smm1p, Dus1p, and 
Dus4p 
ECM30 YLR436C cytoplasm Non-essential protein of unknown function 
EDE1 YBL047C punctate composite Key endocytic protein, binds to membranes in a ubiquitin-dependent manner 
EGD1 YPL037C cytoplasm Subunit beta1 of the nascent polypeptide-associated complex (NAC) involved in protein targeting 
EGD2 YHR193C cytoplasm Alpha subunit of the heteromeric nascent polypeptide-associated complex (NAC) 
ELF1 YKL160W nucleus Transcription elongation factor that contains a conserved zinc finger domain 
ELP2 YGR200C cytoplasm Elongator protein, part of the six-subunit RNA polymerase II Elongator histone acetyltransferase complex 
EMP47 YFL048C vacuolar membrane Integral membrane component of ER-derived COPII-coated vesicles, which function in ER to Golgi transport 
ENT3 YJR125C 0 
Protein containing an N-terminal epsin-like domain 
involved in clathrin recruitment and traffic between the 
Golgi and endosomes; associates with the clathrin adaptor 
Gga2p 
ERD1 YDR414C ambiguous 
Predicted membrane protein required for the retention of 
lumenal endoplasmic reticulum proteins; mutants secrete 
the endogenous ER protein, BiP (Kar2p) 
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ERG2 YMR202W ambiguous 
C-8 sterol isomerase, catalyzes the isomerization of the 
delta-8 double bond to the delta-7 position at an 
intermediate step in ergosterol biosynthesis 
ERJ5 YFR041C ER DnaJ-like protein; may function as a BiP cofactors 
ERP1 YAR002C-A vacuolar membrane 
Protein that forms a heterotrimeric complex with Erp2p, 
Emp24p, and Erv25p; involved in COPII-mediated ER to 
Golgi transport 
ERP2 YAL007C ER Protein that forms a heterotrimeric complex with Erp1p, Emp24p, and Erv25p 
ERV14 YGL054C ER, vacuole 
Protein localized to COPII-coated vesicles, involved in 
vesicle formation and incorporation of specific secretory 
cargo 
ERV25 YML012W ER Protein that forms a heterotrimeric complex with Erp1, Erp2p, and Emp24 
ERV29 YGR284C ER 
Protein localized to COPII-coated vesicles, involved in 
vesicle formation and incorporation of specific secretory 
cargo 
ERV41 YML067C ER 
Protein localized to COPII-coated vesicles, forms a 
complex with Erv46p; involved in the membrane fusion 
stage of transport 
ERV46 YAL042W 0 
Protein localized to COPII-coated vesicles, forms a 
complex with Erv41p; involved in the membrane fusion 
stage of transport 
EUG1 YDR518W 0 Protein disulfide isomerase of the endoplasmic reticulum lumen; may interact with nascent polypeptides in the ER 
FAR8 YMR029C ER, cytoplasm 
Protein involved in G1 cell cycle arrest in response to 
pheromone; interacts with Far3p, Far7p, Far9p, Far10p, 
and Far11p 
FAT1 YBR041W lipid particle Fatty acid transporter and very long-chain fatty acyl-CoA synthetase 
FKH1 YIL131C Nucleus Transcription factor of the forkhead family that regulates the cell cycle and pseudohyphal growth 
FLX1 YIL134W 0 Protein required for transport of flavin adenine dinucleotide (FAD) from mitochondria to the cytosol 
FRE4 YNR060W 0 Ferric reductase, reduces a specific subset of siderophore-bound iron prior to uptake by transporters 
FUN30 YAL019W Nucleus Protein whose overexpression affects chromosome stability, potential Cdc28p substrate; homolog of Snf2p 
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FYV6 YNL133C Nucleus Protein of unknown function; proposed to regulate double-strand break repair via non-homologous end-joining 
GCN2 YDR283C cytoplasm 
Protein kinase, phosphorylates the alpha-subunit of 
translation initiation factor eIF2 (Sui2p) in response to 
starvation 
GCN20 YFR009W cytoplasm Positive regulator of the Gcn2p kinase activity, forms a complex with Gcn1p 
GCN5 YGR252W Nucleus 
Histone acetyltransferase, acetylates N-terminal lysines 
on histones H2B and H3; catalytic subunit of the ADA and 
SAGA histone acetyltransferase complexes 
GCR2 YNL199C 0 Transcriptional activator of genes involved in glycolysis 
GCS1 YDL226C cytoplasm ADP-ribosylation factor GTPase activating protein (ARF GAP), involved in ER-Golgi transport 
GDA1 YEL042W ambiguous, Golgi Guanosine diphosphatase involved in the transport of GDP-mannose into the Golgi lumen  
GET1 YGL020C ER 
Subunit of the GET complex; required for the retrieval of 
HDEL proteins from the Golgi to the ER in an ERD2 
dependent fashion and for tail-anchored protein insertion 
GET2 YER083C ER Subunit of the GET complex 
GET3 YDL100C ER ATPase subunit of the GET complex 
GLO3 YER122C Golgi, early Golgi ADP-ribosylation factor GTPase activating protein (ARF GAP), involved in ER-Golgi transport 
GNP1 YDR508C ER,cell periphery High-affinity glutamine permease, also transports Leu, Ser, Thr, Cys, Met and Asn 
GOS1 YHL031C 0 v-SNARE protein involved in Golgi transport, homolog of the mammalian protein GOS-28/GS28 
GOT1 YMR292W ER 
Evolutionarily conserved non-essential protein found in 
early Golgi cisternae; may be involved in ER-Golgi 
transport  
GSG1 YDR108W cytoplasm 
Subunit of TRAPP (transport protein particle); involved in 
targeting and/or fusion of ER-to-Golgi transport vesicles 
with their acceptor compartment 
GSH2 YOL049W cytoplasm 
Glutathione synthetase, catalyzes the ATP-dependent 
synthesis of glutathione (GSH) from gamma-
glutamylcysteine and glycine 
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GTB1 YDR221W ER 
Glucosidase II beta subunit; forms a complex with alpha 
subunit Rot2p, involved in removal of two glucose 
residues from N-linked glycans  
GTR1 YML121W vacuolar membrane Cytoplasmic GTP binding protein and negative regulator, of the Ran/Tc4 GTPase cycle 
GUP1 YGL084C ER? 
Plasma membrane protein with a possible role in proton 
symport of glycerol; member of the MBOAT family of 
putative membrane-bound O-acyltransferases 
GYP8 YFL027C mitochondrion GTPase-activating protein for yeast Rab family members; involved in the regulation of ER to Golgi vesicle transport 
HAC1 YFL031W cytoplasm, nucleus bZIP transcription factor (ATF/CREB1 homolog) that regulates the unfolded protein response 
HAM1 YJR069C cytoplasm, nucleus Protein of unknown function that may be involved in DNA repair 
HAT2 YEL056W nucleus Subunit of the Hat1p-Hat2p histone acetyltransferase complex; has a role in telomeric silencing 
HEK2 YBL032W cytoplasm RNA binding protein with similarity to hnRNP-K that localizes to the cytoplasm and to subtelomeric DNA 
HHF1 YBR009C nucleus One of two identical histone H4 proteins (see also HHF2);  
HHT1 YBR010W nucleus One of two identical histone H3 proteins (see also HHT2) 
HHT2 YNL031C ambiguous One of two identical histone H3 proteins (see also HHT1) 
HIR3 YJR140C nucleus 
Transcriptional corepressor involved in the cell cycle-
regulated transcription of histone genes HTA1, HTB1, 
HHT1, and HHT2 
HLJ1 YMR161W ER 
Hsp40 Co-chaperone anchored in the ER membrane; 
promotes ER-associated protein degradation (ERAD) of 
integral membrane substrates 
HMG1 YML075C nuclear periphery One of two isozymes of HMG-CoA reductase that catalyzes the conversion of HMG-CoA to mevalonate 
HOP2 YGL033W nucleus 
Meiosis-specific protein that localizes to chromosomes, 
preventing synapsis between nonhomologous 
chromosomes and ensuring synapsis between homologs 
HPC2 YBR215W nucleus Highly charged, basic protein required for normal cell-cycle regulation of histone gene transcription 
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HRD1 YOL013C ER membrane 
Ubiquitin-protein ligase required for endoplasmic 
reticulum-associated degradation; regulated through 
association with Hrd3p; contains an H2 ring finger 
HRD3 YLR207W ER membrane 
Forms the HRD complex with Hrd1p and ERAD 
determinants; engages in ER lumen to cytosol 
communication and coordination of ERAD events 
HSM3 YBR272C cytoplasm Protein of unknown function, involved in DNA mismatch repair during slow growth; has weak similarity to Msh1p 
HSV2 YGR223C Punctate cytoplasmic Phosphatidylinositol 3,5-bisphosphate-binding protein, predicted to fold as a seven-bladed beta-propeller 
HTB2 YBL002W nucleus 
One of two nearly identical (see HTB1) histone H2B 
subtypes required for chromatin assembly and 
chromosome function 
HTZ1 YOL012C nucleus 
Histone variant H2AZ; involved in transcriptional 
regulation through prevention of the spread of silent 
heterochromatin 
HUR1 YGL168W 0 
Protein required for hydroxyurea resistance; has possible 
roles in DNA replication and maintenance of proper 
telomere length 
HXK2 YGL253W cytoplasm Hexokinase isoenzyme 2 that catalyzes phosphorylation of glucose in the cytosol 
HXT8 YJL214W 0 Protein of unknown function with similarity to hexose transporter family members 
ICE2 YIL090W ER membrane Mutations cause defects in cortical ER morphology in both the mother and daughter cells 
IDH1 YNL037C mitochondrion 
Subunit of mitochondrial NAD(+)-dependent isocitrate 
dehydrogenase, which catalyzes the oxidation of isocitrate 
to alpha-ketoglutarate in the TCA cycle 
IES1 YFL013C nucleus Subunit of the INO80 chromatin remodeling complex 
IES4 YOR189W nucleus Protein that associates with the INO80 chromatin remodeling complex under low-salt conditions 
IES5 YER092W nucleus Protein that associates with the INO80 chromatin remodeling complex under low-salt conditions 
ILM1 YJR118C ER Protein of unknown function; may be involved in mitochondrial DNA maintenance 
INP53 YOR109W punctate composite 
Phosphatidylinositol 4,5-bisphosphate 5-phosphatase; 
plays a role in a TGN (trans Golgi network)-to-early 
endosome pathway 
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IPK1 YDR315C nucleus Inositol 1,3,4,5,6-pentakisphosphate 2-kinase; ipk1 gle1 double mutant is inviable 
IRC21 YMR073C cytoplasm Putative protein of unknown function; shares similarity to a human cytochrome oxidoreductase 
IRE1 YHR079C ER membrane 
Serine-threonine kinase and endoribonuclease; 
transmembrane protein that initiates the unfolded protein 
response signal by regulating synthesis of Hac1p through 
HAC1 mRNA splicing 
ISC1 YER019W 0 Inositol phosphosphingolipid phospholipase C 
ISR1 YPR106W 0 
Predicted protein kinase, overexpression causes 
sensitivity to staurosporine, which is a potent inhibitor of 
protein kinase C 
ISW1 YBR245C nucleus Member of the imitation-switch (ISWI) class of ATP-dependent chromatin remodeling complexes 
ISW2 YOR304W nucleus Member of the imitation-switch (ISWI) class of ATP-dependent chromatin remodeling complexes 
ITR1 YDR497C cell periphery, vacuole 
Myo-inositol transporter; member of the sugar transporter 
superfamily 
IXR1 YKL032C nucleus 
Contains two HMG (high mobility group box) domains and 
bends cisplatin-modified DNA by binding to the DNA; 
mediates aerobic transcriptional repression of COX5b 
JEM1 YJL073W ER DnaJ-like chaperone required for nuclear membrane fusion during mating, BiP cofactor during ERAD 
KEL1 YHR158C bud neck, cell periphery, bud 
Protein required for proper cell fusion and cell 
morphology; functions in a complex with Kel2p to 
negatively regulate mitotic exit 
KEX2 YNL238W punctate composite, early Golgi 
Subtilisin-like protease (proprotein convertase), a calcium-
dependent serine protease involved in the activation of 
proproteins of the secretory pathway 
KIN3 YAR018C 0 Nonessential protein kinase with unknown cellular role 
KRE1 YNL322C ER Cell wall glycoprotein involved in beta-glucan assembly 
KRE11 YGR166W punctate composite Protein involved in biosynthesis of cell wall beta-glucans; subunit of the TRAPP (transport protein particle) complex 
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KRE27 YIL027C ER Protein of unknown function; null mutant shows K1 killer toxin resistance 
KTI12 YKL110C cytoplasm Protein associated with the RNA polymerase II Elongator complex 
LAS21 YJL062W ER, plasma membrane 
Integral plasma membrane protein involved in the 
synthesis of the glycosylphosphatidylinositol (GPI) core 
structure; mutations affect cell wall integrity 
LEM3 YNL323W ER, plasma membrane 
Membrane protein of the plasma membrane and ER, 
involved in translocation of phospholipids and 
alkylphosphocholine drugs across the plasma membrane 
LEU3 YLR451W nucleus 
Zinc-finger transcription factor that regulates genes 
involved in branched chain amino acid biosynthesis and 
ammonia assimilation 
LOC1 YFR001W nucleus 
Nuclear protein involved in asymmetric localization of 
ASH1 mRNA; binds double-stranded RNA in vitro; 
constituent of 66S pre-ribosomal particles 
LPD1 YFL018C mitochondrion 
The Dihydrolipoamide dehydrogenase of the pyruvate 
dehydrogenase and 2-oxoglutarate dehydrogenase multi-
enzyme complexes 
LRC3 YKL207W 0 Hypothetical protein 
MAF1 YDR005C cytoplasm,nucleus Negative regulator of RNA polymerase III by targeting the initiation factor TFIIIB 
MDY2 YOL111C cytoplasm 
Protein required for efficient mating; involved in shmoo 
formation and nuclear migration in the pre-zygote; 
contains a ubiquitin-like (UBL) domain 
MEH1 YKR007W vacuolar membrane 
Component of the EGO complex (involved in the 
regulation of microautophagy) and GSE complex (required 
for proper sorting of amino acid permease Gap1p) 
MGA2 YIR033W ER membrane Along with its homolog Spt23p, regulates OLE1 transcription 
MKC7 YDR144C vacuole 
GPI-anchored aspartyl protease (yapsin) involved in 
protein processing; shares functions with Yap3p and 
Kex2p 
MNL1 YHR204W ER 
Alpha mannosidase-like protein of the endoplasmic 
reticulum required for degradation of glycoproteins but not 
for processing of N-linked oligosaccharides 
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MNN2 YBR015C Golgi 
Alpha-1,2-mannosyltransferase, responsible for addition of 
the first alpha-1,2-linked mannose to form the branches on 
the mannan backbone of oligosaccharides 
MNN4 YKL201C 0 
Putative positive regulator of mannosylphosphate 
transferase (Mnn6p), involved in mannosylphosphorylation 
of N-linked oligosaccharides 
MNN5 YJL186W punctate composite 
Alpha-1,2-mannosyltransferase, responsible for addition of 
the second alpha-1,2-linked mannose of the branches on 
the mannan backbone of oligosaccharides 
MNN9 YPL050C Golgi 
Subunit of Golgi mannosyltransferase complex containing 
Anp1p, Mnn10p, Mnn11p, and Hoc1p that mediates 
elongation of the polysaccharide mannan backbone 
MNS1 YJR131W ER membrane 
Alpha-1,2-mannosidase involved in ER quality control; 
catalyzes the removal of one mannose residue from 
Man9GlcNAc to produce a single isomer of Man8GlcNAc  
MPD1 YOR288C vacuole Member of the protein disulfide isomerase (PDI) family 
MSC1 YML128C ER 
Protein of unknown function; msc1 mutants are defective 
in directing meiotic recombination events to homologous 
chromatids 
MSI1 YBR195C cytoplasm, nucleus 
Subunit of chromatin assembly factor I (CAF-I); 
homologous to human retinoblastoma binding proteins 
RbAp48 and RbAp46 
MTC1 YJL123C cytoplasm, Golgi, early Golgi 
Putative protein of unknown function; mtc1 is synthetically 
lethal with cdc13-1 
MTC5 YDR128W vacuolar membrane Hypothetical protein 
MVP1 YMR004W endosome 
Protein required for sorting proteins to the vacuole; Mvp1p 
and Vps1p act in concert to promote membrane traffic to 
the vacuole 
NEM1 YHR004C punctate composite Protein of the nuclear envelope required for the spherical shape of the nucleus; required for normal sporulation 
NFT1 YKR103W cytoplasm,nucleus Putative transporter of the multidrug resistance-associated protein (MRP) subfamily. 
NHP6A YPR052C nucleus 
High-mobility group non-histone chromatin protein, 
functionally redundant with Nhp6Bp; acts to recruit 
transcription factor Rcs1p to certain promoters 
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NHX1 YDR456W endosome Endosomal Na+/H+ exchanger, required for intracellular sequestration of Na+ 
NMD4 YLR363C cytoplasm Protein interacting with Nam7p, may be involved in the nonsense-mediated mRNA decay pathway 
NPL4 YBR170C cytoplasm, nucleus 
Forms a complex with Cdc48p and Ufd1p that recognizes 
ubiquitinated proteins in the endoplasmic reticulum and 
delivers them to the proteasome for degradation 
OLA1 YBR025C cytoplasm Hypothetical protein 
OPI10 YOL032W cytoplasm, nucleus ORF, Uncharacterized 
OPI3 YJR073C ER, vacuole 
Phospholipid methyltransferase (methylene-fatty-acyl-
phospholipid synthase), catalyzes the last two steps in 
phosphatidylcholine biosynthesis 
OST3 YOR085W ER 
Gamma subunit of the oligosaccharyltransferase complex 
of the ER lumen, which catalyzes N-linked glycosylation of 
newly synthesized proteins 
OST5 YGL226C-A ER 
Zeta subunit of the oligosaccharyltransferase complex of 
the ER lumen, which catalyzes N-linked glycosylation of 
newly synthesized proteins 
OYE2 YHR179W cytoplasm, nucleus Widely conserved NADPH oxidoreductase containing flavin mononucleotide (FMN) 
PBP1 YGR178C cytoplasm, nucleus 
Protein interacting with poly(A)-binding protein Pab1p; 
may be involved in controlling the extent of mRNA 
polyadenylation 
PCT1 YGR202C nuclear periphery 
Cholinephosphate cytidylyltransferase, also known as 
CTP:phosphocholine cytidylyltransferase, rate-determining 
enzyme of the CDP-choline pathway for 
phosphatidylcholine synthesis 
PEF1 YGR058W cytoplasm, nucleus Putative protein of unknown function 
PEP7 YDR323C endosome 
Multivalent adaptor protein that facilitates vesicle-
mediated vacuolar protein sorting by ensuring high-fidelity 
vesicle docking and fusion 
PEP8 YJL053W endosome 
Vacuolar sorting protein that forms part of the multimeric 
membrane-associated retromer complex along with 
Vps35p, Vps29p, Vps17p, and Vps5p; essential for 
endosome-to-Golgi retrograde protein transport 
 211 
PET18 YCR020C ambiguous Protein required for respiratory growth and stability of the mitochondrial genome 
PHO80 YOL001W cytoplasm, nucleus 
Cyclin, negatively regulates phosphate metabolism; 
Pho80p-Pho85p (cyclin-CDK complex) phosphorylates 
Pho4p and Swi5p; truncated form of PHO80 affects 
vacuole inheritance 
PHO86 YJL117W ER 
Required for ER exit of the high-affinity phosphate 
transporter Pho84p, specifically required for packaging of 
Pho84p into COPII vesicles 
PMP1 YCR024C-A cell periphery, vacuole 
Small single-membrane span proteolipid that functions as 
a regulatory subunit of the plasma membrane H(+)-
ATPase Pma1p 
PMR1 YGL167C ER 
High affinity Ca2+/Mn2+ P-type ATPase required for Ca2+ 
and Mn2+ transport into Golgi; involved in Ca2+ 
dependent protein sorting and processing 
PMT1 YDL095W ER membrane 
Protein O-mannosyltransferase, transfers mannose 
residues from dolichyl phosphate-D-mannose to protein 
serine/threonine residues; acts in a complex with Pmt2p 
PMT2 YAL023C ER 
Protein O-mannosyltransferase, transfers mannose 
residues from dolichyl phosphate-D-mannose to protein 
serine/threonine residues; acts in a complex with Pmt1p 
PPH21 YDL134C cytoplasm, nucleus Catalytic subunit of protein phosphatase 2A, functionally redundant with Pph22p 
PPT1 YGR123C cytoplasm, nucleus Protein serine/threonine phosphatase with similarity to human phosphatase PP5 
PRM2 YIL037C vacuole 
Pheromone-regulated protein, predicted to have 4 
transmembrane segments and a coiled coil domain; 
regulated by Ste12p 
PSD2 YGR170W Golgi, vacuole 
Phosphatidylserine decarboxylase of the Golgi and 
vacuolar membranes, converts phosphatidylserine to 
phosphatidylethanolamine 
PTC2 YER089C cytoplasm, nucleus 
Type 2C protein phosphatase; dephosphorylates Hog1p to 
limit maximal osmostress induced kinase activity; 
dephosphorylates Ire1p to downregulate the unfolded 
protein response 
PTK2 YJR059W cytoplasm Putative serine/threonine protein kinase involved in regulation of ion transport across plasma membrane 
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PTP1 YDL230W cytoplasm, mitochondria 
Phosphotyrosine-specific protein phosphatase that 
dephosphorylates a broad range of substrates in vivo 
PTR2 YKR093W cell periphery, vacuole 
Integral membrane peptide transporter, mediates transport 
of di- and tri-peptides 
RAD23 YEL037C cytoplasm, nucleus 
Protein with ubiquitin-like N terminus, recognizes and 
binds damaged DNA (with Rad4p) during nucleotide 
excision repair 
RAV1 YJR033C ambiguous Subunit of the RAVE complex (Rav1p, Rav2p, Skp1p), which promotes assembly of the V-ATPase holoenzyme 
RCO1 YMR075W nucleus Essential subunit of the histone deacetylase Rpd3S complex; interacts with Eaf3p 
RER1 YCL001W punctate composite Protein involved in retention of membrane proteins, including Sec12p, in the ER 
REX4 YOL080C nucleolus, nucleus Putative RNA exonuclease possibly involved in pre-rRNA processing and ribosome assembly 
RGP1 YDR137W early Golgi Subunit of a Golgi membrane exchange factor (Ric1p-Rgp1p) that catalyzes nucleotide exchange on Ypt6p 
RLF2 YPR018W Nucleus 
Largest subunit (p90) of the Chromatin Assembly 
Complex (CAF-I); along with Cac2p and Msi1p, 
assembles newly synthesized histones onto recently 
replicated DNA 
ROT2 YBR229C ER, mitochondrion Glucosidase II catalytic subunit required for normal cell wall synthesis 
ROX1 YPR065W nucleus Heme-dependent repressor of hypoxic genes; contains an HMG domain that is responsible for DNA bending activity 
RPA14 YDR156W nucleolus RNA polymerase I subunit A14 
RPL19B YBL027W cytoplasm Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl19Ap  
RPN10 YHR200W cytoplasm, nucleus Non-ATPase base subunit of the 19S regulatory particle (RP) of the 26S proteasome 
RPS11A YDR025W cytoplasm Protein component of the small (40S) ribosomal subunit; identical to Rps11Bp  
RPS12 YOR369C cytoplasm Protein component of the small (40S) ribosomal subunit; has similarity to rat ribosomal protein S12 
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RPS16A YMR143W cytoplasm Protein component of the small (40S) ribosomal subunit; identical to Rps16Bp  
RPS17A YML024W cytoplasm Ribosomal protein 51 (rp51) of the small (40s) subunit; nearly identical to Rps17Bp 
RPS23A YGR118W cytoplasm 
Ribosomal protein 28 (rp28) of the small (40S) ribosomal 
subunit, required for translational accuracy; nearly 
identical to Rps23Bp 
RPS28B YLR264W cytoplasm Protein component of the small (40S) ribosomal subunit; nearly identical to Rps28Ap  
RPS4B YHR203C cytoplasm Protein component of the small (40S) ribosomal subunit; identical to Rps4Ap 
RPS6B YBR181C cytoplasm Protein component of the small (40S) ribosomal subunit; identical to Rps6Ap 
RTN1 YDR233C ER, cell periphery ER membrane protein that interacts with exocyst subunit Sec6p and with Yip3p 
RTT10 YPL183C cytoplasm Hypothetical protein; Cytoplasmic protein with a role in regulation of Ty1 transposition 
RTT106 YNL206C nucleus Protein with a role in regulation of Ty1 transposition 
RUD3 YOR216C punctate composite, Golgi 
Golgi matrix protein involved in the structural organization 
of the cis-Golgi 
SAC7 YDR389W cytoplasm GTPase activating protein (GAP) for Rho1p, involved in signaling to the actin cytoskeleton 
SBH2 YER019C-A ER 
Ssh1p-Sss1p-Sbh2p complex component, involved in 
protein translocation into the endoplasmic reticulum; 
homologous to Sbh1p 
SCJ1 YMR214W ER DnaJ homolog that cooperates with BiP to mediate maturation of proteins as well as during ERAD 
SEC22 YLR268W Golgi 
R-SNARE protein; assembles into SNARE complex with 
Bet1p, Bos1p and Sed5p; involved in anterograde and 
retrograde transport between the ER and Golgi 
SEC28 YIL076W Golgi, early Golgi Epsilon-COP subunit of the coatomer; regulates retrograde Golgi-to-ER protein traffic 
SEC66 YBR171W ER membrane 
Non-essential subunit of the Sec63 complex; with Sec61 
complex and Sec62, performes SRP-dependent and post-
translational SRP-independent protein targeting and 
import into the ER 
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SEC72 YLR292C cytoplasm, ER-localized 
Non-essential subunit of the Sec63 complex; with Sec61 
complex and Sec62, performes SRP-dependent and post-
translational SRP-independent protein targeting and 
import into the ER 
SED4 YCR067C ER membrane 
Functions as a positive regulator of Sar1p probably 
through inhibition of GTPase activation by Sec23p; 
participates in vesicle formation, similar to Sec12p 
SET3 YKR029C nucleus 
Defining member of the SET3 histone deacetylase 
complex which is a meiosis-specific repressor of 
sporulation genes 
SEY1 YOR165W punctate composite 
Protein of unknown function, contains two predicted GTP-
binding motifs GXXXXGKS and DXXG near the N-
terminus 
SFB2 YNL049C ER to Golgi 
Probable component of COPII coated vesicles that binds 
to Sec23p; involved in ER to Golgi transport and in 
autophagy 
SGM1 YJR134C Golgi, early Golgi Protein of unknown function; localizes to COPI coated vesicles and the Golgi apparatus 
SGT2 YOR007C cytoplasm 
Glutamine-rich cytoplasmic protein of unknown function, 
contains tetratricopeptide (TPR) repeats, which often 
mediate protein-protein interactions 
SIF2 YBR103W nucleus 
WD40 repeat-containing subunit of the Set3C histone 
deacetylase complex, which represses early/middle 
sporulation genes 
SIL1 YOL031C ER Nucleotide exchange factor BiP, required for protein translocation into the ER 
SKY1 YMR216C cytoplasm SR protein kinase (SRPK) involved in regulating proteins involved in mRNA metabolism and cation homeostasis 
SLA1 YBL007C cytoplasm, actin 
Cytoskeletal protein binding protein required for assembly 
of the cortical actin cytoskeleton; interacts with proteins 
regulating actin dynamics and involved in endocytosis 
SLP1 YOR154W ambiguous Hypothetical protein 
SMI1 YGR229C punctate composite, late Golgi 
Protein involved in the regulation of cell wall synthesis; 
proposed to be involved in coordinating cell cycle 
progression with cell wall integrity 
SNT1 YCR033W nucleus Subunit of the Set3C deacetylase complex; putative DNA-binding protein 
SOP4 YJL192C ER membrane Suppressor of pma1-7; deletion of SOP4 slows down the export of wild-type Pma1p and Pma1-7 from the ER 
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SPC1 YJR010C-A ER 
Subunit of the signal peptidase complex (SPC), which 
cleaves the signal sequence from proteins targeted to the 
endoplasmic reticulum (ER) 
SPC2 YML055W ER 
Subunit of signal peptidase complex (Spc1p, Spc2p, 
Spc3p, Sec11p), which catalyzes cleavage of N-terminal 
signal sequences of proteins targeted to the secretory 
pathway 
SPE3 YPR069C cytoplasm, nucleus 
Spermidine synthase, involved in biosynthesis of 
spermidine and pantothenic acid; spermidine is required 
for growth of wild-type cells 
SPE4 YLR146C cytoplasm Spermine synthase, required for the biosynthesis of spermine and pantothenic acid 
SPF1 YEL031W ER 
P-type ATPase, ion transporter of the ER membrane 
involved in ER function and Ca2+ homeostasis; required 
for regulating Hmg2p degradation 
SQS1 YNL224C cytoplasm, nucleus Hypothetical protein 
SRP40 YKR092C nucleolus 
Serine-rich protein with a role in preribosome assembly or 
transport; may function as a chaperone of small nucleolar 
ribonucleoprotein particles (snoRNPs) 
SSA2 YLL024C cytoplasm, nucleus Member of heat shock protein 70 (HSP70) family; associated with the chaperonin-containing T-complex 
SSA3 YBL075C cytoplasm 
Member of the heat shock protein 70 (HSP70) family; 
plays a role in SRP-dependent cotranslational protein-
membrane targeting and translocation  
SSA4 YER103W cytoplasm 
Heat shock protein 70 that is highly induced upon stress; 
plays a role in SRP-dependent cotranslational protein-
membrane targeting and translocation 
SSM4 YIL030C ER 
Ubiquitin-protein ligase of the ER/nuclear envelope, 
required for degradation of Alpha2p and other proteins 
containing a Deg1 degradation signal 
STE24 YJR117W ER 
Highly conserved zinc metalloprotease that functions in 
two steps of a-factor maturation, C-terminal CAAX 
proteolysis and the first step of N-terminal proteolytic 
processing 
STP22 YCL008C endosome Component of the ESCRT-I complex, which is involved in ubiquitin-dependent sorting of proteins into the endosome;  
SUM1 YDR310C nucleus Transcriptional repressor required for mitotic repression of middle sporulation-specific genes; telomere maintenance 
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SUR4 YLR372W ER 
Elongase, involved in fatty acid and sphingolipid 
biosynthesis; synthesizes very long chain 20-26-carbon 
fatty acids from C18-CoA primers 
SVP26 YHR181W ER 
May function to promote retention of proteins in the early 
Golgi compartment; mutation affects protein N-
glycosylation and cell wall integrity 
SWC3 YAL011W nucleus Protein of unknown function, component of the Swr1p complex that incorporates Htz1p into chromatin 
SWC5 YBR231C nucleus Protein of unknown function, component of the Swr1p complex that incorporates Htz1p into chromatin 
SWP82 YFL049W nucleus Member of the SWI/SNF chromatin remodeling complex in which it plays an as yet unidentified role 
SYS1 YJL004C early Golgi Integral membrane protein of the Golgi required for targeting of the Arf-like GTPase Arl3p to the Golgi 
TED1 YIL039W ER 
Conserved phosphoesterase domain-containing protein 
that acts together with Emp24p/Erv25p in cargo exit from 
the ER 
THI6 YPL214C cytoplasm, punctate composite 
Bifunctional enzyme with thiamine-phosphate 
pyrophosphorylase and 4-methyl-5-beta-
hydroxyethylthiazole kinase activities, required for 
thiamine biosynthesis 
TIR3 YIL011W Cell wall 
Cell wall mannoprotein of the Srp1p/Tip1p family of 
serine-alanine-rich proteins; expressed under anaerobic 
conditions and required for anaerobic growth 
TLG2 YOL018C early endosome, trans-Golgi 
Syntaxin-like t-SNARE that forms a complex with Tlg1p 
and Vti1p and mediates fusion of endosome-derived 
vesicles with the late Golgi 
TMA19 YKL056C cytoplasm Protein of unknown function that associates with ribosomes 
TOF2 YKR010C nucleolus, mitochondrion 
Protein required for rDNA silencing and mitotic rDNA 
condensation; stimulates Cdc14p phosphatase activity 
and may function to coordinate the release of Cdc14p 
during anaphase 
TRM1 YDR120C nucleus, mitochondrion 
tRNA methyltransferase; produces the modified base 
N2,N2-dimethylguanosine in tRNAs 
TRM7 YBR061C cytoplasm 
2'-O-ribose methyltransferase, methylates the 2'-O-ribose 
of nucleotides at positions 32 and 34 of the tRNA 
anticodon loop 
TRP3 YKL211C cytoplasm Bifunctional enzyme exhibiting both indole-3-glycerol-phosphate synthase and anthranilate synthase activities 
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TSR2 YLR435W cytoplasm, nucleus Protein with a potential role in pre-rRNA processing 
UBC4 YBR082C cytoplasm, nucleus 
Ubiquitin-conjugating enzyme that mediates degradation 
of short-lived and abnormal proteins; interacts with many 
SCF ubiquitin protein ligases 
UBC7 YMR022W ER 
Ubiquitin conjugating enzyme, involved in the ER-
associated protein degradation pathway; requires Cue1p 
for recruitment to the ER membrane 
UBR1 YGR184C 0 
Ubiquitin-protein ligase (E3) that interacts with 
Rad6p/Ubc2p to ubiquitinate substrates of the N-end rule 
pathway 
UBR2 YLR024C cytoplasm Cytoplasmic ubiquitin-protein ligase (E3) 
UBX2 YML013W ER 
UBX (ubiquitin regulatory X) domain-containing protein 
that interacts with Cdc48p; required for degradation of a 
ubiquitylated model substrate 
UBX4 YMR067C cytoplasm, nucleus UBX (ubiquitin regulatory X) domain-containing protein that interacts with Cdc48p 
UFD2 YDL190C cytoplasm, nucleus 
Ubiquitin chain assembly factor (E4) that cooperates with 
the ubiquitination machinery to conjugate ubiquitin to 
substrates; also functions as an E3 
UME1 YPL139C cytoplasm, nucleus Negative regulator of meiosis, required for repression of a subset of meiotic genes during vegetative growth 
USA1 YML029W ER membrane 
Protein involved in ER-associated protein degradation 
(ERAD); component of the Hrd1p complex; interacts with 
the U1 snRNP-specific protein, Snp1p 
UTH1 YKR042W vacuole Mitochondrial outer membrane and cell wall localized SUN family member required for mitochondrial autophagy 
VPS1 YKR001C 
cytoplasm, punctate 
composite, 
endosome 
GTPase required for vacuolar protein sorting; involved in 
regulating peroxisome biogenesis 
VPS28 YPL065W punctate composite Component of the ESCRT-I complex, which is involved in ubiquitin-dependent sorting of proteins into the endosome 
VPS29 YHR012W ambiguous 
Endosomal protein that is a subunit of the membrane-
associated retromer complex essential for endosome-to-
Golgi retrograde transport 
VPS3 YDR495C punctate composite 
Cytoplasmic protein required for the sorting and 
processing of soluble vacuolar proteins, acidification of the 
vacuolar lumen, and assembly of the vacuolar H+-ATPase 
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VPS30 YPL120W vacuole 
Protein that forms a membrane-associated complex with 
Apg14p that is essential for autophagy; involved in 
vacuolar protein sorting 
VPS38 YLR360W endosome Part of a Vps34p phosphatidylinositol 3-kinase complex that functions in carboxypeptidase Y (CPY) sorting 
VPS51 YKR020W punctate composite 
Component of the GARP (Golgi-associated retrograde 
protein) complex, Vps51p-Vps52p-Vps53p-Vps54p, which 
is required for the recycling of proteins from endosomes to 
the late Golgi 
VPS52 YDR484W punctate composite Component of the GARP (Golgi-associated retrograde protein) complex 
VPS53 YJL029C punctate composite, early Golgi 
Component of the GARP (Golgi-associated retrograde 
protein) complex 
VPS54 YDR027C punctate composite, early Golgi 
Component of the GARP (Golgi-associated retrograde 
protein) complex 
VPS71 YML041C nucleus 
Protein of unknown function, component of the Swr1p 
complex that incorporates Htz1p into chromatin; required 
for vacuolar protein sorting 
VPS72 YDR485C nucleus 
Protein of unknown function, component of the Swr1p 
complex that incorporates Htz1p into chromatin; required 
for vacuolar protein sorting 
VPS74 YDR372C cytoplasm, nucleus 
may be involved in vacuolar protein sorting; belongs to a 
family of cytosolic Golgi-associated proteins suggesting 
that it may play a role in secretion 
VPS75 YNL246W nucleus Protein of unknown function involved in vacuolar protein sorting; detected in the nucleus 
VTC1 YER072W ER Vacuolar transporter chaperon (VTC) involved in distributing V-ATPase and other membrane proteins 
VTC4 YJL012C 0 
Vacuolar membrane protein involved in vacuolar 
polyphosphate accumulation; functions as a regulator of 
vacuolar H+-ATPase activity and vacuolar transporter 
chaperones; involved in non-autophagic vacuolar fusion 
WSC4 YHL028W vacuole 
ER membrane protein involved in the translocation of 
soluble secretory proteins and insertion of membrane 
proteins into the ER membrane 
YAP5 YIR018W cytoplasm, nucleus Basic leucine zipper (bZIP) transcription factor 
YBR137W YBR137W cytoplasm Protein of unknown function; binds to Replication Protein A (RPA) 
YBR226C YBR226C 0 Hypothetical protein 
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YBR238C YBR238C cytoplasm, mitochondrion Putative protein of unknown function 
YCK1 YHR135C cytoplasm, nucleus 
Palmitoylated, plasma membrane-bound casein kinase I 
isoform; shares redundant functions with Yck2p in 
morphogenesis, proper septin assembly, endocytic 
trafficking 
YCK2 YNL154C cytoplasm, nucleus Palmitoylated, plasma membrane-bound casein kinase I isoform; shares redundant functions with Yck1p 
YCL045C YCL045C ER Protein of unknown function 
YDL133W YDL133W 0 Hypothetical protein 
YDL157C YDL157C mitochondrion Hypothetical protein 
YDL242W YDL242W 0 Hypothetical protein 
YDR049W YDR049W cytoplasm Hypothetical protein 
YDR056C YDR056C ER Hypothetical protein 
YDR161W YDR161W cytoplasm, nucleus interacts with PP2C 
YEL014C YEL014C Cytoplasm Hypothetical protein 
YEL047C YEL047C cytoplasm, nucleus Fumurate ReDuctase Soluble 
YER064C YER064C Nucleus Non-essential nuclear protein; null mutation has global effects on transcription 
YER140W YER140W Ambiguous Hypothetical protein 
YER156C YER156C cytoplasm, nucleus Hypothetical protein 
YET1 YKL065C ER Endoplasmic reticulum transmembrane protein, homolog of human BAP31 protein 
YFR018C YFR018C 0 Hypothetical protein 
YFR045W YFR045W 0 Putative mitochondrial transport protein; null mutant is viable 
YGL007W YGL007W 0 Hypothetical protein 
YGL231C YGL231C ER Putative protein of unknown function 
YHR003C YHR003C Mitochondrion Protein of unknown function, localized to the mitochondrial outer membrane 
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YHR078W YHR078W 0 Hypothetical protein 
YIL029C YIL029C 0 Hypothetical protein 
YIL032C YIL032C 0 Hypothetical protein 
YIL055C YIL055C Ambiguous Hypothetical protein 
YIP3 YNL044W Golgi, early Golgi Protein localized to COPII vesicles, proposed to be involved in ER to Golgi transport 
YJL055W YJL055W cytoplasm, nucleus Putative protein of unknown function 
YJR088C YJR088C ER Putative protein of unknown function 
YKR043C YKR043C cytoplasm, nucleus Putative protein of unknown function 
YLL014W YLL014W ER Putative protein of unknown function 
YLR104W YLR104W 0 Hypothetical protein 
YLR278C YLR278C Nucleus Zinc-cluster protein of unknown function 
YLR287C YLR287C Cytoplasm Putative protein of unknown function 
YLR402W YLR402W 0 Hypothetical protein 
YML108W YML108W cytoplasm, nucleus 
Putative protein of unknown function whose structure 
defines a new subfamily of the split beta-alpha-beta 
sandwiches 
YMR209C YMR209C Ambiguous Hypothetical protein 
YNL205C YNL205C 0 Hypothetical protein 
YOL159C YOL159C 0 Hypothetical protein 
YOR164C YOR164C Cytoplasm Protein of unknown function; interacts with Mdy2p 
YOS9 YDR057W ER 
Soluble ER lumenal lectin; member of the OS-9 protein 
family; similar to mannose-6-phosphate receptors (MPRs); 
serves as a receptor that recognizes misfolded proteins 
during ERAD 
YPL068C YPL068C Nucleus Hypothetical protein 
YPR063C YPR063C ER Hypothetical protein 
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YPR084W YPR084W 0 Hypothetical protein 
YPR130C YPR130C 0 Hypothetical protein 
YUR1 YJL139C Golgi Mannosyltransferase of the KTR1 family, involved in protein N-glycosylation; located in the Golgi apparatus 
ZAP1 YJL056C cytoplasm, nucleus Zinc-regulated transcription factor; contains seven zinc-finger domains 
VIP1 YLR410W Cytoplasm Protein of unknown function probably involved in the function of the cortical actin cytoskeleton 
YJR088C YJR088C ER Putative protein of unknown function 
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Table 7: The log2 (GFP/RFP) reporter values obtained in the double mutant strains 
when KAR2::NAT or kar2-R217A::NAT were crossed against the genes listed in table 6 
* N/A indicates either that the double mutant s train was inviable or that a value was not obtained due to  
experimental error 
 
Gene name KAR2 (1) KAR2 (2) KAR2 (3) kar2-R217A (1) 
kar2-R217A 
(2) 
ADD66 N/A -0.3026 -0.1376 -0.4876 -0.5018 
AGX1 -0.1732 -0.095 -0.1543 -0.1537 0.2545 
AHC2 -0.0227 0.0194 N/A 0.1109 0.0936 
ALF1 N/A 1.12 2.1491 -0.0737 0.1374 
ALG12 1.5689 1.4467 N/A 2.0574 1.9003 
ALG3 2.2605 2.3585 2.6165 2.5239 2.5824 
ALG5 1.4492 1.5665 1.68 1.6203 1.7557 
ALG6 2.0957 2.041 2.1605 1.9784 2.1465 
ALG8 1.6379 1.7204 1.9019 1.4186 1.6471 
ALG9 1.4766 1.5067 2.0133 1.82 2.0601 
APE3 -0.3075 -0.1964 -0.0032 -0.2365 -0.1701 
ARC18 0.5786 0.6766 0.8138 0.2962 0.4633 
ARL1 0.6144 0.435 0.4247 0.0415 0.0395 
ARO1 0.444 N/A 0.0412 N/A 1.2409 
ARP6 0.1656 0.1677 0.2997 0.9609 0.7772 
ARV1 N/A 4.0563 N/A 3.9095 4.0868 
ASM4 -0.476 -0.3149 N/A -0.3786 -0.3079 
ATG8 -0.2395 -0.1303 N/A -0.2163 -0.1927 
BNR1 -0.0254 -0.1099 0.25 0.1393 0.0236 
BOP2 -0.0678 0.0262 0.0132 -0.1844 -0.0688 
BRE5 N/A -0.0609 0.0013 -0.3313 0.7041 
BST1 3.4961 3.4596 N/A N/A N/A 
BTS1 N/A 0.5123 0.5163 0.5372 0.7367 
BUG1 -0.0477 0.1057 N/A -0.026 0.0119 
CAC2 0.7982 0.8701 0.6998 0.4597 0.4973 
CAJ1 -0.1593 -0.146 -0.0958 -0.1968 0.0422 
CAP1 N/A -0.0499 0.1806 0.0908 0.0732 
CCW12 1.4203 1.4255 1.6152 1.106 1.169 
CKA2 0.8758 0.7563 1.1658 0.873 0.9537 
CNE1 1.1871 N/A 1.0195 0.4831 0.6078 
COG5 N/A 0.1272 N/A 0.0747 0.12 
COG6 0.2687 0.3235 N/A 0.3348 0.2651 
COG8 0.281 0.2635 N/A 0.3694 0.3772 
CPA1 -0.6105 -0.6124 -0.8076 -0.072 -0.366 
 223 
CPR6 0.1262 0.1764 0.1472 0.0706 0.0308 
CRD1 -0.265 -0.3036 N/A -0.4933 -0.5364 
CSF1 3.1702 3.2738 3.2965 3.1871 N/A 
CSN12 -0.6172 -0.524 N/A -0.2944 -0.2212 
CUE1 1.0488 1.0241 1.2673 1.2724 1.2411 
CWH41 0.5218 0.5415 0.5079 0.2974 0.5037 
CWH43 0.2596 0.1953 N/A 0.2471 0.4399 
CYS3 0.7431 1.2647 N/A 1.4175 1.3339 
DAL81 N/A -0.406 N/A 0.27 -0.5153 
DAS1 -0.2274 -0.2246 -0.2562 -0.4231 -0.4143 
DER1 0.8412 0.8263 1.1548 1.0472 1.2184 
DFG10 -0.2762 -0.1662 0.0423 -0.1904 -0.1534 
DGK1 0.0309 -0.0801 0.1163 -0.1759 0.0266 
DIE2 0.7309 0.747 0.9767 1.0174 1.1332 
DOM34 -0.5762 -0.3832 -0.1897 -0.2838 -0.2428 
DRS2 0.2218 0.3238 0.3777 0.8509 0.2448 
DUS3 0.0404 -0.0945 N/A 0.0086 0.1504 
ECM30 0.0089 0.1319 N/A 0.1495 0.1953 
EDE1 0.2082 0.118 N/A 0.1742 N/A 
EGD1 -0.5359 -0.485 -0.5189 -0.696 -0.6082 
EGD2 -0.4217 -0.3985 -0.3263 -0.4963 -0.5187 
ELF1 N/A 0.3241 0.3915 0.3261 0.1272 
ELP2 N/A -0.4381 -0.2428 -0.339 -0.1011 
EMP47 -0.1593 N/A N/A -0.1422 0.291 
ENT3 -0.1379 -0.17 0.1291 -0.1583 -0.1574 
ERD1 2.7915 2.8649 2.6871 1.2 1.4274 
ERG2 0.3868 0.3605 0.4795 0.7894 1.6577 
ERJ5 0.3344 0.1339 N/A 0.543 0.5779 
ERP1 N/A 0.8865 N/A 1.0173 1.1452 
ERP2 0.0939 0.1487 0.3537 0.1355 0.2605 
ERV14 1.9212 1.9181 2.0844 1.5479 1.7306 
ERV25 2.497 2.4537 2.5138 2.8049 3.0125 
ERV29 0.3171 0.4791 0.5387 0.7029 0.8533 
ERV41 N/A -0.2395 -0.3675 -0.3299 -0.2084 
ERV46 -0.3368 -0.3478 -0.3832 -0.5196 -0.3205 
EUG1 0.3093 0.343 0.4621 0.0887 0.0895 
FAR8 -0.1493 -0.1394 -0.0579 0.0008 -0.0352 
FAT1 0.9667 0.9204 0.7502 1.1394 1.825 
FKH1 0.3118 0.346 0.5493 0.2544 N/A 
FLX1 N/A -0.3259 N/A -0.4937 -0.5717 
FRE4 -0.1671 -0.2638 N/A -0.3606 -0.3763 
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FUN30 0.1668 0.1873 0.35 -0.0711 0.0053 
FYV6 N/A N/A 3.7707 0.9685 1.0173 
GCN2 -0.1473 -0.1909 N/A -0.1679 0.0118 
GCN20 -0.2321 -0.2038 N/A -0.1502 -0.0798 
GCN5 -0.9911 -1.1073 -1.1178 -0.9159 -0.5784 
GCR2 0.6388 0.523 1.0012 0.3368 0.4716 
GCS1 0.2911 0.3262 0.2994 0.0912 0.133 
GDA1 0.271 0.2536 0.217 0.3804 0.4991 
GET1 1.0074 2.1743 N/A 1.9191 N/A 
GET1 N/A 2.174 N/A 1.8053 1.4826 
GET2 1.6531 2.1291 2.1414 0.2439 2.8273 
GET2 N/A 1.9979 2.2189 N/A 1.6552 
GET3 1.088 0.7439 0.8375 0.3272 0.4952 
GET3 N/A 0.7498 0.8965 0.5615 0.6747 
GLO3 N/A 2.1866 2.2768 1.0825 1.0169 
GNP1 N/A 0.0259 N/A 1.04 N/A 
GOS1 0.3619 0.3907 0.6255 0.0733 0.6558 
GOT1 0.0115 0.0354 -0.0765 -0.0645 0.066 
GSG1 0.1271 0.2326 N/A 0.2418 0.4019 
GSH2 -0.2563 -0.2227 -0.2941 -0.1497 0.0155 
GTB1 -0.0084 0.0241 N/A 0.0436 0.0931 
GTR1 N/A N/A 0.2049 1.0502 -0.1575 
GUP1 2.8145 2.8369 N/A 1.7755 1.7267 
GYP8 -0.1225 -0.206 N/A -0.2162 -0.0275 
HAC1 -0.6855 -0.7625 N/A -0.816 0.303 
HAM1 -0.4729 -0.3843 N/A -0.3973 -0.3429 
HAT2 -0.2885 -0.2775 -0.2965 -0.2645 -0.2518 
HEK2 0.5033 0.4717 0.609 0.6581 0.563 
HHF1 0.7234 0.8716 N/A 0.7388 0.7461 
HHT1 1.0153 0.9416 N/A 0.7024 0.84 
HHT2 0.3736 0.4076 0.4018 0.446 0.3579 
HIR3 N/A 0.4039 0.1789 -0.1718 -0.1544 
HLJ1 1.4252 1.4709 1.5424 0.1801 0.3611 
HMG1 -0.1158 0.0493 0.171 -0.1673 -0.135 
HOP2 0.3593 -0.0382 0.6456 0.5424 0.6955 
HPC2 0.1999 0.2083 0.1395 0.1312 0.2662 
HRD1 1.7439 1.7391 1.9685 2.4488 2.4536 
HRD3 1.3626 1.4187 1.607 1.7897 1.7966 
HSM3 -0.3339 -0.3362 N/A -0.2623 -0.3894 
HSV2 -0.3109 -0.2498 -0.0406 -0.2932 -0.2978 
HTB2 0.1298 0.144 N/A 0.086 0.1547 
 225 
HTZ1 0.2764 0.2698 0.257 0.566 1.2143 
HUR1 N/A 1.8088 N/A 1.3924 N/A 
HXK2 0.0828 0.2006 0.1962 0.3654 0.1047 
HXT8 N/A -0.0195 0.0632 0.2699 0.3059 
ICE2 0.3416 0.2721 N/A 0.2817 0.3756 
IDH1 -0.2366 N/A N/A -0.501 -0.3749 
IES1 0.4161 N/A 0.2072 -0.1153 -0.1279 
IES4 0.4649 0.5466 0.5486 0.1704 0.3549 
IES5 0.2702 0.2765 0.2859 0.026 -0.0222 
ILM1 0.2108 0.3122 N/A -0.2657 -0.0502 
INP53 -0.03 0.0561 N/A 0.1179 0.1255 
IPK1 N/A -0.5209 -0.4467 -0.9641 -0.9679 
IRC21 0.0136 0.0856 0.0625 0.1232 0.0515 
IRE1 -0.7221 -0.7557 N/A -1.0045 -0.8061 
ISC1 0.1473 0.0055 N/A 0.0409 0.2065 
ISR1 0.2265 0.1717 N/A 0.094 0.1752 
ISW1 N/A 0.4587 0.4685 0.3464 0.5052 
ISW2 0.0596 0.0086 0.1836 -0.2034 -0.1699 
ITR1 0.2206 0.1759 0.2569 0.2211 0.1748 
IXR1 -0.4814 -0.3697 N/A -0.3248 -0.2413 
JEM1 0.0926 0.1329 0.3924 -0.1534 -0.0173 
KEL1 0.3544 0.3648 N/A 0.0383 N/A 
KEX2 N/A N/A N/A N/A N/A 
KIN3 0.7964 0.8447 0.9724 N/A N/A 
KRE1 0.4205 0.4233 0.3309 0.3132 0.5162 
KRE11 0.1763 0.2615 0.1922 0.0133 0.1022 
KRE27 -0.0748 0.0715 0.2655 -0.0805 0.2121 
KRE27 1.2348 2.0262 N/A N/A 1.25 
KTI12 -0.3934 -0.4262 N/A 0.8172 -0.1848 
LAS21 3.5378 3.4031 3.5912 -0.0934 0.1325 
LEM3 N/A 0.5108 0.33 0.2846 1.1182 
LEU3 -0.1948 -0.1944 -0.1252 -0.4378 -0.2416 
LOC1 -0.2638 -0.409 -0.1821 -0.4263 -0.0198 
LPD1 -0.3023 -0.3497 -0.3742 -0.1595 -0.0621 
LRC3 0.0041 0.0238 0.0868 0.2484 0.3037 
MAF1 N/A -0.3837 N/A -0.4498 -0.2919 
MDY2 0.1337 0.0862 0.0857 0.0623 0.0617 
MDY2 0.1783 0.0393 N/A 0.005 0.0333 
MEH1 0.1631 0.2058 N/A -0.1206 -0.0277 
MGA2 1.2413 1.855 N/A N/A 1.9579 
MKC7 -0.0639 -0.0909 N/A -0.1583 0.0147 
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MNL1 0.0096 0.0099 0.1955 0.0729 0.2774 
MNN2 0.3513 0.6881 0.3409 0.499 0.6841 
MNN4 N/A 0.0459 N/A 0.0742 0.1266 
MNN5 -0.0905 -0.0526 -0.1528 -0.2587 -0.0497 
MNN9 -0.2798 -0.1796 N/A -0.128 -0.0967 
MNS1 -0.1794 -0.0977 N/A -0.1314 -0.0371 
MPD1 0.4312 0.3992 0.7255 0.6005 0.7523 
MSC1 N/A 0.5625 N/A 0.5933 0.6133 
MSI1 0.6863 0.5688 N/A 0.4273 0.5566 
MTC1 0.0223 0.0666 0.0614 -0.1691 -0.1998 
MTC5 N/A -0.0859 0.0661 -0.0218 0.1173 
MVP1 N/A 0.1273 0.0625 0.1958 0.1987 
NEM1 0.6303 0.6236 0.4901 0.0258 0.0761 
NFT1 -0.3019 -0.2045 -0.2793 -0.106 -0.1756 
NHP6A N/A -0.2897 N/A -0.4614 -0.4874 
NHX1 0.9253 0.9087 0.9669 0.9044 N/A 
NMD4 -0.411 -0.3996 N/A -0.535 -0.0132 
NPL4 -0.0547 -0.1038 0.0783 -0.089 N/A 
OLA1 -0.3817 -0.2636 N/A 0.7315 -0.2662 
OPI10 -0.2182 -0.194 -0.1824 -0.3669 -0.2127 
OPI3 1.1738 1.1042 0.9375 -0.1078 0.0547 
OST3 2.7665 2.7924 3.032 2.5737 2.6961 
OST5 0.3574 0.4436 N/A 0.8451 0.9685 
OYE2 -0.3308 -0.354 N/A -0.297 -0.1042 
PBP1 -0.386 -0.3965 -0.383 -0.711 -0.5665 
PCT1 0.2794 0.5333 0.3472 0.2782 0.492 
PEF1 0.2869 0.2857 0.3 0.6235 0.8662 
PEP7 -0.5521 -0.4327 -0.4213 -0.8385 -0.7175 
PEP8 N/A 0.2154 0.2205 0.1158 -0.0813 
PET18 -0.0978 -0.1114 N/A -0.1177 0.0981 
PHO80 1.0206 1.0998 1.4642 0.936 0.8744 
PHO86 0.1507 0.1335 N/A -0.1547 0.0003 
PMP1 -0.2068 -0.0008 N/A 0.3381 0.2259 
PMR1 N/A N/A N/A N/A 0.6695 
PMT1 1.6268 1.7885 1.9023 1.2376 1.331 
PMT2 2.8731 2.8002 2.9393 2.2456 2.4578 
PPH21 -0.2545 -0.2571 -0.0514 -0.237 -0.1926 
PPT1 0.0788 0.0994 0.129 0.0285 0.1921 
PRM2 -0.5108 -0.3813 -0.3011 -0.3609 -0.3631 
PSD2 0.1872 0.2804 0.2537 1.7204 1.796 
PTC2 -0.1572 -0.0722 -0.1546 -0.245 -0.2654 
 227 
PTK2 0.1057 0.1609 0.1273 -0.2059 -0.1662 
PTP1 -0.3056 -0.2552 N/A -0.2269 -0.129 
PTR2 -0.3999 -0.2411 N/A -0.1117 -0.0904 
RAD23 N/A -0.1593 N/A -0.3249 -0.0511 
RAV1 N/A 0.3196 N/A -0.1338 -0.1359 
RCO1 0.2493 0.2599 0.5879 0.3516 0.3989 
RER1 0.0691 0.1834 0.1244 0.0761 0.1606 
REX4 -0.3452 -0.3693 -0.3771 -0.4492 -0.1796 
RGP1 0.0552 0.0129 0.1388 -0.0049 0.0837 
RLF2 N/A 0.7573 0.7118 0.4716 0.5184 
ROT2 0.3608 0.4799 0.3556 0.2779 0.9212 
ROX1 -0.3262 -0.2562 N/A -0.4062 -0.238 
RPA14 -0.4042 -0.3279 -0.3745 -0.2453 -0.1017 
RPL19B N/A -0.7237 N/A -0.7764 -0.5536 
RPN10 -0.4709 -0.4916 -0.4196 1.0811 -0.4969 
RPS11A N/A -0.5539 N/A -0.7182 -0.6761 
RPS12 0.2615 0.3334 N/A 0.3318 0.3558 
RPS16A N/A -0.9726 -0.7198 -0.937 0.2938 
RPS17A -1.2305 -1.1744 -0.8818 -0.0176 0.0956 
RPS23A -0.6533 -0.6831 -0.5535 -0.5988 -0.573 
RPS28B -0.7381 -0.7216 -0.6388 -0.6339 -0.5967 
RPS4B -0.1945 -0.2129 -0.1689 -0.3294 -0.1384 
RPS6B -0.7838 -0.7447 -0.7354 -0.8648 -0.698 
RTN1 N/A -0.0583 N/A 0.0908 0.1747 
RTT10 -0.4918 -0.4255 -0.4272 -0.1585 -0.1299 
RTT106 N/A 1.2206 1.1135 0.8873 0.9736 
RUD3 0.2108 0.3105 0.3976 0.5774 0.5627 
SAC7 0.5047 0.4314 0.5158 0.1759 0.2177 
SBH2 N/A -0.1002 0.016 -0.1303 -0.1895 
SCJ1 4.3649 4.3413 4.1895 3.5932 3.641 
SEC22 N/A 0.2104 1.4091 1.0644 1.162 
SEC28 -0.4445 -0.4157 -0.2068 -0.6077 N/A 
SEC66 0.5823 0.9039 N/A 0.4617 0.6793 
SEC72 -0.3077 -0.1593 -0.1711 -0.298 -0.118 
SED4 0.2098 0.1935 0.1375 0.0082 0.1349 
SET3 0.0413 0.0383 N/A 0.46 0.4766 
SEY1 0.2502 0.282 0.6789 0.2016 0.2979 
SFB2 0.0108 -0.0072 N/A -0.087 -0.1069 
SGM1 N/A -0.1728 N/A -0.0444 -0.1467 
SGT2 -0.1256 -0.0435 0.0839 -0.097 -0.0427 
SGT2 -0.0765 -0.0216 N/A -0.0302 -0.0098 
 228 
SIF2 0.4409 0.3734 0.7118 0.6732 0.7489 
SIL1 0.8427 0.7952 0.7596 2.1738 2.2858 
SKY1 1.0151 0.8525 0.8692 0.2682 0.8929 
SLA1 -0.2451 -0.2056 0.0081 -0.0572 0.0827 
SLP1 0.6604 0.6694 N/A 1.0961 1.0042 
SMI1 0.7192 0.7371 0.6811 0.2787 0.2534 
SNT1 0.3716 0.2889 N/A 0.619 1.0913 
SOP4 -0.1696 -0.1335 0.0836 -0.2512 0.0421 
SOP4 4.3107 4.1647 N/A 4.0464 4.2255 
SPC1 0.2288 0.2772 N/A -0.1584 -0.0734 
SPC2 2.1501 2.1871 2.1595 2.4255 2.4953 
SPE3 N/A -0.2623 N/A -0.3921 -0.1916 
SPE4 -0.241 -0.2159 N/A -0.1479 -0.1131 
SPF1 4.0355 4.1732 3.8854 N/A 3.8116 
SQS1 -0.3071 -0.3278 -0.2937 -0.4015 -0.2982 
SRP40 -0.7416 -0.5081 -0.7442 -0.6237 -0.5571 
SSA2 -0.5445 -0.5422 -0.4248 -0.6427 -0.4835 
SSA3 -0.2614 -0.1021 0.0131 -0.269 -0.0007 
SSA4 -0.1672 -0.1969 -0.0541 -0.1219 -0.1605 
SSM4 0.1148 0.1015 N/A -0.0253 0.1036 
STE24 3.9376 3.6018 3.8783 N/A 0.1414 
STP22 0.1079 0.6202 -0.0128 0.4843 0.5861 
SUM1 N/A 0.4928 0.7867 0.7798 1.508 
SUR4 N/A 1.1244 1.0379 -0.0916 0.1502 
SVP26 -0.1751 -0.0725 N/A -0.1587 0.0089 
SWC3 0.0677 0 0.2299 0.2857 0.5833 
SWC5 N/A -0.279 0.3543 0.3558 1.7145 
SWP82 -0.2823 -0.2759 N/A N/A N/A 
SYS1 0.4507 0.431 0.433 -0.1955 -0.057 
TED1 N/A 1.5382 2.1462 1.6456 1.7689 
THI6 -0.444 -0.3306 -0.2218 -0.3299 -0.0818 
TIR3 -0.2403 -0.0796 -0.0087 0.0329 0.051 
TLG2 0.5092 0.5614 0.3656 0.4581 0.4941 
TMA19 N/A -0.3673 -0.377 -0.3432 -0.4059 
TOF2 N/A -0.3272 N/A -0.3709 -0.2987 
TRM1 -0.4789 -0.449 -0.3835 -0.3593 -0.2654 
TRM7 -0.474 -0.5292 N/A -0.0954 -0.1453 
TRP3 -0.2819 -0.0773 N/A -0.2883 -0.2353 
TSR2 -0.7142 -0.6913 -0.645 -0.4088 0.3838 
UBC4 -0.3746 -0.4678 N/A 1.1159 0.3997 
UBC7 1.2917 1.3429 1.3783 1.358 1.5773 
 229 
UBR1 -0.2902 -0.2535 N/A -0.4382 -0.156 
UBR2 -0.2537 -0.2914 -0.305 -0.5643 -0.3329 
UBX2 2.2662 2.4889 2.3746 2.458 2.4054 
UBX4 0.2618 0.4447 0.5309 0.1884 0.241 
UFD2 0.4012 0.528 0.5861 1.1096 0.9859 
UME1 -0.4168 -0.4635 -0.5409 -0.1632 -0.1802 
USA1 1.0185 1.0454 1.2426 1.1749 1.4187 
UTH1 0.5497 0.5791 0.5505 0.4946 0.3289 
VPS1 0.2615 1.3673 N/A 0.8884 0.6482 
VPS28 N/A 0.8283 0.4264 0.7599 0.8172 
VPS29 N/A 0.4075 0.2719 0.2056 0.3904 
VPS3 N/A 0.8052 0.6096 0.8975 1.6597 
VPS30 0.2661 0.0493 0.2336 0.3586 1.3592 
VPS38 0.2221 0.3942 0.3203 0.5317 0.706 
VPS51 N/A 2.1661 N/A 1.3343 1.5537 
VPS52 N/A 1.2331 0.5436 0.5543 0.3038 
VPS53 N/A 0.1693 N/A -0.2292 -0.1082 
VPS54 0.6302 0.5483 N/A 0.337 0.7403 
VPS71 -0.0318 -0.0182 N/A 0.1414 0.306 
VPS72 -0.0939 0.0442 0.3653 0.7041 0.7383 
VPS74 N/A 0.9709 1.1047 0.8605 1.1428 
VPS75 -0.4308 -0.4433 -0.4397 -0.6214 -0.4574 
VTC1 0.0772 0.0065 N/A -0.1919 -0.0342 
VTC4 0.3828 0.2715 N/A -0.1161 -0.1791 
WSC4 -0.0957 -0.169 0.0905 -0.1852 -0.0453 
WT_dhis3::KAN -0.1836 -0.1906 -0.1037 -0.1763 0.1001 
WT_dhis3::KAN -0.1523 -0.097 N/A 0.1061 0.0495 
WT_dhis3::KAN -0.1307 -0.109 0.0082 -0.0741 0.1277 
WT_dhis3::KAN -0.1233 -0.0407 N/A -0.0738 0.0594 
YAP5 -0.1668 -0.0007 -0.0522 N/A 0.1035 
YBR137W -0.1055 -0.1762 N/A -0.1323 -0.1364 
YBR226C -0.0984 -0.0587 -0.1332 -0.0587 0.1039 
YBR238C N/A 0.2066 0.2906 0.0929 0.1563 
YCK1 -0.005 -0.0189 N/A -0.122 0.0542 
YCK2 0.0358 -0.0969 0.2266 -0.0074 0.1632 
YCL045C 0.0717 -0.0305 0.2163 0.1052 0.6969 
YDL133W -0.1234 -0.0421 0.0388 0.064 0.2046 
YDL157C -0.2988 -0.2004 N/A -0.2868 -0.2408 
YDL242W -0.2379 -0.1205 N/A -0.1759 -0.1594 
YDR049W N/A -0.3052 -0.1223 -0.4842 -0.3574 
YDR056C -0.2469 -0.1725 -0.0526 -0.2367 -0.0418 
 230 
YDR056C 1.3567 N/A 2.1945 0.7662 1.8717 
YDR161W -0.4503 -0.4022 -0.2544 -0.5186 -0.5056 
YEL014C 0.0173 -0.0925 0.2138 -0.074 0.1172 
YEL047C -0.2065 -0.1979 N/A -0.21 -0.065 
YER064C 0.2553 0.2963 0.3512 N/A 2.4839 
YER140W 0.7416 0.7471 N/A 1.0665 0.969 
YER156C -0.5263 -0.517 -0.4806 -0.5059 -0.3889 
YET1 -0.1345 -0.1613 -0.1194 -0.1821 -0.1451 
YFR018C 0.1718 0.3126 0.4628 0.0037 0.2754 
YFR045W 0.0339 -0.038 0.1938 0.3731 0.4134 
YGL007W N/A 0.5094 0.7305 0.4308 0.4724 
YGL231C 0.0115 0.1188 N/A 0.0824 0.1496 
YHR003C 0.1275 0.2187 0.4649 -0.0519 -0.0349 
YHR078W 0.5428 0.6113 0.648 0.4358 0.4099 
YIL029C -0.0554 -0.0092 0.1888 -0.0902 -0.0856 
YIL032C -0.1071 -0.0326 N/A -0.1036 -0.0306 
YIL055C -0.0576 0.0158 0.0324 -0.0591 0.0176 
YIP3 -0.0173 0.0412 N/A 0.0664 -0.033 
YJL055W -0.3194 -0.2775 N/A -0.285 -0.131 
YJR088C 0.0671 0.0375 N/A -0.0391 -0.1507 
YKR043C -0.0495 -0.0833 N/A 0.0727 0.015 
YLL014W 0.1803 -0.1132 N/A -0.0378 -0.1071 
YLL014W N/A 0.1607 0.0963 -0.1837 -0.0326 
YLR104W 0.5985 0.58 0.6315 0.2215 0.4957 
YLR278C -0.0155 0.0214 0.2383 0.0856 0.6129 
YLR287C -0.2186 -0.2049 -0.008 -0.0991 -0.0138 
YLR402W -0.2761 -0.2491 -0.4318 0.5954 -0.2476 
YML108W -0.4711 -0.4113 -0.3721 -0.2133 -0.186 
YMR209C -0.4081 -0.271 -0.2711 -0.2617 -0.0463 
YNL205C 0.3131 0.5516 0.5127 0.0254 0.2043 
YOL159C -0.3676 N/A N/A -0.2251 -0.1985 
YOR164C 0.1316 0.1569 N/A 0.0244 0.0748 
YOR164C N/A -0.0558 N/A 0.027 0.0058 
YOS9 0.6535 0.6013 0.6826 0.9719 1.0111 
YPL068C -0.455 -0.3522 N/A -0.1252 0.098 
YPR063C -0.1219 -0.0351 0.1772 -0.2367 -0.0881 
YPR063C -0.0519 -0.0073 0.0014 -0.1651 0.0621 
YPR084W -0.3238 -0.2365 -0.0222 -0.3274 -0.1833 
YPR130C 0.2057 0.2216 0.3872 0.3415 0.3893 
YUR1 0.6046 0.7038 N/A -0.2322 -0.1238 
ZAP1 N/A -0.061 N/A -0.167 -0.1172 
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VIP1 N/A N/A N/A -0.5155 -0.5359 
YJR088C N/A N/A N/A 0.5239 0.4926 
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Table 8: The log2 (GFP/RFP) reporter values obtained in the double mutant strains 
when KAR2 or kar2-P515L were crossed against the genes listed in table 6 
* N/A indicates either that the double mutant strain was inviable or that a value was not obtained due to 
experimental error 
 
Gene name KAR2-WT (1) 
KAR2-WT 
(2) 
KAR2-WT 
(3) 
kar2-
P515L 
(1) 
kar2-
P515L 
(2) 
kar2-
P515L 
(3) 
kar2-
P515L 
(4) 
ADD66 N/A -0.3026 -0.1376 4.8475 N/A N/A N/A 
AGX1 -0.1732 -0.095 -0.1543 4.905 N/A 4.9017 4.9017 
AHC2 -0.0227 0.0194 N/A 4.9802 5.1409 5.0149 5.0149 
ALF1 N/A 1.12 2.1491 4.8706 4.9816 4.8704 4.8704 
ALG12 1.5689 1.4467 N/A N/A 2.035 N/A N/A 
ALG3 2.2605 2.3585 2.6165 N/A 2.2571 2.1496 2.1496 
ALG5 1.4492 1.5665 1.68 1.2547 1.5159 1.4863 1.4863 
ALG6 2.0957 2.041 2.1605 N/A N/A 1.9092 1.9092 
ALG8 1.6379 1.7204 1.9019 N/A 1.9946 1.3604 1.3604 
ALG9 1.4766 1.5067 2.0133 2.8034 N/A 2.4384 2.4384 
APE3 -0.3075 -0.1964 -0.0032 4.9586 5.044 5.0007 5.0007 
ARC18 0.5786 0.6766 0.8138 N/A N/A N/A N/A 
ARL1 0.6144 0.435 0.4247 N/A N/A N/A N/A 
ARO1 0.444 N/A 0.0412 N/A 1.3669 N/A N/A 
ARP6 0.1656 0.1677 0.2997 4.9271 N/A N/A N/A 
ARV1 N/A 4.0563 N/A N/A 4.6 4.6823 4.6823 
ASM4 -0.476 -0.3149 N/A 4.9356 5.095 5.037 5.037 
ATG8 -0.2395 -0.1303 N/A N/A N/A N/A N/A 
BNR1 -0.0254 -0.1099 0.25 N/A N/A N/A N/A 
BOP2 -0.0678 0.0262 0.0132 4.8088 5.0131 4.928 4.928 
BRE5 N/A -0.0609 0.0013 N/A 1.3018 0.0688 0.0688 
BST1 3.4961 3.4596 N/A N/A N/A N/A N/A 
BTS1 N/A 0.5123 0.5163 4.8386 N/A 4.9379 4.9379 
BUG1 -0.0477 0.1057 N/A 4.9805 5.0361 N/A N/A 
CAC2 0.7982 0.8701 0.6998 4.8977 4.8911 4.8273 4.8273 
CAJ1 -0.1593 -0.146 -0.0958 4.8542 N/A N/A N/A 
CAP1 N/A -0.0499 0.1806 N/A N/A N/A N/A 
CCW12 1.4203 1.4255 1.6152 N/A 1.6561 1.6358 1.6358 
CKA2 0.8758 0.7563 1.1658 4.8301 5.0097 4.8435 4.8435 
CNE1 1.1871 N/A 1.0195 N/A N/A N/A N/A 
COG5 N/A 0.1272 N/A N/A N/A N/A N/A 
COG6 0.2687 0.3235 N/A N/A N/A 4.6417 4.6417 
COG8 0.281 0.2635 N/A N/A N/A 1.4328 1.4328 
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CPA1 -0.6105 -0.6124 -0.8076 3.9528 4.3089 4.1934 4.1934 
CPR6 0.1262 0.1764 0.1472 4.8898 4.9829 5.0948 5.0948 
CRD1 -0.265 -0.3036 N/A 4.8087 4.9672 4.8971 4.8971 
CSF1 3.1702 3.2738 3.2965 4.7932 4.9517 4.7345 4.7345 
CSN12 -0.6172 -0.524 N/A 4.7509 N/A 4.9118 4.9118 
CUE1 1.0488 1.0241 1.2673 4.9709 N/A N/A N/A 
CWH41 0.5218 0.5415 0.5079 0.0139 1.8236 0.0657 0.0657 
CWH43 0.2596 0.1953 N/A N/A N/A N/A N/A 
CYS3 0.7431 1.2647 N/A N/A N/A N/A N/A 
DAL81 N/A -0.406 N/A N/A N/A N/A N/A 
DAS1 -0.2274 -0.2246 -0.2562 4.8597 5.0383 4.9589 4.9589 
DER1 0.8412 0.8263 1.1548 4.9363 N/A N/A N/A 
DFG10 -0.2762 -0.1662 0.0423 N/A N/A N/A N/A 
DGK1 0.0309 -0.0801 0.1163 5.0142 5.0489 N/A N/A 
DIE2 0.7309 0.747 0.9767 N/A 1.857 2.1451 2.1451 
DOM34 -0.5762 -0.3832 -0.1897 N/A N/A N/A N/A 
DRS2 0.2218 0.3238 0.3777 N/A N/A N/A N/A 
DUS3 0.0404 -0.0945 N/A 4.9419 4.99 4.9113 4.9113 
ECM30 0.0089 0.1319 N/A N/A N/A 2.5608 2.5608 
EDE1 0.2082 0.118 N/A N/A N/A N/A N/A 
EGD1 -0.5359 -0.485 -0.5189 N/A N/A N/A N/A 
EGD2 -0.4217 -0.3985 -0.3263 4.8987 4.9343 4.9451 4.9451 
ELF1 N/A 0.3241 0.3915 4.6219 4.8121 4.6901 4.6901 
ELP2 N/A -0.4381 -0.2428 N/A N/A N/A N/A 
EMP47 -0.1593 N/A N/A 5.003 5.1176 4.9622 4.9622 
ENT3 -0.1379 -0.17 0.1291 N/A N/A N/A N/A 
ERD1 2.7915 2.8649 2.6871 2.4024 N/A 2.8696 2.8696 
ERG2 0.3868 0.3605 0.4795 N/A N/A N/A N/A 
ERJ5 0.3344 0.1339 N/A N/A N/A N/A N/A 
ERP1 N/A 0.8865 N/A 5.0081 N/A 4.9538 4.9538 
ERP2 0.0939 0.1487 0.3537 4.8963 N/A 4.8319 4.8319 
ERV14 1.9212 1.9181 2.0844 N/A N/A N/A N/A 
ERV25 2.497 2.4537 2.5138 N/A N/A N/A N/A 
ERV29 0.3171 0.4791 0.5387 5.0374 5.0604 5.0641 5.0641 
ERV41 N/A -0.2395 -0.3675 4.9209 4.9793 N/A N/A 
ERV46 -0.3368 -0.3478 -0.3832 4.7351 N/A N/A N/A 
EUG1 0.3093 0.343 0.4621 5.0642 5.0033 5.0615 5.0615 
FAR8 -0.1493 -0.1394 -0.0579 4.7214 N/A N/A N/A 
FAT1 0.9667 0.9204 0.7502 4.9533 5.222 N/A N/A 
FKH1 0.3118 0.346 0.5493 5.0494 5.161 4.9853 4.9853 
FLX1 N/A -0.3259 N/A 4.8974 4.9553 4.9713 4.9713 
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FRE4 -0.1671 -0.2638 N/A 4.8737 5.0043 5.0557 5.0557 
FUN30 0.1668 0.1873 0.35 N/A N/A N/A N/A 
FYV6 N/A N/A 3.7707 N/A N/A N/A N/A 
GCN2 -0.1473 -0.1909 N/A 4.9728 N/A 5.0071 5.0071 
GCN20 -0.2321 -0.2038 N/A 4.8089 4.9757 4.8633 4.8633 
GCN5 -0.9911 -1.1073 -1.1178 4.4177 4.5699 4.5461 4.5461 
GCR2 0.6388 0.523 1.0012 4.6344 4.7974 4.6531 4.6531 
GCS1 0.2911 0.3262 0.2994 N/A N/A N/A N/A 
GDA1 0.271 0.2536 0.217 4.8675 4.9016 N/A N/A 
GET1 1.0074 2.1743 N/A 1.4237 1.5037 1.4687 1.4687 
GET1 N/A 2.174 N/A 1.2572 1.4764 1.1663 1.1663 
GET2 1.6531 2.1291 2.1414 1.3742 1.0155 1.5855 1.5855 
GET2 N/A 1.9979 2.2189 0.9009 1.2431 1.0052 1.0052 
GET3 1.088 0.7439 0.8375 N/A N/A N/A N/A 
GET3 N/A 0.7498 0.8965 N/A 1.6618 N/A N/A 
GLO3 N/A 2.1866 2.2768 N/A 1.484 1.0926 1.0926 
GNP1 N/A 0.0259 N/A N/A N/A N/A N/A 
GOS1 0.3619 0.3907 0.6255 N/A N/A N/A N/A 
GOT1 0.0115 0.0354 -0.0765 4.7679 N/A N/A N/A 
GSG1 0.1271 0.2326 N/A 4.7775 N/A N/A N/A 
GSH2 -0.2563 -0.2227 -0.2941 4.7858 N/A N/A N/A 
GTB1 -0.0084 0.0241 N/A N/A N/A N/A N/A 
GTR1 N/A N/A 0.2049 N/A N/A N/A N/A 
GUP1 2.8145 2.8369 N/A N/A 1.564 N/A N/A 
GYP8 -0.1225 -0.206 N/A 5.0308 5.0353 5.0615 5.0615 
HAC1 -0.6855 -0.7625 N/A -0.4921 -0.3815 -0.4008 -0.4008 
HAM1 -0.4729 -0.3843 N/A 4.8761 5.0353 5.0037 5.0037 
HAT2 -0.2885 -0.2775 -0.2965 4.948 4.9718 4.8339 4.8339 
HEK2 0.5033 0.4717 0.609 5.0438 5.0951 4.9242 4.9242 
HHF1 0.7234 0.8716 N/A 5.2798 5.2597 5.1748 5.1748 
HHT1 1.0153 0.9416 N/A N/A 5.2259 N/A N/A 
HHT2 0.3736 0.4076 0.4018 5.0319 N/A 5.0838 5.0838 
HIR3 N/A 0.4039 0.1789 4.9602 5.0852 5.0716 5.0716 
HLJ1 1.4252 1.4709 1.5424 4.7715 N/A N/A N/A 
HMG1 -0.1158 0.0493 0.171 5.0581 5.1311 5.1103 5.1103 
HOP2 0.3593 -0.0382 0.6456 4.9879 5.0827 4.8954 4.8954 
HPC2 0.1999 0.2083 0.1395 4.8399 N/A 4.9458 4.9458 
HRD1 1.7439 1.7391 1.9685 N/A N/A N/A N/A 
HRD3 1.3626 1.4187 1.607 4.8857 4.9661 N/A N/A 
HSM3 -0.3339 -0.3362 N/A 4.84 4.9028 N/A N/A 
HSV2 -0.3109 -0.2498 -0.0406 4.972 5.0522 N/A N/A 
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HTB2 0.1298 0.144 N/A 5.1025 5.2308 5.0985 5.0985 
HTZ1 0.2764 0.2698 0.257 4.9917 N/A 4.907 4.907 
HUR1 N/A 1.8088 N/A 1.6749 1.7251 N/A N/A 
HXK2 0.0828 0.2006 0.1962 5.0751 5.0806 5.0286 5.0286 
HXT8 N/A -0.0195 0.0632 N/A 1.5888 2.6444 2.6444 
ICE2 0.3416 0.2721 N/A N/A N/A N/A N/A 
IDH1 -0.2366 N/A N/A 4.8428 4.9899 N/A N/A 
IES1 0.4161 N/A 0.2072 4.9054 4.9457 4.8693 4.8693 
IES4 0.4649 0.5466 0.5486 5.1402 5.1547 5.0405 5.0405 
IES5 0.2702 0.2765 0.2859 4.6967 4.8733 4.8389 4.8389 
ILM1 0.2108 0.3122 N/A 4.6726 4.8708 4.8858 4.8858 
INP53 -0.03 0.0561 N/A N/A N/A N/A N/A 
IPK1 N/A -0.5209 -0.4467 4.5937 N/A N/A N/A 
IRC21 0.0136 0.0856 0.0625 4.8417 4.9941 N/A N/A 
IRE1 -0.7221 -0.7557 N/A N/A -0.5201 N/A N/A 
ISC1 0.1473 0.0055 N/A 4.7271 4.8558 N/A N/A 
ISR1 0.2265 0.1717 N/A N/A N/A 4.9644 4.9644 
ISW1 N/A 0.4587 0.4685 N/A N/A 4.658 4.658 
ISW2 0.0596 0.0086 0.1836 4.7884 4.8788 N/A N/A 
ITR1 0.2206 0.1759 0.2569 5.0406 5.1085 5.0552 5.0552 
IXR1 -0.4814 -0.3697 N/A 4.7271 4.8979 4.8093 4.8093 
JEM1 0.0926 0.1329 0.3924 4.9603 5.0946 5.0282 5.0282 
KEL1 0.3544 0.3648 N/A 4.8795 N/A 4.9238 4.9238 
KEX2 N/A N/A N/A N/A 4.3747 N/A N/A 
KIN3 0.7964 0.8447 0.9724 4.8769 N/A N/A N/A 
KRE1 0.4205 0.4233 0.3309 N/A N/A N/A N/A 
KRE11 0.1763 0.2615 0.1922 N/A N/A N/A N/A 
KRE27 -0.0748 0.0715 0.2655 4.9526 4.9377 4.8536 4.8536 
KRE27 1.2348 2.0262 N/A N/A N/A N/A N/A 
KTI12 -0.3934 -0.4262 N/A 4.5282 N/A 4.7962 4.7962 
LAS21 3.5378 3.4031 3.5912 N/A 4.3515 N/A N/A 
LEM3 N/A 0.5108 0.33 4.6951 N/A N/A N/A 
LEU3 -0.1948 -0.1944 -0.1252 N/A N/A 4.7667 4.7667 
LOC1 -0.2638 -0.409 -0.1821 0.8579 0.8958 0.9927 0.9927 
LPD1 -0.3023 -0.3497 -0.3742 4.682 N/A 4.8509 4.8509 
LRC3 0.0041 0.0238 0.0868 4.7828 4.9824 4.9158 4.9158 
MAF1 N/A -0.3837 N/A 4.8597 4.9494 4.988 4.988 
MDY2 0.1337 0.0862 0.0857 4.8511 N/A N/A N/A 
MDY2 0.1783 0.0393 N/A 4.8032 N/A N/A N/A 
MEH1 0.1631 0.2058 N/A 4.3977 N/A 4.4841 4.4841 
MGA2 1.2413 1.855 N/A N/A N/A N/A N/A 
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MKC7 -0.0639 -0.0909 N/A 4.8147 4.9683 N/A N/A 
MNL1 0.0096 0.0099 0.1955 4.8114 4.9512 4.9229 4.9229 
MNN2 0.3513 0.6881 0.3409 N/A N/A N/A N/A 
MNN4 N/A 0.0459 N/A 4.961 5.1569 5.0768 5.0768 
MNN5 -0.0905 -0.0526 -0.1528 4.9084 N/A N/A N/A 
MNN9 -0.2798 -0.1796 N/A 4.8905 N/A 4.9598 4.9598 
MNS1 -0.1794 -0.0977 N/A 4.8817 N/A 4.9288 4.9288 
MPD1 0.4312 0.3992 0.7255 4.8904 N/A 4.8805 4.8805 
MSC1 N/A 0.5625 N/A 4.9396 N/A N/A N/A 
MSI1 0.6863 0.5688 N/A 4.7716 N/A 4.7582 4.7582 
MTC1 0.0223 0.0666 0.0614 N/A N/A N/A N/A 
MTC5 N/A -0.0859 0.0661 4.8602 N/A 4.8324 4.8324 
MVP1 N/A 0.1273 0.0625 N/A 1.6008 1.3831 1.3831 
NEM1 0.6303 0.6236 0.4901 N/A N/A N/A N/A 
NFT1 -0.3019 -0.2045 -0.2793 4.9085 5.0007 5.0541 5.0541 
NHP6A N/A -0.2897 N/A 4.9413 5.0527 4.9104 4.9104 
NHX1 0.9253 0.9087 0.9669 4.7306 N/A N/A N/A 
NMD4 -0.411 -0.3996 N/A 4.6773 N/A N/A N/A 
NPL4 -0.0547 -0.1038 0.0783 4.7343 4.9444 4.8506 4.8506 
OLA1 -0.3817 -0.2636 N/A 4.7715 N/A N/A N/A 
OPI10 -0.2182 -0.194 -0.1824 4.8091 N/A 4.7772 4.7772 
OPI3 1.1738 1.1042 0.9375 N/A 1.4184 N/A N/A 
OST3 2.7665 2.7924 3.032 2.4841 N/A 2.7566 2.7566 
OST5 0.3574 0.4436 N/A N/A N/A N/A N/A 
OYE2 -0.3308 -0.354 N/A 4.8774 N/A N/A N/A 
PBP1 -0.386 -0.3965 -0.383 N/A N/A N/A N/A 
PCT1 0.2794 0.5333 0.3472 4.9564 5.0012 4.917 4.917 
PEF1 0.2869 0.2857 0.3 4.7166 N/A N/A N/A 
PEP7 -0.5521 -0.4327 -0.4213 N/A N/A N/A N/A 
PEP8 N/A 0.2154 0.2205 N/A N/A N/A N/A 
PET18 -0.0978 -0.1114 N/A 4.8922 N/A 4.9635 4.9635 
PHO80 1.0206 1.0998 1.4642 N/A N/A N/A N/A 
PHO86 0.1507 0.1335 N/A 4.5831 N/A 4.8015 4.8015 
PMP1 -0.2068 -0.0008 N/A 4.5719 4.724 4.1826 4.1826 
PMR1 N/A N/A N/A N/A N/A N/A N/A 
PMT1 1.6268 1.7885 1.9023 4.8475 N/A 4.7204 4.7204 
PMT2 2.8731 2.8002 2.9393 4.9697 N/A N/A N/A 
PPH21 -0.2545 -0.2571 -0.0514 4.9636 5.0113 5.0842 5.0842 
PPT1 0.0788 0.0994 0.129 4.8278 5.0542 4.937 4.937 
PRM2 -0.5108 -0.3813 -0.3011 4.7651 N/A 4.9172 4.9172 
PSD2 0.1872 0.2804 0.2537 4.7455 N/A N/A N/A 
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PTC2 -0.1572 -0.0722 -0.1546 4.8724 5.0909 4.8134 4.8134 
PTK2 0.1057 0.1609 0.1273 4.6736 4.6726 4.7514 4.7514 
PTP1 -0.3056 -0.2552 N/A 4.7791 N/A N/A N/A 
PTR2 -0.3999 -0.2411 N/A 4.8314 4.9002 4.8568 4.8568 
RAD23 N/A -0.1593 N/A 4.684 N/A N/A N/A 
RAV1 N/A 0.3196 N/A N/A N/A N/A N/A 
RCO1 0.2493 0.2599 0.5879 4.8797 N/A 4.9871 4.9871 
RER1 0.0691 0.1834 0.1244 N/A N/A N/A N/A 
REX4 -0.3452 -0.3693 -0.3771 4.818 N/A N/A N/A 
RGP1 0.0552 0.0129 0.1388 N/A N/A N/A N/A 
RLF2 N/A 0.7573 0.7118 4.9558 4.9143 N/A N/A 
ROT2 0.3608 0.4799 0.3556 N/A 0.4715 N/A N/A 
ROX1 -0.3262 -0.2562 N/A N/A 4.8139 N/A N/A 
RPA14 -0.4042 -0.3279 -0.3745 5.4107 5.503 N/A N/A 
RPL19B N/A -0.7237 N/A 4.6689 4.765 4.7895 4.7895 
RPN10 -0.4709 -0.4916 -0.4196 4.7383 N/A 4.8414 4.8414 
RPS11A N/A -0.5539 N/A N/A N/A N/A N/A 
RPS12 0.2615 0.3334 N/A 4.9478 5.0448 4.984 4.984 
RPS16A N/A -0.9726 -0.7198 N/A N/A N/A N/A 
RPS17A -1.2305 -1.1744 -0.8818 N/A N/A N/A N/A 
RPS23A -0.6533 -0.6831 -0.5535 N/A N/A N/A N/A 
RPS28B -0.7381 -0.7216 -0.6388 4.8616 N/A N/A N/A 
RPS4B -0.1945 -0.2129 -0.1689 4.8894 4.8838 4.9081 4.9081 
RPS6B -0.7838 -0.7447 -0.7354 4.789 N/A N/A N/A 
RTN1 N/A -0.0583 N/A N/A N/A N/A N/A 
RTT10 -0.4918 -0.4255 -0.4272 4.7068 N/A N/A N/A 
RTT106 N/A 1.2206 1.1135 4.6798 4.9507 4.7708 4.7708 
RUD3 0.2108 0.3105 0.3976 1.3502 1.1519 1.5549 1.5549 
SAC7 0.5047 0.4314 0.5158 N/A N/A N/A N/A 
SBH2 N/A -0.1002 0.016 4.9132 4.9896 N/A N/A 
SCJ1 4.3649 4.3413 4.1895 N/A N/A N/A N/A 
SEC22 N/A 0.2104 1.4091 N/A 1.9324 1.2763 1.2763 
SEC28 -0.4445 -0.4157 -0.2068 4.8435 N/A 4.7341 4.7341 
SEC66 0.5823 0.9039 N/A N/A N/A N/A N/A 
SEC72 -0.3077 -0.1593 -0.1711 4.9476 4.9245 4.8347 4.8347 
SED4 0.2098 0.1935 0.1375 N/A 5.1198 N/A N/A 
SET3 0.0413 0.0383 N/A N/A N/A 4.9314 4.9314 
SEY1 0.2502 0.282 0.6789 4.9784 5.0932 4.979 4.979 
SFB2 0.0108 -0.0072 N/A 5.0021 5.1779 5.0605 5.0605 
SGM1 N/A -0.1728 N/A 4.8527 5.0487 4.9646 4.9646 
SGT2 -0.1256 -0.0435 0.0839 N/A N/A 4.9093 4.9093 
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SGT2 -0.0765 -0.0216 N/A 4.9204 N/A N/A N/A 
SIF2 0.4409 0.3734 0.7118 4.9299 N/A N/A N/A 
SIL1 0.8427 0.7952 0.7596 N/A N/A N/A N/A 
SKY1 1.0151 0.8525 0.8692 4.8474 4.9463 4.7741 4.7741 
SLA1 -0.2451 -0.2056 0.0081 4.8129 5.1908 4.9326 4.9326 
SLP1 0.6604 0.6694 N/A 4.8377 4.9626 4.8105 4.8105 
SMI1 0.7192 0.7371 0.6811 N/A N/A N/A N/A 
SNT1 0.3716 0.2889 N/A N/A N/A N/A N/A 
SOP4 -0.1696 -0.1335 0.0836 5.023 N/A 4.902 4.902 
SOP4 4.3107 4.1647 N/A N/A N/A N/A N/A 
SPC1 0.2288 0.2772 N/A N/A N/A N/A N/A 
SPC2 2.1501 2.1871 2.1595 1.9617 2.1142 2.3728 2.3728 
SPE3 N/A -0.2623 N/A 4.8302 N/A N/A N/A 
SPE4 -0.241 -0.2159 N/A 5.0643 5.1149 N/A N/A 
SPF1 4.0355 4.1732 3.8854 3.7708 3.8997 3.7111 3.7111 
SQS1 -0.3071 -0.3278 -0.2937 N/A N/A N/A N/A 
SRP40 -0.7416 -0.5081 -0.7442 N/A N/A N/A N/A 
SSA2 -0.5445 -0.5422 -0.4248 4.7344 N/A N/A N/A 
SSA3 -0.2614 -0.1021 0.0131 4.9032 N/A 4.974 4.974 
SSA4 -0.1672 -0.1969 -0.0541 5.0645 N/A 4.9256 4.9256 
SSM4 0.1148 0.1015 N/A 4.8749 5.2087 N/A N/A 
STE24 3.9376 3.6018 3.8783 N/A 4.5955 3.8806 3.8806 
STP22 0.1079 0.6202 -0.0128 N/A N/A N/A N/A 
SUM1 N/A 0.4928 0.7867 N/A N/A N/A N/A 
SUR4 N/A 1.1244 1.0379 4.612 N/A N/A N/A 
SVP26 -0.1751 -0.0725 N/A N/A N/A N/A N/A 
SWC3 0.0677 0 0.2299 5.0359 5.1268 4.9658 4.9658 
SWC5 N/A -0.279 0.3543 4.9967 5.1128 5.0591 5.0591 
SWP82 -0.2823 -0.2759 N/A 4.965 N/A 4.9758 4.9758 
SYS1 0.4507 0.431 0.433 N/A N/A N/A N/A 
TED1 N/A 1.5382 2.1462 N/A 4.857 N/A N/A 
THI6 -0.444 -0.3306 -0.2218 4.928 4.9764 N/A N/A 
TIR3 -0.2403 -0.0796 -0.0087 4.8293 5.0918 4.9058 4.9058 
TLG2 0.5092 0.5614 0.3656 N/A N/A N/A N/A 
TMA19 N/A -0.3673 -0.377 N/A N/A N/A N/A 
TOF2 N/A -0.3272 N/A 4.9101 N/A N/A N/A 
TRM1 -0.4789 -0.449 -0.3835 4.8815 N/A 4.8473 4.8473 
TRM7 -0.474 -0.5292 N/A 4.6852 N/A N/A N/A 
TRP3 -0.2819 -0.0773 N/A 4.5727 4.7837 4.7171 4.7171 
TSR2 -0.7142 -0.6913 -0.645 N/A N/A N/A N/A 
UBC4 -0.3746 -0.4678 N/A N/A N/A N/A N/A 
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UBC7 1.2917 1.3429 1.3783 4.7704 N/A 4.7828 4.7828 
UBR1 -0.2902 -0.2535 N/A 4.8827 4.9669 4.8562 4.8562 
UBR2 -0.2537 -0.2914 -0.305 4.8534 N/A N/A N/A 
UBX2 2.2662 2.4889 2.3746 N/A N/A N/A N/A 
UBX4 0.2618 0.4447 0.5309 N/A 4.9412 N/A N/A 
UFD2 0.4012 0.528 0.5861 4.872 4.9804 4.9068 4.9068 
UME1 -0.4168 -0.4635 -0.5409 4.9621 N/A N/A N/A 
USA1 1.0185 1.0454 1.2426 4.9623 N/A 4.9626 4.9626 
UTH1 0.5497 0.5791 0.5505 4.9346 5.0852 4.9142 4.9142 
VPS1 0.2615 1.3673 N/A N/A N/A N/A N/A 
VPS28 N/A 0.8283 0.4264 N/A N/A N/A N/A 
VPS29 N/A 0.4075 0.2719 N/A N/A N/A N/A 
VPS3 N/A 0.8052 0.6096 0.7544 1.5432 0.7802 0.7802 
VPS30 0.2661 0.0493 0.2336 4.7348 N/A N/A N/A 
VPS38 0.2221 0.3942 0.3203 4.6567 N/A 4.7274 4.7274 
VPS51 N/A 2.1661 N/A N/A N/A N/A N/A 
VPS52 N/A 1.2331 0.5436 N/A N/A N/A N/A 
VPS53 N/A 0.1693 N/A 1.0983 1.0152 1.0706 1.0706 
VPS54 0.6302 0.5483 N/A 1.1974 N/A 1.1372 1.1372 
VPS71 -0.0318 -0.0182 N/A 4.9423 N/A 4.9771 4.9771 
VPS72 -0.0939 0.0442 0.3653 5.0342 5.2261 5.0731 5.0731 
VPS74 N/A 0.9709 1.1047 N/A N/A N/A N/A 
VPS75 -0.4308 -0.4433 -0.4397 4.8047 4.8379 N/A N/A 
VTC1 0.0772 0.0065 N/A 4.835 N/A N/A N/A 
VTC4 0.3828 0.2715 N/A 5.0979 N/A 5.1222 5.1222 
WSC4 -0.0957 -0.169 0.0905 4.8885 N/A 4.9041 4.9041 
WT_dhis3::KAN -0.1836 -0.1906 -0.1037 4.8189 N/A 4.8037 4.8037 
WT_dhis3::KAN -0.1523 -0.097 N/A 4.8551 N/A 5.009 5.009 
WT_dhis3::KAN -0.1307 -0.109 0.0082 4.7755 5.044 N/A N/A 
WT_dhis3::KAN -0.1233 -0.0407 N/A 4.9636 4.9464 4.8969 4.8969 
YAP5 -0.1668 -0.0007 -0.0522 4.9589 5.0585 N/A N/A 
YBR137W -0.1055 -0.1762 N/A 5.0961 N/A 4.9454 4.9454 
YBR226C -0.0984 -0.0587 -0.1332 N/A 4.9943 N/A N/A 
YBR238C N/A 0.2066 0.2906 4.9173 4.973 4.9262 4.9262 
YCK1 -0.005 -0.0189 N/A 4.7895 N/A 4.8592 4.8592 
YCK2 0.0358 -0.0969 0.2266 4.9584 5.0138 4.9083 4.9083 
YCL045C 0.0717 -0.0305 0.2163 4.9179 5.0346 4.8829 4.8829 
YDL133W -0.1234 -0.0421 0.0388 4.8683 4.9657 4.9903 4.9903 
YDL157C -0.2988 -0.2004 N/A 4.8773 4.9667 4.9132 4.9132 
YDL242W -0.2379 -0.1205 N/A 4.9408 4.9842 5.011 5.011 
YDR049W N/A -0.3052 -0.1223 N/A N/A N/A N/A 
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YDR056C -0.2469 -0.1725 -0.0526 4.9039 4.9786 4.8769 4.8769 
YDR056C 1.3567 N/A 2.1945 4.716 N/A N/A N/A 
YDR161W -0.4503 -0.4022 -0.2544 4.7213 N/A N/A N/A 
YEL014C 0.0173 -0.0925 0.2138 4.7233 4.8364 N/A N/A 
YEL047C -0.2065 -0.1979 N/A 4.8579 N/A 4.8527 4.8527 
YER064C 0.2553 0.2963 0.3512 4.8314 4.9477 4.7721 4.7721 
YER140W 0.7416 0.7471 N/A N/A N/A N/A N/A 
YER156C -0.5263 -0.517 -0.4806 4.5741 4.6056 4.6928 4.6928 
YET1 -0.1345 -0.1613 -0.1194 4.882 4.9803 N/A N/A 
YFR018C 0.1718 0.3126 0.4628 4.8222 4.968 4.7512 4.7512 
YFR045W 0.0339 -0.038 0.1938 N/A 1.465 N/A N/A 
YGL007W N/A 0.5094 0.7305 N/A N/A 3.4512 3.4512 
YGL231C 0.0115 0.1188 N/A 4.8734 4.9368 4.8587 4.8587 
YHR003C 0.1275 0.2187 0.4649 4.9562 5.0713 4.9411 4.9411 
YHR078W 0.5428 0.6113 0.648 N/A N/A 4.479 4.479 
YIL029C -0.0554 -0.0092 0.1888 4.9549 N/A N/A N/A 
YIL032C -0.1071 -0.0326 N/A 4.8917 5.0296 N/A N/A 
YIL055C -0.0576 0.0158 0.0324 4.8008 5.0357 N/A N/A 
YIP3 -0.0173 0.0412 N/A 4.9537 5.0773 N/A N/A 
YJL055W -0.3194 -0.2775 N/A 4.8702 N/A 5.0816 5.0816 
YJR088C 0.0671 0.0375 N/A N/A 4.8799 N/A N/A 
YKR043C -0.0495 -0.0833 N/A 4.8608 5.0382 5.0378 5.0378 
YLL014W 0.1803 -0.1132 N/A N/A 5.0348 N/A N/A 
YLL014W N/A 0.1607 0.0963 4.8652 N/A N/A N/A 
YLR104W 0.5985 0.58 0.6315 N/A N/A N/A N/A 
YLR278C -0.0155 0.0214 0.2383 4.8983 5.052 5.0131 5.0131 
YLR287C -0.2186 -0.2049 -0.008 4.8996 N/A 4.9972 4.9972 
YLR402W -0.2761 -0.2491 -0.4318 N/A N/A N/A N/A 
YML108W -0.4711 -0.4113 -0.3721 4.8246 4.9602 4.8951 4.8951 
YMR209C -0.4081 -0.271 -0.2711 5.1044 5.0539 N/A N/A 
YNL205C 0.3131 0.5516 0.5127 4.8877 5.0766 4.9432 4.9432 
YOL159C -0.3676 N/A N/A 4.7779 4.9752 4.8913 4.8913 
YOR164C 0.1316 0.1569 N/A 4.8373 N/A 4.8794 4.8794 
YOR164C N/A -0.0558 N/A 4.6761 N/A 4.8455 4.8455 
YOS9 0.6535 0.6013 0.6826 N/A N/A N/A N/A 
YPL068C -0.455 -0.3522 N/A 5.0066 N/A 5.0229 5.0229 
YPR063C -0.1219 -0.0351 0.1772 4.8921 5.0559 5.0042 5.0042 
YPR063C -0.0519 -0.0073 0.0014 4.8225 5.0008 4.9675 4.9675 
YPR084W -0.3238 -0.2365 -0.0222 4.8502 5.0079 N/A N/A 
YPR130C 0.2057 0.2216 0.3872 4.8456 N/A 4.8912 4.8912 
YUR1 0.6046 0.7038 N/A N/A 5.007 N/A N/A 
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ZAP1 N/A -0.061 N/A N/A 1.3806 0.9357 0.9357 
VIP1 N/A N/A N/A N/A N/A N/A N/A 
YJR088C N/A N/A N/A N/A N/A N/A N/A 
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Table 9: The log2 (GFP/RFP) reporter values obtained in the double mutant strains 
when KAR2::NAT or kar2-P515L-DamP::NAT were crossed against the genes listed in table 
6 
* N/A indicates either that the double mutant strain was inviable or that a  value was not obtained due to  
experimental error 
 
Array name KAR2-WT (1) 
KAR2-WT 
(2) 
KAR2-WT 
(3) 
kar2-P515L-
DamP (1) 
kar2-P515L-
DamP (2) 
kar2-P515L-
DamP (3) 
ADD66 N/A -0.3026 -0.1376 1.2085 1.3261 1.3036 
AGX1 -0.1732 -0.095 -0.1543 1.3184 1.4848 N/A 
AHC2 -0.0227 0.0194 N/A 1.1874 1.334 1.4429 
ALF1 N/A 1.12 2.1491 1.344 1.2716 N/A 
ALG12 1.5689 1.4467 N/A 1.6915 1.4232 1.3722 
ALG3 2.2605 2.3585 2.6165 1.6522 1.4654 1.9978 
ALG5 1.4492 1.5665 1.68 1.1646 1.2825 1.3523 
ALG6 2.0957 2.041 2.1605 1.2927 1.4438 N/A 
ALG8 1.6379 1.7204 1.9019 1.0997 1.2918 1.3923 
ALG9 1.4766 1.5067 2.0133 N/A N/A N/A 
APE3 -0.3075 -0.1964 -0.0032 1.133 1.3161 0.8998 
ARC18 0.5786 0.6766 0.8138 1.3672 1.3607 1.4121 
ARL1 0.6144 0.435 0.4247 1.2193 1.4985 1.2915 
ARO1 0.444 N/A 0.0412 1.2788 1.2712 1.3964 
ARP6 0.1656 0.1677 0.2997 1.2688 1.4044 1.351 
ARV1 N/A 4.0563 N/A N/A N/A 1.7804 
ASM4 -0.476 -0.3149 N/A 1.3517 1.4696 N/A 
ATG8 -0.2395 -0.1303 N/A 1.3919 1.3725 1.0304 
BNR1 -0.0254 -0.1099 0.25 1.5128 N/A 1.2935 
BOP2 -0.0678 0.0262 0.0132 1.4773 1.6924 1.3978 
BRE5 N/A -0.0609 0.0013 1.4151 1.6425 1.3542 
BST1 3.4961 3.4596 N/A N/A 1.3815 1.2512 
BTS1 N/A 0.5123 0.5163 1.8871 2.2546 1.2025 
BUG1 -0.0477 0.1057 N/A 1.3772 1.5591 1.1671 
CAC2 0.7982 0.8701 0.6998 1.5713 1.6411 1.5231 
CAJ1 -0.1593 -0.146 -0.0958 1.3602 1.421 1.4738 
CAP1 N/A -0.0499 0.1806 1.3169 1.3613 1.2333 
CCW12 1.4203 1.4255 1.6152 1.3702 1.5081 1.4044 
CKA2 0.8758 0.7563 1.1658 1.3843 1.7614 1.8113 
CNE1 1.1871 N/A 1.0195 1.3048 1.2239 1.292 
COG5 N/A 0.1272 N/A 1.2195 1.2176 1.3197 
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COG6 0.2687 0.3235 N/A 1.3728 1.5027 1.3182 
COG8 0.281 0.2635 N/A 1.45 1.5356 1.2231 
CPA1 -0.6105 -0.6124 -0.8076 1.01 1.118 1.225 
CPR6 0.1262 0.1764 0.1472 1.3859 1.5037 1.4232 
CRD1 -0.265 -0.3036 N/A 1.3638 1.1944 1.2403 
CSF1 3.1702 3.2738 3.2965 1.4231 1.4478 1.4199 
CSN12 -0.6172 -0.524 N/A 1.1814 1.1932 1.0864 
CUE1 1.0488 1.0241 1.2673 1.5819 1.8063 1.4657 
CWH41 0.5218 0.5415 0.5079 1.6628 1.9109 1.242 
CWH43 0.2596 0.1953 N/A 1.4282 1.3978 1.2821 
CYS3 0.7431 1.2647 N/A 1.3414 N/A 1.3688 
DAL81 N/A -0.406 N/A 1.1538 1.1183 1.1124 
DAS1 -0.2274 -0.2246 -0.2562 0.7985 1.0798 1.2254 
DER1 0.8412 0.8263 1.1548 1.6344 2.0282 1.5346 
DFG10 -0.2762 -0.1662 0.0423 1.2798 1.2799 1.116 
DGK1 0.0309 -0.0801 0.1163 1.3575 1.3247 1.4716 
DIE2 0.7309 0.747 0.9767 1.2285 1.3323 1.5417 
DOM34 -0.5762 -0.3832 -0.1897 1.1267 1.2258 1.0474 
DRS2 0.2218 0.3238 0.3777 1.2452 1.3204 1.35 
DUS3 0.0404 -0.0945 N/A 1.343 1.5386 1.2808 
ECM30 0.0089 0.1319 N/A 1.3736 1.3881 1.0424 
EDE1 0.2082 0.118 N/A 1.1855 1.2883 1.2417 
EGD1 -0.5359 -0.485 -0.5189 0.7362 0.6065 1.2035 
EGD2 -0.4217 -0.3985 -0.3263 0.6712 0.8267 1.0712 
ELF1 N/A 0.3241 0.3915 1.3764 1.376 N/A 
ELP2 N/A -0.4381 -0.2428 1.3201 1.1906 1.3696 
EMP47 -0.1593 N/A N/A 1.4585 1.4009 1.4058 
ENT3 -0.1379 -0.17 0.1291 1.1239 1.3909 1.2647 
ERD1 2.7915 2.8649 2.6871 1.1923 1.4203 1.4007 
ERG2 0.3868 0.3605 0.4795 0.9431 1.3308 1.3032 
ERJ5 0.3344 0.1339 N/A 1.6101 1.3683 1.4167 
ERP1 N/A 0.8865 N/A 1.9039 1.5768 1.3411 
ERP2 0.0939 0.1487 0.3537 1.4133 1.3711 1.2611 
ERV14 1.9212 1.9181 2.0844 1.7614 2.0047 1.5675 
ERV25 2.497 2.4537 2.5138 1.5177 1.4715 1.634 
ERV29 0.3171 0.4791 0.5387 1.7034 1.736 1.4974 
ERV41 N/A -0.2395 -0.3675 1.1535 1.1688 1.074 
ERV46 -0.3368 -0.3478 -0.3832 0.7421 0.9939 0.9487 
EUG1 0.3093 0.343 0.4621 1.4904 N/A N/A 
FAR8 -0.1493 -0.1394 -0.0579 1.1623 1.2928 1.3615 
FAT1 0.9667 0.9204 0.7502 1.3661 1.5601 1.5512 
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FKH1 0.3118 0.346 0.5493 N/A N/A 1.6651 
FLX1 N/A -0.3259 N/A 1.4329 1.3416 1.4058 
FRE4 -0.1671 -0.2638 N/A 1.3029 1.0992 0.7137 
FUN30 0.1668 0.1873 0.35 1.4583 1.4928 1.517 
FYV6 N/A N/A 3.7707 1.1166 1.1468 1.2354 
GCN2 -0.1473 -0.1909 N/A 1.0331 1.12 N/A 
GCN20 -0.2321 -0.2038 N/A 1.2835 1.429 1.2285 
GCN5 -0.9911 -1.1073 -1.1178 1.1615 1.1642 1.3648 
GCR2 0.6388 0.523 1.0012 1.3922 1.384 1.2907 
GCS1 0.2911 0.3262 0.2994 1.2876 1.4013 1.3111 
GDA1 0.271 0.2536 0.217 1.2463 1.3983 1.416 
GET1 1.0074 2.1743 N/A 1.251 1.5964 1.424 
GET1 N/A 2.174 N/A 1.4287 1.5456 1.2639 
GET2 1.6531 2.1291 2.1414 1.1161 1.303 1.1641 
GET2 N/A 1.9979 2.2189 1.1887 1.204 1.1559 
GET3 1.088 0.7439 0.8375 1.3095 1.4931 1.4989 
GET3 N/A 0.7498 0.8965 N/A 1.1577 1.3213 
GLO3 N/A 2.1866 2.2768 1.4833 1.6502 1.5158 
GNP1 N/A 0.0259 N/A 0.9554 1.1085 N/A 
GOS1 0.3619 0.3907 0.6255 1.2517 1.3514 1.2728 
GOT1 0.0115 0.0354 -0.0765 1.2998 1.3359 1.2961 
GSG1 0.1271 0.2326 N/A 1.2592 1.6761 1.3042 
GSH2 -0.2563 -0.2227 -0.2941 1.1592 1.2904 1.2214 
GTB1 -0.0084 0.0241 N/A 1.4393 1.491 1.5725 
GTR1 N/A N/A 0.2049 0.9645 0.9785 1.3166 
GUP1 2.8145 2.8369 N/A 1.5706 1.5491 1.1434 
GYP8 -0.1225 -0.206 N/A 1.3388 1.2733 1.3813 
HAC1 -0.6855 -0.7625 N/A 0.6111 0.6941 0.537 
HAM1 -0.4729 -0.3843 N/A -0.0336 -0.2384 1.1161 
HAT2 -0.2885 -0.2775 -0.2965 1.0907 1.2806 1.0342 
HEK2 0.5033 0.4717 0.609 1.7912 1.688 1.8775 
HHF1 0.7234 0.8716 N/A N/A N/A 1.5359 
HHT1 1.0153 0.9416 N/A N/A 1.4757 1.2255 
HHT2 0.3736 0.4076 0.4018 1.4472 1.6219 1.3177 
HIR3 N/A 0.4039 0.1789 1.5803 1.4809 1.4345 
HLJ1 1.4252 1.4709 1.5424 1.3038 1.5259 1.4562 
HMG1 -0.1158 0.0493 0.171 1.3338 1.2805 1.5527 
HOP2 0.3593 -0.0382 0.6456 1.9731 2.0025 2.1094 
HPC2 0.1999 0.2083 0.1395 1.1804 1.2984 1.3113 
HRD1 1.7439 1.7391 1.9685 1.4955 1.6066 1.7561 
HRD3 1.3626 1.4187 1.607 1.8509 2.2958 2.5182 
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HSM3 -0.3339 -0.3362 N/A 1.3436 1.3689 1.3456 
HSV2 -0.3109 -0.2498 -0.0406 0.9543 1.106 1.1079 
HTB2 0.1298 0.144 N/A 1.2897 1.5062 1.3139 
HTZ1 0.2764 0.2698 0.257 1.3119 1.5172 1.4319 
HUR1 N/A 1.8088 N/A 1.4252 1.5811 N/A 
HXK2 0.0828 0.2006 0.1962 N/A N/A 1.5114 
HXT8 N/A -0.0195 0.0632 N/A 1.1646 1.116 
ICE2 0.3416 0.2721 N/A 1.5249 1.8163 1.4205 
IDH1 -0.2366 N/A N/A 1.2402 1.4247 1.0758 
IES1 0.4161 N/A 0.2072 1.4961 1.5706 1.4908 
IES4 0.4649 0.5466 0.5486 1.6234 1.4294 1.3954 
IES5 0.2702 0.2765 0.2859 1.7733 2.0119 1.4092 
ILM1 0.2108 0.3122 N/A 1.2081 1.4293 1.3005 
INP53 -0.03 0.0561 N/A 1.3394 1.3619 1.4145 
IPK1 N/A -0.5209 -0.4467 1.1663 1.2189 0.9864 
IRC21 0.0136 0.0856 0.0625 1.3971 1.6048 N/A 
IRE1 -0.7221 -0.7557 N/A 0.2803 0.5253 0.2888 
ISC1 0.1473 0.0055 N/A 1.291 1.4106 1.3857 
ISR1 0.2265 0.1717 N/A N/A 1.4325 1.3985 
ISW1 N/A 0.4587 0.4685 1.3335 1.4628 1.4419 
ISW2 0.0596 0.0086 0.1836 N/A N/A N/A 
ITR1 0.2206 0.1759 0.2569 1.4597 1.4928 1.1999 
IXR1 -0.4814 -0.3697 N/A 1.2839 N/A 1.2919 
JEM1 0.0926 0.1329 0.3924 1.2527 1.4349 1.5575 
KEL1 0.3544 0.3648 N/A 1.2086 1.266 1.372 
KEX2 N/A N/A N/A N/A N/A N/A 
KIN3 0.7964 0.8447 0.9724 1.1237 1.2663 1.3754 
KRE1 0.4205 0.4233 0.3309 1.1988 1.304 1.2926 
KRE11 0.1763 0.2615 0.1922 1.1715 1.3599 1.166 
KRE27 -0.0748 0.0715 0.2655 1.4773 N/A 1.3378 
KRE27 1.2348 2.0262 N/A 1.208 N/A 1.3081 
KTI12 -0.3934 -0.4262 N/A 1.3165 1.4653 1.4437 
LAS21 3.5378 3.4031 3.5912 1.527 1.5235 1.3899 
LEM3 N/A 0.5108 0.33 1.4935 1.5046 1.7544 
LEU3 -0.1948 -0.1944 -0.1252 1.3918 1.1941 1.2512 
LOC1 -0.2638 -0.409 -0.1821 0.8067 1.0657 0.9176 
LPD1 -0.3023 -0.3497 -0.3742 1.3208 1.4176 1.272 
LRC3 0.0041 0.0238 0.0868 1.3747 N/A 1.5393 
MAF1 N/A -0.3837 N/A 1.0667 1.382 0.9576 
MDY2 0.1337 0.0862 0.0857 1.2459 1.5308 1.2809 
MDY2 0.1783 0.0393 N/A N/A N/A 1.1502 
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MEH1 0.1631 0.2058 N/A 1.2977 N/A 1.2994 
MGA2 1.2413 1.855 N/A 1.3952 1.5407 1.2119 
MKC7 -0.0639 -0.0909 N/A 1.2357 1.2909 1.3012 
MNL1 0.0096 0.0099 0.1955 1.2897 1.3456 1.4916 
MNN2 0.3513 0.6881 0.3409 1.3408 1.5266 1.3917 
MNN4 N/A 0.0459 N/A 1.175 1.3069 N/A 
MNN5 -0.0905 -0.0526 -0.1528 1.2361 1.4207 1.3058 
MNN9 -0.2798 -0.1796 N/A 1.035 1.2891 1.2224 
MNS1 -0.1794 -0.0977 N/A 1.2638 N/A 1.2137 
MPD1 0.4312 0.3992 0.7255 1.5134 1.7032 1.6953 
MSC1 N/A 0.5625 N/A 1.4253 1.2648 1.2741 
MSI1 0.6863 0.5688 N/A 1.3928 1.4599 1.3423 
MTC1 0.0223 0.0666 0.0614 1.373 1.433 1.1041 
MTC5 N/A -0.0859 0.0661 1.1699 1.1847 1.3581 
MVP1 N/A 0.1273 0.0625 1.3085 1.3468 1.1516 
NEM1 0.6303 0.6236 0.4901 1.1252 1.1959 1.2322 
NFT1 -0.3019 -0.2045 -0.2793 1.2408 1.3591 1.3241 
NHP6A N/A -0.2897 N/A 1.1691 1.282 0.8856 
NHX1 0.9253 0.9087 0.9669 1.3524 1.5373 1.4686 
NMD4 -0.411 -0.3996 N/A 1.1848 N/A 0.862 
NPL4 -0.0547 -0.1038 0.0783 1.3152 N/A N/A 
OLA1 -0.3817 -0.2636 N/A 1.202 1.4063 1.3359 
OPI10 -0.2182 -0.194 -0.1824 1.3003 1.482 1.4013 
OPI3 1.1738 1.1042 0.9375 1.3647 1.4385 1.3341 
OST3 2.7665 2.7924 3.032 1.3312 1.4938 1.4736 
OST5 0.3574 0.4436 N/A 1.3811 1.3714 2.1107 
OYE2 -0.3308 -0.354 N/A N/A N/A 1.2821 
PBP1 -0.386 -0.3965 -0.383 0.6763 0.957 1.2827 
PCT1 0.2794 0.5333 0.3472 1.1717 1.7385 1.5698 
PEF1 0.2869 0.2857 0.3 1.4102 1.5384 1.3055 
PEP7 -0.5521 -0.4327 -0.4213 1.255 1.4311 1.3183 
PEP8 N/A 0.2154 0.2205 N/A 1.4587 1.3428 
PET18 -0.0978 -0.1114 N/A 1.2347 1.2398 N/A 
PHO80 1.0206 1.0998 1.4642 1.0284 1.181 1.2134 
PHO86 0.1507 0.1335 N/A 1.0908 1.2473 1.3851 
PMP1 -0.2068 -0.0008 N/A 1.3189 1.4367 1.0666 
PMR1 N/A N/A N/A 1.4306 1.5947 1.256 
PMT1 1.6268 1.7885 1.9023 1.3667 1.6166 0.8062 
PMT2 2.8731 2.8002 2.9393 N/A N/A N/A 
PPH21 -0.2545 -0.2571 -0.0514 1.3773 N/A N/A 
PPT1 0.0788 0.0994 0.129 1.4085 1.4911 1.3733 
 247 
PRM2 -0.5108 -0.3813 -0.3011 N/A 0.9595 0.8702 
PSD2 0.1872 0.2804 0.2537 1.5748 1.8388 1.3987 
PTC2 -0.1572 -0.0722 -0.1546 1.2749 1.4181 0.9693 
PTK2 0.1057 0.1609 0.1273 1.1338 1.3596 1.2573 
PTP1 -0.3056 -0.2552 N/A N/A 1.0062 N/A 
PTR2 -0.3999 -0.2411 N/A 1.1609 1.4355 1.1161 
RAD23 N/A -0.1593 N/A 1.1837 1.4606 1.284 
RAV1 N/A 0.3196 N/A 1.1947 1.2663 1.3983 
RCO1 0.2493 0.2599 0.5879 1.4564 1.4695 1.2276 
RER1 0.0691 0.1834 0.1244 0.5543 0.7864 1.2147 
REX4 -0.3452 -0.3693 -0.3771 1.1144 1.3307 1.5057 
RGP1 0.0552 0.0129 0.1388 1.3136 1.427 1.3147 
RLF2 N/A 0.7573 0.7118 1.3581 N/A 1.2942 
ROT2 0.3608 0.4799 0.3556 1.2546 1.2631 1.2334 
ROX1 -0.3262 -0.2562 N/A N/A 1.3723 1.2899 
RPA14 -0.4042 -0.3279 -0.3745 1.3145 1.2998 1.3547 
RPL19B N/A -0.7237 N/A 1.0705 1.3145 0.8418 
RPN10 -0.4709 -0.4916 -0.4196 0.8291 1.1272 0.9901 
RPS11A N/A -0.5539 N/A 0.5651 0.7442 0.7185 
RPS12 0.2615 0.3334 N/A 1.3134 1.3382 1.266 
RPS16A N/A -0.9726 -0.7198 1.0976 1.1275 0.5827 
RPS17A -1.2305 -1.1744 -0.8818 0.5455 0.7648 0.5229 
RPS23A -0.6533 -0.6831 -0.5535 1.1653 1.1708 N/A 
RPS28B -0.7381 -0.7216 -0.6388 1.3337 1.3962 1.2337 
RPS4B -0.1945 -0.2129 -0.1689 1.2514 1.3098 1.2183 
RPS6B -0.7838 -0.7447 -0.7354 0.6354 0.9658 0.7481 
RTN1 N/A -0.0583 N/A N/A N/A 1.0288 
RTT10 -0.4918 -0.4255 -0.4272 1.2274 1.1721 1.0792 
RTT106 N/A 1.2206 1.1135 1.4465 1.566 1.9725 
RUD3 0.2108 0.3105 0.3976 1.2728 1.4141 1.1596 
SAC7 0.5047 0.4314 0.5158 1.3438 1.4465 1.4548 
SBH2 N/A -0.1002 0.016 1.0674 1.1948 1.5431 
SCJ1 4.3649 4.3413 4.1895 1.4231 1.5774 1.6153 
SEC22 N/A 0.2104 1.4091 1.2745 1.3561 1.3528 
SEC28 -0.4445 -0.4157 -0.2068 1.1839 1.2679 1.0218 
SEC66 0.5823 0.9039 N/A N/A 1.6404 1.0147 
SEC72 -0.3077 -0.1593 -0.1711 1.0151 1.1716 1.1387 
SED4 0.2098 0.1935 0.1375 1.6305 1.5332 1.4254 
SET3 0.0413 0.0383 N/A 1.3158 1.5088 1.2223 
SEY1 0.2502 0.282 0.6789 1.3614 1.4814 1.5156 
SFB2 0.0108 -0.0072 N/A N/A 1.4124 1.3549 
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SGM1 N/A -0.1728 N/A 1.2342 1.2171 1.0964 
SGT2 -0.1256 -0.0435 0.0839 1.7652 1.7638 0.9859 
SGT2 -0.0765 -0.0216 N/A 1.2975 1.2572 1.2638 
SIF2 0.4409 0.3734 0.7118 1.4601 1.4704 1.4899 
SIL1 0.8427 0.7952 0.7596 2.1508 2.0302 1.3515 
SKY1 1.0151 0.8525 0.8692 1.3125 1.3964 1.4169 
SLA1 -0.2451 -0.2056 0.0081 1.1669 1.2259 1.0008 
SLP1 0.6604 0.6694 N/A 1.2748 1.2411 2.0419 
SMI1 0.7192 0.7371 0.6811 1.1648 1.3114 1.2073 
SNT1 0.3716 0.2889 N/A N/A N/A 1.6083 
SOP4 -0.1696 -0.1335 0.0836 1.2314 1.2421 1.3799 
SOP4 4.3107 4.1647 N/A 1.8681 1.8673 N/A 
SPC1 0.2288 0.2772 N/A 1.4882 1.5582 1.515 
SPC2 2.1501 2.1871 2.1595 N/A N/A 2.0062 
SPE3 N/A -0.2623 N/A 1.2779 1.4497 1.3306 
SPE4 -0.241 -0.2159 N/A 1.3411 1.5517 1.23 
SPF1 4.0355 4.1732 3.8854 1.7391 1.827 1.6193 
SQS1 -0.3071 -0.3278 -0.2937 1.0435 1.3113 1.0628 
SRP40 -0.7416 -0.5081 -0.7442 1.1306 1.2113 1.1925 
SSA2 -0.5445 -0.5422 -0.4248 N/A 0.5627 0.6317 
SSA3 -0.2614 -0.1021 0.0131 1.1775 1.3789 1.2748 
SSA4 -0.1672 -0.1969 -0.0541 1.3195 1.3719 1.5504 
SSM4 0.1148 0.1015 N/A 1.1614 1.2996 1.4552 
STE24 3.9376 3.6018 3.8783 1.545 1.6058 1.4167 
STP22 0.1079 0.6202 -0.0128 1.4053 1.428 1.4299 
SUM1 N/A 0.4928 0.7867 1.3473 1.5455 1.329 
SUR4 N/A 1.1244 1.0379 1.6287 1.606 1.4034 
SVP26 -0.1751 -0.0725 N/A 1.1946 1.297 1.1311 
SWC3 0.0677 0 0.2299 1.2296 1.3869 1.3419 
SWC5 N/A -0.279 0.3543 1.269 1.4145 1.3435 
SWP82 -0.2823 -0.2759 N/A 1.2516 1.2585 1.3513 
SYS1 0.4507 0.431 0.433 1.4686 1.3535 1.4038 
TED1 N/A 1.5382 2.1462 N/A 1.2814 1.4875 
THI6 -0.444 -0.3306 -0.2218 N/A 1.2275 1.2805 
TIR3 -0.2403 -0.0796 -0.0087 2.0435 2.0162 N/A 
TLG2 0.5092 0.5614 0.3656 1.3162 1.43 1.3724 
TMA19 N/A -0.3673 -0.377 1.0432 1.2841 1.25 
TOF2 N/A -0.3272 N/A 1.0176 1.1208 1.1468 
TRM1 -0.4789 -0.449 -0.3835 N/A 1.1247 1.0752 
TRM7 -0.474 -0.5292 N/A 1.3014 1.4943 1.1727 
TRP3 -0.2819 -0.0773 N/A 1.057 1.2335 1.2193 
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TSR2 -0.7142 -0.6913 -0.645 1.0766 1.486 1.3685 
UBC4 -0.3746 -0.4678 N/A 1.1952 1.5088 1.2774 
UBC7 1.2917 1.3429 1.3783 1.6042 1.6115 1.7886 
UBR1 -0.2902 -0.2535 N/A 1.1165 1.1473 1.1367 
UBR2 -0.2537 -0.2914 -0.305 1.0406 1.2484 1.2786 
UBX2 2.2662 2.4889 2.3746 1.5324 1.6453 1.1544 
UBX4 0.2618 0.4447 0.5309 1.6651 1.3666 1.3796 
UFD2 0.4012 0.528 0.5861 1.3641 1.2966 1.405 
UME1 -0.4168 -0.4635 -0.5409 N/A N/A 1.1389 
USA1 1.0185 1.0454 1.2426 1.2826 1.3429 1.9966 
UTH1 0.5497 0.5791 0.5505 1.4341 1.5415 1.4521 
VPS1 0.2615 1.3673 N/A N/A N/A 1.3602 
VPS28 N/A 0.8283 0.4264 1.3465 1.3262 1.138 
VPS29 N/A 0.4075 0.2719 1.4069 1.4506 1.4385 
VPS3 N/A 0.8052 0.6096 1.1195 1.39 1.4858 
VPS30 0.2661 0.0493 0.2336 1.3152 1.335 1.3384 
VPS38 0.2221 0.3942 0.3203 1.2594 1.2821 1.1267 
VPS51 N/A 2.1661 N/A 1.6906 1.6099 1.5593 
VPS52 N/A 1.2331 0.5436 1.2403 1.1907 0.9941 
VPS53 N/A 0.1693 N/A 0.9574 1.3321 0.9876 
VPS54 0.6302 0.5483 N/A 1.2935 1.4449 1.2212 
VPS71 -0.0318 -0.0182 N/A 1.1151 1.4836 1.3071 
VPS72 -0.0939 0.0442 0.3653 1.2739 1.4339 1.4797 
VPS74 N/A 0.9709 1.1047 1.2554 1.3554 1.3866 
VPS75 -0.4308 -0.4433 -0.4397 1.0391 0.8712 N/A 
VTC1 0.0772 0.0065 N/A 1.387 1.3688 1.2579 
VTC4 0.3828 0.2715 N/A 1.2573 1.0931 1.3416 
WSC4 -0.0957 -0.169 0.0905 1.2109 1.3528 1.2051 
WT_dhis3::KAN -0.1836 -0.1906 -0.1037 1.1828 1.3547 1.362 
WT_dhis3::KAN -0.1523 -0.097 N/A 1.3866 1.4266 1.2943 
WT_dhis3::KAN -0.1307 -0.109 0.0082 1.4181 1.5422 1.1536 
WT_dhis3::KAN -0.1233 -0.0407 N/A 1.0803 1.3806 1.3996 
YAP5 -0.1668 -0.0007 -0.0522 1.3449 1.3965 1.4791 
YBR137W -0.1055 -0.1762 N/A 0.8448 1.2813 1.3909 
YBR226C -0.0984 -0.0587 -0.1332 1.3191 1.4964 1.3058 
YBR238C N/A 0.2066 0.2906 1.4843 1.5536 1.5507 
YCK1 -0.005 -0.0189 N/A 1.2878 1.4766 1.3152 
YCK2 0.0358 -0.0969 0.2266 1.341 1.367 1.3693 
YCL045C 0.0717 -0.0305 0.2163 1.5941 1.6003 1.5495 
YDL133W -0.1234 -0.0421 0.0388 1.362 1.4191 1.2095 
YDL157C -0.2988 -0.2004 N/A 1.1208 N/A 1.0219 
 250 
YDL242W -0.2379 -0.1205 N/A 1.2086 1.2495 1.0765 
YDR049W N/A -0.3052 -0.1223 1.1069 1.0795 1.3349 
YDR056C -0.2469 -0.1725 -0.0526 1.2334 1.2098 1.2863 
YDR056C 1.3567 N/A 2.1945 1.1759 1.2431 1.3075 
YDR161W -0.4503 -0.4022 -0.2544 0.8104 0.9824 0.8856 
YEL014C 0.0173 -0.0925 0.2138 1.3312 1.3709 1.6713 
YEL047C -0.2065 -0.1979 N/A 1.2013 1.2855 1.2537 
YER064C 0.2553 0.2963 0.3512 1.4698 1.5901 1.4876 
YER140W 0.7416 0.7471 N/A 1.2755 1.4658 1.161 
YER156C -0.5263 -0.517 -0.4806 1.0079 1.1611 1.2494 
YET1 -0.1345 -0.1613 -0.1194 1.371 1.4433 N/A 
YFR018C 0.1718 0.3126 0.4628 N/A N/A 1.7982 
YFR045W 0.0339 -0.038 0.1938 1.0881 1.142 1.089 
YGL007W N/A 0.5094 0.7305 N/A N/A N/A 
YGL231C 0.0115 0.1188 N/A 1.3657 1.5072 1.8734 
YHR003C 0.1275 0.2187 0.4649 1.3698 1.6072 N/A 
YHR078W 0.5428 0.6113 0.648 1.5723 1.5933 1.9016 
YIL029C -0.0554 -0.0092 0.1888 1.4044 1.505 1.2702 
YIL032C -0.1071 -0.0326 N/A N/A N/A 1.6423 
YIL055C -0.0576 0.0158 0.0324 N/A 1.6474 N/A 
YIP3 -0.0173 0.0412 N/A 1.4422 1.6121 1.3722 
YJL055W -0.3194 -0.2775 N/A 1.0943 N/A 1.2663 
YJR088C 0.0671 0.0375 N/A 1.5648 1.5113 1.413 
YKR043C -0.0495 -0.0833 N/A 1.1545 1.5397 1.2877 
YLL014W 0.1803 -0.1132 N/A 1.1763 1.311 1.4977 
YLL014W N/A 0.1607 0.0963 1.4255 1.2536 1.5711 
YLR104W 0.5985 0.58 0.6315 1.7867 1.8268 2.0021 
YLR278C -0.0155 0.0214 0.2383 1.4494 1.5661 1.4338 
YLR287C -0.2186 -0.2049 -0.008 1.2097 1.3232 1.2614 
YLR402W -0.2761 -0.2491 -0.4318 1.2214 1.2906 1.2172 
YML108W -0.4711 -0.4113 -0.3721 N/A 0.9704 1.4419 
YMR209C -0.4081 -0.271 -0.2711 1.2776 1.1654 1.1672 
YNL205C 0.3131 0.5516 0.5127 1.7752 1.9589 1.4742 
YOL159C -0.3676 N/A N/A 0.9597 0.9966 0.5792 
YOR164C 0.1316 0.1569 N/A 1.1363 1.4046 1.0235 
YOR164C N/A -0.0558 N/A 1.2163 1.1282 1.1693 
YOS9 0.6535 0.6013 0.6826 1.6682 2.0266 1.25 
YPL068C -0.455 -0.3522 N/A 1.2823 1.3717 1.2345 
YPR063C -0.1219 -0.0351 0.1772 1.2808 1.3464 1.2715 
YPR063C -0.0519 -0.0073 0.0014 1.5655 1.4855 1.2752 
YPR084W -0.3238 -0.2365 -0.0222 1.2869 1.2331 1.1877 
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YPR130C 0.2057 0.2216 0.3872 1.5138 1.5537 1.5685 
YUR1 0.6046 0.7038 N/A 1.8835 1.8934 1.1988 
ZAP1 N/A -0.061 N/A 1.3266 1.2887 1.2528 
VIP1 N/A N/A N/A 1.4133 1.4638 1.3198 
YJR088C N/A N/A N/A 1.3236 1.3598 1.3772 
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Table 10: The log2 (GFP/RFP) reporter values obtained in the double mutant strains 
when KAR2::NAT or kar2-DamP::NAT were crossed against the genes listed in table 6 
* N/A indicates either that the double mutant strain was inviable or that a  value was not obtained due to  
experimental error 
 
Array name KAR2-WT (1) 
KAR2-WT 
(2) 
KAR2-WT 
(3) 
kar2-DamP 
(1) 
kar2-DamP 
(2) 
kar2-DamP 
(3) 
ADD66 N/A -0.3026 -0.1376 2.5465 2.4373 2.6834 
AGX1 -0.1732 -0.095 -0.1543 2.8911 2.7169 3.1566 
AHC2 -0.0227 0.0194 N/A 2.9825 2.8081 3.1582 
ALF1 N/A 1.12 2.1491 3.1292 3.2188 3.4635 
ALG12 1.5689 1.4467 N/A 4.065 3.9737 4.1249 
ALG3 2.2605 2.3585 2.6165 4.2769 4.1799 4.458 
ALG5 1.4492 1.5665 1.68 3.9246 3.8527 4.0534 
ALG6 2.0957 2.041 2.1605 3.988 3.8859 4.094 
ALG8 1.6379 1.7204 1.9019 3.8557 3.8763 3.9603 
ALG9 1.4766 1.5067 2.0133 3.8455 3.7143 4.1095 
APE3 -0.3075 -0.1964 -0.0032 2.8132 2.5373 2.7676 
ARC18 0.5786 0.6766 0.8138 3.2375 3.0596 N/A 
ARL1 0.6144 0.435 0.4247 3.2318 3.0029 3.1179 
ARO1 0.444 N/A 0.0412 3.0749 N/A 2.7678 
ARP6 0.1656 0.1677 0.2997 N/A N/A 1.3841 
ARV1 N/A 4.0563 N/A N/A 4.3813 N/A 
ASM4 -0.476 -0.3149 N/A 2.7297 2.4785 2.8706 
ATG8 -0.2395 -0.1303 N/A 2.7951 2.8023 2.9815 
BNR1 -0.0254 -0.1099 0.25 2.9367 2.7232 2.9099 
BOP2 -0.0678 0.0262 0.0132 2.9143 2.826 3.1534 
BRE5 N/A -0.0609 0.0013 3.1659 2.9928 3.4063 
BST1 3.4961 3.4596 N/A N/A 4.0688 4.1959 
BTS1 N/A 0.5123 0.5163 3.2477 3.1468 3.479 
BUG1 -0.0477 0.1057 N/A 3.0298 2.8981 3.0287 
CAC2 0.7982 0.8701 0.6998 2.4896 N/A 2.6174 
CAJ1 -0.1593 -0.146 -0.0958 N/A N/A 0.8649 
CAP1 N/A -0.0499 0.1806 2.7368 2.7007 2.9446 
CCW12 1.4203 1.4255 1.6152 3.5601 3.5229 N/A 
CKA2 0.8758 0.7563 1.1658 3.3463 3.3891 3.5639 
CNE1 1.1871 N/A 1.0195 3.7495 3.6487 3.6209 
COG5 N/A 0.1272 N/A 3.0597 2.8972 3.1394 
COG6 0.2687 0.3235 N/A 3.1571 3.0191 3.1701 
COG8 0.281 0.2635 N/A 3.1594 2.939 3.0471 
 253 
CPA1 -0.6105 -0.6124 -0.8076 N/A 0.7245 0.7495 
CPR6 0.1262 0.1764 0.1472 2.8794 2.7975 2.8961 
CRD1 -0.265 -0.3036 N/A 2.6619 2.5602 2.74 
CSF1 3.1702 3.2738 3.2965 3.8797 3.8107 3.8819 
CSN12 -0.6172 -0.524 N/A 2.5755 2.1655 2.6344 
CUE1 1.0488 1.0241 1.2673 3.3636 3.4115 3.6266 
CWH41 0.5218 0.5415 0.5079 3.6007 3.5231 3.6546 
CWH43 0.2596 0.1953 N/A 3.0602 3.0004 3.2231 
CYS3 0.7431 1.2647 N/A 2.7749 0.7769 0.594 
DAL81 N/A -0.406 N/A 1.8445 N/A 2.0848 
DAS1 -0.2274 -0.2246 -0.2562 2.746 N/A N/A 
DER1 0.8412 0.8263 1.1548 3.3119 3.3254 3.6256 
DFG10 -0.2762 -0.1662 0.0423 2.7896 2.607 2.8758 
DGK1 0.0309 -0.0801 0.1163 2.7984 2.8383 2.9692 
DIE2 0.7309 0.747 0.9767 3.6338 N/A 4.0154 
DOM34 -0.5762 -0.3832 -0.1897 2.5631 2.217 2.8243 
DRS2 0.2218 0.3238 0.3777 2.8358 2.7873 3.0148 
DUS3 0.0404 -0.0945 N/A 2.9885 2.7648 3.1584 
ECM30 0.0089 0.1319 N/A 2.8082 2.6597 2.9784 
EDE1 0.2082 0.118 N/A 3.0617 2.8891 3.2135 
EGD1 -0.5359 -0.485 -0.5189 2.1864 2.0266 2.2946 
EGD2 -0.4217 -0.3985 -0.3263 2.4522 2.2991 2.3553 
ELF1 N/A 0.3241 0.3915 3.3535 3.3188 N/A 
ELP2 N/A -0.4381 -0.2428 2.1496 2.0744 1.6163 
EMP47 -0.1593 N/A N/A 3.1133 2.8127 3.0563 
ENT3 -0.1379 -0.17 0.1291 3.0287 2.78 3.0036 
ERD1 2.7915 2.8649 2.6871 N/A 4.0922 4.1165 
ERG2 0.3868 0.3605 0.4795 2.6141 N/A 2.74 
ERJ5 0.3344 0.1339 N/A 3.8756 3.7731 3.9357 
ERP1 N/A 0.8865 N/A 3.4511 3.3027 3.581 
ERP2 0.0939 0.1487 0.3537 2.9572 2.9197 3.3003 
ERV14 1.9212 1.9181 2.0844 3.7492 3.6891 3.878 
ERV25 2.497 2.4537 2.5138 3.9585 3.9073 4.0946 
ERV29 0.3171 0.4791 0.5387 3.2628 3.206 3.5264 
ERV41 N/A -0.2395 -0.3675 2.5686 2.3715 2.7124 
ERV46 -0.3368 -0.3478 -0.3832 2.263 2.4016 2.6447 
EUG1 0.3093 0.343 0.4621 2.9165 2.7959 2.9438 
FAR8 -0.1493 -0.1394 -0.0579 3.0565 2.8663 3.2273 
FAT1 0.9667 0.9204 0.7502 3.4794 3.4849 3.1712 
FKH1 0.3118 0.346 0.5493 3.2749 3.065 3.3213 
FLX1 N/A -0.3259 N/A 2.2277 2.0448 N/A 
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FRE4 -0.1671 -0.2638 N/A 2.7928 2.6258 2.8527 
FUN30 0.1668 0.1873 0.35 3.1766 3.1091 3.2636 
FYV6 N/A N/A 3.7707 N/A N/A N/A 
GCN2 -0.1473 -0.1909 N/A 2.8612 N/A 2.8283 
GCN20 -0.2321 -0.2038 N/A 2.6275 2.4935 2.7376 
GCN5 -0.9911 -1.1073 -1.1178 0.2752 1.3052 1.1574 
GCR2 0.6388 0.523 1.0012 2.7389 2.4653 2.9423 
GCS1 0.2911 0.3262 0.2994 3.1776 2.8061 2.9281 
GDA1 0.271 0.2536 0.217 3.1889 3.1869 3.3276 
GET1 1.0074 2.1743 N/A 3.7403 N/A 3.69 
GET1 N/A 2.174 N/A 0.6968 N/A N/A 
GET2 1.6531 2.1291 2.1414 3.5438 3.5312 3.6069 
GET2 N/A 1.9979 2.2189 N/A N/A 3.6282 
GET3 1.088 0.7439 0.8375 3.0495 3.0315 3.201 
GET3 N/A 0.7498 0.8965 2.8429 2.6966 3.0059 
GLO3 N/A 2.1866 2.2768 3.2772 N/A 3.6136 
GNP1 N/A 0.0259 N/A 2.6539 2.3769 2.9122 
GOS1 0.3619 0.3907 0.6255 3.1786 2.9582 3.3504 
GOT1 0.0115 0.0354 -0.0765 2.8663 2.7866 3.0223 
GSG1 0.1271 0.2326 N/A 2.9718 2.9325 3.2026 
GSH2 -0.2563 -0.2227 -0.2941 2.7218 N/A 2.8758 
GTB1 -0.0084 0.0241 N/A 3.2048 2.9705 3.3221 
GTR1 N/A N/A 0.2049 N/A 2.5203 2.5749 
GUP1 2.8145 2.8369 N/A N/A N/A N/A 
GYP8 -0.1225 -0.206 N/A 2.9422 N/A 2.997 
HAC1 -0.6855 -0.7625 N/A 0.2194 0.2538 0.0556 
HAM1 -0.4729 -0.3843 N/A 2.7226 2.584 2.7865 
HAT2 -0.2885 -0.2775 -0.2965 2.7424 2.6747 2.8807 
HEK2 0.5033 0.4717 0.609 3.0631 3.0304 3.2032 
HHF1 0.7234 0.8716 N/A 3.065 N/A 3.0687 
HHT1 1.0153 0.9416 N/A 3.1306 2.9705 3.1238 
HHT2 0.3736 0.4076 0.4018 3.0903 N/A 2.9383 
HIR3 N/A 0.4039 0.1789 3.0878 2.9818 3.1983 
HLJ1 1.4252 1.4709 1.5424 3.534 3.5602 3.6727 
HMG1 -0.1158 0.0493 0.171 2.9064 2.8927 3.0003 
HOP2 0.3593 -0.0382 0.6456 3.2908 3.2556 3.2139 
HPC2 0.1999 0.2083 0.1395 2.6725 2.8546 3.0477 
HRD1 1.7439 1.7391 1.9685 3.8746 3.8638 4.0252 
HRD3 1.3626 1.4187 1.607 3.8574 3.8234 4.0247 
HSM3 -0.3339 -0.3362 N/A 2.5105 2.4283 2.6904 
HSV2 -0.3109 -0.2498 -0.0406 2.7412 2.5043 2.9103 
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HTB2 0.1298 0.144 N/A 2.6711 2.5248 2.9081 
HTZ1 0.2764 0.2698 0.257 0.7159 2.2788 2.6363 
HUR1 N/A 1.8088 N/A 2.9534 N/A N/A 
HXK2 0.0828 0.2006 0.1962 3.0196 2.7899 3.1457 
HXT8 N/A -0.0195 0.0632 2.6217 2.4447 2.8173 
ICE2 0.3416 0.2721 N/A 0.9514 2.5682 N/A 
IDH1 -0.2366 N/A N/A 2.6664 2.5984 3.0893 
IES1 0.4161 N/A 0.2072 2.5145 2.832 2.9241 
IES4 0.4649 0.5466 0.5486 3.0713 3.1358 3.37 
IES5 0.2702 0.2765 0.2859 2.8985 2.6584 2.8234 
ILM1 0.2108 0.3122 N/A 3.1048 N/A N/A 
INP53 -0.03 0.0561 N/A 3.1301 3.0524 3.2428 
IPK1 N/A -0.5209 -0.4467 2.6782 2.5167 2.7568 
IRC21 0.0136 0.0856 0.0625 2.9122 2.5898 2.9599 
IRE1 -0.7221 -0.7557 N/A 0.0145 0.1204 N/A 
ISC1 0.1473 0.0055 N/A 2.8153 2.7094 3.0367 
ISR1 0.2265 0.1717 N/A 3.9926 3.6432 3.8853 
ISW1 N/A 0.4587 0.4685 3.2237 3.1486 3.3355 
ISW2 0.0596 0.0086 0.1836 2.8313 2.9232 3.0102 
ITR1 0.2206 0.1759 0.2569 2.9568 2.7884 2.9854 
IXR1 -0.4814 -0.3697 N/A 2.3203 1.9981 2.2462 
JEM1 0.0926 0.1329 0.3924 2.9921 2.9242 3.1801 
KEL1 0.3544 0.3648 N/A 3.0195 3.0719 3.2556 
KEX2 N/A N/A N/A N/A N/A N/A 
KIN3 0.7964 0.8447 0.9724 3.2633 3.296 3.5473 
KRE1 0.4205 0.4233 0.3309 3.4334 3.3613 3.4477 
KRE11 0.1763 0.2615 0.1922 3.0944 2.9066 3.196 
KRE27 -0.0748 0.0715 0.2655 2.8602 2.6789 3.0919 
KRE27 1.2348 2.0262 N/A 3.0246 2.8901 2.7729 
KTI12 -0.3934 -0.4262 N/A 2.3927 2.262 2.2906 
LAS21 3.5378 3.4031 3.5912 4.1402 N/A N/A 
LEM3 N/A 0.5108 0.33 2.8922 2.9669 3.0478 
LEU3 -0.1948 -0.1944 -0.1252 2.7296 2.7123 2.9304 
LOC1 -0.2638 -0.409 -0.1821 0.004 -0.3145 N/A 
LPD1 -0.3023 -0.3497 -0.3742 1.4837 1.5295 1.8212 
LRC3 0.0041 0.0238 0.0868 N/A 2.6247 3.1179 
MAF1 N/A -0.3837 N/A 3.0948 2.8557 2.9406 
MDY2 0.1337 0.0862 0.0857 2.8443 2.8365 2.909 
MDY2 0.1783 0.0393 N/A 2.7037 2.6129 2.8261 
MEH1 0.1631 0.2058 N/A 2.3406 N/A 2.6145 
MGA2 1.2413 1.855 N/A 3.6848 3.473 3.9056 
 256 
MKC7 -0.0639 -0.0909 N/A 2.7526 2.8378 2.9364 
MNL1 0.0096 0.0099 0.1955 2.9223 2.8778 3.1582 
MNN2 0.3513 0.6881 0.3409 3.5477 3.3866 3.4778 
MNN4 N/A 0.0459 N/A 2.9762 2.8418 2.9954 
MNN5 -0.0905 -0.0526 -0.1528 N/A 2.8157 3.1151 
MNN9 -0.2798 -0.1796 N/A 3.109 N/A 3.0434 
MNS1 -0.1794 -0.0977 N/A 3.0205 2.8068 3.1103 
MPD1 0.4312 0.3992 0.7255 3.173 3.0925 3.485 
MSC1 N/A 0.5625 N/A 3.3638 3.006 3.2515 
MSI1 0.6863 0.5688 N/A 2.6413 2.584 2.8259 
MTC1 0.0223 0.0666 0.0614 3.0975 2.9287 3.2276 
MTC5 N/A -0.0859 0.0661 2.9682 2.9428 2.8893 
MVP1 N/A 0.1273 0.0625 2.8482 2.6354 2.8746 
NEM1 0.6303 0.6236 0.4901 3.3705 3.3794 3.5123 
NFT1 -0.3019 -0.2045 -0.2793 2.772 2.6218 2.9645 
NHP6A N/A -0.2897 N/A 2.9881 2.7324 3.0752 
NHX1 0.9253 0.9087 0.9669 3.4638 3.1182 3.2983 
NMD4 -0.411 -0.3996 N/A 1.2725 1.8642 2.1158 
NPL4 -0.0547 -0.1038 0.0783 2.645 2.626 2.7379 
OLA1 -0.3817 -0.2636 N/A 2.2866 2.0933 2.3149 
OPI10 -0.2182 -0.194 -0.1824 2.3101 2.4523 2.499 
OPI3 1.1738 1.1042 0.9375 N/A 2.9526 3.1901 
OST3 2.7665 2.7924 3.032 N/A 4.232 N/A 
OST5 0.3574 0.4436 N/A 3.5245 N/A 3.5891 
OYE2 -0.3308 -0.354 N/A 2.606 2.5539 2.761 
PBP1 -0.386 -0.3965 -0.383 2.4829 2.4234 2.6335 
PCT1 0.2794 0.5333 0.3472 3.322 2.9788 3.3089 
PEF1 0.2869 0.2857 0.3 2.6662 2.5107 2.5976 
PEP7 -0.5521 -0.4327 -0.4213 2.8939 2.7317 2.9853 
PEP8 N/A 0.2154 0.2205 2.9984 2.893 3.0943 
PET18 -0.0978 -0.1114 N/A 2.9683 2.8198 3.1702 
PHO80 1.0206 1.0998 1.4642 2.5382 N/A 3.1939 
PHO86 0.1507 0.1335 N/A 2.6379 2.4922 3.074 
PMP1 -0.2068 -0.0008 N/A 2.8842 2.7168 3.0581 
PMR1 N/A N/A N/A N/A N/A N/A 
PMT1 1.6268 1.7885 1.9023 3.8769 3.7149 3.9298 
PMT2 2.8731 2.8002 2.9393 4.2059 4.0725 4.188 
PPH21 -0.2545 -0.2571 -0.0514 2.9366 2.9231 2.831 
PPT1 0.0788 0.0994 0.129 3.0069 2.9469 3.131 
PRM2 -0.5108 -0.3813 -0.3011 2.6102 2.4737 2.7358 
PSD2 0.1872 0.2804 0.2537 2.7043 2.6188 2.9686 
 257 
PTC2 -0.1572 -0.0722 -0.1546 2.7997 2.5252 2.7871 
PTK2 0.1057 0.1609 0.1273 2.7016 2.3755 2.7284 
PTP1 -0.3056 -0.2552 N/A 2.76 2.6616 3.0096 
PTR2 -0.3999 -0.2411 N/A 2.623 2.5558 2.7258 
RAD23 N/A -0.1593 N/A 2.8456 2.6912 2.9642 
RAV1 N/A 0.3196 N/A 2.9881 2.9164 3.0474 
RCO1 0.2493 0.2599 0.5879 3.1567 N/A 3.0973 
RER1 0.0691 0.1834 0.1244 3.2369 3.1283 3.3479 
REX4 -0.3452 -0.3693 -0.3771 2.6546 2.6458 2.853 
RGP1 0.0552 0.0129 0.1388 3.1472 2.8321 3.0638 
RLF2 N/A 0.7573 0.7118 2.7614 2.6434 2.6264 
ROT2 0.3608 0.4799 0.3556 3.462 3.3515 3.5004 
ROX1 -0.3262 -0.2562 N/A 2.7084 2.5016 2.8336 
RPA14 -0.4042 -0.3279 -0.3745 N/A 3.2361 3.3746 
RPL19B N/A -0.7237 N/A 2.0774 1.9401 2.212 
RPN10 -0.4709 -0.4916 -0.4196 2.0841 2.5159 2.6369 
RPS11A N/A -0.5539 N/A 1.468 1.0653 N/A 
RPS12 0.2615 0.3334 N/A 3.2767 N/A 3.2744 
RPS16A N/A -0.9726 -0.7198 0.9374 0.9633 1.1238 
RPS17A -1.2305 -1.1744 -0.8818 0.2816 0.1368 0.2106 
RPS23A -0.6533 -0.6831 -0.5535 1.9199 N/A 2.2467 
RPS28B -0.7381 -0.7216 -0.6388 1.6051 1.3 1.5796 
RPS4B -0.1945 -0.2129 -0.1689 2.6024 2.4834 2.8117 
RPS6B -0.7838 -0.7447 -0.7354 1.3172 1.1735 1.4549 
RTN1 N/A -0.0583 N/A 2.6248 2.5622 3.1061 
RTT10 -0.4918 -0.4255 -0.4272 2.8499 2.5663 2.8621 
RTT106 N/A 1.2206 1.1135 3.0048 N/A 3.1166 
RUD3 0.2108 0.3105 0.3976 3.3791 3.2006 3.4653 
SAC7 0.5047 0.4314 0.5158 3.1824 N/A N/A 
SBH2 N/A -0.1002 0.016 2.7162 2.6472 2.9145 
SCJ1 4.3649 4.3413 4.1895 4.7751 4.9275 4.8058 
SEC22 N/A 0.2104 1.4091 3.4796 3.3956 3.4277 
SEC28 -0.4445 -0.4157 -0.2068 2.6313 2.5664 2.9394 
SEC66 0.5823 0.9039 N/A 3.8299 3.7579 3.5583 
SEC72 -0.3077 -0.1593 -0.1711 2.6316 2.5705 2.8723 
SED4 0.2098 0.1935 0.1375 3.138 2.9358 3.1128 
SET3 0.0413 0.0383 N/A 2.6104 2.4798 3.0672 
SEY1 0.2502 0.282 0.6789 3.2642 3.1521 3.4138 
SFB2 0.0108 -0.0072 N/A 3.1322 2.8112 3.1244 
SGM1 N/A -0.1728 N/A 2.7363 N/A 2.9101 
SGT2 -0.1256 -0.0435 0.0839 2.7442 N/A 2.7529 
 258 
SGT2 -0.0765 -0.0216 N/A 2.7761 2.7286 3.0444 
SIF2 0.4409 0.3734 0.7118 2.9558 2.7769 3.1048 
SIL1 0.8427 0.7952 0.7596 4.1279 4.0968 4.2479 
SKY1 1.0151 0.8525 0.8692 2.6191 2.7431 2.626 
SLA1 -0.2451 -0.2056 0.0081 2.7031 2.9154 3.0219 
SLP1 0.6604 0.6694 N/A 3.6367 3.5457 3.6958 
SMI1 0.7192 0.7371 0.6811 3.2659 3.0535 N/A 
SNT1 0.3716 0.2889 N/A 2.9019 2.7798 3.1685 
SOP4 -0.1696 -0.1335 0.0836 2.8041 2.6672 2.9562 
SOP4 4.3107 4.1647 N/A N/A 4.4091 N/A 
SPC1 0.2288 0.2772 N/A 3.5198 3.4022 3.7074 
SPC2 2.1501 2.1871 2.1595 N/A 4.4818 4.4578 
SPE3 N/A -0.2623 N/A 2.7156 2.5734 2.8932 
SPE4 -0.241 -0.2159 N/A 2.9366 N/A 2.8974 
SPF1 4.0355 4.1732 3.8854 N/A N/A N/A 
SQS1 -0.3071 -0.3278 -0.2937 2.9326 2.4152 2.6733 
SRP40 -0.7416 -0.5081 -0.7442 0.854 0.7463 1.0875 
SSA2 -0.5445 -0.5422 -0.4248 1.1362 1.2638 1.519 
SSA3 -0.2614 -0.1021 0.0131 2.8105 2.5929 N/A 
SSA4 -0.1672 -0.1969 -0.0541 3.0795 2.6967 2.9376 
SSM4 0.1148 0.1015 N/A 3.0409 2.7941 3.0654 
STE24 3.9376 3.6018 3.8783 4.5561 4.5266 4.71 
STP22 0.1079 0.6202 -0.0128 3.2683 N/A 3.1268 
SUM1 N/A 0.4928 0.7867 3.2263 3.2521 3.4499 
SUR4 N/A 1.1244 1.0379 3.4442 N/A 3.2132 
SVP26 -0.1751 -0.0725 N/A 3.0174 2.8297 3.1419 
SWC3 0.0677 0 0.2299 2.8763 2.7758 2.9982 
SWC5 N/A -0.279 0.3543 0.9132 1.8942 N/A 
SWP82 -0.2823 -0.2759 N/A 2.8378 2.6982 2.8603 
SYS1 0.4507 0.431 0.433 3.339 N/A 3.1705 
TED1 N/A 1.5382 2.1462 3.6137 3.4538 3.8598 
THI6 -0.444 -0.3306 -0.2218 2.3984 2.3741 2.6304 
TIR3 -0.2403 -0.0796 -0.0087 2.9643 2.7827 3.1547 
TLG2 0.5092 0.5614 0.3656 3.2882 3.1991 3.2059 
TMA19 N/A -0.3673 -0.377 1.8164 1.6427 2.0072 
TOF2 N/A -0.3272 N/A 2.5296 N/A 2.6112 
TRM1 -0.4789 -0.449 -0.3835 2.4714 2.5132 2.7583 
TRM7 -0.474 -0.5292 N/A 2.9097 2.6074 3.0938 
TRP3 -0.2819 -0.0773 N/A 2.3632 2.1605 2.3783 
TSR2 -0.7142 -0.6913 -0.645 1.6298 0.815 0.7744 
UBC4 -0.3746 -0.4678 N/A 3.2077 N/A N/A 
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UBC7 1.2917 1.3429 1.3783 3.2812 3.5457 3.9213 
UBR1 -0.2902 -0.2535 N/A 2.4926 2.3375 2.5815 
UBR2 -0.2537 -0.2914 -0.305 2.5418 2.6623 2.6207 
UBX2 2.2662 2.4889 2.3746 4.1043 N/A 3.6718 
UBX4 0.2618 0.4447 0.5309 3.4238 N/A 3.4711 
UFD2 0.4012 0.528 0.5861 3.2315 3.0315 3.3212 
UME1 -0.4168 -0.4635 -0.5409 2.7891 2.6684 2.999 
USA1 1.0185 1.0454 1.2426 3.5164 N/A 3.6818 
UTH1 0.5497 0.5791 0.5505 3.5934 3.3705 3.465 
VPS1 0.2615 1.3673 N/A N/A 0.9219 0.9268 
VPS28 N/A 0.8283 0.4264 3.2947 N/A N/A 
VPS29 N/A 0.4075 0.2719 3.0525 3.0165 3.1224 
VPS3 N/A 0.8052 0.6096 2.9092 N/A 2.8017 
VPS30 0.2661 0.0493 0.2336 3.04 2.9275 3.052 
VPS38 0.2221 0.3942 0.3203 3.0688 2.9769 3.1425 
VPS51 N/A 2.1661 N/A 3.3009 N/A N/A 
VPS52 N/A 1.2331 0.5436 3.199 N/A 3.1438 
VPS53 N/A 0.1693 N/A N/A N/A N/A 
VPS54 0.6302 0.5483 N/A 3.3282 N/A 3.1722 
VPS71 -0.0318 -0.0182 N/A N/A 2.5521 3.0799 
VPS72 -0.0939 0.0442 0.3653 2.9319 2.8832 3.1025 
VPS74 N/A 0.9709 1.1047 3.5251 3.438 3.5782 
VPS75 -0.4308 -0.4433 -0.4397 2.6352 2.433 2.7126 
VTC1 0.0772 0.0065 N/A 2.7134 2.6735 2.9317 
VTC4 0.3828 0.2715 N/A 2.8766 2.7609 2.9074 
WSC4 -0.0957 -0.169 0.0905 2.8811 2.7297 2.8914 
WT_dhis3::KAN -0.1836 -0.1906 -0.1037 2.6099 2.5797 2.8337 
WT_dhis3::KAN -0.1523 -0.097 N/A 2.8722 2.7211 2.9742 
WT_dhis3::KAN -0.1307 -0.109 0.0082 2.7491 2.6386 2.9858 
WT_dhis3::KAN -0.1233 -0.0407 N/A 2.9647 2.5932 2.9928 
YAP5 -0.1668 -0.0007 -0.0522 2.9958 2.8162 3.0039 
YBR137W -0.1055 -0.1762 N/A 2.7868 2.5566 2.8057 
YBR226C -0.0984 -0.0587 -0.1332 N/A 2.5409 N/A 
YBR238C N/A 0.2066 0.2906 3.1121 3.1279 3.232 
YCK1 -0.005 -0.0189 N/A 2.7122 2.5065 2.9442 
YCK2 0.0358 -0.0969 0.2266 2.9744 2.6823 3.1728 
YCL045C 0.0717 -0.0305 0.2163 3.006 2.8568 3.1365 
YDL133W -0.1234 -0.0421 0.0388 2.9 2.7258 3.0115 
YDL157C -0.2988 -0.2004 N/A 2.6387 2.5476 2.6918 
YDL242W -0.2379 -0.1205 N/A 2.8562 2.4892 2.7678 
YDR049W N/A -0.3052 -0.1223 2.6189 2.5266 N/A 
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YDR056C -0.2469 -0.1725 -0.0526 2.7715 2.6433 N/A 
YDR056C 1.3567 N/A 2.1945 N/A 2.8184 3.4509 
YDR161W -0.4503 -0.4022 -0.2544 2.6419 2.3207 2.5315 
YEL014C 0.0173 -0.0925 0.2138 2.8714 2.9043 3.2099 
YEL047C -0.2065 -0.1979 N/A 2.7943 2.799 2.9254 
YER064C 0.2553 0.2963 0.3512 2.8813 2.8125 3.039 
YER140W 0.7416 0.7471 N/A 3.6608 3.4553 3.6717 
YER156C -0.5263 -0.517 -0.4806 1.9875 1.6668 N/A 
YET1 -0.1345 -0.1613 -0.1194 2.8357 2.8351 3.0001 
YFR018C 0.1718 0.3126 0.4628 3.1931 N/A 3.2364 
YFR045W 0.0339 -0.038 0.1938 2.6447 N/A 2.9486 
YGL007W N/A 0.5094 0.7305 2.5107 N/A 2.9468 
YGL231C 0.0115 0.1188 N/A 2.9281 2.8855 3.1128 
YHR003C 0.1275 0.2187 0.4649 3.058 3.0393 3.1417 
YHR078W 0.5428 0.6113 0.648 3.3316 3.4334 3.4925 
YIL029C -0.0554 -0.0092 0.1888 2.769 2.9657 3.1493 
YIL032C -0.1071 -0.0326 N/A 3.0066 N/A 3.0545 
YIL055C -0.0576 0.0158 0.0324 2.9755 2.6341 3.0795 
YIP3 -0.0173 0.0412 N/A 2.9284 2.7978 3.0609 
YJL055W -0.3194 -0.2775 N/A 2.659 N/A 3.0149 
YJR088C 0.0671 0.0375 N/A 2.7397 N/A 2.9611 
YKR043C -0.0495 -0.0833 N/A 2.764 2.7849 2.9805 
YLL014W 0.1803 -0.1132 N/A 3.0683 2.8969 2.9985 
YLL014W N/A 0.1607 0.0963 2.7313 2.6235 3.0018 
YLR104W 0.5985 0.58 0.6315 3.0919 3.1183 3.5239 
YLR278C -0.0155 0.0214 0.2383 3.1216 2.8648 3.114 
YLR287C -0.2186 -0.2049 -0.008 2.8009 2.562 2.9834 
YLR402W -0.2761 -0.2491 -0.4318 2.2528 2.0721 2.2696 
YML108W -0.4711 -0.4113 -0.3721 2.7038 2.2523 N/A 
YMR209C -0.4081 -0.271 -0.2711 2.7183 2.6305 2.7969 
YNL205C 0.3131 0.5516 0.5127 2.8976 2.6854 3.0763 
YOL159C -0.3676 N/A N/A 2.827 2.5746 3.0011 
YOR164C 0.1316 0.1569 N/A 2.7957 2.5802 3.0102 
YOR164C N/A -0.0558 N/A 2.7324 2.5636 2.9671 
YOS9 0.6535 0.6013 0.6826 3.2603 3.1857 N/A 
YPL068C -0.455 -0.3522 N/A 1.9766 1.6325 2.3994 
YPR063C -0.1219 -0.0351 0.1772 2.8197 2.7892 2.8922 
YPR063C -0.0519 -0.0073 0.0014 2.9047 2.8168 3.1021 
YPR084W -0.3238 -0.2365 -0.0222 2.7326 2.5418 2.8408 
YPR130C 0.2057 0.2216 0.3872 3.0359 3.0021 3.0793 
YUR1 0.6046 0.7038 N/A 3.634 3.3977 3.4959 
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ZAP1 N/A -0.061 N/A 0.4101 N/A -0.0107 
VIP1 N/A N/A N/A 3.3562 N/A N/A 
YJR088C N/A N/A N/A 4.0615 N/A N/A 
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(A) kar2-R217A::NAT 
(B) sec71∆ 
Table 11: A list of the gene deletions that exhibited the highest correlation 
coefficients for (A) kar2-R217A::NAT, (B) sec71∆, and (C) sec72∆, and their corresponding 
genetic interaction values. 
* A p ositive genetic in teraction v alue which i s s tatistically s ignificant i s h ighlighted in  yellow a nd a  
negative value in blue. 
** A p ositive genetic i nteraction v alue means t hat t he d ouble mutant s train h ad a  lo wer le vel o f U PR 
induction than what was predicted 
*** N/A indicates either that the double mutant strain was inviable or that a value was not obtained due to 
experimental error 
 
 
Mutant SEC72 VPS52 SEC71 GTR1 GNP1 NPL4 SPT4 ILM1 STP22 MEH1 PMR1 VTC4 PMP1 MVP1 SMI1 GCR2 RAV1 ERG2 VPS53 
Correlation  
coefficient 0.4514 0.4054 0.3969 0.3958 0.3706 0.3695 0.3385 0.3299 0.3204 0.3161 0.3101 0.3017 0.2959 0.2922 0.2912 0.2871 0.2754 0.27 0.2639 
kar2-R217A -0.0826 0.478 0.2962 N/A -0.9504 0.06 N/A 1.2534 -0.3178 0.2567 0.9296 0.4451 -0.2634 -0.0643 0.399 0.0052 0.4813 N/A 0.993 
sec71∆  -0.2528 N/A N/A -0.0566 N/A 0.2683 0.7198 -0.1357 N/A 0.3284 N/A 0.0184 -0.1995 -0.0316 -0.418 0.1127 0.39 -0.0686 N/A 
sec72∆  N/A N/A -0.2528 N/A N/A N/A -0.1563 0.778 N/A N/A 0.4156 N/A N/A N/A N/A N/A N/A N/A N/A 
 
 
 
Mutant CCW12 SEC72 
YGL00
7W ARC18 PMT2 ERD1 KIN3 PMP1 STP22 ILM1 SUR4 EUG1 ERV14 LAS21 PER1 VTC4 LHS1 ERG2 ERV25 
Correlation 
coefficient 0.6328 0.6128 0.5676 0.5645 0.5465 0.5417 0.5341 0.524 0.5099 0.5091 0.5014 0.4834 0.4796 0.4792 0.4755 0.4713 0.4701 0.4623 0.4603 
kar2-R217A 0.6068 -0.0826 0.1297 0.2665 0.3465 1.3922 N/A -0.2634 -0.3178 1.2534 0.9569 0.3607 0.1744 3.2132 N/A 0.4451 N/A N/A -0.3317 
sec71∆  N/A -0.2528 N/A N/A N/A 1.4758 0.1551 -0.1995 N/A -0.1357 0.3603 0.2961 0.7577 N/A 2.879 0.0184 N/A -0.0686 0.6962 
sec72∆  0.4514 N/A N/A N/A -0.1295 0.3587 N/A N/A N/A 0.778 0.4122 N/A 0.4913 0.1916 0.5395 N/A 0.3387 N/A 0.0842 
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(C) sec72∆  
Mutant SEC66 kar2-R217A IRC21 SPT4 ILM1 
YLR10
4W SKY1 VTC4 ERV41 RPS4B VTC1 PEF1 NPL4 PTK2 MKC7 
YPL06
8C GTR1 PHO80 PSD2 
Correlation  
coefficient 0.6128 0.4514 0.3885 0.3719 0.3471 0.338 0.3336 0.3272 0.3245 0.3195 0.3059 0.3047 0.3025 0.2975 0.2958 0.2843 0.2819 0.2709 0.2708 
kar2-R217A 0.2962 N/A -0.1058 N/A 1.2534 0.2392 0.0598 0.4451 -0.081 -0.0326 0.2215 -0.4772 0.06 0.3016 -0.1455 -0.1854 N/A 0.1383 -1.6155 
sec71∆  N/A 0.2962 0.4533 0.7198 -0.1357 -0.8337 0.7792 0.0184 -0.3313 0.1517 0.2916 0.498 0.2683 0.195 -0.0131 0.0107 -0.0566 0.9376 -0.0806 
sec72∆  -0.2528 -0.0826 N/A -0.1563 0.778 -0.3427 0.6003 N/A N/A N/A N/A 0.2264 N/A N/A N/A N/A N/A 0.4689 -0.0871 
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APPENDIX C 
STRUCTURAL DETERMINATION OF A TRUNCATION MUTANT OF BIP THAT IS 
CONFINED TO AN ADP-BOUND CONFORMATION DUE TO THE G247D 
MUTATION IN THE ATPASE DOMAIN 
This work was performed with an undergraduate researcher, Brigid K. Jensen, in the Brodsky laboratory, and in 
collaboration with the laboratory of Andrew VanDemark at the University of Pittsburgh, Department of Biological 
Sciences. 
 
As de scribed i n s ection 2.2.1, a fter ne arly 2 de cades of  r esearch, t he f ield of  x -ray 
crystallography still faces the challenge of obtaining the crystal structure of a full-length Hsp70. 
The closest rejoinder to this challenge has been the resolution of the crystal structure of Hsp70 
truncation mutants that lack the flexible lid domain7, 12. The first such structure to be solved was 
of truncated bovine Hsc70 in the nucleotide-free state, and it revealed a conformation in which 
the substrate binding domain wrapped around the ATPase domain by establishing contacts with 
the inter-domain linker as well as subdomain Ia of the ATPase domain7 (Figure 4A). However, 
these observations were contradictory to NMR and directed mutagenesis studies with full-length 
bacterial H sp70. Specifically, it ha d be en s hown t hat i ndicated t hat t he A TPase and s ubstrate 
binding domains are di sjointed in the nucleotide-free and  ADP-bound s tates, whereas they are 
closely packed in the ATP-bound state78-81. Given that the crystal structure of truncated bovine 
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Hsc70 w as s tabilized by  mutating charged s urface residues and b y adding os molytes7, it is  
possible t hat cer tain aspects of  t his s tructure are ex perimental a rtefacts. To resolve t hese 
contradictions, a c rystal structure of  t runcated rat Hsc70 in t he ADP-bound s tate was solved12 
and showed that the ATPase and substrate binding domains are indeed disjointed in the presence 
of ADP (F igure 4B), a s suggested b y NMR and directed mutagenesis s tudies. F ree movement 
between these domains in the presence of ADP is further supported by the protease susceptibility 
patterns of  s everal H sp70s i n t he presence of  di fferent nuc leotides403-406. Alternately, it is  
plausible t hat di fferent H sp70s a dopt di fferent c onformations, a nd t herefore, t he t hree-
dimensional structures of bovine and rat Hsc70 truncations varied. This implies that the crystal 
structure of every prokaryotic or eukaryotic Hsp70 may need to be solved in order to understand 
the function of that specific Hsp70.   
The cr ystal s tructures of  ne ither f ull-length B iP nor  i ndividual B iP domains ha ve be en 
solved. Since human BiP is correlated to several diseases (refer to section 1.2.9), knowledge of 
its three-dimensional structure, in the absence and presence of specific cofactors, can be utilized 
for targeted drug design. Because yeast and human BiP share 70% overall sequence identity, the 
immediate goal of this study is to obtain the three-dimensional crystal structure of yeast BiP by 
combining pr evious s uccessful a pproaches w ith a  nove l a pproach. T o t his e nd, t wo t runcation 
mutants of  yeast B iP, D 559X a nd K584X, w ere generated b y s ite-directed mutagenesis in the 
plasmid pMR2623151 that drives IPTG-inducible hexahistidine-tagged BiP expression in E. coli; 
this w as in accordance w ith successful attempts to crystallize Hsp70 t runcations7, 1 2. 
Additionally, a point mutation, G247D, was introduced into BiP’s ATPase domain, which causes 
the pr otein t o be  t rapped i n a n ADP-bound c onformation151; t his a pproach i s nov el a nd i s 
predicted to surmount the contradictions observed in previous NMR and crystallographic studies.  
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The f irst s tep i nvolved t he opt imization of  B iP purification i n a h eterologous b acterial 
expression system for improved protein purity and yield. Next, the biochemical properties of the 
G247D-D559X a nd G 247D-K584X B iP t runcation m utants w ere c ompared t o w ild-type a nd 
G247D BiP. Finally, prior to crystallization, the mul timeric s tatus of  each pr eparation was 
examined us ing s ize-exclusion c hromatography and na tive gel e lectrophoresis. Based on t hese 
results, conditions are being optimized to obtain a homogeneous protein preparation of G247D-
K584X BiP that contains a single oligomeric state.  
C.1 OPTIMIZATION OF PROTEIN PURIFICATION 
In this section, I outline an optimized protein purification protocol which yields around 60-100 
mg of protein at concentrations of 6-10 mg/ml. To arrive at this protocol, several modifications 
were made to a purification method that was described by McClellan et al., 1998151.  
C.1.1 Protein induction using the ZYP-5052 autoinduction medium 
(Note that the autoinduction medium can be used for IPTG-inducible proteins expressed from the 
T7 promoter only.) 
1. Grow overnight cultures (2*50mls) of the desired strain in LB-Amp (Ampicillin at a conc. of 
50ug/ml) at 37°C (~16-18hrs).  
2. The next day, spin down cells at 5000 rpm for 5 min. Resuspend in 2*20ml ZY media.  
3. Add t his t o 2*2L o f ZYP-5052+Amp i n 4 L Fermbach flasks (refer t o s ection C .1.3 for 
information with regards to ZY and ZYP-5052 media preparation).  
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4. Split each 2L volume into 4*500ml quantities in 1L flasks. Grow at 37°C until OD600 is close 
to 2. This could take anywhere from 4-6 h based on the E. coli strain. 
5. Once the desired OD600 is reached, grow at room temperature (23°C) for 24hrs.  
[Principle behind autoinduction
6. Harvest cells at 5000 rpm for 5 min (2*2L total). 
: When the OD600 is 2 or  higher, the cells enter stationary phase. 
During this s tage of  growth, they switch from u tilizing glucose as a  carbon source to ut ilizing 
lactose, which is when the protein of interest is induced.] 
7. Wash pellets with 2*200ml sterile double-distilled water 
8. W ash pe llets with 2*50ml sonication buffer (50m M HEPES, pH 7.4, 300mM NaCl, 10mM 
imidazole, 5mM β-mercaptaoethanol, 10%glycerol) and store pellets at -20°C. 
C.1.2 Protein purification 
Column 1- 
1. Thaw cells on i ce. Resuspend in 30 ml of sonication buffer. Add protease inhibitors (PMSF, 
pepstatin, leupeptin) to a final concentration 1mM.  
2. Sonicate cells at a medium setting for 6 x 30 seconds with 2 m inutes on ice in-between. The 
setting depends on the sonicator brand. 
3. Centrifuge at 10,000 rpm for 10 minutes in a Sorvall SS-34 rotor. This is to spin out cell debris 
and unbroken cells. 
4. Load the cleared cell lysate onto a 10 ml
5. W ash t he c olumn w ith t he f ollowing s olutions a nd s ave e ach wash for ana lysis b y S DS-
PAGE: 
 Ni2+-NTA column equilibrated in sonication buffer. 
Collect flow through. 
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Wash 0  50ml sonication buffer 
Wash 1  55ml sonication buffer + 1% Triton X-100 
Wash 2  55ml sonication buffer + 1M NaCl 
Wash 3  55ml sonication buffer + 5mM ATP 
Wash 4  55ml sonication buffer + 0.5M Tris, pH 7.4 
Wash 5  55ml sonication buffer + 25mM imidazole  
*Note that the column may turn grayish in color during the loading step and remain so during the 
first couple of washes. This isn’t anything to panic about! 
6. Elution: Add 40m L elution b uffer ( sonication b uffer + 250m M i midazole). C ollect 2m l 
fractions. Analyze b y S DS-PAGE and Coomassie B rilliant B lue s taining to determine pe ak 
fractions. 
Column 2- 
1. Pool the peak fractions from the first column and dilute 1:3 (to a maximum volume of 50ml) 
in buffer QA (20mM HEPES, pH 7.4, 150mM KCl, 5mM MgCl2, 10% Glycerol).  
2. Load slowly onto a  15ml
3. Wash and elute with the following solutions: 
 Q-Sepharose C olumn e quilibrated i n b uffer Q A; collect f low 
through. 
Wash 1   80ml buffer QA 
Wash 2  40ml buffer QB (20mM HEPES, pH 7.4, 350mM KCl, 5mM MgCl2, 10% Glycerol) 
Wash 3  20mL buffer QC (20mM HEPES, pH 7.4, 2.15M KCl, 5mM MgCl2, 10% Glycerol) 
(BiP truncation mutants bind poorly to the column. Any protein that does bind elutes in washes 1 and 2) 
4. Analyze b y SDS-PAGE and Coomassie Brilliant Blue s taining to determine pe ak fractions; 
pool. 
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Column 3- 
1. S lowly l oad the pool ed f ractions onto a  4ml
2. Elute with 24 ml of e lution buffer (20mM HEPES, pH 7.4, 150m M KCl, 5mM MgCl2, 250 
mM Imidazole,10% Glycerol ); collect 2 ml fractions. 
 Ni2+-NTA c olumn e quilibrated i n b uffer X ’ 
(20mM HEPES, pH 7.4, 150m M KCl, 5mM MgCl2, 10 mM Imidazole, 10% Glycerol); collect 
flow through. 
3. Analyze by SDS-PAGE and Coomassie Brilliant Blue staining to determine peak fractions. 
4. Alternatively, measure t he c oncentration of each fraction using a Bradford A ssay. T his is  
important if the protein of interest has a tendency to crash out of solution at high concentrations. 
Dialysis- 
1. Pool the peak fractions and dialyze overnight in the cold room (~16 h) in dialysis buffer (50 
mM Tris pH 7.4, 125 mM NaCl, 25 mM KCl, 10% Glycerol) at a ratio of 1 ml protein to1000 ml 
dialysis buffer. 
2. The next day, pool protein and determine concentration using a Bradford assay. Also, resolve 
the protein using SDS-PAGE and determine its concentration by comparison to BSA standards.  
3. The protein can be stored at 4°C for long periods of time.  
C.1.3 ZYP-5052 Autoinduction Media 
This is to be made directly before use; add in the following order 
ZY Media    1856ml 
1M MgSO4   2ml 
1000x Trace Metals Mix 2ml 
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50x5052   40ml 
20xNPS   100ml 
Antibiotics as needed. 
- ZY Media 
Tryptone  20g 
Yeast Extract  10g 
DDW   1860ml 
Autoclave 
- 1000x Trace Metals Mix (see next page) 
- 50x5052 
Glycerol by weight  125g 
DDW   365ml 
Glucose (dextrose) 12.5g 
Alpha-lactose  50g 
Autoclave 
- 20xNPS   
 Final conc. (200mM PO4, 25mM SO4, 50mM NH4, 100mM Na, 50mM K)  ph ~6.75 
DDW    800ml 
(NH4)2SO4  66g Ammonium Sulfate 
KH2PO4  136g (Monobasic) Potassium Phosphate 
Na2HPO4  142g Disodium Phosphate 
Autoclave 
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C.1.4 An example of the stepwise purification of G247D-K584X BiP  
Parts A to C of Figure 39 show Coomassie Brilliant Blue-stained denaturing polyacrylamide gels 
that were used to analyze the fractions obtained from each column of a sample G247D-K584X 
BiP preparation.  
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Figure 39: An example of the step-wise purification of G247D-K584X BiP. 
 The Coomassie Brilliant Blue s taining patterns of SDS-PAGE resolved f ractions obtained 
for G 247D-K584X BiP f rom (A) Column 1= Ni2+-NTA ag arose af finity chromatography, (B) 
Column 2= Q-sepharose ion e xchange c hromatography, a nd (C) Column 3=  Ni2+-NTA a garose 
affinity chromatography, are shown. The truncated protein migrates at the expected molecular mass 
of 60 kD a as indicated by its proximity to the 56 kD a band of the molecular mass marker. (D) A 
comparison of  t he i ndicated w ild-type ( WT) a nd m utant B iP pr oteins pur ified a ccording t o t he 
protocol described in section C.1. 3 µg of wild-type, G247D and G247D-K584X BiP and 1 µg of 
G247D-D559X B iP w ere r esolved b y S DS-PAGE a nd vi sualized by Coomassie B rilliant Blue 
staining.   
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 Using this optimized pr otocol, wild-type, G 247D, G 247D-K584X, a nd G247D-D559X 
BiP pr oteins w ere pur ified a t c oncentrations of  3.0, 5.5, 8.7 a nd 5.8 m g/ml, r espectively, i n 
volumes greater than 8 m l. Figure 39D depicts a  Coomassie Brilliant Blue-stained SDS-PAGE 
gel that was utilized to compare the wild-type and mutant BiP proteins.  
C.2 COMPARING THE BIOCHEMICAL PROPERTIES OF WILD-TYPE AND 
MUTANT BIP PROTEINS 
The first property that was analyzed was the ability of the wild-type and mutant BiP proteins to 
hydrolyze ATP (as described in chapter 2). It had previously been demonstrated that the ‘frozen’ 
conformation a dopted by G 247D BiP l eads t o a  de crease i n i ts A TP h ydrolysis r ate151. 
Accordingly, the endogenous ATPase activity of G247D BiP was found to be 0.75 nmol of ATP 
hydrolyzed/mg/min, nearly 4-fold lower than the endogenous ATPase activity of wild-type BiP 
(Figure 40). Similarly, the G247D-K584X, and G247D-D559X BiP truncation mutants exhibited 
greatly reduced ATPase activities. 
Next, the protease susceptibility patterns of the wild-type and mutant BiP proteins were 
examined in the presence of Proteinase K (as described in chapter 2). Preliminary observations 
indicate tha t w hile the  w ild-type p rotein und ergoes a  nuc leotide-dependent conformational 
change which is observed as a change in its protease susceptibility pattern, the three BiP mutants 
are confined to an ADP-bound conformation, as anticipated151 (data not shown). 
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Figure 40: A comparison of the endogenous ATPase activities of wild-type and 
mutant BiP proteins. 
 The e ndogenous A TPase a ctivities of  3 µg of  wild-type a nd mutant B iP is olates w as 
measured at 30°C. ATPase activity is expressed as nmoles of ATP hydrolyzed per milligram of 
protein per minute. Data represent the means of a minimum of two independent experiments. 
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C.3  CHARACTERIZATION OF THE MULTIMERIC STATE OF THE G247D-K584X 
AND G247D-D559X BIP MUTANTS 
Several studies with unique Hsp70s, including human BiP, have demonstrated that these proteins 
form hi gher order ol igomers, pr edominantly dimers, i n solution407-417. Therefore, t he n ext s tep 
involved the determination of the  mul timeric s tate of  G247D-K584X and G247D-D559X BiP. 
This information becomes especially important prior to crystallization because the presence of  
multiple oligomeric forms can affect crystal formation418.  
First, ~ 20 m g of  G 247D-D559X BiP w as s ubjected to size ex clusion chromatography 
using a  s ephacryl S -300 r esin i n a G E H ealthcare f ast pr otein l iquid c hromatography (FPLC) 
setup u sing t he buf fer: 50 m M T ris, pH  7.4, 1 25 m M N aCl, 25 m M KCl, 10%  g lycerol. A s 
fractions w ere be ing col lected, the U V abs orbance of  each fraction was measured at 280 nm, 
thus generating a column protein profile (Figure 41A, top panel). Intriguingly, G247D-D559X 
BiP separated as two distinct peaks suggesting that the protein preparation contained at least two 
different ol igomeric s tates. W hen t he fractions w ere s ubsequently resolved b y na tive gel 
electrophoresis f ollowed b y C oomassie Brilliant Blue s taining ( Figure 41A, bot tom pa nel), I 
found t hat t he f irst pe ak c ontained t wo di stinct ol igomeric s pecies while t he s econd pe ak 
contained a  t hird ol igomeric form. Furthermore, it appeared that t he ol igomers comprising the 
first peak could spontaneously convert into the third oligomeric form if  maintained in solution 
for extended pe riods of  time (data not  shown). This observation was no t encouraging b ecause 
crystal formation takes several weeks, and the equilibrium behavior of the oligomeric states of 
G247D-D559X BiP could abrogate the seeding of a crystal. 
Next, ~ 20 m g of  G 247D-K584X BiP w as s ubjected t o s ize e xclusion chromatography 
using a s ephacryl S -300 r esin i n a  s imilar F PLC s etup w ith t he buf fer: 50 m M 
 277 
 278 
Figure 41: Characterization of the multimeric states of G247D-D559X and G247D-
K584X BiP. 
 Size exclusion chromatography and native gel e lectrophoresis ( followed by Coomassie 
Brilliant B lue s taining) were pe rformed on (A) G247D-D559X B iP, a nd (B) G247D-K584X 
BiP. T he U V a bsorbance s pectra obt ained for e ach pr otein p reparation a re s hown and t he 
corresponding p eak fractions i ndicated. T he l ane de noted by a  ‘*’ acted a s a  m arker f or t he 
position of the monomeric species on the native gel. 
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Tris, pH 7.4, 125 m M NaCl, 25 m M KCl, 10% glycerol. The resulting column profile (Figure 
41B, t op pa nel) contained a  s ingle pe ak t hat c orresponded t o a  pr edominant l ower or der 
oligomer, with seemingly insignificant amounts of a higher order oligomer (Figure 41B, bottom 
panel). H owever, w hen t his pr eparation of G 247D-K584X BiP w as u tilized in preliminary 
crystallization attempts, the protein precipitated out of solution, suggesting that the higher order 
oligomer ne gatively affected crystal f ormation. Therefore, different con ditions w ere t ested to 
abolish the contaminating higher order oligomer. 
To this end, ~5 mg of G247D-K584X BiP was incubated on ice with the detergent, Triton 
X-100, at a final concentration of 0.05% and the reducing agent, DTT, at a final concentration of 
5 mM for 30 min, and subjected to size exclusion chromatography in the buffer: 50 mM Tris pH 
7.4, 125 m M N aCl, 25 m M K Cl, 0.05%  T riton X -100, 5 m M D TT, 10 % g lycerol. H owever, 
native gel electrophoresis of the resulting fractions showed that this treatment did not eliminate 
the higher order oligomer (Figure 42A). Next, the pH of the solutions used for columns 2 and 3 
during purification was altered from 7.4 to 8.2, in keeping with the crystallization attempts of rat 
Hsc7012. When the resulting protein, which remained soluble over extended periods of time, was 
analyzed using size exclusion chromatography in the buffer: 50 mM Tris, pH 8.2, 125 mM NaCl, 
25 mM KCl, 10% glycerol, followed by native gel electrophoresis, there was a reduction in the 
higher or der ol igomeric s pecies ( Figure 42B). Finally, s ize ex clusion chromatography was 
performed with the buffer: 50 mM Tris, pH 8.2, 475 mM NaCl, 25 mM KCl, 10% glycerol, and 
subsequent na tive gel e lectrophoresis de termined that the higher order ol igomer was abolished 
(Figure 42C). Taken together, these experiments indicate that G247D-K584X BiP purified at a 
pH of 8.2 can be resolved into a single oligomeric state when treated with high concentrations of 
salt (i.e., 500 mM). 
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Figure 42: Optimization of the conditions under which G247D-K584X BiP separates as 
a single oligomeric species. 
 Size e xclusion c hromatography f ollowed b y native ge l e lectrophoresis ( visualized u sing 
Coomassie B rilliant B lue s taining) w as pe rformed on G 247D-K584X B iP unde r t he f ollowing 
conditions: (A) 50 mM Tris, pH 7.4, 125 mM NaCl, 25 mM KCl, 0.05% Triton X-100, 5 mM DTT, 
10% glycerol, (B) 50 mM Tris, pH 8.2, 125 mM NaCl, 25 mM KCl, 10% glycerol, and (C) 50 mM 
Tris, pH 8.2, 475 m M NaCl, 25 m M KCl, 10% glycerol. * indicates the column load in denaturing 
sample buf fer, w hile t he num bers 1 -15 i ndicate t he fractions obt ained f rom s ize exclusion 
chromatography. 
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C.4  CONCLUSIONS AND FUTURE DIRECTIONS 
As s ummarized i n t he previous s ections, a  pu rification pr otocol h as b een opt imized t o yield 
highly enriched BiP pr oteins at  conc entrations t hat a re s ufficient f or c rystallization pur poses. 
Moreover, improved conditions to obtain a single oligomeric state of G247D-K584X BiP have 
been de termined. Therefore, t he immediate goal is t o obtain l arge amounts of  t his protein and 
crystallize it. In the future, the G247D mutant in the context of full-length BiP will be analyzed 
in a similar manner, and hopefully, crystallized. Importantly, data obtained from crystallographic 
studies will be corroborated using NMR analyses, following which mutagenesis studies will be 
performed to establish a structure-function correlation in vivo. 
 
 283 
BIBLIOGRAPHY 
1. Flaherty, K.M., DeLuca-Flaherty, C. & McKay, D.B. Three-dimensional structure of the 
ATPase fragment of a 70K heat-shock cognate protein. Nature 346, 623-8 (1990). 
2. Li, J., Qian, X. & Sha, B. The crystal structure of the yeast Hsp40 Ydj1 complexed with 
its peptide substrate. Structure 11, 1475-83 (2003). 
3. Denic, V., Quan, E.M. & Weissman, J.S. A luminal surveillance complex that selects 
misfolded glycoproteins for ER-associated degradation. Cell 126, 349-59 (2006). 
4. Corpet, F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 
16, 10881-90 (1988). 
5. Vembar, S.S. & Brodsky, J.L. One step at a time: endoplasmic reticulum-associated 
degradation. Nat Rev Mol Cell Biol 9, 944-57 (2008). 
6. Thrower, J.S., Hoffman, L., Rechsteiner, M. & Pickart, C.M. Recognition of the 
polyubiquitin proteolytic signal. EMBO J 19, 94-102 (2000). 
7. Jiang, J., Prasad, K., Lafer, E.M. & Sousa, R. Structural basis of interdomain 
communication in the Hsc70 chaperone. Mol Cell 20, 513-24 (2005). 
8. Jahn, T.R. & Radford, S.E. The Yin and Yang of protein folding. FEBS Journal 272, 
5962-5970 (2005). 
9. Zhu, X. et al. Structural analysis of substrate binding by the molecular chaperone DnaK. 
Science 272, 1606-14 (1996). 
10. Labarga, A., Valentin, F., Anderson, M. & Lopez, R. Web services at the European 
bioinformatics institute. Nucleic Acids Res 35, W6-11 (2007). 
11. Sayle, R.A. & Milner-White, E.J. RASMOL: biomolecular graphics for all. Trends 
Biochem Sci 20, 374 (1995). 
12. Chang, Y.W., Sun, Y.J., Wang, C. & Hsiao, C.D. Crystal structures of the 70-kDa heat 
shock proteins in domain disjoining conformation. J Biol Chem 283, 15502-11 (2008). 
13. Varshavsky, A. Discovery of cellular regulation by protein degradation. J Biol Chem 283, 
34469-89 (2008). 
14. Liu, Q. & Hendrickson, W.A. Insights into Hsp70 chaperone activity from a crystal 
structure of the yeast Hsp110 Sse1. Cell 131, 106-20 (2007). 
15. Jiang, J. et al. Structural basis of J cochaperone binding and regulation of Hsp70. Mol 
Cell 28, 422-33 (2007). 
16. Ellis, R.J. Macromolecular crowding: obvious but underappreciated. Trends Biochem Sci. 
26, 597-604 (2001). 
17. Despa, F., Orgill, D.P. & Lee, R.C. Molecular Crowding Effects on Protein Stability. 
Annals of the New York Academy of Sciences 1066, 54-66 (2005). 
18. Jahn, T.R. & Radford, S.E. Folding versus aggregation: polypeptide conformations on 
competing pathways. Arch Biochem Biophys 469, 100-17 (2008). 
 284 
19. Bukau, B., Weissman, J.S. & Horwich, A. Molecular Chaperones and Protein Quality 
Control. Cell 125, 443-451 (2006). 
20. Balch, W.E., Morimoto, R.I., Dillin, A. & Kelly, J.W. Adapting Proteostasis for Disease 
Intervention. Science 319, 916-919 (2008). 
21. Gaestel, M. Molecular chaperones in signal transduction. Handb Exp Pharmacol, 93-109 
(2006). 
22. Calderwood, S.K., Mambula, S.S. & Gray, P.J., Jr. Extracellular heat shock proteins in 
cell signaling and immunity. Ann N Y Acad Sci 1113, 28-39 (2007). 
23. Saibil, H. Molecular chaperones: containers and surfaces for folding, stabilising or 
unfolding proteins. Curr Opin Struct Biol 10, 251-8 (2000). 
24. Mayer, M.P. & Bukau, B. Hsp70 chaperones: cellular functions and molecular 
mechanism. Cell Mol Life Sci 62, 670-84 (2005). 
25. Young, J.C., Barral, J.M. & Ulrich Hartl, F. More than folding: localized functions of 
cytosolic chaperones. Trends Biochem Sci 28, 541-7 (2003). 
26. Liberek, K., Lewandowska, A. & Zietkiewicz, S. Chaperones in control of protein 
disaggregation. EMBO J 27, 328-35 (2008). 
27. Rapoport, T.A. Protein translocation across the eukaryotic endoplasmic reticulum and 
bacterial plasma membranes. Nature 450, 663-9 (2007). 
28. Macario, A.J. & Conway de Macario, E. Molecular chaperones: multiple functions, 
pathologies, and potential applications. Front Biosci 12, 2588-600 (2007). 
29. Eisenberg, E. & Greene, L.E. Multiple roles of auxilin and hsc70 in clathrin-mediated 
endocytosis. Traffic 8, 640-6 (2007). 
30. Takayama, S., Reed, J.C. & Homma, S. Heat-shock proteins as regulators of apoptosis. 
Oncogene 22, 9041-7 (2003). 
31. Daugaard, M., Rohde, M. & Jaattela, M. The heat shock protein 70 family: Highly 
homologous proteins with overlapping and distinct functions. FEBS Lett 581, 3702-10 
(2007). 
32. Nishikawa, S., Brodsky, J.L. & Nakatsukasa, K. Roles of molecular chaperones in 
endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD). J 
Biochem 137, 551-5 (2005). 
33. Buck, T.M., Wright, C.M. & Brodsky, J.L. The activities and function of molecular 
chaperones in the endoplasmic reticulum. Semin Cell Dev Biol 18, 751-61 (2007). 
34. Haas, I.G. & Wabl, M. Immunoglobulin heavy chain binding protein. Nature 306, 387-9 
(1983). 
35. Munro, S. & Pelham, H.R. An Hsp70-like protein in the ER: identity with the 78 kd 
glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 46, 291-
300 (1986). 
36. Polaina, J. & Conde, J. Genes involved in the control of nuclear fusion during the sexual 
cycle of Saccharomyces cerevisiae. Mol Gen Genet 186, 253-8 (1982). 
37. Rose, M.D., Misra, L.M. & Vogel, J.P. KAR2, a karyogamy gene, is the yeast homolog 
of the mammalian BiP/GRP78 gene. Cell 57, 1211-21 (1989). 
38. Normington, K., Kohno, K., Kozutsumi, Y., Gething, M.J. & Sambrook, J. S. cerevisiae 
encodes an essential protein homologous in sequence and function to mammalian BiP. 
Cell 57, 1223-36 (1989). 
 285 
39. Shiu, R.P., Pouyssegur, J. & Pastan, I. Glucose depletion accounts for the induction of 
two transformation-sensitive membrane proteinsin Rous sarcoma virus-transformed chick 
embryo fibroblasts. Proc Natl Acad Sci U S A 74, 3840-4 (1977). 
40. Pouyssegur, J., Shiu, R.P. & Pastan, I. Induction of two transformation-sensitive 
membrane polypeptides in normal fibroblasts by a block in glycoprotein synthesis or 
glucose deprivation. Cell 11, 941-7 (1977). 
41. Carla Fama, M. et al. The Saccharomyces cerevisiae YFR041C/ERJ5 gene encoding a 
type I membrane protein with a J domain is required to preserve the folding capacity of 
the endoplasmic reticulum. Biochim Biophys Acta 1773, 232-42 (2007). 
42. Brightman, S.E., Blatch, G.L. & Zetter, B.R. Isolation of a mouse cDNA encoding MTJ1, 
a new murine member of the DnaJ family of proteins. Gene 153, 249-54 (1995). 
43. Skowronek, M.H., Rotter, M. & Haas, I.G. Molecular characterization of a novel 
mammalian DnaJ-like Sec63p homolog. Biol Chem 380, 1133-8 (1999). 
44. Tyedmers, J. et al. Homologs of the yeast Sec complex subunits Sec62p and Sec63p are 
abundant proteins in dog pancreas microsomes. Proc Natl Acad Sci U S A 97, 7214-9 
(2000). 
45. Bies, C. et al. A Scj1p homolog and folding catalysts present in dog pancreas 
microsomes. Biol Chem 380, 1175-82 (1999). 
46. Yu, M., Haslam, R.H. & Haslam, D.B. HEDJ, an Hsp40 co-chaperone localized to the 
endoplasmic reticulum of human cells. J Biol Chem 275, 24984-92 (2000). 
47. Lau, P.P. et al. A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B 
mRNA editing. J Biol Chem 276, 46445-52 (2001). 
48. Prols, F. et al. Upregulation of the cochaperone Mdg1 in endothelial cells is induced by 
stress and during in vitro angiogenesis. Exp Cell Res 269, 42-53 (2001). 
49. Shen, Y., Meunier, L. & Hendershot, L.M. Identification and characterization of a novel 
endoplasmic reticulum (ER) DnaJ homologue, which stimulates ATPase activity of BiP 
in vitro and is induced by ER stress. J Biol Chem 277, 15947-56 (2002). 
50. Cunnea, P.M. et al. ERdj5, an endoplasmic reticulum (ER)-resident protein containing 
DnaJ and thioredoxin domains, is expressed in secretory cells or following ER stress. J 
Biol Chem 278, 1059-66 (2003). 
51. Hosoda, A., Kimata, Y., Tsuru, A. & Kohno, K. JPDI, a novel endoplasmic reticulum-
resident protein containing both a BiP-interacting J-domain and thioredoxin-like motifs. J 
Biol Chem 278, 2669-76 (2003). 
52. Lee, T.G., Tang, N., Thompson, S., Miller, J. & Katze, M.G. The 58,000-dalton cellular 
inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) 
is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol 14, 2331-42 
(1994). 
53. Barber, G.N. et al. The 58-kilodalton inhibitor of the interferon-induced double-stranded 
RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic 
properties. Proc Natl Acad Sci U S A 91, 4278-82 (1994). 
54. Tang, N.M., Ho, C.Y. & Katze, M.G. The 58-kDa cellular inhibitor of the double 
stranded RNA-dependent protein kinase requires the tetratricopeptide repeat 6 and DnaJ 
motifs to stimulate protein synthesis in vivo. J Biol Chem 271, 28660-6 (1996). 
55. Saito, H. & Uchida, H. Initiation of the DNA replication of bacteriophage lambda in 
Escherichia coli K12. J Mol Biol 113, 1-25 (1977). 
 286 
56. Yochem, J. et al. Genetic analysis of two genes, dnaJ and dnaK, necessary for 
Escherichia coli and bacteriophage lambda DNA replication. Mol Gen Genet 164, 9-14 
(1978). 
57. Saito, H. & Uchida, H. Organization and expression of the dnaJ and dnaK genes of 
Escherichia coli K12. Mol Gen Genet 164, 1-8 (1978). 
58. Tilly, K., McKittrick, N., Zylicz, M. & Georgopoulos, C. The dnaK protein modulates 
the heat-shock response of Escherichia coli. Cell 34, 641-6 (1983). 
59. Sousa, R. & Lafer, E.M. Keep the traffic moving: mechanism of the Hsp70 motor. Traffic 
7, 1596-603 (2006). 
60. Genevaux, P., Georgopoulos, C. & Kelley, W.L. The Hsp70 chaperone machines of 
Escherichia coli: a paradigm for the repartition of chaperone functions. Mol Microbiol 66, 
840-57 (2007). 
61. Saibil, H.R. Chaperone machines in action. Curr Opin Struct Biol 18, 35-42 (2008). 
62. Meimaridou, E., Gooljar, S.B. & Chapple, J.P. From hatching to dispatching: the multiple 
cellular roles of the Hsp70 molecular chaperone machinery. J Mol Endocrinol 42, 1-9 
(2009). 
63. Zylicz, M., LeBowitz, J.H., McMacken, R. & Georgopoulos, C. The dnaK protein of 
Escherichia coli possesses an ATPase and autophosphorylating activity and is essential in 
an in vitro DNA replication system. Proc Natl Acad Sci U S A 80, 6431-5 (1983). 
64. Macejak, D., Rayfield, M. & Luftig, R. Isolation and characterization of human HSP70 
expressed in Escherichia coli. Arch Biochem Biophys 280, 53-60 (1990). 
65. Barany, M. ATPase activity of myosin correlated with speed of muscle shortening. J Gen 
Physiol 50, Suppl:197-218 (1967). 
66. Hennessy, F., Nicoll, W.S., Zimmermann, R., Cheetham, M.E. & Blatch, G.L. Not all J 
domains are created equal: implications for the specificity of Hsp40-Hsp70 interactions. 
Protein Sci 14, 1697-709 (2005). 
67. Rudiger, S., Schneider-Mergener, J. & Bukau, B. Its substrate specificity characterizes 
the DnaJ co-chaperone as a scanning factor for the DnaK chaperone. EMBO J 20, 1042-
50 (2001). 
68. Craig, E.A., Huang, P., Aron, R. & Andrew, A. The diverse roles of J-proteins, the 
obligate Hsp70 co-chaperone. Rev Physiol Biochem Pharmacol 156, 1-21 (2006). 
69. Ziegelhoffer, T., Lopez-Buesa, P. & Craig, E.A. The dissociation of ATP from hsp70 of 
Saccharomyces cerevisiae is stimulated by both Ydj1p and peptide substrates. J Biol 
Chem 270, 10412-9 (1995). 
70. Mayer, M., Reinstein, J. & Buchner, J. Modulation of the ATPase cycle of BiP by 
peptides and proteins. J Mol Biol 330, 137-44 (2003). 
71. Buchberger, A., Valencia, A., McMacken, R., Sander, C. & Bukau, B. The chaperone 
function of DnaK requires the coupling of ATPase activity with substrate binding through 
residue E171. EMBO J 13, 1687-95 (1994). 
72. Burkholder, W.F. et al. Isolation and characterization of an Escherichia coli DnaK mutant 
with impaired ATPase activity. J Mol Biol 242, 364-77 (1994). 
73. Hendershot, L.M. et al. In vivo expression of mammalian BiP ATPase mutants causes 
disruption of the endoplasmic reticulum. Mol Biol Cell 6, 283-96 (1995). 
74. Hendershot, L. et al. Inhibition of immunoglobulin folding and secretion by dominant 
negative BiP ATPase mutants. Proc Natl Acad Sci U S A 93, 5269-74 (1996). 
 287 
75. O'Brien, M.C., Flaherty, K.M. & McKay, D.B. Lysine 71 of the chaperone protein Hsc70 
Is essential for ATP hydrolysis. J Biol Chem 271, 15874-8 (1996). 
76. Hurley, J.H. The sugar kinase/heat shock protein 70/actin superfamily: implications of 
conserved structure for mechanism. Annu Rev Biophys Biomol Struct 25, 137-62 (1996). 
77. Kassenbrock, C.K. & Kelly, R.B. Interaction of heavy chain binding protein 
(BiP/GRP78) with adenine nucleotides. EMBO J 8, 1461-7 (1989). 
78. Revington, M., Zhang, Y., Yip, G.N., Kurochkin, A.V. & Zuiderweg, E.R. NMR 
investigations of allosteric processes in a two-domain Thermus thermophilus Hsp70 
molecular chaperone. J Mol Biol 349, 163-83 (2005). 
79. Swain, J.F. et al. Hsp70 chaperone ligands control domain association via an allosteric 
mechanism mediated by the interdomain linker. Mol Cell 26, 27-39 (2007). 
80. Vogel, M., Mayer, M.P. & Bukau, B. Allosteric regulation of Hsp70 chaperones involves 
a conserved interdomain linker. J Biol Chem 281, 38705-11 (2006). 
81. Vogel, M., Bukau, B. & Mayer, M.P. Allosteric regulation of Hsp70 chaperones by a 
proline switch. Mol Cell 21, 359-67 (2006). 
82. Moro, F., Fernandez-Saiz, V. & Muga, A. The lid subdomain of DnaK is required for the 
stabilization of the substrate-binding site. J Biol Chem 279, 19600-6 (2004). 
83. Fernandez-Saiz, V., Moro, F., Arizmendi, J.M., Acebron, S.P. & Muga, A. Ionic contacts 
at DnaK substrate binding domain involved in the allosteric regulation of lid dynamics. J 
Biol Chem 281, 7479-88 (2006). 
84. Raviol, H., Sadlish, H., Rodriguez, F., Mayer, M.P. & Bukau, B. Chaperone network in 
the yeast cytosol: Hsp110 is revealed as an Hsp70 nucleotide exchange factor. EMBO J 
25, 2510-8 (2006). 
85. Andreasson, C., Fiaux, J., Rampelt, H., Mayer, M.P. & Bukau, B. Hsp110 is a nucleotide-
activated exchange factor for Hsp70. J Biol Chem 283, 8877-84 (2008). 
86. Harrison, C.J., Hayer-Hartl, M., Di Liberto, M., Hartl, F. & Kuriyan, J. Crystal structure 
of the nucleotide exchange factor GrpE bound to the ATPase domain of the molecular 
chaperone DnaK. Science 276, 431-5 (1997). 
87. Sondermann, H. et al. Structure of a Bag/Hsc70 complex: convergent functional 
evolution of Hsp70 nucleotide exchange factors. Science 291, 1553-7 (2001). 
88. Polier, S., Dragovic, Z., Hartl, F.U. & Bracher, A. Structural basis for the cooperation of 
Hsp70 and Hsp110 chaperones in protein folding. Cell 133, 1068-79 (2008). 
89. Schuermann, J.P. et al. Structure of the Hsp110:Hsc70 nucleotide exchange machine. Mol 
Cell 31, 232-43 (2008). 
90. Shomura, Y. et al. Regulation of Hsp70 function by HspBP1: structural analysis reveals 
an alternate mechanism for Hsp70 nucleotide exchange. Mol Cell 17, 367-79 (2005). 
91. Suh, W.C. et al. Interaction of the Hsp70 molecular chaperone, DnaK, with its 
cochaperone DnaJ. Proc Natl Acad Sci U S A 95, 15223-8 (1998). 
92. Suh, W.C., Lu, C.Z. & Gross, C.A. Structural features required for the interaction of the 
Hsp70 molecular chaperone DnaK with its cochaperone DnaJ. J Biol Chem 274, 30534-9 
(1999). 
93. Rothblatt, J.A., Deshaies, R.J., Sanders, S.L., Daum, G. & Schekman, R. Multiple genes 
are required for proper insertion of secretory proteins into the endoplasmic reticulum in 
yeast. J Cell Biol 109, 2641-52 (1989). 
 288 
94. Sadler, I. et al. A yeast gene important for protein assembly into the endoplasmic 
reticulum and the nucleus has homology to DnaJ, an Escherichia coli heat shock protein. 
J Cell Biol 109, 2665-75 (1989). 
95. Feldheim, D., Rothblatt, J. & Schekman, R. Topology and functional domains of Sec63p, 
an endoplasmic reticulum membrane protein required for secretory protein translocation. 
Mol Cell Biol 12, 3288-96 (1992). 
96. Deshaies, R.J., Sanders, S.L., Feldheim, D.A. & Schekman, R. Assembly of yeast Sec 
proteins involved in translocation into the endoplasmic reticulum into a membrane-bound 
multisubunit complex. Nature 349, 806-8 (1991). 
97. Jermy, A.J., Willer, M., Davis, E., Wilkinson, B.M. & Stirling, C.J. The Brl domain in 
Sec63p is required for assembly of functional endoplasmic reticulum translocons. J Biol 
Chem 281, 7899-906 (2006). 
98. Brodsky, J.L. & Schekman, R. A Sec63p-BiP complex from yeast is required for protein 
translocation in a reconstituted proteoliposome. J Cell Biol 123, 1355-63 (1993). 
99. Matlack, K.E., Plath, K., Misselwitz, B. & Rapoport, T.A. Protein transport by purified 
yeast Sec complex and Kar2p without membranes. Science 277, 938-41 (1997). 
100. Panzner, S., Dreier, L., Hartmann, E., Kostka, S. & Rapoport, T.A. Posttranslational 
protein transport in yeast reconstituted with a purified complex of Sec proteins and 
Kar2p. Cell 81, 561-70 (1995). 
101. Green, N., Fang, H. & Walter, P. Mutants in three novel complementation groups inhibit 
membrane protein insertion into and soluble protein translocation across the endoplasmic 
reticulum membrane of Saccharomyces cerevisiae. J Cell Biol 116, 597-604 (1992). 
102. Feldheim, D., Yoshimura, K., Admon, A. & Schekman, R. Structural and functional 
characterization of Sec66p, a new subunit of the polypeptide translocation apparatus in 
the yeast endoplasmic reticulum. Mol Biol Cell 4, 931-9 (1993). 
103. Feldheim, D. & Schekman, R. Sec72p contributes to the selective recognition of signal 
peptides by the secretory polypeptide translocation complex. J Cell Biol 126, 935-43 
(1994). 
104. Kurihara, T. & Silver, P. Suppression of a sec63 mutation identifies a novel component 
of the yeast endoplasmic reticulum translocation apparatus. Mol Biol Cell 4, 919-30 
(1993). 
105. Lyman, S.K. & Schekman, R. Binding of secretory precursor polypeptides to a translocon 
subcomplex is regulated by BiP. Cell 88, 85-96 (1997). 
106. Fang, H. & Green, N. Nonlethal sec71-1 and sec72-1 mutations eliminate proteins 
associated with the Sec63p-BiP complex from S. cerevisiae. Mol Biol Cell 5, 933-42 
(1994). 
107. Brodsky, J.L., Hamamoto, S., Feldheim, D. & Schekman, R. Reconstitution of protein 
translocation from solubilized yeast membranes reveals topologically distinct roles for 
BiP and cytosolic Hsc70. J Cell Biol 120, 95-102 (1993). 
108. Scidmore, M.A., Okamura, H.H. & Rose, M.D. Genetic interactions between KAR2 and 
SEC63, encoding eukaryotic homologues of DnaK and DnaJ in the endoplasmic 
reticulum. Mol Biol Cell 4, 1145-59 (1993). 
109. Brodsky, J.L., Goeckeler, J. & Schekman, R. BiP and Sec63p are required for both co- 
and posttranslational protein translocation into the yeast endoplasmic reticulum. Proc 
Natl Acad Sci U S A 92, 9643-6 (1995). 
 289 
110. Lyman, S.K. & Schekman, R. Interaction between BiP and Sec63p is required for the 
completion of protein translocation into the ER of Saccharomyces cerevisiae. J Cell Biol 
131, 1163-71 (1995). 
111. Corsi, A.K. & Schekman, R. The lumenal domain of Sec63p stimulates the ATPase 
activity of BiP and mediates BiP recruitment to the translocon in Saccharomyces 
cerevisiae. J Cell Biol 137, 1483-93 (1997). 
112. Misselwitz, B., Staeck, O., Matlack, K.E. & Rapoport, T.A. Interaction of BiP with the J-
domain of the Sec63p component of the endoplasmic reticulum protein translocation 
complex. J Biol Chem 274, 20110-5 (1999). 
113. Matlack, K.E., Misselwitz, B., Plath, K. & Rapoport, T.A. BiP acts as a molecular ratchet 
during posttranslational transport of prepro-alpha factor across the ER membrane. Cell 
97, 553-64 (1999). 
114. Young, B.P., Craven, R.A., Reid, P.J., Willer, M. & Stirling, C.J. Sec63p and Kar2p are 
required for the translocation of SRP-dependent precursors into the yeast endoplasmic 
reticulum in vivo. EMBO J 20, 262-71 (2001). 
115. Hamman, B.D., Hendershot, L.M. & Johnson, A.E. BiP maintains the permeability 
barrier of the ER membrane by sealing the lumenal end of the translocon pore before and 
early in translocation. Cell 92, 747-58 (1998). 
116. Alder, N.N., Shen, Y., Brodsky, J.L., Hendershot, L.M. & Johnson, A.E. The molecular 
mechanisms underlying BiP-mediated gating of the Sec61 translocon of the endoplasmic 
reticulum. J Cell Biol 168, 389-99 (2005). 
117. Blumberg, H. & Silver, P.A. A homologue of the bacterial heat-shock gene DnaJ that 
alters protein sorting in yeast. Nature 349, 627-30 (1991). 
118. Schlenstedt, G., Harris, S., Risse, B., Lill, R. & Silver, P.A. A yeast DnaJ homologue, 
Scj1p, can function in the endoplasmic reticulum with BiP/Kar2p via a conserved domain 
that specifies interactions with Hsp70s. J Cell Biol 129, 979-88 (1995). 
119. Silberstein, S., Schlenstedt, G., Silver, P.A. & Gilmore, R. A role for the DnaJ 
homologue Scj1p in protein folding in the yeast endoplasmic reticulum. J Cell Biol 143, 
921-33 (1998). 
120. Nishikawa, S.I., Fewell, S.W., Kato, Y., Brodsky, J.L. & Endo, T. Molecular chaperones 
in the yeast endoplasmic reticulum maintain the solubility of proteins for 
retrotranslocation and degradation. J Cell Biol 153, 1061-70 (2001). 
121. Jonikas, M.C. et al. Comprehensive characterization of genes required for protein folding 
in the endoplasmic reticulum. Science 323, 1693-7 (2009). 
122. Nishikawa, S. & Endo, T. The yeast JEM1p is a DnaJ-like protein of the endoplasmic 
reticulum membrane required for nuclear fusion. J Biol Chem 272, 12889-92 (1997). 
123. Nishikawa, S. & Endo, T. Reinvestigation of the functions of the hydrophobic segment of 
Jem1p, a yeast endoplasmic reticulum membrane protein mediating nuclear fusion. 
Biochem Biophys Res Commun 244, 785-9 (1998). 
124. Marcus, N.Y., Marcus, R.A., Schmidt, B.Z. & Haslam, D.B. Contribution of the 
HEDJ/ERdj3 cysteine-rich domain to substrate interactions. Arch Biochem Biophys 468, 
147-58 (2007). 
125. Jin, Y., Zhuang, M. & Hendershot, L.M. ERdj3, a luminal ER DnaJ homologue, binds 
directly to unfolded proteins in the mammalian ER: identification of critical residues. 
Biochemistry 48, 41-9 (2009). 
 290 
126. Caplan, A.J. & Douglas, M.G. Characterization of YDJ1: a yeast homologue of the 
bacterial dnaJ protein. J Cell Biol 114, 609-21 (1991). 
127. Cyr, D.M., Lu, X. & Douglas, M.G. Regulation of Hsp70 function by a eukaryotic DnaJ 
homolog. J Biol Chem 267, 20927-31 (1992). 
128. Meunier, L., Usherwood, Y.K., Chung, K.T. & Hendershot, L.M. A subset of chaperones 
and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind 
nascent proteins. Mol Biol Cell 13, 4456-69 (2002). 
129. Shen, Y. & Hendershot, L.M. ERdj3, a stress-inducible endoplasmic reticulum DnaJ 
homologue, serves as a cofactor for BiP's interactions with unfolded substrates. Mol Biol 
Cell 16, 40-50 (2005). 
130. Jin, Y., Awad, W., Petrova, K. & Hendershot, L.M. Regulated release of ERdj3 from 
unfolded proteins by BiP. EMBO J 27, 2873-82 (2008). 
131. Petrova, K., Oyadomari, S., Hendershot, L.M. & Ron, D. Regulated association of 
misfolded endoplasmic reticulum lumenal proteins with P58/DNAJc3. EMBO J 27, 2862-
72 (2008). 
132. Boisrame, A., Beckerich, J.M. & Gaillardin, C. Sls1p, an endoplasmic reticulum 
component, is involved in the protein translocation process in the yeast Yarrowia 
lipolytica. J Biol Chem 271, 11668-75 (1996). 
133. Boisrame, A., Kabani, M., Beckerich, J.M., Hartmann, E. & Gaillardin, C. Interaction of 
Kar2p and Sls1p is required for efficient co-translational translocation of secreted 
proteins in the yeast Yarrowia lipolytica. J Biol Chem 273, 30903-8 (1998). 
134. Kabani, M., Beckerich, J.M. & Gaillardin, C. Sls1p stimulates Sec63p-mediated 
activation of Kar2p in a conformation-dependent manner in the yeast endoplasmic 
reticulum. Mol Cell Biol 20, 6923-34 (2000). 
135. Tyson, J.R. & Stirling, C.J. LHS1 and SIL1 provide a lumenal function that is essential 
for protein translocation into the endoplasmic reticulum. EMBO J 19, 6440-52 (2000). 
136. Craven, R.A., Egerton, M. & Stirling, C.J. A novel Hsp70 of the yeast ER lumen is 
required for the efficient translocation of a number of protein precursors. EMBO J 15, 
2640-50 (1996). 
137. Baxter, B.K., James, P., Evans, T. & Craig, E.A. SSI1 encodes a novel Hsp70 of the 
Saccharomyces cerevisiae endoplasmic reticulum. Mol Cell Biol 16, 6444-56 (1996). 
138. Saris, N., Holkeri, H., Craven, R.A., Stirling, C.J. & Makarow, M. The Hsp70 homologue 
Lhs1p is involved in a novel function of the yeast endoplasmic reticulum, refolding and 
stabilization of heat-denatured protein aggregates. J Cell Biol 137, 813-24 (1997). 
139. Steel, G.J., Fullerton, D.M., Tyson, J.R. & Stirling, C.J. Coordinated activation of Hsp70 
chaperones. Science 303, 98-101 (2004). 
140. Weitzmann, A., Volkmer, J. & Zimmermann, R. The nucleotide exchange factor activity 
of Grp170 may explain the non-lethal phenotype of loss of Sil1 function in man and 
mouse. FEBS Lett 580, 5237-40 (2006). 
141. Goeckeler, J.L., Stephens, A., Lee, P., Caplan, A.J. & Brodsky, J.L. Overexpression of 
yeast Hsp110 homolog Sse1p suppresses ydj1-151 thermosensitivity and restores Hsp90-
dependent activity. Mol Biol Cell 13, 2760-70 (2002). 
142. Kimura, T. et al. Interactions among yeast protein-disulfide isomerase proteins and 
endoplasmic reticulum chaperone proteins influence their activities. J Biol Chem 280, 
31438-41 (2005). 
 291 
143. Gillece, P., Luz, J.M., Lennarz, W.J., de La Cruz, F.J. & Romisch, K. Export of a 
cysteine-free misfolded secretory protein from the endoplasmic reticulum for degradation 
requires interaction with protein disulfide isomerase. J Cell Biol 147, 1443-56 (1999). 
144. Takeuchi, M., Kimata, Y., Hirata, A., Oka, M. & Kohno, K. Saccharomyces cerevisiae 
Rot1p is an ER-localized membrane protein that may function with BiP/Kar2p in protein 
folding. J Biochem 139, 597-605 (2006). 
145. Takeuchi, M., Kimata, Y. & Kohno, K. Saccharomyces cerevisiae Rot1 is an essential 
molecular chaperone in the endoplasmic reticulum. Mol Biol Cell 19, 3514-25 (2008). 
146. Deshaies, R.J. & Schekman, R. A yeast mutant defective at an early stage in import of 
secretory protein precursors into the endoplasmic reticulum. J Cell Biol 105, 633-45 
(1987). 
147. Esnault, Y., Blondel, M.O., Deshaies, R.J., Scheckman, R. & Kepes, F. The yeast SSS1 
gene is essential for secretory protein translocation and encodes a conserved protein of 
the endoplasmic reticulum. EMBO J 12, 4083-93 (1993). 
148. Esnault, Y., Feldheim, D., Blondel, M.O., Schekman, R. & Kepes, F. SSS1 encodes a 
stabilizing component of the Sec61 subcomplex of the yeast protein translocation 
apparatus. J Biol Chem 269, 27478-85 (1994). 
149. Toikkanen, J. et al. Yeast protein translocation complex: isolation of two genes SEB1 and 
SEB2 encoding proteins homologous to the Sec61 beta subunit. Yeast 12, 425-38 (1996). 
150. Sanders, S.L., Whitfield, K.M., Vogel, J.P., Rose, M.D. & Schekman, R.W. Sec61p and 
BiP directly facilitate polypeptide translocation into the ER. Cell 69, 353-65 (1992). 
151. McClellan, A.J. et al. Specific molecular chaperone interactions and an ATP-dependent 
conformational change are required during posttranslational protein translocation into the 
yeast ER. Mol Biol Cell 9, 3533-45 (1998). 
152. Deshaies, R.J. & Schekman, R. SEC62 encodes a putative membrane protein required for 
protein translocation into the yeast endoplasmic reticulum. J Cell Biol 109, 2653-64 
(1989). 
153. Deshaies, R.J. & Schekman, R. Structural and functional dissection of Sec62p, a 
membrane-bound component of the yeast endoplasmic reticulum protein import 
machinery. Mol Cell Biol 10, 6024-35 (1990). 
154. Meyer, H.A. et al. Mammalian Sec61 is associated with Sec62 and Sec63. J Biol Chem 
275, 14550-7 (2000). 
155. Gorlich, D., Hartmann, E., Prehn, S. & Rapoport, T.A. A protein of the endoplasmic 
reticulum involved early in polypeptide translocation. Nature 357, 47-52 (1992). 
156. Osborne, A.R., Rapoport, T.A. & van den Berg, B. Protein translocation by the 
Sec61/SecY channel. Annu Rev Cell Dev Biol 21, 529-50 (2005). 
157. McCormick, P.J., Miao, Y., Shao, Y., Lin, J. & Johnson, A.E. Cotranslational protein 
integration into the ER membrane is mediated by the binding of nascent chains to 
translocon proteins. Mol Cell 12, 329-41 (2003). 
158. Wiedmann, M., Goerlich, D., Hartmann, E., Kurzchalia, T.V. & Rapoport, T.A. 
Photocrosslinking demonstrates proximity of a 34 kDa membrane protein to different 
portions of preprolactin during translocation through the endoplasmic reticulum. FEBS 
Lett 257, 263-8 (1989). 
159. Bohni, P.C., Deshaies, R.J. & Schekman, R.W. SEC11 is required for signal peptide 
processing and yeast cell growth. J Cell Biol 106, 1035-42 (1988). 
 292 
160. Fang, H., Panzner, S., Mullins, C., Hartmann, E. & Green, N. The homologue of 
mammalian SPC12 is important for efficient signal peptidase activity in Saccharomyces 
cerevisiae. J Biol Chem 271, 16460-5 (1996). 
161. Mullins, C., Meyer, H.A., Hartmann, E., Green, N. & Fang, H. Structurally related Spc1p 
and Spc2p of yeast signal peptidase complex are functionally distinct. J Biol Chem 271, 
29094-9 (1996). 
162. Fang, H., Mullins, C. & Green, N. In addition to SEC11, a newly identified gene, SPC3, 
is essential for signal peptidase activity in the yeast endoplasmic reticulum. J Biol Chem 
272, 13152-8 (1997). 
163. Meyer, H.A. & Hartmann, E. The yeast SPC22/23 homolog Spc3p is essential for signal 
peptidase activity. J Biol Chem 272, 13159-64 (1997). 
164. Helenius, A. & Aebi, M. Roles of N-linked glycans in the endoplasmic reticulum. Annu 
Rev Biochem 73, 1019-49 (2004). 
165. Hebert, D.N., Garman, S.C. & Molinari, M. The glycan code of the endoplasmic 
reticulum: asparagine-linked carbohydrates as protein maturation and quality-control 
tags. Trends Cell Biol 15, 364-70 (2005). 
166. Simons, J.F., Ferro-Novick, S., Rose, M.D. & Helenius, A. BiP/Kar2p serves as a 
molecular chaperone during carboxypeptidase Y folding in yeast. J Cell Biol 130, 41-9 
(1995). 
167. Swanton, E. & Bulleid, N.J. Protein folding and translocation across the endoplasmic 
reticulum membrane. Mol Membr Biol 20, 99-104 (2003). 
168. Skach, W.R. The expanding role of the ER translocon in membrane protein folding. J 
Cell Biol 179, 1333-5 (2007). 
169. Gething, M.J. Role and regulation of the ER chaperone BiP. Semin Cell Dev Biol 10, 
465-72 (1999). 
170. Hendershot, L.M. The ER function BiP is a master regulator of ER function. Mt Sinai J 
Med 71, 289-97 (2004). 
171. Blond-Elguindi, S. et al. Affinity panning of a library of peptides displayed on 
bacteriophages reveals the binding specificity of BiP. Cell 75, 717-28 (1993). 
172. Flynn, G.C., Pohl, J., Flocco, M.T. & Rothman, J.E. Peptide-binding specificity of the 
molecular chaperone BiP. Nature 353, 726-30 (1991). 
173. Ghaemmaghami, S. et al. Global analysis of protein expression in yeast. Nature 425, 737-
41 (2003). 
174. Kanapin, A. et al. Mouse proteome analysis. Genome Res 13, 1335-44 (2003). 
175. Ellgaard, L. & Helenius, A. Quality control in the endoplasmic reticulum. Nat Rev Mol 
Cell Biol 4, 181-91 (2003). 
176. McCracken, A.A. & Brodsky, J.L. Assembly of ER-associated protein degradation in 
vitro: dependence on cytosol, calnexin, and ATP. J Cell Biol 132, 291-8 (1996). 
177. Nair, U. & Klionsky, D.J. Molecular mechanisms and regulation of specific and 
nonspecific autophagy pathways in yeast. J Biol Chem 280, 41785-8 (2005). 
178. Kassenbrock, C.K., Garcia, P.D., Walter, P. & Kelly, R.B. Heavy-chain binding protein 
recognizes aberrant polypeptides translocated in vitro. Nature 333, 90-3 (1988). 
179. Knittler, M.R., Dirks, S. & Haas, I.G. Molecular chaperones involved in protein 
degradation in the endoplasmic reticulum: quantitative interaction of the heat shock 
cognate protein BiP with partially folded immunoglobulin light chains that are degraded 
in the endoplasmic reticulum. Proc Natl Acad Sci U S A 92, 1764-8 (1995). 
 293 
180. Dong, M., Bridges, J.P., Apsley, K., Xu, Y. & Weaver, T.E. ERdj4 and ERdj5 Are 
Required for Endoplasmic Reticulum-associated Protein Degradation of Misfolded 
Surfactant Protein C. Mol Biol Cell 19, 2620-30 (2008). 
181. Kabani, M. et al. Dependence of endoplasmic reticulum-associated degradation on the 
peptide binding domain and concentration of BiP. Mol Biol Cell 14, 3437-48 (2003). 
182. Hammond, C. & Helenius, A. Folding of VSV G protein: sequential interaction with BiP 
and calnexin. Science 266, 456-8 (1994). 
183. Stronge, V.S., Saito, Y., Ihara, Y. & Williams, D.B. Relationship between calnexin and 
BiP in suppressing aggregation and promoting refolding of protein and glycoprotein 
substrates. J Biol Chem 276, 39779-87 (2001). 
184. Zhang, J.X., Braakman, I., Matlack, K.E. & Helenius, A. Quality control in the secretory 
pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with 
C-terminal truncations. Mol Biol Cell 8, 1943-54 (1997). 
185. Molinari, M., Galli, C., Piccaluga, V., Pieren, M. & Paganetti, P. Sequential assistance of 
molecular chaperones and transient formation of covalent complexes during protein 
degradation from the ER. J Cell Biol 158, 247-57 (2002). 
186. Molinari, M., Galli, C., Vanoni, O., Arnold, S.M. & Kaufman, R.J. Persistent 
glycoprotein misfolding activates the glucosidase II/UGT1-driven calnexin cycle to delay 
aggregation and loss of folding competence. Mol Cell 20, 503-12 (2005). 
187. Svedine, S., Wang, T., Halaban, R. & Hebert, D.N. Carbohydrates act as sorting 
determinants in ER-associated degradation of tyrosinase. J Cell Sci 117, 2937-49 (2004). 
188. Le Fourn, V., Siffroi-Fernandez, S., Ferrand, M. & Franc, J.L. Competition between 
calnexin and BiP in the endoplasmic reticulum can lead to the folding or degradation of 
human thyroperoxidase. Biochemistry 45, 7380-8 (2006). 
189. Ushioda, R. et al. ERdj5 is required as a disulfide reductase for degradation of misfolded 
proteins in the ER. Science 321, 569-72 (2008). 
190. Plemper, R.K., Bohmler, S., Bordallo, J., Sommer, T. & Wolf, D.H. Mutant analysis links 
the translocon and BiP to retrograde protein transport for ER degradation. Nature 388, 
891-5 (1997). 
191. Pilon, M., Schekman, R. & Romisch, K. Sec61p mediates export of a misfolded secretory 
protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J 16, 4540-
8 (1997). 
192. Kalies, K.U., Allan, S., Sergeyenko, T., Kroger, H. & Romisch, K. The protein 
translocation channel binds proteasomes to the endoplasmic reticulum membrane. EMBO 
J 24, 2284-93 (2005). 
193. Kostova, Z., Tsai, Y.C. & Weissman, A.M. Ubiquitin ligases, critical mediators of 
endoplasmic reticulum-associated degradation. Semin Cell Dev Biol 18, 770-9 (2007). 
194. Okuda-Shimizu, Y. & Hendershot, L.M. Characterization of an ERAD pathway for 
nonglycosylated BiP substrates, which require Herp. Mol Cell 28, 544-54 (2007). 
195. Schulze, A. et al. The ubiquitin-domain protein HERP forms a complex with components 
of the endoplasmic reticulum associated degradation pathway. J Mol Biol 354, 1021-7 
(2005). 
196. Lilley, B.N. & Ploegh, H.L. A membrane protein required for dislocation of misfolded 
proteins from the ER. Nature 429, 834-40 (2004). 
 294 
197. Ye, Y., Shibata, Y., Yun, C., Ron, D. & Rapoport, T.A. A membrane protein complex 
mediates retro-translocation from the ER lumen into the cytosol. Nature 429, 841-7 
(2004). 
198. Carvalho, P., Goder, V. & Rapoport, T.A. Distinct ubiquitin-ligase complexes define 
convergent pathways for the degradation of ER proteins. Cell 126, 361-73 (2006). 
199. Travers, K.J. et al. Functional and genomic analyses reveal an essential coordination 
between the unfolded protein response and ER-associated degradation. Cell 101, 249-58 
(2000). 
200. Casagrande, R. et al. Degradation of proteins from the ER of S. cerevisiae requires an 
intact unfolded protein response pathway. Mol Cell 5, 729-35 (2000). 
201. Ng, D.T., Spear, E.D. & Walter, P. The unfolded protein response regulates multiple 
aspects of secretory and membrane protein biogenesis and endoplasmic reticulum quality 
control. J Cell Biol 150, 77-88 (2000). 
202. Friedlander, R., Jarosch, E., Urban, J., Volkwein, C. & Sommer, T. A regulatory link 
between ER-associated protein degradation and the unfolded-protein response. Nat Cell 
Biol 2, 379-84 (2000). 
203. Hollien, J. & Weissman, J.S. Decay of endoplasmic reticulum-localized mRNAs during 
the unfolded protein response. Science 313, 104-7 (2006). 
204. Mori, K. et al. A 22 bp cis-acting element is necessary and sufficient for the induction of 
the yeast KAR2 (BiP) gene by unfolded proteins. EMBO J 11, 2583-93 (1992). 
205. Kohno, K., Normington, K., Sambrook, J., Gething, M.J. & Mori, K. The promoter 
region of the yeast KAR2 (BiP) gene contains a regulatory domain that responds to the 
presence of unfolded proteins in the endoplasmic reticulum. Mol Cell Biol 13, 877-90 
(1993). 
206. Cox, J.S., Shamu, C.E. & Walter, P. Transcriptional induction of genes encoding 
endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell 
73, 1197-206 (1993). 
207. Mori, K., Ma, W., Gething, M.J. & Sambrook, J. A transmembrane protein with a 
cdc2+/CDC28-related kinase activity is required for signaling from the ER to the nucleus. 
Cell 74, 743-56 (1993). 
208. Cox, J.S. & Walter, P. A novel mechanism for regulating activity of a transcription factor 
that controls the unfolded protein response. Cell 87, 391-404 (1996). 
209. Nikawa, J., Akiyoshi, M., Hirata, S. & Fukuda, T. Saccharomyces cerevisiae IRE2/HAC1 
is involved in IRE1-mediated KAR2 expression. Nucleic Acids Res 24, 4222-6 (1996). 
210. Okamura, K., Kimata, Y., Higashio, H., Tsuru, A. & Kohno, K. Dissociation of 
Kar2p/BiP from an ER sensory molecule, Ire1p, triggers the unfolded protein response in 
yeast. Biochem Biophys Res Commun 279, 445-50 (2000). 
211. Shamu, C.E. & Walter, P. Oligomerization and phosphorylation of the Ire1p kinase 
during intracellular signaling from the endoplasmic reticulum to the nucleus. EMBO J 15, 
3028-39 (1996). 
212. Welihinda, A.A. & Kaufman, R.J. The unfolded protein response pathway in 
Saccharomyces cerevisiae. Oligomerization and trans-phosphorylation of Ire1p (Ern1p) 
are required for kinase activation. J Biol Chem 271, 18181-7 (1996). 
213. Zhou, J. et al. The crystal structure of human IRE1 luminal domain reveals a conserved 
dimerization interface required for activation of the unfolded protein response. Proc Natl 
Acad Sci U S A 103, 14343-8 (2006). 
 295 
214. Kimata, Y. et al. Genetic evidence for a role of BiP/Kar2 that regulates Ire1 in response 
to accumulation of unfolded proteins. Mol Biol Cell 14, 2559-69 (2003). 
215. Kimata, Y., Oikawa, D., Shimizu, Y., Ishiwata-Kimata, Y. & Kohno, K. A role for BiP as 
an adjustor for the endoplasmic reticulum stress-sensing protein Ire1. J Cell Biol 167, 
445-56 (2004). 
216. Credle, J.J., Finer-Moore, J.S., Papa, F.R., Stroud, R.M. & Walter, P. On the mechanism 
of sensing unfolded protein in the endoplasmic reticulum. Proc Natl Acad Sci U S A 102, 
18773-84 (2005). 
217. Oikawa, D., Kimata, Y. & Kohno, K. Self-association and BiP dissociation are not 
sufficient for activation of the ER stress sensor Ire1. J Cell Sci 120, 1681-8 (2007). 
218. Kimata, Y. et al. Two regulatory steps of ER-stress sensor Ire1 involving its cluster 
formation and interaction with unfolded proteins. J Cell Biol 179, 75-86 (2007). 
219. Sidrauski, C., Cox, J.S. & Walter, P. tRNA ligase is required for regulated mRNA 
splicing in the unfolded protein response. Cell 87, 405-13 (1996). 
220. Patil, C.K., Li, H. & Walter, P. Gcn4p and novel upstream activating sequences regulate 
targets of the unfolded protein response. PLoS Biol 2, E246 (2004). 
221. Aragon, T. et al. Messenger RNA targeting to endoplasmic reticulum stress signalling 
sites. Nature 457, 736-40 (2009). 
222. Korennykh, A.V. et al. The unfolded protein response signals through high-order 
assembly of Ire1. Nature 457, 687-93 (2009). 
223. Liu, C.Y. & Kaufman, R.J. The unfolded protein response. J Cell Sci 116, 1861-2 (2003). 
224. Wu, J. & Kaufman, R.J. From acute ER stress to physiological roles of the Unfolded 
Protein Response. Cell Death Differ 13, 374-84 (2006). 
225. Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein 
response. Nat Rev Mol Cell Biol 8, 519-29 (2007). 
226. Burdakov, D., Petersen, O.H. & Verkhratsky, A. Intraluminal calcium as a primary 
regulator of endoplasmic reticulum function. Cell Calcium 38, 303-10 (2005). 
227. Michalak, M., Robert Parker, J.M. & Opas, M. Ca2+ signaling and calcium binding 
chaperones of the endoplasmic reticulum. Cell Calcium 32, 269-78 (2002). 
228. Macer, D.R. & Koch, G.L. Identification of a set of calcium-binding proteins in 
reticuloplasm, the luminal content of the endoplasmic reticulum. J Cell Sci 91 ( Pt 1), 61-
70 (1988). 
229. Lievremont, J.P., Rizzuto, R., Hendershot, L. & Meldolesi, J. BiP, a major chaperone 
protein of the endoplasmic reticulum lumen, plays a direct and important role in the 
storage of the rapidly exchanging pool of Ca2+. J Biol Chem 272, 30873-9 (1997). 
230. Lytton, J., Westlin, M. & Hanley, M.R. Thapsigargin inhibits the sarcoplasmic or 
endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 266, 17067-71 
(1991). 
231. Brostrom, M.A. & Brostrom, C.O. Calcium dynamics and endoplasmic reticular function 
in the regulation of protein synthesis: implications for cell growth and adaptability. Cell 
Calcium 34, 345-63 (2003). 
232. Cai, J.W., Henderson, B.W., Shen, J.W. & Subjeck, J.R. Induction of glucose regulated 
proteins during growth of a murine tumor. J Cell Physiol 154, 229-37 (1993). 
233. Gazit, G., Kane, S.E., Nichols, P. & Lee, A.S. Use of the stress-inducible grp78/BiP 
promoter in targeting high level gene expression in fibrosarcoma in vivo. Cancer Res 55, 
1660-3 (1995). 
 296 
234. Rose, M.D. Nuclear fusion in the yeast Saccharomyces cerevisiae. Annu Rev Cell Dev 
Biol 12, 663-95 (1996). 
235. Conde, J. & Fink, G.R. A mutant of Saccharomyces cerevisiae defective for nuclear 
fusion. Proc Natl Acad Sci U S A 73, 3651-5 (1976). 
236. Rose, M.D. & Fink, G.R. KAR1, a gene required for function of both intranuclear and 
extranuclear microtubules in yeast. Cell 48, 1047-60 (1987). 
237. Ng, D.T. & Walter, P. ER membrane protein complex required for nuclear fusion. J Cell 
Biol 132, 499-509 (1996). 
238. Brizzio, V. et al. Genetic interactions between KAR7/SEC71, KAR8/JEM1, KAR5, and 
KAR2 during nuclear fusion in Saccharomyces cerevisiae. Mol Biol Cell 10, 609-26 
(1999). 
239. Quinones, Q.J., de Ridder, G.G. & Pizzo, S.V. GRP78: a chaperone with diverse roles 
beyond the endoplasmic reticulum. Histol Histopathol 23, 1409-16 (2008). 
240. Dudek, J. et al. Functions and pathologies of BiP and its interaction partners. Cell Mol 
Life Sci (2009). 
241. Paton, A.W. et al. AB5 subtilase cytotoxin inactivates the endoplasmic reticulum 
chaperone BiP. Nature 443, 548-52 (2006). 
242. Falguieres, T. & Johannes, L. Shiga toxin B-subunit binds to the chaperone BiP and the 
nucleolar protein B23. Biol Cell 98, 125-34 (2006). 
243. Triantafilou, K., Fradelizi, D., Wilson, K. & Triantafilou, M. GRP78, a coreceptor for 
coxsackievirus A9, interacts with major histocompatibility complex class I molecules 
which mediate virus internalization. J Virol 76, 633-43 (2002). 
244. Jindadamrongwech, S., Thepparit, C. & Smith, D.R. Identification of GRP 78 (BiP) as a 
liver cell expressed receptor element for dengue virus serotype 2. Arch Virol 149, 915-27 
(2004). 
245. Davila, S. et al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. 
Nat Genet 36, 575-7 (2004). 
246. Schulmann, K. et al. HNPCC-associated small bowel cancer: clinical and molecular 
characteristics. Gastroenterology 128, 590-9 (2005). 
247. Mori, Y. et al. Instabilotyping reveals unique mutational spectra in microsatellite-
unstable gastric cancers. Cancer Res 62, 3641-5 (2002). 
248. Annesi, G. et al. SIL1 and SARA2 mutations in Marinesco-Sjogren and chylomicron 
retention diseases. Clin Genet 71, 288-9 (2007). 
249. Jung, V. et al. Genomic and expression analysis of the 3q25-q26 amplification unit 
reveals TLOC1/SEC62 as a probable target gene in prostate cancer. Mol Cancer Res 4, 
169-76 (2006). 
250. Nogalska, A. et al. Homocysteine-induced endoplasmic reticulum protein (Herp) is up-
regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-
induced cultured human muscle fibers. J Neurochem 96, 1491-9 (2006). 
251. Sai, X. et al. Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-
mediated generation of amyloid beta-protein. J Biol Chem 277, 12915-20 (2002). 
252. Lee, A.S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer 
Res 67, 3496-9 (2007). 
253. Wang, M., Wey, S., Zhang, Y., Ye, R. & Lee, A.S. Role of the Unfolded Protein 
Response Regulator GRP78/BiP in Development, Cancer and Neurological Disorders. 
Antioxid Redox Signal (2009). 
 297 
254. Scheuner, D. & Kaufman, R.J. The unfolded protein response: a pathway that links 
insulin demand with beta-cell failure and diabetes. Endocr Rev 29, 317-33 (2008). 
255. Chung, K.T., Shen, Y. & Hendershot, L.M. BAP, a mammalian BiP-associated protein, is 
a nucleotide exchange factor that regulates the ATPase activity of BiP. J Biol Chem 277, 
47557-63 (2002). 
256. Zhang, L., Lai, E., Teodoro, T. & Volchuk, A. GRP78, but Not Protein-disulfide 
Isomerase, Partially Reverses Hyperglycemia-induced Inhibition of Insulin Synthesis and 
Secretion in Pancreatic {beta}-Cells. J Biol Chem 284, 5289-98 (2009). 
257. Paschen, W. & Mengesdorf, T. Endoplasmic reticulum stress response and 
neurodegeneration. Cell Calcium 38, 409-15 (2005). 
258. Matus, S. et al. The stress rheostat: an interplay between the unfolded protein response 
(UPR) and autophagy in neurodegeneration. Curr Mol Med 8, 157-72 (2008). 
259. Walsh, P., Bursac, D., Law, Y.C., Cyr, D. & Lithgow, T. The J-protein family: 
modulating protein assembly, disassembly and translocation. EMBO Rep 5, 567-71 
(2004). 
260. Werner-Washburne, M., Stone, D.E. & Craig, E.A. Complex interactions among 
members of an essential subfamily of hsp70 genes in Saccharomyces cerevisiae. Mol Cell 
Biol 7, 2568-77 (1987). 
261. Sahi, C. & Craig, E.A. Network of general and specialty J protein chaperones of the yeast 
cytosol. Proc Natl Acad Sci U S A 104, 7163-8 (2007). 
262. Sayeed, A. & Ng, D.T. Search and destroy: ER quality control and ER-associated protein 
degradation. Crit Rev Biochem Mol Biol 40, 75-91 (2005). 
263. Hebert, D.N. & Molinari, M. In and out of the ER: protein folding, quality control, 
degradation, and related human diseases. Physiol Rev 87, 1377-408 (2007). 
264. Anelli, T. & Sitia, R. Protein quality control in the early secretory pathway. EMBO J 27, 
315-27 (2008). 
265. Brodsky, J.L. The protective and destructive roles played by molecular chaperones during 
ERAD (endoplasmic-reticulum-associated degradation). Biochem J 404, 353-63 (2007). 
266. Bole, D.G., Hendershot, L.M. & Kearney, J.F. Posttranslational association of 
immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting 
and secreting hybridomas. J Cell Biol 102, 1558-66 (1986). 
267. Gething, M.J., McCammon, K. & Sambrook, J. Expression of wild-type and mutant 
forms of influenza hemagglutinin: the role of folding in intracellular transport. Cell 46, 
939-50 (1986). 
268. Vogel, J.P., Misra, L.M. & Rose, M.D. Loss of BiP/GRP78 function blocks translocation 
of secretory proteins in yeast. J Cell Biol 110, 1885-95 (1990). 
269. Nguyen, T.H., Law, D.T. & Williams, D.B. Binding protein BiP is required for 
translocation of secretory proteins into the endoplasmic reticulum in Saccharomyces 
cerevisiae. Proc Natl Acad Sci U S A 88, 1565-9 (1991). 
270. Holkeri, H., Paunola, E., Jamsa, E. & Makarow, M. Dissection of the translocation and 
chaperoning functions of yeast BiP/Kar2p in vivo. J Cell Sci 111 ( Pt 6), 749-57 (1998). 
271. Flynn, G.C., Chappell, T.G. & Rothman, J.E. Peptide binding and release by proteins 
implicated as catalysts of protein assembly. Science 245, 385-90 (1989). 
272. Melnick, J., Aviel, S. & Argon, Y. The endoplasmic reticulum stress protein GRP94, in 
addition to BiP, associates with unassembled immunoglobulin chains. J Biol Chem 267, 
21303-6 (1992). 
 298 
273. Kuznetsov, G., Chen, L.B. & Nigam, S.K. Multiple molecular chaperones complex with 
misfolded large oligomeric glycoproteins in the endoplasmic reticulum. J Biol Chem 272, 
3057-63 (1997). 
274. Skowronek, M.H., Hendershot, L.M. & Haas, I.G. The variable domain of nonassembled 
Ig light chains determines both their half-life and binding to the chaperone BiP. Proc Natl 
Acad Sci U S A 95, 1574-8 (1998). 
275. Lee, Y.K., Brewer, J.W., Hellman, R. & Hendershot, L.M. BiP and immunoglobulin light 
chain cooperate to control the folding of heavy chain and ensure the fidelity of 
immunoglobulin assembly. Mol Biol Cell 10, 2209-19 (1999). 
276. Hellman, R., Vanhove, M., Lejeune, A., Stevens, F.J. & Hendershot, L.M. The in vivo 
association of BiP with newly synthesized proteins is dependent on the rate and stability 
of folding and not simply on the presence of sequences that can bind to BiP. J Cell Biol 
144, 21-30 (1999). 
277. Mayer, M., Kies, U., Kammermeier, R. & Buchner, J. BiP and PDI cooperate in the 
oxidative folding of antibodies in vitro. J Biol Chem 275, 29421-5 (2000). 
278. Brodsky, J.L. et al. The requirement for molecular chaperones during endoplasmic 
reticulum-associated protein degradation demonstrates that protein export and import are 
mechanistically distinct. J Biol Chem 274, 3453-60 (1999). 
279. Lee, R.J. et al. Uncoupling retro-translocation and degradation in the ER-associated 
degradation of a soluble protein. EMBO J 23, 2206-15 (2004). 
280. Morris, J.A., Dorner, A.J., Edwards, C.A., Hendershot, L.M. & Kaufman, R.J. 
Immunoglobulin binding protein (BiP) function is required to protect cells from 
endoplasmic reticulum stress but is not required for the secretion of selective proteins. J 
Biol Chem 272, 4327-34 (1997). 
281. Cox, J.S., Chapman, R.E. & Walter, P. The unfolded protein response coordinates the 
production of endoplasmic reticulum protein and endoplasmic reticulum membrane. Mol 
Biol Cell 8, 1805-14 (1997). 
282. Umebayashi, K., Hirata, A., Horiuchi, H., Ohta, A. & Takagi, M. Unfolded protein 
response-induced BiP/Kar2p production protects cell growth against accumulation of 
misfolded protein aggregates in the yeast endoplasmic reticulum. Eur J Cell Biol 78, 726-
38 (1999). 
283. Bertolotti, A., Zhang, Y., Hendershot, L.M., Harding, H.P. & Ron, D. Dynamic 
interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell 
Biol 2, 326-32 (2000). 
284. Liu, C.Y., Wong, H.N., Schauerte, J.A. & Kaufman, R.J. The protein 
kinase/endoribonuclease IRE1alpha that signals the unfolded protein response has a 
luminal N-terminal ligand-independent dimerization domain. J Biol Chem 277, 18346-56 
(2002). 
285. Latterich, M. & Schekman, R. The karyogamy gene KAR2 and novel proteins are 
required for ER-membrane fusion. Cell 78, 87-98 (1994). 
286. Fourie, A.M., Sambrook, J.F. & Gething, M.J. Common and divergent peptide binding 
specificities of hsp70 molecular chaperones. J Biol Chem 269, 30470-8 (1994). 
287. Todd-Corlett, A., Jones, E., Seghers, C. & Gething, M.J. Lobe IB of the ATPase domain 
of Kar2p/BiP interacts with Ire1p to negatively regulate the unfolded protein response in 
Saccharomyces cerevisiae. J Mol Biol 367, 770-87 (2007). 
 299 
288. Kaiser, C., Michaelis, S., Mitchell, A. & Cold Spring Harbor Laboratory. Methods in 
yeast genetics : a Cold Spring Harbor Laboratory course manual (Cold Spring Harbor 
Laboratory Press, Cold Spring Harbor, NY, 1994). 
289. Mumberg, D., Muller, R. & Funk, M. Yeast vectors for the controlled expression of 
heterologous proteins in different genetic backgrounds. Gene 156, 119-22 (1995). 
290. Van Driessche, B., Tafforeau, L., Hentges, P., Carr, A.M. & Vandenhaute, J. Additional 
vectors for PCR-based gene tagging in Saccharomyces cerevisiae and 
Schizosaccharomyces pombe using nourseothricin resistance. Yeast 22, 1061-8 (2005). 
291. Wang, W. & Malcolm, B.A. Two-stage PCR protocol allowing introduction of multiple 
mutations, deletions and insertions using QuikChange Site-Directed Mutagenesis. 
Biotechniques 26, 680-2 (1999). 
292. Pierpaoli, E.V., Gisler, S.M. & Christen, P. Sequence-specific rates of interaction of 
target peptides with the molecular chaperones DnaK and DnaJ. Biochemistry 37, 16741-8 
(1998). 
293. Zhang, Y., Michaelis, S. & Brodsky, J.L. CFTR expression and ER-associated 
degradation in yeast. Methods Mol Med 70, 257-65 (2002). 
294. Stirling, C.J., Rothblatt, J., Hosobuchi, M., Deshaies, R. & Schekman, R. Protein 
translocation mutants defective in the insertion of integral membrane proteins into the 
endoplasmic reticulum. Mol Biol Cell 3, 129-42 (1992). 
295. Morrow, M.W. & Brodsky, J.L. Yeast ribosomes bind to highly purified reconstituted 
Sec61p complex and to mammalian p180. Traffic 2, 705-16 (2001). 
296. Kim, W., Spear, E.D. & Ng, D.T. Yos9p detects and targets misfolded glycoproteins for 
ER-associated degradation. Mol Cell 19, 753-64 (2005). 
297. Rose, M. & Botstein, D. Construction and use of gene fusions to lacZ (beta-
galactosidase) that are expressed in yeast. Methods Enzymol 101, 167-80 (1983). 
298. Hansen, W., Garcia, P.D. & Walter, P. In vitro protein translocation across the yeast 
endoplasmic reticulum: ATP-dependent posttranslational translocation of the prepro-
alpha-factor. Cell 45, 397-406 (1986). 
299. Nakatsukasa, K., Huyer, G., Michaelis, S. & Brodsky, J.L. Dissecting the ER-associated 
degradation of a misfolded polytopic membrane protein. Cell 132, 101-12 (2008). 
300. Bhamidipati, A., Denic, V., Quan, E.M. & Weissman, J.S. Exploration of the topological 
requirements of ERAD identifies Yos9p as a lectin sensor of misfolded glycoproteins in 
the ER lumen. Mol Cell 19, 741-51 (2005). 
301. Hrizo, S.L. et al. The Hsp110 molecular chaperone stabilizes apolipoprotein B from 
endoplasmic reticulum-associated degradation (ERAD). J Biol Chem 282, 32665-75 
(2007). 
302. Awad, W., Estrada, I., Shen, Y. & Hendershot, L.M. BiP mutants that are unable to 
interact with endoplasmic reticulum DnaJ proteins provide insights into interdomain 
interactions in BiP. Proc Natl Acad Sci U S A 105, 1164-9 (2008). 
303. Misselwitz, B., Staeck, O. & Rapoport, T.A. J proteins catalytically activate Hsp70 
molecules to trap a wide range of peptide sequences. Mol Cell 2, 593-603 (1998). 
304. West, R.W., Jr., Yocum, R.R. & Ptashne, M. Saccharomyces cerevisiae GAL1-GAL10 
divergent promoter region: location and function of the upstream activating sequence 
UASG. Mol Cell Biol 4, 2467-78 (1984). 
305. Julius, D., Schekman, R. & Thorner, J. Glycosylation and processing of prepro-alpha-
factor through the yeast secretory pathway. Cell 36, 309-18 (1984). 
 300 
306. Waters, M.G. & Blobel, G. Secretory protein translocation in a yeast cell-free system can 
occur posttranslationally and requires ATP hydrolysis. J Cell Biol 102, 1543-50 (1986). 
307. Rothblatt, J.A. & Meyer, D.I. Secretion in yeast: translocation and glycosylation of 
prepro-alpha-factor in vitro can occur via an ATP-dependent post-translational 
mechanism. EMBO J 5, 1031-6 (1986). 
308. Rothblatt, J.A. & Meyer, D.I. Secretion in yeast: reconstitution of the translocation and 
glycosylation of alpha-factor and invertase in a homologous cell-free system. Cell 44, 
619-28 (1986). 
309. Waters, M.G., Evans, E.A. & Blobel, G. Prepro-alpha-factor has a cleavable signal 
sequence. J Biol Chem 263, 6209-14 (1988). 
310. Caplan, S., Green, R., Rocco, J. & Kurjan, J. Glycosylation and structure of the yeast MF 
alpha 1 alpha-factor precursor is important for efficient transport through the secretory 
pathway. J Bacteriol 173, 627-35 (1991). 
311. Hasilik, A. & Tanner, W. Biosynthesis of the vacuolar yeast glycoprotein 
carboxypeptidase Y. Conversion of precursor into the enzyme. Eur J Biochem 85, 599-
608 (1978). 
312. Hemmings, B.A., Zubenko, G.S., Hasilik, A. & Jones, E.W. Mutant defective in 
processing of an enzyme located in the lysosome-like vacuole of Saccharomyces 
cerevisiae. Proc Natl Acad Sci U S A 78, 435-9 (1981). 
313. Stevens, T., Esmon, B. & Schekman, R. Early stages in the yeast secretory pathway are 
required for transport of carboxypeptidase Y to the vacuole. Cell 30, 439-48 (1982). 
314. Cyr, D.M., Langer, T. & Douglas, M.G. DnaJ-like proteins: molecular chaperones and 
specific regulators of Hsp70. Trends Biochem Sci 19, 176-81 (1994). 
315. Johnson, J.L. & Craig, E.A. An essential role for the substrate-binding region of Hsp40s 
in Saccharomyces cerevisiae. J Cell Biol 152, 851-6 (2001). 
316. Pelham, H.R., Hardwick, K.G. & Lewis, M.J. Sorting of soluble ER proteins in yeast. 
EMBO J 7, 1757-62 (1988). 
317. Hardwick, K.G., Lewis, M.J., Semenza, J., Dean, N. & Pelham, H.R. ERD1, a yeast gene 
required for the retention of luminal endoplasmic reticulum proteins, affects glycoprotein 
processing in the Golgi apparatus. EMBO J 9, 623-30 (1990). 
318. Oh, C.S., Toke, D.A., Mandala, S. & Martin, C.E. ELO2 and ELO3, homologues of the 
Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required 
for sphingolipid formation. J Biol Chem 272, 17376-84 (1997). 
319. Kobayashi, S.D. & Nagiec, M.M. Ceramide/long-chain base phosphate rheostat in 
Saccharomyces cerevisiae: regulation of ceramide synthesis by Elo3p and Cka2p. 
Eukaryot Cell 2, 284-94 (2003). 
320. Roberts, C.J., Pohlig, G., Rothman, J.H. & Stevens, T.H. Structure, biosynthesis, and 
localization of dipeptidyl aminopeptidase B, an integral membrane glycoprotein of the 
yeast vacuole. J Cell Biol 108, 1363-73 (1989). 
321. Klionsky, D.J. & Emr, S.D. Membrane protein sorting: biosynthesis, transport and 
processing of yeast vacuolar alkaline phosphatase. EMBO J 8, 2241-50 (1989). 
322. Hann, B.C., Stirling, C.J. & Walter, P. SEC65 gene product is a subunit of the yeast 
signal recognition particle required for its integrity. Nature 356, 532-3 (1992). 
323. Finke, K. et al. A second trimeric complex containing homologs of the Sec61p complex 
functions in protein transport across the ER membrane of S. cerevisiae. EMBO J 15, 
1482-94 (1996). 
 301 
324. Huyer, G. et al. Distinct machinery is required in Saccharomyces cerevisiae for the 
endoplasmic reticulum-associated degradation of a multispanning membrane protein and 
a soluble luminal protein. J Biol Chem 279, 38369-78 (2004). 
325. Zhang, Y. et al. Hsp70 molecular chaperone facilitates endoplasmic reticulum-associated 
protein degradation of cystic fibrosis transmembrane conductance regulator in yeast. Mol 
Biol Cell 12, 1303-14 (2001). 
326. Fewell, S.W., Pipas, J.M. & Brodsky, J.L. Mutagenesis of a functional chimeric gene in 
yeast identifies mutations in the simian virus 40 large T antigen J domain. Proc Natl 
Acad Sci U S A 99, 2002-7 (2002). 
327. Youker, R.T., Walsh, P., Beilharz, T., Lithgow, T. & Brodsky, J.L. Distinct roles for the 
Hsp40 and Hsp90 molecular chaperones during cystic fibrosis transmembrane 
conductance regulator degradation in yeast. Mol Biol Cell 15, 4787-97 (2004). 
328. Kang, C.M. & Jiang, Y.W. Genome-wide survey of non-essential genes required for 
slowed DNA synthesis-induced filamentous growth in yeast. Yeast 22, 79-90 (2005). 
329. Huh, W.K. et al. Global analysis of protein localization in budding yeast. Nature 425, 
686-91 (2003). 
330. Ng, D.T., Brown, J.D. & Walter, P. Signal sequences specify the targeting route to the 
endoplasmic reticulum membrane. J Cell Biol 134, 269-78 (1996). 
331. Hegde, R.S. & Bernstein, H.D. The surprising complexity of signal sequences. Trends 
Biochem Sci 31, 563-71 (2006). 
332. Haeuptle, M.T., Flint, N., Gough, N.M. & Dobberstein, B. A tripartite structure of the 
signals that determine protein insertion into the endoplasmic reticulum membrane. J Cell 
Biol 108, 1227-36 (1989). 
333. Schuldiner, M. et al. Exploration of the function and organization of the yeast early 
secretory pathway through an epistatic miniarray profile. Cell 123, 507-19 (2005). 
334. Schuldiner, M., Collins, S.R., Weissman, J.S. & Krogan, N.J. Quantitative genetic 
analysis in Saccharomyces cerevisiae using epistatic miniarray profiles (E-MAPs) and its 
application to chromatin functions. Methods 40, 344-52 (2006). 
335. Collins, S.R., Schuldiner, M., Krogan, N.J. & Weissman, J.S. A strategy for extracting 
and analyzing large-scale quantitative epistatic interaction data. Genome Biol 7, R63 
(2006). 
336. Krogan, N.J. et al. Global landscape of protein complexes in the yeast Saccharomyces 
cerevisiae. Nature 440, 637-43 (2006). 
337. Roguev, A., Wiren, M., Weissman, J.S. & Krogan, N.J. High-throughput genetic 
interaction mapping in the fission yeast Schizosaccharomyces pombe. Nat Methods 4, 
861-6 (2007). 
338. Collins, S.R. et al. Functional dissection of protein complexes involved in yeast 
chromosome biology using a genetic interaction map. Nature 446, 806-10 (2007). 
339. Collins, S.R. et al. Toward a comprehensive atlas of the physical interactome of 
Saccharomyces cerevisiae. Mol Cell Proteomics 6, 439-50 (2007). 
340. Typas, A. et al. High-throughput, quantitative analyses of genetic interactions in E. coli. 
Nat Methods 5, 781-7 (2008). 
341. Wilmes, G.M. et al. A genetic interaction map of RNA-processing factors reveals links 
between Sem1/Dss1-containing complexes and mRNA export and splicing. Mol Cell 32, 
735-46 (2008). 
 302 
342. Roguev, A. et al. Conservation and rewiring of functional modules revealed by an 
epistasis map in fission yeast. Science 322, 405-10 (2008). 
343. Typas, A. et al. High-throughput, quantitative analyses of genetic interactions in E. coli. 
Nat Methods 5, 781-787 (2008). 
344. Breslow, D.K. et al. A comprehensive strategy enabling high-resolution functional 
analysis of the yeast genome. Nat Methods 5, 711-8 (2008). 
345. Fiedler, D. et al. Functional organization of the S. cerevisiae phosphorylation network. 
Cell 136, 952-63 (2009). 
346. Young, J.C., Agashe, V.R., Siegers, K. & Hartl, F.U. Pathways of chaperone-mediated 
protein folding in the cytosol. Nat Rev Mol Cell Biol 5, 781-91 (2004). 
347. Liberek, K., Marszalek, J., Ang, D., Georgopoulos, C. & Zylicz, M. Escherichia coli 
DnaJ and GrpE heat shock proteins jointly stimulate ATPase activity of DnaK. Proc Natl 
Acad Sci U S A 88, 2874-8 (1991). 
348. Gassler, C.S. et al. Mutations in the DnaK chaperone affecting interaction with the DnaJ 
cochaperone. Proc Natl Acad Sci U S A 95, 15229-34 (1998). 
349. Gall, W.E. et al. The auxilin-like phosphoprotein Swa2p is required for clathrin function 
in yeast. Curr Biol 10, 1349-58 (2000). 
350. Cheetham, M.E. & Caplan, A.J. Structure, function and evolution of DnaJ: conservation 
and adaptation of chaperone function. Cell Stress Chaperones 3, 28-36 (1998). 
351. Caplan, A.J., Cyr, D.M. & Douglas, M.G. YDJ1p facilitates polypeptide translocation 
across different intracellular membranes by a conserved mechanism. Cell 71, 1143-55 
(1992). 
352. Lu, Z. & Cyr, D.M. The conserved carboxyl terminus and zinc finger-like domain of the 
co-chaperone Ydj1 assist Hsp70 in protein folding. J Biol Chem 273, 5970-8 (1998). 
353. Caplan, A.J., Tsai, J., Casey, P.J. & Douglas, M.G. Farnesylation of YDJ1p is required 
for function at elevated growth temperatures in Saccharomyces cerevisiae. J Biol Chem 
267, 18890-5 (1992). 
354. Wei, J. & Hendershot, L.M. Characterization of the nucleotide binding properties and 
ATPase activity of recombinant hamster BiP purified from bacteria. J Biol Chem 270, 
26670-6 (1995). 
355. Wright, C.M. et al. The Hsp40 molecular chaperone Ydj1p, along with the protein kinase 
C pathway, affects cell-wall integrity in the yeast Saccharomyces cerevisiae. Genetics 
175, 1649-64 (2007). 
356. Ito, H., Fukuda, Y., Murata, K. & Kimura, A. Transformation of intact yeast cells treated 
with alkali cations. J Bacteriol 153, 163-8 (1983). 
357. Coughlan, C.M., Walker, J.L., Cochran, J.C., Wittrup, K.D. & Brodsky, J.L. Degradation 
of mutated bovine pancreatic trypsin inhibitor in the yeast vacuole suggests post-
endoplasmic reticulum protein quality control. J Biol Chem 279, 15289-97 (2004). 
358. Christianson, T.W., Sikorski, R.S., Dante, M., Shero, J.H. & Hieter, P. Multifunctional 
yeast high-copy-number shuttle vectors. Gene 110, 119-22 (1992). 
359. Lorenz, M.C. et al. Gene disruption with PCR products in Saccharomyces cerevisiae. 
Gene 158, 113-7 (1995). 
360. Becker, J., Walter, W., Yan, W. & Craig, E.A. Functional interaction of cytosolic hsp70 
and a DnaJ-related protein, Ydj1p, in protein translocation in vivo. Mol Cell Biol 16, 
4378-86 (1996). 
 303 
361. Oka, M. et al. Loss of Hsp70-Hsp40 chaperone activity causes abnormal nuclear 
distribution and aberrant microtubule formation in M-phase of Saccharomyces cerevisiae. 
J Biol Chem 273, 29727-37 (1998). 
362. Kushnirov, V.V., Kryndushkin, D.S., Boguta, M., Smirnov, V.N. & Ter-Avanesyan, 
M.D. Chaperones that cure yeast artificial [PSI+] and their prion-specific effects. Curr 
Biol 10, 1443-6 (2000). 
363. Park, S.H. et al. The cytoplasmic Hsp70 chaperone machinery subjects misfolded and 
endoplasmic reticulum import-incompetent proteins to degradation via the ubiquitin-
proteasome system. Mol Biol Cell 18, 153-65 (2007). 
364. Metzger, M.B., Maurer, M.J., Dancy, B.M. & Michaelis, S. Degradation of a cytosolic 
protein requires endoplasmic reticulum-associated degradation machinery. J Biol Chem 
283, 32302-16 (2008). 
365. Lu, Z. & Cyr, D.M. Protein folding activity of Hsp70 is modified differentially by the 
hsp40 co-chaperones Sis1 and Ydj1. J Biol Chem 273, 27824-30 (1998). 
366. Tsai, J. & Douglas, M.G. A conserved HPD sequence of the J-domain is necessary for 
YDJ1 stimulation of Hsp70 ATPase activity at a site distinct from substrate binding. J 
Biol Chem 271, 9347-54 (1996). 
367. Lesage, G. & Bussey, H. Cell wall assembly in Saccharomyces cerevisiae. Microbiol Mol 
Biol Rev 70, 317-43 (2006). 
368. Fliss, A.E., Rao, J., Melville, M.W., Cheetham, M.E. & Caplan, A.J. Domain 
requirements of DnaJ-like (Hsp40) molecular chaperones in the activation of a steroid 
hormone receptor. J Biol Chem 274, 34045-52 (1999). 
369. Nelson, R.J., Ziegelhoffer, T., Nicolet, C., Werner-Washburne, M. & Craig, E.A. The 
translation machinery and 70 kd heat shock protein cooperate in protein synthesis. Cell 
71, 97-105 (1992). 
370. Shaner, L., Gibney, P.A. & Morano, K.A. The Hsp110 protein chaperone Sse1 is required 
for yeast cell wall integrity and morphogenesis. Curr Genet 54, 1-11 (2008). 
371. Yang, X.X. et al. The molecular chaperone Hsp90 is required for high osmotic stress 
response in Saccharomyces cerevisiae. FEMS Yeast Res 6, 195-204 (2006). 
372. Cintron, N.S. & Toft, D. Defining the requirements for Hsp40 and Hsp70 in the Hsp90 
chaperone pathway. J Biol Chem 281, 26235-44 (2006). 
373. Caplan, A.J., Langley, E., Wilson, E.M. & Vidal, J. Hormone-dependent transactivation 
by the human androgen receptor is regulated by a dnaJ protein. J Biol Chem 270, 5251-7 
(1995). 
374. Luke, M.M., Sutton, A. & Arndt, K.T. Characterization of SIS1, a Saccharomyces 
cerevisiae homologue of bacterial dnaJ proteins. J Cell Biol 114, 623-38 (1991). 
375. Pesce, E.R. et al. The Plasmodium falciparum heat shock protein 40, Pfj4, associates with 
heat shock protein 70 and shows similar heat induction and localisation patterns. Int J 
Biochem Cell Biol 40, 2914-26 (2008). 
376. Nicoll, W.S. et al. Cytosolic and ER J-domains of mammalian and parasitic origin can 
functionally interact with DnaK. Int J Biochem Cell Biol 39, 736-51 (2007). 
377. Botha, M., Pesce, E.R. & Blatch, G.L. The Hsp40 proteins of Plasmodium falciparum 
and other apicomplexa: regulating chaperone power in the parasite and the host. Int J 
Biochem Cell Biol 39, 1781-803 (2007). 
378. Burkholder, W.F. et al. Mutations in the C-terminal fragment of DnaK affecting peptide 
binding. Proc Natl Acad Sci U S A 93, 10632-7 (1996). 
 304 
379. Gragerov, A., Zeng, L., Zhao, X., Burkholder, W. & Gottesman, M.E. Specificity of 
DnaK-peptide binding. J Mol Biol 235, 848-54 (1994). 
380. Yan, Z. et al. Yeast Barcoders: a chemogenomic application of a universal donor-strain 
collection carrying bar-code identifiers. Nat Methods 5, 719-25 (2008). 
381. Winzeler, E.A. et al. Functional characterization of the S. cerevisiae genome by gene 
deletion and parallel analysis. Science 285, 901-6 (1999). 
382. Giaever, G. et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 
418, 387-91 (2002). 
383. Semenza, J.C., Hardwick, K.G., Dean, N. & Pelham, H.R. ERD2, a yeast gene required 
for the receptor-mediated retrieval of luminal ER proteins from the secretory pathway. 
Cell 61, 1349-57 (1990). 
384. Kalies, K.U., Rapoport, T.A. & Hartmann, E. The beta subunit of the Sec61 complex 
facilitates cotranslational protein transport and interacts with the signal peptidase during 
translocation. J Cell Biol 141, 887-94 (1998). 
385. Chavan, M., Yan, A. & Lennarz, W.J. Subunits of the translocon interact with 
components of the oligosaccharyl transferase complex. J Biol Chem 280, 22917-24 
(2005). 
386. Helmers, J., Schmidt, D., Glavy, J.S., Blobel, G. & Schwartz, T. The beta-subunit of the 
protein-conducting channel of the endoplasmic reticulum functions as the guanine 
nucleotide exchange factor for the beta-subunit of the signal recognition particle receptor. 
J Biol Chem 278, 23686-90 (2003). 
387. Toikkanen, J.H., Miller, K.J., Soderlund, H., Jantti, J. & Keranen, S. The beta subunit of 
the Sec61p endoplasmic reticulum translocon interacts with the exocyst complex in 
Saccharomyces cerevisiae. J Biol Chem 278, 20946-53 (2003). 
388. Lipschutz, J.H., Lingappa, V.R. & Mostov, K.E. The exocyst affects protein synthesis by 
acting on the translocation machinery of the endoplasmic reticulum. J Biol Chem 278, 
20954-60 (2003). 
389. Lipschutz, J.H. & Mostov, K.E. Exocytosis: the many masters of the exocyst. Curr Biol 
12, R212-4 (2002). 
390. Leroux, A. & Rokeach, L.A. Inter-species complementation of the translocon beta 
subunit requires only its transmembrane domain. PLoS ONE 3, e3880 (2008). 
391. De Craene, J.O. et al. Rtn1p is involved in structuring the cortical endoplasmic reticulum. 
Mol Biol Cell 17, 3009-20 (2006). 
392. Gavin, A.C. et al. Functional organization of the yeast proteome by systematic analysis of 
protein complexes. Nature 415, 141-7 (2002). 
393. Gavin, A.C. et al. Proteome survey reveals modularity of the yeast cell machinery. 
Nature 440, 631-6 (2006). 
394. Newman, J.R. et al. Single-cell proteomic analysis of S. cerevisiae reveals the 
architecture of biological noise. Nature 441, 840-6 (2006). 
395. Biederer, T., Volkwein, C. & Sommer, T. Degradation of subunits of the Sec61p 
complex, an integral component of the ER membrane, by the ubiquitin-proteasome 
pathway. EMBO Journal 15, 2069–2076 (1996). 
396. Hampton, R.Y., Gardner, R.G. & Rine, J. Role of 26S proteasome and HRD genes in the 
degradation of 3-hydroxy-3- methylglutaryl-CoA reductase, an integral endoplasmic 
reticulum membrane protein Molecular Biology of the Cell 7, 2029-2044 (1996). 
 305 
397. Schuldiner, M. et al. The GET complex mediates insertion of tail-anchored proteins into 
the ER membrane. Cell 134, 634-45 (2008). 
398. Weerapana, E. & Imperiali, B. Asparagine-linked protein glycosylation: from eukaryotic 
to prokaryotic systems. Glycobiology 16, 91R-101R (2006). 
399. Lewis, M.J. & Pelham, H.R. SNARE-mediated retrograde traffic from the Golgi complex 
to the endoplasmic reticulum. Cell 85, 205-15 (1996). 
400. Lewis, M.J., Rayner, J.C. & Pelham, H.R. A novel SNARE complex implicated in 
vesicle fusion with the endoplasmic reticulum. EMBO J 16, 3017-24 (1997). 
401. te Heesen, S. & Aebi, M. The genetic interaction of kar2 and wbp1 mutations. Distinct 
functions of binding protein BiP and N-linked glycosylation in the processing pathway of 
secreted proteins in Saccharomyces cerevisiae. Eur J Biochem 222, 631-7 (1994). 
402. Mitra, N., Sinha, S., Ramya, T.N. & Surolia, A. N-linked oligosaccharides as outfitters 
for glycoprotein folding, form and function. Trends Biochem Sci 31, 156-63 (2006). 
403. Liberek, K., Skowyra, D., Zylicz, M., Johnson, C. & Georgopoulos, C. The Escherichia 
coli DnaK chaperone, the 70-kDa heat shock protein eukaryotic equivalent, changes 
conformation upon ATP hydrolysis, thus triggering its dissociation from a bound target 
protein. J Biol Chem 266, 14491-6 (1991). 
404. Banecki, B., Zylicz, M., Bertoli, E. & Tanfani, F. Structural and functional relationships 
in DnaK and DnaK756 heat-shock proteins from Escherichia coli. J Biol Chem 267, 
25051-8 (1992). 
405. Buchberger, A. et al. Nucleotide-induced conformational changes in the ATPase and 
substrate binding domains of the DnaK chaperone provide evidence for interdomain 
communication. J Biol Chem 270, 16903-10 (1995). 
406. Fung, K.L., Hilgenberg, L., Wang, N.M. & Chirico, W.J. Conformations of the 
nucleotide and polypeptide binding domains of a cytosolic Hsp70 molecular chaperone 
are coupled. J Biol Chem 271, 21559-65 (1996). 
407. Kim, D., Lee, Y.J. & Corry, P.M. Constitutive HSP70: oligomerization and its 
dependence on ATP binding. J Cell Physiol 153, 353-61 (1992). 
408. Heuser, J. & Steer, C.J. Trimeric binding of the 70-kD uncoating ATPase to the vertices 
of clathrin triskelia: a candidate intermediate in the vesicle uncoating reaction. J Cell Biol 
109, 1457-66 (1989). 
409. Freiden, P.J., Gaut, J.R. & Hendershot, L.M. Interconversion of three differentially 
modified and assembled forms of BiP. EMBO J 11, 63-70 (1992). 
410. Palleros, D.R., Reid, K.L., Shi, L. & Fink, A.L. DnaK ATPase activity revisited. FEBS 
Lett 336, 124-8 (1993). 
411. Carlino, A. et al. Interactions of liver Grp78 and Escherichia coli recombinant Grp78 
with ATP: multiple species and disaggregation. Proc Natl Acad Sci U S A 89, 2081-5 
(1992). 
412. Blond-Elguindi, S., Fourie, A.M., Sambrook, J.F. & Gething, M.J. Peptide-dependent 
stimulation of the ATPase activity of the molecular chaperone BiP is the result of 
conversion of oligomers to active monomers. J Biol Chem 268, 12730-5 (1993). 
413. Brown, C.R., Martin, R.L., Hansen, W.J., Beckmann, R.P. & Welch, W.J. The 
constitutive and stress inducible forms of hsp 70 exhibit functional similarities and 
interact with one another in an ATP-dependent fashion. J Cell Biol 120, 1101-12 (1993). 
414. Anderson, J.V., Haskell, D.W. & Guy, C.L. Differential influence of ATP on native 
spinach 70-kilodalton heat-shock cognates. Plant Physiol 104, 1371-80 (1994). 
 306 
415. Schonfeld, H.J., Schmidt, D., Schroder, H. & Bukau, B. The DnaK chaperone system of 
Escherichia coli: quaternary structures and interactions of the DnaK and GrpE 
components. J Biol Chem 270, 2183-9 (1995). 
416. Bhattacharyya, T. et al. Cloning and subcellular localization of human mitochondrial 
hsp70. J Biol Chem 270, 1705-10 (1995). 
417. Benaroudj, N., Batelier, G., Triniolles, F. & Ladjimi, M.M. Self-association of the 
molecular chaperone HSC70. Biochemistry 34, 15282-90 (1995). 
418. Geerlof, A. et al. The impact of protein characterization in structural proteomics. Acta 
Crystallogr D Biol Crystallogr 62, 1125-36 (2006). 
 
 
